{
  "meta": {
    "title": "Ini-Cet_Grand_Test_1",
    "url": "https://brainandscalpel.vercel.app/ini-cet-grand-test-1-e822960f.html",
    "scrapedAt": "2025-11-30T12:54:38.868Z"
  },
  "questions": [
    {
      "text": "Which of the following can transport a substance against its concentration gradient?<div class='question-desc-html'><ol>\n<li>Simple diffusion</li>\n<li>Secondary active counter-transport</li>\n<li>Secondary active co-transport</li>\n<li>Primary active transport</li>\n<li>Facilitated diffusion</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 & 5"
        },
        {
          "id": 2,
          "text": "2, 4, & 5"
        },
        {
          "id": 3,
          "text": "2, 3, & 4"
        },
        {
          "id": 4,
          "text": "3, 4, & 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Secondary active counter-transport, secondary active co-transport, and primary active transport can transport a substance against its concentration gradient.</p>\n<p><strong>Simple</strong>&nbsp;<strong>diffusion&nbsp;</strong>refers to the process of random movement of a <strong>substance along its concentration gradient.</strong></p>\n<p><strong>Facilitated diffusion:</strong>&nbsp;Transporting the molecule from one side of the cell membrane to the other is done with the help of transport proteins called <strong>carriers</strong>.&nbsp;Molecules move from areas of high concentration to areas of low concentration. <strong>No energy</strong> input is required when carrier proteins move substances in the direction of their gradients. <strong>Glucose transport</strong> by the glucose transporter is an example, which moves glucose down its concentration gradient from the ECF to the cytoplasm of the cell.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f0941e4fba2d41b1b3d7366a52269fe3x1280x1057.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Transporting <strong>more than one substance together&nbsp;</strong>using a single transport protein against the gradient is known as <strong>secondary active transport</strong>.&nbsp;An example of one such protein is <strong>SGLT 1</strong>,&nbsp;the cotransporter of <strong>sodium</strong> and <strong>glucose</strong> from the intestinal lumen into mucosal cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1e39cd526e184e4fbe13680c4237ad48x1280x1135.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Active transport </strong>is&nbsp;the transporting of substances <strong>against</strong> the gradient and requires energy. Ca<sup>2+</sup>-ATPase that pumps out <strong>calcium</strong> out of the cells is an example.</p><hr><h3>Related Pearl: Characteristics of different types of transport</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Simple diffusion</strong></td>\n<td><strong>Facilitated diffusion</strong></td>\n<td><strong>Primary active transport</strong></td>\n<td>Secondary active transport <strong>Cotransport</strong></td>\n<td>Secondary active transport <strong>Countertransport</strong></td>\n</tr>\n<tr>\n<td>Electrochemical gradient</td>\n<td>Downhill</td>\n<td>Downhill</td>\n<td>Uphill</td>\n<td>Uphill</td>\n<td>Uphill</td>\n</tr>\n<tr>\n<td>Carrier mediated</td>\n<td>No</td>\n<td>Yes</td>\n<td>Yes</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Metabolic energy</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n<td>Indirect</td>\n<td>Indirect</td>\n</tr>\n<tr>\n<td>Na<sup>+</sup> gradient</td>\n<td>No</td>\n<td>No</td>\n<td>--</td>\n<td>Yes (same direction)</td>\n<td>Yes (opposite direction)</td>\n</tr>\n<tr>\n<td>\n<p>Inhibits Na<sup>+</sup>-K<sup>+</sup> pump</p>\n&nbsp;</td>\n<td>--</td>\n<td>--</td>\n<td>Inhibits</td>\n<td>Inhibits</td>\n<td>&nbsp;Inhibits</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Glucose Transporters</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Function</strong></p>\n</td>\n<td>\n<p><strong>Major sites of expression</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Secondary active transport</strong></p>\n<p><strong>(Na </strong><strong><sup>+</sup></strong> <strong>-glucose cotransport)</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>SGLT 1</p>\n</td>\n<td>\n<p>Absorption of glucose</p>\n</td>\n<td>\n<p>Small intestine, renal tubules</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>SGLT 2</p>\n</td>\n<td>\n<p>Absorption of glucose</p>\n</td>\n<td>\n<p>Renal tubules</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Facilitated diffusion</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 1</p>\n</td>\n<td>\n<p>Basal glucose uptake</p>\n</td>\n<td>\n<p>Placenta, blood-brain barrier, brain, red cells, kidneys, colon, many other organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 2</p>\n</td>\n<td>\n<p>&beta;-cell glucose sensor; transport out of intestinal and renal epithelial cells</p>\n</td>\n<td>\n<p>&beta; cells of islets, liver, epithelial cells of small intestine, kidneys</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 3</p>\n</td>\n<td>\n<p>Basal glucose uptake</p>\n</td>\n<td>\n<p>Brain, placenta, kidneys, many other organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 4</p>\n</td>\n<td>\n<p>Insulin-stimulated glucose uptake</p>\n</td>\n<td>\n<p>Skeletal and cardiac muscle, adipose tissue, other tissues</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 5</p>\n</td>\n<td>\n<p>Fructose transport</p>\n</td>\n<td>\n<p>Jejunum, sperm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GLUT 6</p>\n</td>\n<td>Function not known</td>\n<td>Brain, spleen, leucocytes</td>\n</tr>\n<tr>\n<td>GLUT 7</td>\n<td>Glucose-6-phosphate transporter in the endoplasmic reticulum</td>\n<td>Liver</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5551",
      "difficulty": "easy"
    },
    {
      "text": "A lesion at the site marked by the red arrow would result in",
      "choices": [
        {
          "id": 1,
          "text": "Unilateral blindness"
        },
        {
          "id": 2,
          "text": "Homonymous hemianopia"
        },
        {
          "id": 3,
          "text": "Bitemporal hemianopia"
        },
        {
          "id": 4,
          "text": "Binasal hemianopia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A lesion at the&nbsp;<strong>occipital lobe&nbsp;</strong>would&nbsp;result in <strong>homonymous hemianopia</strong> with macular sparing.</p>\n<p><strong>Homonymous</strong> <strong>hemianopia (HH)</strong> involves loss of vision on the same side of the visual field in both eyes. HH is characteristically seen in lesions involving the visual pathway <strong>posterior to the optic chiasma.</strong></p>\n<p>HH<strong>&nbsp;</strong>may be either complete or incomplete.&nbsp;</p>\n<ul>\n<li>A <strong>complete HH</strong> is characterized by loss of entire hemifield on the same side in both eyes.</li>\n<li>An <strong>incomplete HH</strong> is characterized by partial loss of visual field on the same side in both eyes. Incomplete HH is further classified as <strong>congruous</strong> or <strong>incongruous,</strong> depending on whether the extent of partial loss of visual field in both the eyes is same or different, respectively.</li>\n</ul>\n<p>Lesions involving the occipital lobe usually shows macular sparing because macular representation is seperate and quite large as compared to peripheral vision. Moreover, the macular area in the occipital lobe is supplied by&nbsp;both the posterior and middle cerebral arteries. In case of vascular lesions (e.g. stroke) affecting the occipital lobe, it is less likely that both these arteries are involved.</p><hr><h3>Related Pearl: Lesions in the optic pathway</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/99e36d0f854b491da018065066ccac41x1280x2202.PNG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5e6706752b2243f395c0320ea0a3ef7cx1280x1910.JPEG\" alt=\"Pearl Image\"><p><strong>Transection</strong> of the <strong>pathways</strong> at the locations indicated by the letters causes the visual field defects shown in the diagram above.</p>\n<ul>\n<li>The fibers from the nasal half of each retina decussate in the optic chiasm, so that the fibers in the optic tracts are those from the temporal half of one retina and the nasal half of the other.</li>\n<li>A <strong>lesion</strong> that interrupts<strong>&nbsp;the</strong>&nbsp;<strong>optic nerve</strong> causes <strong>blindness</strong> in <strong>that eye</strong>.</li>\n<li><strong>Lesions</strong> affecting the <strong>optic chiasma</strong> destroy fibers from both nasal hemiretinas and produce a <strong>heteronymous</strong> (opposite sides of the visual fields) <strong>hemianopia.</strong></li>\n<li>A <strong>lesion</strong> in <strong>one optic tract</strong> causes blindness in half of the visual field and is called <strong>homonymous</strong> (same side of both visual fields)&nbsp;<strong>hemianopia (half-blindness).</strong></li>\n<li><strong>Occipital lesions</strong> may <strong>spare</strong> the fibers from the <strong>macula</strong>&nbsp;because of the separation in the brain of these fibers from the other subserving vision.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/2364cc2e97234e0fb348e4774b7d4d20.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5539",
      "difficulty": "easy"
    },
    {
      "text": "Perivascular cellular infiltrates, edema, granuloma formation, and cell destruction are characteristic histopathological features associated with which type of hypersensitivity reaction?",
      "choices": [
        {
          "id": 1,
          "text": "Type III"
        },
        {
          "id": 2,
          "text": "Type IV"
        },
        {
          "id": 3,
          "text": "Type I"
        },
        {
          "id": 4,
          "text": "Type II"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Perivascular cellular infiltrates,</strong> edema, <strong>granuloma formation</strong>, and <strong>cell destruction are</strong> characteristic histopathological features associated with <strong>type IV hypersensitivity reaction.</strong></p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Mechanisms of Hypersensitivity Reactions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Immune Mechanisms</strong></p>\n</td>\n<td>\n<p><strong>Histopathological lesions</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immediate </strong><br /><strong>&nbsp;hypersensitivity<br />(type I)<br /></strong></p>\n<ul>\n<li>Anaphylaxis</li>\n<li>Allergies</li>\n<li>Bronchial asthma</li>\n<li>Atopic dermatitis</li>\n</ul>\n</td>\n<td>\n<p>Production of IgE antibody &rarr;immediate release of vasoactive amines from mast cells</p>\n</td>\n<td>\n<p>Vascular dilatation, edema, smooth muscle contraction, mucus production, tissue injury, inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Antibody-mediated hypersensitivity<br />(type II)<br /></strong></p>\n<ul>\n<li>Autoimmune hemolytic anemia</li>\n<li>Goodpasture syndrome</li>\n</ul>\n</td>\n<td>\n<p>Production of IgG, IgM &rarr; binds to antigen on target cell or tissue &rarr; phagocytosis or lysis of target cell by activated complement or Fc receptors; recruitment of leukocytes</p>\n</td>\n<td>\n<p>Phagocytosis and lysis of cells; inflammation;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immune complex-mediated hypersensitivity<br /> (type III)<br /></strong></p>\n<ul>\n<li>SLE</li>\n<li>Serum sickness</li>\n<li>Arthus reaction</li>\n</ul>\n</td>\n<td>\n<p>Deposition of antigen-antibody complexes &rarr; complement activation &rarr;recruitment of leukocytes by complement products and Fc receptors &rarr; release of enzymes and other toxic molecules</p>\n</td>\n<td>\n<p>Inflammation, necrotizing vasculitis (fibrinoid necrosis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-mediated hypersensitivity<br />(type IV)</strong></p>\n<ul>\n<li>Contact dermatitis</li>\n<li>Multiple sclerosis</li>\n<li>Type 1 diabetes</li>\n<li>Tuberculosis</li>\n</ul>\n</td>\n<td>\n<p>Activated T lymphocytes &rarr;</p>\n<p>1. Release of cytokines, inflammation, and macrophage activation</p>\n<p>2. T-cell-mediated cytotoxicity</p>\n</td>\n<td>\n<p>Perivascular cellular infiltrates; edema; granuloma formation; cell destruction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f55cab6c8fd44a7abfe8a663dde3980ex1280x2567.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2a98b94d6a9479b8e6e885ee59366cex1280x2089.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d92e092ef5874477a6da091ca3b1234ax1280x1360.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/56fc1dfb49434818b5057534a97d6621x1280x4218.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Examples of Type IV Hypersensitivity</h3><p>Type IV Hypersensitivity Reactions&nbsp;</p>\n<ul>\n<li>Tuberculin reaction</li>\n<li>Lepromin test</li>\n<li>Multiple sclerosis</li>\n<li>Chronic graft rejection</li>\n<li>Contact dermatitis</li>\n<li>Sarcoidosis</li>\n<li>Primary biliary cirrhosis</li>\n<li>Type I lepra reaction</li>\n<li>Crohn&rsquo;s disease</li>\n<li>Psoriasis</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f2bf7fce299546679d2c2cac15eca714x1280x4218.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5516",
      "difficulty": "easy"
    },
    {
      "text": "As part of a pretransplant workup, a 59-year-old man with a previous history of MI undergoes cardiac catheterization to determine his cardiac fitness. During estimation of his systolic function, in what phase of the cardiac cycle do expect to see his peak left ventricular pressure?",
      "choices": [
        {
          "id": 1,
          "text": "Isovolumetric relaxation"
        },
        {
          "id": 2,
          "text": "Rapid filling"
        },
        {
          "id": 3,
          "text": "Isovolumetric contraction"
        },
        {
          "id": 4,
          "text": "Ventricular ejection"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Peak ventricular pressure</strong> occurs during <strong>ventricular ejection</strong></p>\n<p>As is clear from <strong>Wigger's diagram</strong> below, peak pressure in the ventricles in systole corresponds to the <strong>ejection phase. </strong></p>\n<p>Isovolumetric contraction occurs when the pressure of the left ventricle goes from the pressure level of the left atrium to that of the aorta, following which the aortic valves open. Isovolumentric relaxation occurs during the reverse process, while the left ventricle's pressure falls.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7c11ba5e94b749528b9e51f2fefad15ex783x600.PNG\" alt=\"Explanation Image\"><p><strong>The Cardiac Cycle:</strong></p>\n<p><strong>Diastole </strong></p>\n<ul>\n<li><strong>Protodiastole</strong><br />Before the semilunar valve closes, even though ventricular muscle is relaxed, blood flow into great vessels is due to the momentum of blood.</li>\n<li><strong>Iso-volumetric Relaxation</strong><br />The ventricular muscle continues to relax, even though the ventricular volume does not change, with all valves closed.</li>\n<li><strong>Ventricular Filling<br /></strong>Isovolumetric relaxation ends when the ventricular pressure falls below the atrial pressure and the AV valves open, permitting the ventricles to fill.</li>\n<li><strong>Atrial Systole<br /></strong>During the last third of diastole, the atria contract and give additional thrust to the inflow of blood into the ventricles. It correlates with the 'a' wave in JVP.</li>\n</ul>\n<p><strong>Systole </strong></p>\n<ul>\n<li><strong>Isovolumetric Contraction<br /></strong>The ventricular muscle continues to contract, even though the ventricular volume does not change, with all valves closed. <strong><br /></strong>It correlates with the ‘c’ wave of JVP.</li>\n<li><strong>Ventricular Ejection<br /></strong>When the ventricular pressures rise above aortic and pulmonary pressures the valves open, and ventricular ejection begins. <strong>Peak pressures</strong> in the left and right ventricles are about <strong>120</strong> and 25 mmHg, respectively. </li>\n</ul><hr><h3>Related Pearl: JVP waveform and the abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bbe4a977c84587903e8637a0d9303cx1280x1005.JPEG\" alt=\"Pearl Image\"><p>1) The <strong>a-wave</strong> corresponds to <strong>atrial contraction</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prominent a-waves</strong></td>\n<td>Pulmonary hypertension, right atrial thrombus/ mass, and tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Cannon a-waves</strong></td>\n<td>\n<p>Complete AV block, ventricular tachycardia, and premature atrial/ junctional/ ventricular beats</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent a-waves</strong></td>\n<td>Atrial fibrillation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>2) The <strong>c-wave</strong> corresponds to the <strong>bulging of tricuspid valve</strong> into right atrium during ventricular contraction.</p>\n<p>&nbsp;</p>\n<p>3) The <strong>x-descent</strong> corresponds to <strong>atrial relaxation</strong> during atrial diastole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Absent x-descent</strong></td>\n<td>Severe tricuspid regurgitation</td>\n</tr>\n<tr>\n<td><strong>Rapid x-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>4) The <strong>v-wave</strong> corresponds to the <strong>venous filling</strong> of right atrium.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Dominant v-waves</strong></td>\n<td>Tricuspid regurgitation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>5) The <strong>y-descent</strong> corresponds to the&nbsp;<strong>passive emptying of the right atrium</strong> into right ventricle.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prolonged y-descent</strong></td>\n<td>Tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Rapid y-descent</strong></td>\n<td>\n<p>Constrictive pericarditis and isolated severe tricuspid regurgitation</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent y-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Heart sounds</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Heart Sound</strong></p>\n</td>\n<td>\n<p><strong>Frequency</strong></p>\n</td>\n<td>\n<p><strong>Duration</strong></p>\n</td>\n<td>\n<p><strong>Associated Event</strong></p>\n</td>\n<td>\n<p><strong>ECG Correlation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S1</p>\n</td>\n<td>\n<p>25-45 Hz</p>\n</td>\n<td>\n<p>0.15 sec</p>\n</td>\n<td>\n<p>Closure of AV Valves-Onset of Ventricular systole</p>\n</td>\n<td>\n<p>Later half of R wave</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S2</p>\n</td>\n<td>\n<p>50 Hz</p>\n</td>\n<td>\n<p>0.12 sec</p>\n</td>\n<td>\n<p>Closure of Semilunar Valves-Onset of ventricular diastole</p>\n</td>\n<td>\n<p>Later half of T wave</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S3</p>\n</td>\n<td>\n<p>Low</p>\n</td>\n<td>\n<p>0.1 sec</p>\n</td>\n<td>\n<p>First rapid filling phase of ventricular diastole</p>\n</td>\n<td>\n<p>Between the T and P wave</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S4</p>\n</td>\n<td>\n<p>Below 20 Hz</p>\n</td>\n<td>\n<p>0.1 sec</p>\n</td>\n<td>\n<p>Last rapid filling phase of ventricular diastole due to atrial contraction</p>\n</td>\n<td>\n<p>Following P wave</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5556",
      "difficulty": "hard"
    },
    {
      "text": "How should you administer adenosine to a patient with SVT for pharmacological cardioversion?",
      "choices": [
        {
          "id": 1,
          "text": "6 mg IV bolus over 2-3 seconds followed by a rapid flush with 20 mL NS"
        },
        {
          "id": 2,
          "text": "6 mg IV bolus over 2-3 minutes followed by a 20 ml saline flush to avoid line irritation"
        },
        {
          "id": 3,
          "text": "6 mg slow IV infusion over 20-30 minutes"
        },
        {
          "id": 4,
          "text": "6 mg slow IV infusion over 20 minutes followed by 12 mg in 40 minutes"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Adenosine should be administered as a <strong>6 mg IV bolus over 2-3 seconds</strong> followed by a <strong>rapid flush with 20 mL NS</strong></p>\n<p>Adenosine is an ultra-short acting drug with a half-life being&nbsp;<strong>less than 10 seconds</strong>. It activates an&nbsp;<strong>inward rectifier K+ current</strong>&nbsp;along with&nbsp;<strong>inhibition of calcium current</strong>. The results of&nbsp;these actions are marked hyperpolarization and suppression of calcium-dependent action potentials.</p>\n<p>When given as a&nbsp;<strong>bolus dose</strong>, adenosine directly inhibits&nbsp;<strong>AV nodal conduction</strong>&nbsp;but has lesser effects on the SA node. Currently,&nbsp;Adenosine is used for the prompt conversion of&nbsp;<strong>paroxysmal supraventricular tachycardia</strong>&nbsp;to sinus rhythm because of its high efficacy (90&ndash;95%) and very short duration of action. It is usually given in a bolus dose of&nbsp;<strong>6 mg f</strong>ollowed by a dose of&nbsp;<strong>12 mg</strong>&nbsp;if required.&nbsp;<strong>Flushing, shortness of breath, and chest burning</strong>&nbsp;are some of its adverse effects.</p>\n<p>&nbsp;</p>\n<p><strong>Treatment of PSVT:&nbsp;</strong></p>\n<p>In hemodynamically <strong>stable</strong> patients, <strong>carotid massage/Valsalva</strong> maneuver should be attempted first. If the <strong>vagal maneuvers</strong> fail or cannot be performed, <strong>intravenous adenosine</strong> can be used.&nbsp;It is usually given in a bolus dose of&nbsp;<strong>6 mg</strong> followed by a dose of&nbsp;<strong>12 mg</strong>&nbsp;if required. If there is no termination of the PSVT, Then the next step is IV ibutilide + AV nodal&ndash;blocking agent (or)IV procainamide + AV nodal&ndash;blocking agent (or) <strong>Cardioversion</strong>.&nbsp;In the <strong>presence of hypotension </strong>with unconsciousness or respiratory distress, QRS-synchronous <strong>direct current cardioversion</strong> is warranted.</p>\n<p>The ECG below shows PSVT.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2fbcf5dbbd664b00b0670113380120dfx720x363.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cd9a6ec33c144fb4adad1694357aee0ax1280x1845.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Supraventricular tachycardias</h3><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R' waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5670",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following acts as an RNA-directed nuclease?",
      "choices": [
        {
          "id": 1,
          "text": "CRISPR-Cas9"
        },
        {
          "id": 2,
          "text": "S1 nuclease"
        },
        {
          "id": 3,
          "text": "Exonuclease III"
        },
        {
          "id": 4,
          "text": "Phosphatase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>CRISPR-Cas9</strong>&nbsp;acts as an<strong> RNA-directed nuclease.</strong></p>\n<p>Clustered regularly interspaced short palindromic repeats-associated gene 9, or <strong>CRISPR</strong>-<strong>Cas9</strong>, is a&nbsp;DNA editing/gene regulatory system. It involves two essential components:&nbsp;<strong>Cas9</strong>, an endonuclease that causes a double-stranded DNA break, allowing modifications to the genomic DNA to be made; and a synthetic single-guide RNA, or <strong>sgRNA</strong>, responsible for guiding Cas9 to its target.</p>\n<p>Once the sgRNA has directed the Cas9 to the section of the genomic DNA to be edited, the 3&rsquo; end of the sgRNA comes to lie across a specific sequence of DNA adjacent to the editing side called the <strong>protospacer adjacent motif</strong> or <strong>PAM</strong>. The Cas9 now causes a double-stranded break in the DNA at the PAM site, which is then repaired by a <strong>non-homologous end-joining</strong>.</p>\n<p>The following image shows&nbsp;CRISPR-Cas9 system:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/55d34c1a7d75486a8ef76803f4b55946x1280x857.PNG\" alt=\"Explanation Image\"><p class=\"p1\">Some important enzymes used in recombinant DNA research</p>\n<table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p2\"><strong>Enzyme<span class=\"Apple-converted-space\">&nbsp;</span></strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p2\"><strong>Reaction<span class=\"Apple-converted-space\">&nbsp;</span></strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p2\"><strong>Primary Use<span class=\"Apple-converted-space\">&nbsp;</span></strong></p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\"><strong>Phosphatase</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Dephosphorylates 5&prime; ends of RNA and DNA</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p3\">Removal of 5&prime;-PO<span class=\"s1\"><sub>4&nbsp;</sub>(phosphate)&nbsp;</span>groups prior to kinase labeling</li>\n<li class=\"p3\">Prevent self-ligation<span class=\"Apple-converted-space\">&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">DNA ligase<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Catalyzes bonds between DNA molecules<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p3\">Joining of DNA molecules<span class=\"Apple-converted-space\">&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">DNA polymerase I<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Synthesizes double-stranded DNA from single-stranded DNA<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p3\">Synthesis of double-stranded cDNA</li>\n<li class=\"p3\">DNA labeling and nick translation</li>\n<li class=\"p3\">Generation of blunt ends from sticky ends<span class=\"Apple-converted-space\">&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Thermostable DNA polymerases<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Synthesize DNA at elevated temperatures (60-80&deg;C)<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p3\">Polymerase chain reaction (DNA synthesis)</li>\n<li class=\"p3\">Mutagenesis<span class=\"Apple-converted-space\">&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">DNase I<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Produces single-stranded nicks in DNA, under appropriate conditions</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p3\">Nick translation</li>\n<li>Mapping of hypersensitive sites</li>\n<li>Mapping protein-DNA interactions<span class=\"Apple-converted-space\">&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\"><strong>Exonuclease III<span class=\"Apple-converted-space\">&nbsp;</span></strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Removes nucleotides from 3&prime; ends of DNA<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p3\">DNA sequencing</li>\n<li class=\"p3\">ChIP-Exo</li>\n<li class=\"p3\">Mapping of DNA-protein interactions<span class=\"Apple-converted-space\">&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">RNAse H<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Degrades the RNA portion of a DNA&ndash;RNA hybrid<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p3\">Synthesis of cDNA from mRNA<span class=\"Apple-converted-space\">&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\"><strong>S1 nuclease<span class=\"Apple-converted-space\">&nbsp;</span></strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Degrades single-stranded DNA<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li class=\"p3\">Removal of &ldquo;hairpin&rdquo; in synthesis of cDNA</li>\n<li class=\"p3\">RNA mapping studies&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">CRISPR-Cas9/C2c2<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">RNA-targeted DNA-, or RNA-directed nuclease<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">Genome editing and variations modulation<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5480",
      "difficulty": "easy"
    },
    {
      "text": "As per ACLS, CPR can be considered to be of high quality when ETCO2 is _____.",
      "choices": [
        {
          "id": 1,
          "text": "5-10 mmHg"
        },
        {
          "id": 2,
          "text": "At least 10-20 mmHg"
        },
        {
          "id": 3,
          "text": "25-35 mm Hg"
        },
        {
          "id": 4,
          "text": "At least 35-45 mm Hg"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>As per ACLS, CPR can be considered to be of <strong>high quality</strong> when <strong>ETCO<sub>2</sub> is at least 10-20 mmHg</strong>.</p>\n<p>Failure to maintain ETCO<sub>2</sub> at &gt;10 mm Hg during adult CPR is a reflection of poor cardiac output and it is found to strongly predicts unsuccessful resuscitation.</p>\n<p>Monitoring ETCO<sub>2</sub> during CPR can be used to assess blood flow in 2 ways:</p>\n<ul>\n<li>To improve chest compression performance if ETCO<sub>2</sub> is &lt;10 mm Hg during CPR</li>\n<li>To consider an abrupt sustained increase to a normal value (35 to 40 mm Hg) as an indicator of ROSC</li>\n</ul>\n<p><strong>High-quality cardiopulmonary resuscitation (CPR):</strong></p>\n<ul>\n<li>Push hard (at least 5 cm) and fast (100–120/min) and allow complete chest recoil.</li>\n<li>Minimize interruptions in compressions (10 seconds or less).</li>\n<li>Avoid excessive ventilation.</li>\n<li>Rotate the compressor every 2 minutes or earlier if fatigued.</li>\n<li>If no advanced airway, 30:2 compression- ventilation ratio.</li>\n<li>Quantitative waveform capnography– If PetCO<sub>2</sub> &lt;10 mm Hg, attempt to improve CPR quality.</li>\n<li>Intra-arterial pressure: If relaxation phase (diastolic) pressure &lt;20 mm Hg, attempt to improve CPR quality.</li>\n</ul>\n<p>Effective chest compression in <strong>adults</strong>:</p>\n<ul>\n<li>Provide <strong>100–120 compressions per minute</strong> (30 compressions for every 15-18 sec).</li>\n<li>Place your arms, one over the other in the midline, on the lower 1/3rd of the patient's sternum, and lock your arms.</li>\n<li>Use both arms to press the chest to a depth of<strong> 5-6 cm</strong> (2–2.4 inches)or more.</li>\n<li>Press hard and fast</li>\n<li>Allow for <strong>full chest recoil</strong> after every compression.</li>\n</ul>\n<p>Effective chest compressions in a<strong> child older than 1 year and up to puberty:</strong></p>\n<ul>\n<li>The compression rate is 100–120/min  (30 compressions for every 15–18 sec).</li>\n<li><strong>One or both palms</strong> are placed in the midline.</li>\n<li>Depth of compression is <strong>2 inches.</strong></li>\n<li>Press hard and fast</li>\n<li>Allow for full chest recoil after every compression.</li>\n</ul>\n<p>Effective chest compressions in<strong> infants (&lt;1 year):</strong></p>\n<ul>\n<li>100 to 120 compressions per minute (30 compressions for every 15–18 sec).</li>\n<li><strong>One provider: Place two fingers</strong>, one between the nipple line and the other 1 cm below.</li>\n<li><strong>Two providers:</strong> Encircle the infant's torso with both hands with<strong> both thumbs</strong> pointing cephalic positioned 1 cm below the nipples over the sternum. </li>\n<li>Depth of compressions should be at least <strong>1.5 inches or 1/3 the depth</strong> of the infant’s chest.</li>\n<li>Press hard and fast</li>\n<li>Allow for full chest recoil after every compression.</li>\n</ul><hr><h3>Related Pearl: High quality CPR for adults</h3><ul>\n<li>Push hard:&nbsp;<strong>5-6cm </strong>depth</li>\n<li>Push fast:&nbsp;<strong>100-120/min</strong>&nbsp;frequency</li>\n<li>Allow for <strong>complete chest recoil</strong></li>\n<li>Minimize interruptions in compressions <strong>&lt;10 seconds</strong></li>\n<li>Avoid excessive ventilation</li>\n<li>Rotate compressor every<strong>&nbsp;2 min</strong>&nbsp;or earlier if fatigued</li>\n<li>If no advanced airway,&nbsp;<strong>30:2&nbsp;</strong>compression-ventilation ratio</li>\n</ul>\n<p><strong>Attempt to improve CPR quality if :</strong></p>\n<ul>\n<li>Quantitative waveform capnography -&nbsp;<strong>PETCO2 &lt;10mmHg</strong>,&nbsp;</li>\n<li>Intra-arterial pressure -&nbsp;If relaxation phase (<strong>diastolic) pressure &lt;20mmHg</strong></li>\n</ul><hr><h3>Related Pearl: Adult cardiac arrest algorithm (Updated as per 2020 guidelines)</h3><p>The adult cardiac arrest algorithm is based on the AHA guidelines as shown below.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2bdbdbe380bd43f59ef07a42a15ff9bax1280x3518.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5606",
      "difficulty": "medium"
    },
    {
      "text": "On being asked \"Have you had any trouble sleeping lately?\" the patient replies \"I usually sleep in my bed, but now I'm sleeping on the sofa.\" What is this type of response known as?",
      "choices": [
        {
          "id": 1,
          "text": "Tangentiality"
        },
        {
          "id": 2,
          "text": "Circumstantiality"
        },
        {
          "id": 3,
          "text": "Derailment"
        },
        {
          "id": 4,
          "text": "Desultory thoughts"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>As the patient has given a <strong>reply that is appropriate to the general topic</strong> but does <strong>not answer the question exactly</strong>; it is <strong>tangentiality</strong>. The speech moves away from the actual answer.</p>\n<p><strong>Circumstantiality: </strong>The patient <strong>includes irrelevant details</strong> and <strong>goes on talking in a roundabout manner</strong>, but their thought <strong>ultimately reaches the answer</strong></p>\n<p>Example: Doctor: \"How did you get that bruise?\"<br />Patient: \"I woke up and had a cup of coffee, read the newspaper, and went for a walk. It was a wonderful day in the park. I returned home and watched the TV. I took a nap in the afternoon after lunch. I slipped and fell in the bathroom. The fall gave me this bruise.\"</p>\n<p><strong>Derailment: </strong>A <strong>breakdown in both </strong>the<strong> logical connection</strong> between ideas <strong>and</strong> the overall sense of <strong>goal-directedness</strong>. The words make sentences, but the <strong>sentences do not make sense.</strong></p>\n<p>Example: \"Some people just don't understand why I had breakfast in America during the first world war\"</p>\n<p><strong>Desultory thoughts</strong>: Speech is <strong>grammatically correct</strong>;<strong> </strong>however, <strong>sudden unrelated ideas force their way</strong> <strong>in</strong> from time to time.</p>\n<p>Example: My actual problem is that the people never understand me and my stomach feels like an empty bucket\"</p><hr><h3>Related Pearl: Classification of disorders of thought</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/88386ca930ff4b0395b824b1506c2efdx1280x1761.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Disorders of thought and perception</h3><p><span><strong>DISORDERS OF THOUGHT</strong></span></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>DISORDER OF STREAM OF THOUGHT</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>(A) Disorder of tempo</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Flight of Ideas</span></p>\n<p><span>Continuous flow of rapid speech that jumps from topic to topic</span></p>\n<ul>\n<li>\n<p><span>\"I like mangoes, the weather is nice, India is great\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Retardation of thinking</span></p>\n<p><span>Slow speed of speech and a prolonged latent period before a response</span></p>\n<ul>\n<li>\n<p><span>\"I went to the market (pause)......... the shop was closed\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iii) Circumstantialities</span></p>\n<p><span>Inclusion of irrelevant details and going on in a roundabout manner, but their thought ultimately reaches the answer</span></p>\n<ul>\n<li>\n<p><span>Doctor: \"How did you get that bruise?\"</span></p>\n</li>\n<li>\n<p><span>Patient: \"I woke up and had a cup of coffee, read the newspaper and went for a walk. It was a wonderful day in the park. I returned home and watched the TV. I took a nap in the afternoon after lunch. I slipped and fell in the bathroom. The fall gave me this bruise.\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iv) Clang associations</span></p>\n<p><span>Jumping from one word to another irrelevant rhyming word</span></p>\n<ul>\n<li>\n<p><span>I am Sam...I like jam...I travel in a tram\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>(B) Disorder of continuity</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Perseveration</span></p>\n<p><span>Repetition of out of context words, phrases, or ideas beyond the point of relevance.</span></p>\n<ul>\n<li>\n<p><span>Q1. What's your name?: \"Rahul\"</span></p>\n</li>\n<li>\n<p><span>Q2. Where are you from?: \"Rahul\"</span></p>\n</li>\n<li>\n<p><span>Q3. How old are you?: \"Rahul\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Thought blocking</span></p>\n<p><span>A sudden disruption of thought or a break in the flow of ideas</span></p>\n<ul>\n<li>\n<p><span>\"I went to the market (extreme silence)....................\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>DISORDER OF FORM OF THOUGHT</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Tangentiality</span></p>\n<p><span>In response to a question, the patient gives a reply that is appropriate to the general topic but does not answer the question exactly. The speech moves away from the actual answer.</span></p>\n<ul>\n<li><span>Doctor: \"Have you had any trouble sleeping lately?\"</span></li>\n<li><span>Patient: \"I usually sleep in my bed, but now I'm sleeping on the sofa\"</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Derailment</span></p>\n<p><span>A breakdown in both the logical connection between ideas and the overall sense of goal-directedness. The words make sentences, but the sentences do not make sense.</span></p>\n<ul>\n<li><span>\"Some people just don't understand why I had breakfast in America during the first world war\"</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iii) Neologisms</span></p>\n<p><span>Bringing in new words that do not exist.</span></p>\n<ul>\n<li><span>The world is not 'gooder' for people like me\"</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iv) Desultory thoughts</span></p>\n<p><span>Speech is grammatically correct, however, sudden unrelated ideas force their way in from time to time.</span></p>\n<ul>\n<li><span>My actual problem is that the people never understand me and my stomach feels like an empty bucket\"</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(v) Word salad</span></p>\n<p><span>Using a mixture of unintelligible meaningless words and sentences</span></p>\n<ul>\n<li><span>Tree bus rain food home car tiger\"</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>DISORDER OF POSSESSION OF THOUGHT</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>A. Thought alienation</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Thought insertion</span></p>\n<p><span>Thoughts are being inserted into the patient's mind and they recognize them as being foreign and coming from without any stimulus</span></p>\n<ul>\n<li>\n<p><span>\"I have repeated thoughts of killing my neighbors and I believe aliens are putting these ideas into my head at night\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Thought withdrawal</span></p>\n<p><span>Delusion that someone or something is removing from one's mind and the patient has no power over this.</span></p>\n<ul>\n<li>\n<p><span>\"Lately, I am losing all my memories and I believe that the 'government agents' are stealing them when I go to sleep\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iii) Thought broadcasting</span></p>\n<p><span>Belief that one's thoughts are quietly escaping from one's mind and that other people might be able to access them and hear or see them.</span></p>\n<ul>\n<li>\n<p><span>\"I believe my exact thoughts appear on the TV and the internet and I think I can broadcast them globally\" </span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iv) Thought echo</span></p>\n<p><span>Patient hears the 'echo' of his own thoughts in the form of a voice after he has made the thought.</span></p>\n<ul>\n<li>\n<p><span>\"I thought of making a sandwich in the morning and surprisingly a voice, from nowhere, told me to make a sandwich out loud\"</span><span> </span></p>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span> <strong>B. </strong><strong>Obsessions and Compulsions</strong></span></p>\n<p><span>1. Obsessions</span></p>\n<p><span>Recurrent and persistent thoughts, impulses. or images that cause distress to oneself.</span></p>\n<ul>\n<li><span>Fear of dirt or contamination</span></li>\n<li><span>Fear of becoming ill</span></li>\n<li><span>Constant thoughts of a certain number</span></li>\n<li><span>Need for symmetry or exactness</span></li>\n<li><span>Worry about whether something has been done \"right\"</span></li>\n<li><span>Forbidden sexual or religious thoughts</span></li>\n</ul>\n<p><span>2. Compulsions</span></p>\n<p><span>Repetitive behaviors or actions that the person feels driven to perform in response to an obsession</span></p>\n<ul>\n<li><span>Washing hands</span></li>\n<li><span>Blinking eyes</span></li>\n<li><span>Counting items, such as currency</span></li>\n<li><span>Checking to see if doors are locked</span></li>\n<li><span>Arranging items in a certain way</span></li>\n<li><span>Requiring constant approval from people around them</span></li>\n</ul>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td> <span><strong>DISORDER OF CONTENT OF THOUGHT</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Phobias</span></p>\n<p><span>Persistent fear of an object or situation, typically disproportional to the actual danger posed, in which the sufferer goes to great lengths in avoiding it</span></p>\n<ul>\n<li>\n<div><span>Arachnophobia - fear of spider</span></div>\n</li>\n<li>\n<div><span>Barophobia - fear of gravity</span></div>\n</li>\n<li>\n<div><span>Cynophobia - fear of dogs</span></div>\n</li>\n<li>\n<div><span>Hemophobia - fear of blood</span></div>\n</li>\n<li>\n<div><span>Nosocomephobia - fear of hospitals</span></div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Religious preoccupations</span></p>\n<p><span>Thoughts involving religious themes or subject matter.</span></p>\n<ul>\n<li>\n<p><span>\"I get instructions from God on how to make my country great\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iii) Ideas of hopelessness</span></p>\n<p><span>Thoughts of complete despair where the patient strongly believes that the circumstances will never get better for him.</span></p>\n<ul>\n<li>\n<p><span>\"I am never going to pass my final exams, no matter how hard I study\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iv) Antisocial urges</span></p>\n<p><span>Thoughts of indulging in some behaviors or actions that harm or lack consideration for the well being of others.</span></p>\n<ul>\n<li>\n<p><span>\"I have these urges to go rob a bank or blackmail my neighbors for their money\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(v) Delusions</span></p>\n<p><span>False beliefs that are strongly held and unchangeable in the face of refuting evidence and that are not consistent with the person's educational, social and cultural background.</span></p>\n<p><span>The three main criteria for a belief to be considered a delusion are:</span></p>\n<ul>\n<li>\n<div><span>Certainty (held with complete confidence)</span></div>\n</li>\n<li>\n<div><span>Incorrigibility (not changeable by proof to the contrary)</span></div>\n</li>\n<li>\n<div><span>Impossibility or falsity of content (implausible, bizarre or patently untrue)</span></div>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<table>\n<tbody>\n<tr>\n<td> <span><strong>DISORDERS OF PERCEPTIONS</strong></span></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>\n<p><span><strong>Illusion</strong>: Misinterpretation of real external stimuli.</span></p>\n</li>\n<li>\n<p><span><strong>Hallucination</strong>: False sensory perception, externally.</span></p>\n</li>\n<li>\n<p><span><strong>Pseudohallucination</strong>: False sensory perception from within and having an insight.</span></p>\n</li>\n<li>\n<p><strong><span>Depersonalization:</span></strong><span> Feeling as if one is disconnected from reality, feeling detached from one's own thoughts and one's own physical body.</span><strong><span><br /></span></strong></p>\n<p><span>\"I sometimes drift into a dream-like state where I lose contact with my own self\"</span></p>\n</li>\n<li>\n<p><strong><span>Derealization: </span></strong><span>Alteration in the perception or experience of the external world so that it seems unreal.</span><strong><span><br /></span></strong></p>\n<p><span>\"The world and everything around is nothing but just a dream\"</span></p>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5618",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true regarding radiological findings of Diffuse Axonal Injury?<div class='question-desc-html'><ol>\n<li>CT scan would appear normal in all cases.</li>\n<li>MRI is the investigation of choice for assessing the condition</li>\n<li>Non-hemorrhagic lesions appear as regions of high FLAIR signal&nbsp;</li>\n<li>Hemorrhagic changes are better picked up by the SWI sequence.</li>\n<li>Typical MR spectroscopy findings are&nbsp;elevation of choline peak and reduction of NAA</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 4, 5"
        },
        {
          "id": 2,
          "text": "1, 2, 3,"
        },
        {
          "id": 3,
          "text": "2, 3, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 2, 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Though CT may not show typical changes in the majority of patients with diffuse axonal injury, it is not normal in all patients.</p>\n<p>Diffuse axonal injury (<strong>white matter shearing</strong>) is the result of shearing forces, typically from a&nbsp;<strong>rotational acceleration&nbsp;</strong>of the brain within the rigid cranium.</p>\n<p>This causes damage to microvasculature and disruption of axons in the subcortical parasagittal white matter, cerebellum, fornix, and internal &amp; external capsule.</p>\n<p>Most commonly it occurs in high-velocity automobile accidents. Patients are usually&nbsp;<strong>unconscious</strong>&nbsp;from the moment of impact and remain the same until death.</p>\n<p><strong>Diffuse axonal injury is characterized by multiple focal lesions</strong>&nbsp;with a characteristic distribution.&nbsp;<strong>CT</strong>&nbsp;may appear&nbsp;<strong>normal in the majority of cases&nbsp;</strong>but<strong>&nbsp;may show&nbsp;hemorrhagic foci in the corpus callosum and dorsolateral rostral brainstem.&nbsp;</strong><strong>Non-hemorrhagic lesions</strong> appear <strong>hypodense</strong> and typically become <strong>more evident</strong> once <strong>edema</strong> develops around them. Non-hemorrhagic lesions are often associated with <strong>disproportionate cerebral swelling</strong>.</p>\n<p><strong>MRI</strong>&nbsp;is the&nbsp;<strong>modality of choice</strong>&nbsp;for&nbsp;<strong>assessing suspected diffuse axonal injury</strong>&nbsp;even in patients with entirely normal CT of the brain. MRI, especially&nbsp;<strong>SWI&nbsp;</strong>(susceptibility-weighted imaging) &amp; <strong>GRE</strong> (Gradient Echo)&nbsp;are highly sensitive to paramagnetic blood products. They may demonstrate small regions of susceptibility artifact at the grey-white matter junction, in the corpus callosum, or the brain stem.</p>\n<p>Some lesions may be <strong>entirely non-hemorrhagic</strong> and can be picked up by using high <strong>FLAIR signals</strong> that they produce. It is important to note that the <strong>FLAIR changes</strong> may typically get&nbsp;<strong>resolved within 3 months</strong>, while <strong>SWI changes</strong> may <strong>persist for about a year.</strong></p>\n<p>&nbsp;</p><p>Knowing that <strong>CT is not normal in all cases</strong> of Diffuse Axonal Injury could have helped solve this question by ruling out other choices.</p><hr><h3>Related Pearl: Diffuse Axonal Injury</h3><p>The mechanism of diffuse axonal injury (DAI) is primarily a non-impact rotational acceleration-deceleration injury. This leads to the deformation of the axons by stretching them.</p>\n<p>Pathology of DAI:</p>\n<ul>\n<li>Changes in permeability of the axolemma</li>\n<li>Axonal swelling</li>\n<li>Intracellular calcium accumulation</li>\n<li>Proteolysis</li>\n<li>The collapse of the cytoskeleton</li>\n<li>'<strong>Retraction balls</strong> or globes' - bulbous and clubbed axons. Seen earliest at 12-18 hours. The number of retraction balls begins to decrease<strong> after 2-3 weeks after injury</strong> and a cluster of microglial cells appears followed by astrocytosis and demyelination.</li>\n<li>Immuno-histochemistry shows beta-amyloid precursor protein - the <strong>most reliable</strong> indicator of axon damage. Seen earliest at 2-3 hours. </li>\n</ul>\n<p>Image shows scattered axonal retraction balls stained with Congo Red:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cf55a5006e2e477ebb43d97d7e373764x1280x1139.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5044",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is used to stain calcium in tissue sections?",
      "choices": [
        {
          "id": 1,
          "text": "Phosphotungstic acid hematoxylin"
        },
        {
          "id": 2,
          "text": "Allizarin Red"
        },
        {
          "id": 3,
          "text": "Masson’s trichrome"
        },
        {
          "id": 4,
          "text": "Masson–Fontana stain"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The special stains used for calcium in tissue sections are <strong>von Kossa and Alizarin Red</strong>. </p>\n<p><strong>Phosphotungstic acid hematoxylin</strong> <strong>staining</strong> is used to demonstrate <strong>fibrin</strong> in the tissue. <strong>Masson–Fontana stain</strong> is used to demonstrate <strong>melanin. Masson trichrome stain </strong>is used to <strong>demonstrate</strong> <strong>collagen in tissue</strong></p><hr><h3>Related Pearl: Various stains and their applications in Pathology and Microbiology</h3><table>\n<tbody>\n<tr>\n<td><strong>Staining technique</strong></td>\n<td><strong>Cells/inclusions stained</strong></td>\n<td><strong>Disorders</strong></td>\n</tr>\n<tr>\n<td><strong>H&amp;E</strong></td>\n<td>Most common stain used in routine&nbsp;<strong>histopathology</strong></td>\n<td>Commonly used for all slides</td>\n</tr>\n<tr>\n<td><strong>Papanicolaou stain</strong></td>\n<td>Universal stain for <strong>cytological</strong> preparations</td>\n<td>Cytological studies</td>\n</tr>\n<tr>\n<td><strong>PAS</strong></td>\n<td>Demonstrate&nbsp;<strong>glycogen,&nbsp;mucin,&nbsp;fungi, </strong>macrophages&nbsp;</td>\n<td>Whipple's disease, adenocarcinomas,&nbsp;and glycogen-positive tumors (Ewings sarcoma, renal cell carcinoma)</td>\n</tr>\n<tr>\n<td><strong><strong>PTAH (</strong></strong><strong>Phosphotungstic acid hematoxylin)</strong></td>\n<td>Fibrin</td>\n<td>Gliosis, Ependymomas, Tumours of skeletal muscles, Fibrin deposits</td>\n</tr>\n<tr>\n<td><strong>Alcian blue</strong></td>\n<td>For <strong>acid mucins</strong>: Positive stain for mucins of the intestinal mucosa and negative stain for mucins of gastric mucosa and Brunner's gland</td>\n<td>Barrett's esophagus, Gastric disorders</td>\n</tr>\n<tr>\n<td><strong>Perl's Prussian blue</strong></td>\n<td>Demonstrate&nbsp;<strong>hemosiderin and iron</strong></td>\n<td>Hemochromatosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson&ndash;Fontana stain</strong></td>\n<td>Demonstrate <strong>melanin</strong></td>\n<td>Nevus and malignant melanoma</td>\n</tr>\n<tr>\n<td><strong>von Kossa method</strong></td>\n<td>Demonstrate&nbsp;<strong>calcium</strong></td>\n<td>Calcification of tissues</td>\n</tr>\n<tr>\n<td><strong>Van Gieson stain</strong></td>\n<td>\n<p>Demonstrate <strong>collagen </strong>in; Differentiate amyloid from collagen</p>\n</td>\n<td>Spindle-cell neoplasm; Delineate extent of fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson trichrome stain</strong></td>\n<td>Demonstrate <strong>collagen and muscle</strong></td>\n<td>Connective tissue disorders, muscle and fibroblast tumors, liver cirrhosis, neuromuscular diseases&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Reticulin stain</strong></td>\n<td>Demonstrate <strong>reticulin fibers</strong></td>\n<td>Distinguish epithelial from non-epithelial neoplasm, Hodgkin's lymphoma, early cirrhosis of the&nbsp;liver, myelofibrosis</td>\n</tr>\n<tr>\n<td><strong>Verhoeff's method</strong></td>\n<td>Demonstrate <strong>elastic fibers</strong></td>\n<td>Malignant hypertension, arteriovenous malformation aneurysms, Marfan's syndrome, emphysema lung</td>\n</tr>\n<tr>\n<td><strong>Oil red O</strong> <strong>Sudan Black</strong> <strong>Sudan III/IV</strong></td>\n<td>Demonstrate&nbsp;<strong>fat/lipids</strong></td>\n<td>Fatty liver-fat embolism-fibroma vs. thecoma of the&nbsp;ovary-liposarcoma&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Microbiology stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>&nbsp;Uses</strong></td>\n</tr>\n<tr>\n<td><strong>Ziehl&ndash;Neelsen Stain</strong></td>\n<td>Mycobacteria (all species, including <em>Mycobacterium leprae</em>), <em>Nocardia </em>spp. Cyst of&nbsp;<em>Cryptosporidium parvum</em>, <em>Isospora </em>spp., and&nbsp;<em>Cyclospora</em>&nbsp;spp., Head of sperms</td>\n</tr>\n<tr>\n<td><strong>Masson&rsquo;s Fontana</strong></td>\n<td>Melanin and argentaffin Cells</td>\n</tr>\n<tr>\n<td><strong>Gomori Methenamine Silver</strong></td>\n<td>Fungi</td>\n</tr>\n<tr>\n<td><strong>Luxol Fast Blue (LFB)</strong></td>\n<td>Myelin</td>\n</tr>\n<tr>\n<td><strong>Phosphotungstic Acid-hematoxylin</strong></td>\n<td>Cross striations of skeletal muscle, fibrin</td>\n</tr>\n<tr>\n<td><strong>Toluidine blue</strong></td>\n<td>Mast cells</td>\n</tr>\n<tr>\n<td><strong>Warthin&ndash;Starry</strong></td>\n<td>Helicobacter pylori, spirochetes</td>\n</tr>\n<tr>\n<td><strong>Van Gieson</strong></td>\n<td>Collagen fibres</td>\n</tr>\n<tr>\n<td><strong>Mucicarmine</strong></td>\n<td>Mucin, <em>Cryptococcus</em> capsule</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5665",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old woman in puerperium presents with headache, 1 episode of generalized seizures, and confusion. On examination, she is found to have papilledema. The contrast-enhanced CT of the head is shown below. What is the drug of choice for the acute management of her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Warfarin"
        },
        {
          "id": 2,
          "text": "Aspirin"
        },
        {
          "id": 3,
          "text": "Streptokinase"
        },
        {
          "id": 4,
          "text": "IV heparin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical scenario and the CECT image showing the <strong>empty delta sign</strong> are characteristic of <strong>cerebral venous thrombosis</strong>. <strong>IV heparin</strong> is the <strong>drug of choice </strong>in cerebral venous thrombosis.</p>\n<p>Cerebral venous thrombosis is the occlusion of the lateral sagittal sinuses (central venous sinus thrombosis) or small cortical veins (cortical venous thrombosis). Symptoms and signs include the following:</p>\n<ul>\n<li><strong>Headache: </strong>most common, with or without vomiting</li>\n<li>Seizures</li>\n<li>Intracranial hypertension and papilledema</li>\n<li>Focal neurological deficits</li>\n<li>Altered mental status</li>\n<li>Coma</li>\n</ul>\n<p>It is commonly seen in <strong>hypercoagulable states</strong>. Risk factors include the following:</p>\n<ul>\n<li><strong>Oral contraceptive pill use</strong></li>\n<li>Pregnancy and puerperium</li>\n<li>Inflammatory bowel disease</li>\n<li>Dehydration</li>\n<li>Intracranial infections</li>\n<li><strong>Thrombophilias</strong> like antiphospholipid syndrome, polycythemia, sickle cell anemia, protein C, S deficiency, factor V Leiden mutation, antithrombin III deficiency</li>\n</ul>\n<p><strong>MRI Brain </strong>with MR venography<strong> </strong>is the <strong>most sensitive investigation</strong>. Alternatively, CECT brain can also be done. The <strong>empty delta sign</strong> is a sign of dural venous sinus <strong>thrombosis</strong> of the <strong>superior sagittal sinus</strong>, where contrast outlines a triangular filling defect (clot). It is seen with a CECT scan or MRI.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/42da88b230dd4b1c9d7739b79b58d8c6x1280x1325.JPEG\" alt=\"Explanation Image\"><div>\n<p>CECT image showing the <strong>empty delta sign</strong> in the superior sagittal sinus posteriorly, with a large infarct in the left hemisphere causing a midline shift to the right:</p>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d86266bf61a475899099a7fbcb15ee7x463x491.PNG\" alt=\"Explanation Image\"><p><br />Treatment of CVT includes</p>\n<ul>\n<li aria-level=\"1\"><strong>Acute treatment </strong>is with IV Heparin or low-molecular-weight heparin (LMWH). <strong>IV heparin</strong> is the <strong>drug of choice</strong> in cerebral venous thrombosis. It prevents further thrombosis and reduces venous hypertension and ischemia.</li>\n</ul>\n<ul>\n<li aria-level=\"1\"><strong>Maintenance therapy:</strong><br />\n<ul>\n<li aria-level=\"1\">Anticoagulation is often continued <strong>indefinitely</strong> if <strong>thrombophilia</strong> is diagnosed.</li>\n<li aria-level=\"1\">If there is no underlying hypercoagulable state, treatment with vitamin K antagonists like <strong>warfarin</strong> for <strong>3–6 months</strong> may be initiated and then converted to <strong>aspirin</strong>, depending on the degree of resolution of the venous sinus thrombus. </li>\n<li aria-level=\"1\">In <strong>pregnant</strong> women:\n<ul>\n<li aria-level=\"1\">Anticoagulation with <strong>LMWH</strong> throughout <strong>pregnancy</strong> and till <strong>8 weeks postpartum</strong>.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/18beb61ae64a4b618b94c592c6ac0386.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5615",
      "difficulty": "medium"
    },
    {
      "text": "A traveler presents to your OPD with profuse watery diarrhea. You suspect it to be a case of cholera due to the recent outbreak in his hometown. You would recommend isolation of the patient until:",
      "choices": [
        {
          "id": 1,
          "text": "3 days of antibiotic therapy"
        },
        {
          "id": 2,
          "text": "7 days of antibiotic therapy"
        },
        {
          "id": 3,
          "text": "12 days of antibiotic therapy"
        },
        {
          "id": 4,
          "text": "A negative stool antigen test is obtained"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>duration of isolation</strong> recommended for a patient with <strong>cholera</strong> is until <strong>3 days of antibiotic therapy</strong>.</p>\n<p><em>Vibrio cholerae</em> is a comma-shaped, gram-negative bacillus with darting motility. It has a single <strong>polar flagellum</strong>. It causes <strong>cholera</strong>, an acute diarrheal disease. It is marked by painless, profuse, watery diarrhea with flecks of mucus (<strong>rice-water stools</strong>) associated with effortless <strong>vomiting</strong>.</p>\n<p>Infection is acquired by ingestion of <strong>contaminated</strong> food and water. The organisms produce an <strong>enterotoxin</strong> known as <strong>cholera toxin</strong> (CT). It has 1 A and 5 B subunits. The <strong>B subunit</strong> (binding units) fixes to the<strong> GM1</strong> ganglioside receptors on<strong> jejunal epithelial cells</strong>. The A subunit dissociates into the A2 fragment, which attaches the A1 fragment to the B subunit. This results in prolonged<strong> accumulation</strong> of <strong>cAMP</strong>, which causes an outpouring of large amounts of water and electrolytes into the intestinal lumen. Ultimately, it results in <strong>profuse watery diarrhea</strong>. </p>\n<p>In addition to the <strong>cholera toxin</strong>, additional toxins such as<strong> zona occludens toxin</strong> and accessory cholera toxin are also produced. The former alters intestinal permeability by its action on intestinal epithelial cells. The characteristic <strong>darting mobility</strong> and its hindrance by antiserum can be used for rapid microscopic diagnosis.</p>\n<p>Fluid resuscitation by <strong>rice-based ORS</strong> is recommended. Antibiotics that can be used include <strong>fluoroquinolones</strong>, <strong>tetracycline</strong>, <strong>Azithromycin</strong>, ampicillin, or Trimethoprim -Sulfamethoxazole (TMP-SMX).</p><hr><h3>Related Pearl: Periods of Isolation for Selected Diseases</h3><p><strong class=\"ng-binding\"> Periods of Isolation for Selected Diseases</strong></p>\n<div class=\"panel-body ng-scope\">\n<p class=\"ng-binding ng-scope\"> </p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Duration of Isolation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chickenpox</p>\n</td>\n<td>\n<p>Until all lesions are crusted – usually about 6 days after onset of rash.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Measles</p>\n</td>\n<td>\n<p>From the onset of symptoms (catarrhal stage) to 5 days after the appearance of the rash</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cholera</p>\n</td>\n<td>\n<p>Until 3 days of tetracycline therapy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diphtheria </p>\n</td>\n<td>\n<p>Until 48 hours of antibiotics.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Shigellosis and salmonellosis</p>\n</td>\n<td>\n<p>Until 3 consecutive negative stool cultures.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis A</p>\n</td>\n<td>\n<p>3 weeks.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Influenza</p>\n</td>\n<td>\n<p>3 days after onset.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polio</p>\n</td>\n<td>\n<p>2 weeks in adult; 6 weeks in children.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tuberculosis (sputum +)</p>\n</td>\n<td>\n<p>Until 3 weeks of effective chemotherapy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Herpes zoster</p>\n</td>\n<td>\n<p>6 days after onset of rash.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mumps</p>\n</td>\n<td>\n<p>Until the swelling subsides.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pertussis</p>\n</td>\n<td>\n<p>4 weeks or until paroxysms cease. </p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Meningococcal meningitis</p>\n</td>\n<td>\n<p>Until the first 24 hours of effective antibiotic therapy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Streptococcal pharyngitis</p>\n</td>\n<td>\n<p>Until the first 6 hours of effective antibiotic therapy.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5502",
      "difficulty": "hard"
    },
    {
      "text": "In a COVID-19 ward, which of the following wastes should not be disposed off in the yellow bin?",
      "choices": [
        {
          "id": 1,
          "text": "Used gloves"
        },
        {
          "id": 2,
          "text": "Non-plastic coverall/Semi-plastic coverall"
        },
        {
          "id": 3,
          "text": "Diapers with feces of immobile COVID-19 patients"
        },
        {
          "id": 4,
          "text": "Head cover/Cap and shoe cover"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Used gloves&nbsp;</strong>should be disposed off in the <strong>red bin.</strong>&nbsp;</p><hr><h3>Related Pearl: Biomedical Waste (BMW) Management -COVID 19</h3><p>In addition to the current BMW Management rules, the following measures are proposed</p>\n<ul>\n<li>To report opening/operation of COVID 19 Ward/ICU/Lab/Collection Centre to <strong>SPCB</strong> (State Pollution Control Board) and <strong>CBWTF</strong> (Common Biomedical Waste Treatment Facility) in that area</li>\n<li>Dedicated sanitation workers deputed only to collect COVID 19 BMW</li>\n<li>It is mandatory for all BMW bags and containers from COVID 19 areas to carry <strong>\"COVID 19 WASTE\"</strong> label</li>\n<li>Keep separate colour coded bins with <strong>foot operated lids</strong></li>\n<li>The inner and outer surfaces of these containers must be disinfected daily with <strong>1% sodium hypochlorite</strong> solution</li>\n<li>To ensure no leaks, <strong>double layers&nbsp;</strong>(2 bags) are used</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>COLOUR OF THE BIN</strong></td>\n<td><strong>PERSONAL PROTECTIVE EQUIPMENT(PPE)</strong></td>\n<td><strong>OTHER WASTE</strong></td>\n</tr>\n<tr>\n<td><strong>Red Bin</strong></td>\n<td>\n<ul>\n<li>Goggles</li>\n<li>Face shield&nbsp;</li>\n<li>Splash-proof apron</li>\n<li>Plastic coverall</li>\n<li>Hazmat suit</li>\n<li>Nitrile gloves</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Used gloves</li>\n</ul>\n<p><strong>Laboratory waste</strong></p>\n<ul>\n<li>Pre-treated viral transport media</li>\n<li>Plastic vials and cryovials</li>\n<li>Vacutainers</li>\n<li>Eppendorf tubes</li>\n<li>Pipette tips</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Yellow Bin</strong></td>\n<td>\n<ul>\n<li>Used mask(triple layer mask, N95 mask)</li>\n<li>Head cover/Cap, Shoe cover</li>\n<li>Disposable linen gown&nbsp;</li>\n<li>Non-plastic/Semi-plastic coverall</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>Diapers with feces of immobile COVID 19 patients&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Biomedical waste disposal</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp;<span> Yellow bag </span></strong><strong><span>(non-chlorinated)</span></strong><strong><span>&nbsp;</span>&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type of Waste</p>\n</td>\n<td>&nbsp;Treatment and Disposal Options</td>\n</tr>\n<tr>\n<td>\n<p><strong>Human anatomical waste</strong></p>\n<p><strong>Animal anatomical waste</strong></p>\n</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n</td>\n</tr>\n<tr>\n<td><strong>Soiled Waste: </strong>Items like dressings, cotton swabs, and plaster casts contaminated with blood and body fluids and bags containing residual discarded blood.</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n<p>or</p>\n<p>Autoclaving/Microwaving/ Hydroclaving</p>\n<p>Later - Shredding/mutilation</p>\n</td>\n</tr>\n<tr>\n<td>Discarded linen, mattresses, beddings contaminated with blood or body fluid,<strong> routine masks, and gowns</strong></td>\n<td>\n<p>Non- chlorinated chemical disinfection<br />followed by incineration or Plazma<br />Pyrolysis or for energy recovery.<br />In absence of the above facilities, shredding,&nbsp;mutilation, or a combination of&nbsp;sterilization and shredding is used.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microbiology, biotechnology, clinical laboratory waste</strong></p>\n<p>(Autoclave safe plastic bags used)</p>\n<p><strong>Blood bags</strong>, laboratory<br />cultures, stocks or&nbsp;specimens of microorganisms,<br />live or&nbsp;attenuated vaccines,&nbsp;human and animal cell&nbsp;cultures used in&nbsp;research, industrial&nbsp;laboratories, production&nbsp;of biological, residual&nbsp;toxins, dishes, and&nbsp;devices used for&nbsp;cultures.</p>\n</td>\n<td>\n<p>Pre-treatment with nonchlorinated chemicals</p>\n<p>Later - Incineration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Expired/discarded medicine, cytotoxic drugs</p>\n</td>\n<td>Incineration/plasma pyrolysis/ disposal in a secured landfill</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><strong>Chemical waste</strong></p>\n<p>Chemicals used in biological production&nbsp;and used or discarded<br />disinfectants.</p>\n</td>\n<td>\n<p>Disposal- incineration/plasma<br />pyrolysis</p>\n<p>Encapsulation-&nbsp;hazardous waste treatment, storage, and&nbsp;disposal facility.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chemical liquid</strong>&nbsp;<strong>waste</strong> :<br />Liquid waste generated&nbsp;due to the use of chemicals&nbsp;in the production of<br />biological and used or&nbsp;<strong>discarded disinfectants,</strong>&nbsp;silver X-ray film<br />developing liquid,<br />discarded formalin,<br />infected <strong>secretions,</strong><br /><strong>aspirated body&nbsp;fluids</strong>,&nbsp;liquid from&nbsp;laboratories and floor&nbsp;washings, cleaning,&nbsp;house-keeping and<br />disinfecting activities&nbsp;etc.</p>\n<p>&nbsp;</p>\n</td>\n<td>After resource recovery, the chemical<br />liquid waste shall be pre-treated before&nbsp;mixing with other wastewater.&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp; Red&nbsp;bag (non-chlorinated)&nbsp;&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><strong>&nbsp;Type of Waste</strong></td>\n<td>\n<p><strong>&nbsp;<span>Treatment and Disposal Options</span></strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Recyclable contaminated</strong> waste</p>\n<p>Contaminated waste tubing, bottles, intravenous tubes and sets, <strong>catheters,</strong> <strong>urine bags</strong>, syringes (without needles and fixed needle syringes with their needles cut), <strong>vacutainers with</strong> <strong>needles cut,</strong> and gloves.</p>\n</td>\n<td>\n<p><strong>Autoclaving/Microwaving/<br />Hydroclaving</strong></p>\n<p>Followed by Shredding/mutilation</p>\n<p>And later, Energy recovery/Plastics to diesel or fuel oil/road-making</p>\n<p>Not to be sent to landfill</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>&nbsp; White (translucent)&nbsp;&nbsp;<br />(puncture-proof, leak-proof containers)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Type of Waste</strong></td>\n<td>\n<p><strong>Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Waste Sharps including metals.</strong></p>\n<p>Needles, syringes with fixed needles, needles from needle tip cutter or burner, scalpels, blades, or any other <strong>contaminated sharp</strong> object that may cause puncture and cuts. This includes both used, discarded, and contaminated metal sharps</p>\n</td>\n<td>\n<p>Autoclaving/ Dry heat sterilization</p>\n<p>Followed by - <strong>Shredding/mutilation</strong>/<br />encapsulation</p>\n<p>Later by - Iron foundries/sanitary landfill/waste sharps</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p>&nbsp;<span><strong><span>&nbsp; Blue&nbsp;&nbsp;</span><br /></strong></span><span><strong><span>(Puncture proof and leak proof containers with blue colored marking)</span></strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type of Waste&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glassware</strong></p>\n<p>Broken or discarded and contaminated glass including medicine <strong>vials</strong> and <strong>ampules except</strong> those containing <strong>cytotoxic</strong> waste.</p>\n<p><strong>Metallic body implants</strong></p>\n</td>\n<td>\n<p>Sodium hypochlorite/Autoclaving/<br />Microwaving/Hydroclaving</p>\n<p>Later - Recycling</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;Note: <strong>Ash</strong> from the <strong>incineration</strong> of biomedical waste shall be disposed of at a <strong>common hazardous waste treatment and disposal facility</strong>. However, it may also be disposed of in a <strong>municipal landfill</strong>, <strong>if</strong> the toxic metals in incineration ash are <strong>within</strong> the <strong>regulatory quantities</strong> as defined under the Hazardous Waste (Management and Handling and Transboundary Movement) Rules, 2008 as amended from time to time.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5507",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following EEG findings in a patient would warrant treatment with ACTH?",
      "choices": [
        {
          "id": 1,
          "text": "4"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "1"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>ACTH</strong> is used in the management of children with <strong>infantile spasms</strong>. The EEG in image 4 shows the characteristic <strong>hypsarrhythmic</strong>&nbsp;pattern - high voltage waves with a chaotic background, that is typically seen in infantile spasms.&nbsp;</p>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Typical EEG feature</strong></td>\n</tr>\n<tr>\n<td>&nbsp;West syndrome</td>\n<td>\n<p>Hypsarrhythmia (high-voltage waves with chaotic background)</p>\n<p>(Image 4)</p>\n</td>\n</tr>\n<tr>\n<td>Creutzfeldt-Jakob disease (CJD)</td>\n<td>\n<p>Periodic biphasic or triphasic sharp-wave complexes seen as spikes.</p>\n<p>(Image 1)</p>\n</td>\n</tr>\n<tr>\n<td>Absence seizures</td>\n<td>\n<p>3 Hz spike and slow-wave (spike and dome pattern)</p>\n<p>(Image 2)</p>\n</td>\n</tr>\n<tr>\n<td>Juvenile myoclonic epilepsy</td>\n<td>\n<p>4-5 Hz spike</p>\n<p>(Image 3)</p>\n</td>\n</tr>\n<tr>\n<td>Lennox-Gastaut syndrome</td>\n<td>\n<ul>\n<li>1-2 Hz spike and slow waves</li>\n<li>polyspike bursts in sleep</li>\n<li>slow background in wakefulness</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Infantile epileptic spasm</strong> is an <strong>age-specific seizure disorder</strong> that predominantly occurs <strong>before the age of one</strong>. Some cases may be diagnosed late as this condition may be mistaken to be&nbsp;hyperirritability, exaggerated startle responses, and/or colic.&nbsp;</p>\n<p><strong>Clinical features</strong></p>\n<ul>\n<li>Spasms involve the muscles of the neck, trunk, and extremities</li>\n<li>They are symmetric and synchronous</li>\n<li>There is an initial phasic contraction that lasts less than two seconds and involves sudden, brief, contractions of various muscle groups</li>\n<li>The next phase is a tonic contraction phase that is less intense and lasts up to ten seconds</li>\n<li>Motor arrest &nbsp;or a period of attenuated responsiveness may occur following the contraction and lasts up to 90 seconds</li>\n<li>Deviation of the eyes, nystagmus and change in respiratory pattern may be seen in some patients</li>\n<li>Most patients develop neurodevelopmental delay</li>\n<li>The triad of<strong> spasms, arrest of psychomotor development, and hypsarrhythmia is known as West syndrome</strong></li>\n</ul>\n<p><strong>Diagnosis</strong></p>\n<ul>\n<li>EEG\n<ul>\n<li><strong>Interictal: Hypsarrythmia</strong> is the defining feature of infantile spasms and is characterized by very high voltage, random, slow waves, and spikes in all cortical areas. These spikes vary in duration and location. This finding may precede the onset of spasms.&nbsp;Hypsarrhythmia is the typical interictal EEG finding, <strong>seen between episodes.</strong></li>\n<li><strong>Ictal</strong>: The ictal EEG generally shows a high-voltage slow-wave transient followed by a general attenuation of activity. <strong>Electrodecremental response</strong> which is generalized attenuation may occur with or without clinical evidence of a seizure</li>\n</ul>\n</li>\n<li>Neuroimaging with CT/MRI is recommended in all patients</li>\n<li>Metabolic and genetic testing may be done to identify the etiology</li>\n<li>EMG reveals a characteristic rhomboid pattern which may help to distinguish between brief tonic and myoclonic seizures</li>\n</ul>\n<p><strong>Treatment</strong></p>\n<p>The major options for the treatment of IS include hormonal therapy, mainly corticotropin (<strong>ACTH</strong>), and antiseizure medication, mainly&nbsp;vigabatrin.</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/63e2e11ff38f46c7b43dcfe711b91107x480x600.JPEG\" alt=\"Explanation Image\"><p>CJD is a&nbsp;<strong>spongiform encephalopathy</strong>&nbsp;caused by a&nbsp;<strong>prion</strong>. It presents as&nbsp;<strong>rapidly progressive dementia</strong>&nbsp;and is&nbsp;<strong>fatal within 1 year</strong>&nbsp;of onset of symptoms.&nbsp;The EEG shows <strong>periodic biphasic or triphasic sharp-wave complexes</strong> seen as spikes.</p>\n<p>Patients present with&nbsp;<strong>myoclonus</strong>,&nbsp;<strong>akinetic mutism</strong>, cerebellar or visual disturbances and pyramidal/extrapyramidal dysfunction (hypokinesia). Insomnia, apathy and other behavioral abnormalities may be seen.</p>\n<p>Four types of Creutzfeldt-Jakob disease have been described:</p>\n<ol>\n<li>Sporadic (sCJD): Accounts for 85-90% of cases\n<ul>\n<li>MRI shows&nbsp;<strong>cortical ribbon sign</strong></li>\n</ul>\n</li>\n<li>Variant (vCJD): mad cow disease, Kuru\n<ul>\n<li>MRI&nbsp;shows&nbsp;<strong>hockey stick sign</strong></li>\n</ul>\n</li>\n<li>Familial (fCJD): 10% of cases (these individuals carry a PRPc mutation)</li>\n<li>Iatrogenic</li>\n</ol>\n<p><strong>CSF</strong>&nbsp;analysis shows a positive assay for&nbsp;<strong>14-3-3 protein</strong>.&nbsp;Management is mainly supportive.</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/efcb62d44824493a946e842532b2684bx1279x1139.JPEG\" alt=\"Explanation Image\"><p><strong>Absence seizures&nbsp;</strong>are characterised by&nbsp;sudden,&nbsp;<strong>brief lapse of consciousness</strong>&nbsp;with&nbsp;<strong>preserved postural control</strong>&nbsp;and&nbsp;<strong>no post-ictal confusion</strong>&nbsp;is seen in Absence seizures. Usually, the seizure lasts only a few seconds.</p>\n<p>They are predominantly seen in children between&nbsp;<strong>four to ten</strong>&nbsp;years of age, with a&nbsp;<strong>decline in academic performance</strong>&nbsp;in school and&nbsp;<strong>unexplained 'daydreaming'.</strong></p>\n<p>The following subtle motor signs may accompany the episodes</p>\n<ul>\n<li><strong>Rapid blinking</strong>&nbsp;of the eyelids</li>\n<li><strong>Chewing movements</strong></li>\n<li>Small-amplitude&nbsp;<strong>clonic movement</strong>&nbsp;of the&nbsp;<strong>hands</strong></li>\n</ul>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\"><strong>EEG</strong>&nbsp;shows generalised&nbsp;<strong>symmetric 3 Hz spike and wave</strong>&nbsp;pattern.&nbsp;<strong>Hyperventilation</strong>&nbsp;can provokes these EEG discharges and seizures.</p>\n<p><strong>MRI</strong>&nbsp;appears&nbsp;<strong>normal</strong>&nbsp;hence not routinely recommended.&nbsp;<strong>Laboratory investigations</strong>&nbsp;are&nbsp;<strong>not specifically useful.</strong></p>\n</div>\n</div>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p><strong>Ethosuximide</strong>&nbsp;is the drug of choice for&nbsp;<strong>uncomplicated typical absence seizure</strong></p>\n<p><strong>Sodium valproate</strong>&nbsp;is the first-line therapy for&nbsp;<strong>absence seizures</strong>&nbsp;in cases&nbsp;<strong>associated with secondary GTCS</strong>&nbsp;and&nbsp;<strong>atypical absence</strong></p>\n<p>Drugs like&nbsp;<strong>carbamazepine, oxcarbazepine</strong>&nbsp;and&nbsp;<strong>phenytoin</strong>&nbsp;can worsen the&nbsp;<strong>absence</strong>, myoclonic, tonic and atonic seizures and are therefore avoided</p>\n<p>&nbsp;</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/476ee2dba1554e1ab2971878f6dd02d2x672x627.PNG\" alt=\"Explanation Image\"><p><strong>Juvenile myoclonic epilepsy&nbsp;</strong>is&nbsp;also known as&nbsp;<strong>Janz syndrome.&nbsp;</strong>This disorder typically first manifests itself between the ages of 12 and 18. It presents with brief episodes of involuntary muscle twitching occurring early in the morning after awakening. They can be provoked by sleep deprivation. Most patients also have generalized seizures that affect the entire brain and many also have absence seizures.&nbsp;Myoclonic seizures are characterized by:</p>\n<ul>\n<li>Preserved consciousness</li>\n<li>Preserved postural control</li>\n<li>Lack of postictal confusion</li>\n</ul>\n<div class=\"page\" title=\"Page 3098\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The EEG shows a bilaterally synchronous spike (<strong>4-5 Hz polyspike</strong>&nbsp;) and slow-wave discharges. The drug of choice for juvenile myoclonic epilepsy is&nbsp;<strong>valproate (Sodium and calcium channel blocker).&nbsp;</strong>Lamotrigine is also useful.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/75cae724847c4098ac0141b65449c8d8x800x389.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: EEG Waves</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>EEG Waves</strong></p>\n</td>\n<td>\n<p><strong>Frequency (in Hz)</strong></p>\n</td>\n<td>\n<p><strong>Amplitude (in &mu;V)</strong></p>\n</td>\n<td>\n<p><strong>Location where it is best-recorded</strong></p>\n</td>\n<td>\n<p><strong>Reactivity </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alpha rhythm</p>\n</td>\n<td>\n<p>8-13</p>\n</td>\n<td>\n<p>50-100</p>\n</td>\n<td>\n<p>Parieto-occipital regions</p>\n</td>\n<td>\n<p>Adults at rest- awake but relaxed with eyes closed, wandering mind</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Beta rhythm</p>\n</td>\n<td>\n<p>13-30</p>\n</td>\n<td>\n<p>5-10</p>\n</td>\n<td>\n<p>Frontal regions</p>\n</td>\n<td>\n<p>Adults with eyes open</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Theta waves</p>\n</td>\n<td>\n<p>4-8</p>\n</td>\n<td>\n<p>&lt;200</p>\n</td>\n<td>\n<p>Parietal and temporal regions in children;</p>\n<p>In experimental animals- hippocampus</p>\n</td>\n<td>\n<p>Normally seen in children during moderate sleep;</p>\n<p>In adults who are in deep relaxation and meditation;</p>\n<p>Seen in excess- depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Delta waves</p>\n</td>\n<td>\n<p>0.5-4</p>\n</td>\n<td>\n<p>20-200 (large amplitude)</p>\n</td>\n<td>\n<p>Occipito-temporal</p>\n</td>\n<td>\n<p>Deep sleep;</p>\n<p>Appearance in awake state- Organic brain damage</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d138b5cab972480792777f74e156c166.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5531",
      "difficulty": "medium"
    },
    {
      "text": "While reporting X-Rays in your radiology rotation, you notice a chest X-Ray with a characteristic egg-on-string appearance. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Tetralogy of Fallot"
        },
        {
          "id": 2,
          "text": "Total anomalous pulmonary venous return"
        },
        {
          "id": 3,
          "text": "Ebstein's anomaly"
        },
        {
          "id": 4,
          "text": "Transposition of great arteries"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Egg-on-string appearance</strong>&nbsp;is the characteristic radiological sign on chest X-rays in<strong> transposition of great arteries (TGA)</strong>.&nbsp;</p>\n<p>Here, the typical chest x-ray shows <strong>mild cardiomegaly, a narrow mediastinum</strong> (the classic <strong>egg-shaped heart</strong> or egg on a string appearance), with <strong>normal to increased pulmonary blood flow.&nbsp;</strong>Egg-on-a-string appearance refers to a&nbsp;<strong>globular-shaped&nbsp;heart due to an abnormal convexity of the right atrial border and left atrial enlargement.</strong></p>\n<p>ECHO is diagnostic. The&nbsp;size of the interatrial communication and the ductus arteriosus, the degree of mixing assessed, any associated ventricular outflow tract obstruction, or a septal defect, can be assessed by color Doppler examination.&nbsp;</p>\n<p>Pathology of TGA: The <strong>deoxygenated blood</strong> returning from the body <strong>goes inappropriately out the aorta and back to the body again</strong>, while oxygenated pulmonary venous blood is returned directly to the lungs. Survival in the immediate neonatal period is due to the mixture of oxygenated and deoxygenated blood provided by the foramen ovale and the ductus arteriosus. 50% of patients also have a ventricular septal defect (VSD).</p>\n<p><strong>TGA</strong> is the <strong>most specific heart disease </strong>in <strong>infants of diabetic mothers.&nbsp;</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/154bdf156ec448e4a05b1f24d6a63205x1024x667.JPEG\" alt=\"Explanation Image\"><p><strong>Box-shaped heart</strong> is seen in <strong>Ebstein's anomaly</strong>.&nbsp;There is severe right-sided cardiomegaly due to an elongated and enlarged right atrium which leads to an elevated apex.&nbsp;</p>\n<p><strong>Snowman heart</strong> is seen in&nbsp;<strong>total anomalous pulmonary venous return</strong>.&nbsp;It refers to the configuration of the heart and the superior mediastinal borders resembling a snowman. It is also referred to as the<strong> figure of 8 sign.</strong></p>\n<p><strong>Boot shaped heart</strong>&nbsp;is seen in children with<strong> Tetralogy of Fallot (TOF).</strong></p>\n<p>&nbsp;</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Radiological findings in some congenital heart defects</h3><p><strong>Boot shaped heart - Tetralogy of Fallot (TOF)</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b8d455f894f24e8e9c147e7c3a178428x510x558.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Egg on string appearance - Transposition of Great Arteries (TGA)</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ad3fe6b6422548c8856299317c3e47c5x510x522.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Snowman's heart appearance or figure of 8 appearance</strong> -&nbsp;<strong>Supracardiac TAPVC</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c4d273d1af7445fdad02e659555c9e69x510x494.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Box Shaped Heart - Ebstein's Anomaly</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d07d5041004645849e8cce1dd37bd092x510x640.GIF\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Radiological Signs in Congenital Heart Diseases</h3><div>\n<table>\n<tbody>\n<tr>\n<td><strong>Anomaly</strong></td>\n<td><strong>Sign</strong></td>\n</tr>\n<tr>\n<td>Tetralogy of Fallot</td>\n<td>Coeur en sabot</td>\n</tr>\n<tr>\n<td>Transposition of great vessels (TGV)</td>\n<td>Egg on string</td>\n</tr>\n<tr>\n<td>Partial anomalous pulmonary venous return</td>\n<td>Scimitar sign</td>\n</tr>\n<tr>\n<td>Total anomalous pulmonary venous return</td>\n<td>Snowman sign</td>\n</tr>\n<tr>\n<td>Endocardial cushion defects</td>\n<td>Gooseneck sign</td>\n</tr>\n<tr>\n<td>Ebstein anomaly</td>\n<td>Box-shaped heart</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5533",
      "difficulty": "easy"
    },
    {
      "text": "Popular tactics used by marketing campaigns are based on the concept of priming. Which of the following structures is it dependent on?",
      "choices": [
        {
          "id": 1,
          "text": "Amygdala"
        },
        {
          "id": 2,
          "text": "Hippocampus"
        },
        {
          "id": 3,
          "text": "Neocortex"
        },
        {
          "id": 4,
          "text": "Striatum"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>F</strong><strong>acilitation of the recognition</strong> of words or objects <strong>by prior exposure</strong> to them is known as <strong>priming.</strong> Priming is dependent on the <strong>neocortex </strong>and is a form of <strong>implicit memory</strong>.</p>\n<p>Memory is usually divided into two forms: <strong>Explicit</strong> or <strong>declarative</strong> memory is associated with <strong>consciousness</strong> or awareness. <strong>Implicit</strong> or <strong>nondeclarative</strong> memory does not involve awareness and its retention does not usually involve processing in the hippocampus. </p>\n<p>Explicit and many forms of implicit memory involve</p>\n<ul>\n<li>Short-term memory and</li>\n<li>Long-term memory.</li>\n</ul>\n<p><strong>Short-term memory:</strong></p>\n<p>It lasts <strong>seconds to minutes;</strong> the encoding process for short-term explicit memory involves the <strong>hippocampus</strong>. It lasts only until the person continues to think about the number or facts.</p>\n<p><strong>Working memory </strong>is a form of short-term memory that keeps the information available, usually for very short periods of time, until the individual plans actions based on it.</p>\n<p><strong>Long-term memory:</strong></p>\n<p>It stores memories that can be recollected after years or even for a lifetime. These memories are stored in various parts of the <strong>neocortex</strong>. The various parts of the memories, such as visual, auditory, and olfactory, are localized to the cortical regions concerned with these functions. All these parts of the memories are brought together by long-term changes in the strength of transmission at relevant synaptic junctions so that all the components are brought to consciousness when that particular memory is recalled.</p>\n<p><strong>Neural basis of memory:</strong></p>\n<p>The basis of memory is the <strong>alteration in the strength</strong> of the selected synaptic connections. Second messenger systems contribute to the changes in the neural circuits, which are required for learning and memory. Alterations in the cellular membrane channels also contribute to it. </p>\n<p> </p>\n<p> </p>\n<p> </p><hr><h3>Related Pearl: Forms of Memory</h3><p>From physiologic point of view memory is divided into explicit and implicit forms.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1c881fbfcdfc4d689ab3dcd3b68aad8fx1280x802.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9629b6b0ef314e459062d7b6674917b4x1280x928.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5558",
      "difficulty": "medium"
    },
    {
      "text": "Sequentially arrange the steps involved in the progression of the action potential in a nerve cell.<div class='question-desc-html'><ol>\n<li>Na+ channels open in response to depolarizing stimulus.</li>\n<li>Sodium conductance decreases.</li>\n<li>Na+ channels close and K+ channels open. </li>\n<li>Rapid depolarization occurs.</li>\n<li>Repolarization occurs.</li>\n<li>The membrane reaches threshold potential.</li>\n<li>Both channels are closed. The membrane returns to RMP.</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-6-4-2-3-5-7"
        },
        {
          "id": 2,
          "text": "1-4-2-6-3-5-7"
        },
        {
          "id": 3,
          "text": "1-4-2-6-5-3-7"
        },
        {
          "id": 4,
          "text": "1-3-5-6-4-2-7"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The sequence of events during the action potential occurs in the following sequence.</p>\n<p>1. Resting-state: <strong>Both channels</strong> are<strong> closed</strong></p>\n<p>2. <strong>Na<sup>+</sup> channels open</strong> in response to depolarizing stimulus. Sodium enters the cell. The membrane reaches <strong>threshold potential.</strong></p>\n<p>3. The sodium influx causes the <strong>opening </strong>of more <strong>Na<sup>+ </sup></strong><strong>channels</strong> through a <strong>positive feedback</strong> mechanism. <strong>Rapid depolarization</strong> occurs.</p>\n<p>4. Sodium conductance decreases.</p>\n<p>5. <strong>Na<sup>+</sup></strong> channels<strong> close</strong> and <strong>K<sup>+</sup></strong> channels<strong> open</strong>. <strong>Repolarization</strong> occurs.</p>\n<p>6. <strong>Sodium</strong> channels are <strong>reset</strong> and are ready to respond to another depolarizing stimulus (<strong>relative refractory period</strong>). During this phase, the <strong>K<sup>+</sup></strong> channels remain open and <strong>slowly return</strong> to the <strong>closed</strong> state causing <strong>after-hyperpolarization</strong>.</p>\n<p>7. Both channels are closed. The membrane returns to <strong>RMP</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b7ddca57aa114fca80bfea1841dd7ebbx1279x1402.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Graded potential vs Action potential</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Graded Potential</strong></p>\n</td>\n<td>\n<p><strong>Action Potential</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Amplitude proportionate to strength of stimulus. It is graded.</p>\n</td>\n<td>\n<p>Independent of stimulus intensity &ndash; all or none response</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Can be depolarising or hyperpolarizing</p>\n</td>\n<td>\n<p>Depolarizing</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Is conducted decrementally - amplitude decreases with distance</p>\n</td>\n<td>\n<p>Self-propagated unchanged in amplitude</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Generated spontaneously or in response to stimuli- physical, chemical</p>\n</td>\n<td>\n<p>Generated only in response to Membrane Depolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Can be summated</p>\n</td>\n<td>\n<p>Cannot be summated</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Has no threshold and refractory period</p>\n</td>\n<td>\n<p>Has a threshold about 15 mv depolarized relative to the resting potential.</p>\n<p>Has a refractory period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Not always followed by some action</p>\n</td>\n<td>\n<p>Always followed by some action</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5550",
      "difficulty": "medium"
    },
    {
      "text": "Prompt surgical management would be indicated in a patient with Sheehan syndrome if there is _______.<div class='question-desc-html'><ol>\n<li>Significant visual loss</li>\n<li>Progressive visual loss</li>\n<li>Cranial nerve palsy</li>\n<li>Hypopituitarism</li>\n<li>Loss of consciousness</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3, or 4"
        },
        {
          "id": 2,
          "text": "1, 2, 3, or 5"
        },
        {
          "id": 3,
          "text": "2, 4, or 5"
        },
        {
          "id": 4,
          "text": "1, 4 or 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Significant </strong>or <strong>progressive</strong> <strong>visual loss</strong>, <strong>cranial nerve palsy</strong>, or<strong> loss of consciousness</strong> are considered indications for <strong>urgent surgical decompression</strong> in patients with <strong>Sheehan syndrome </strong>(option B- 1, 2, 3, or 5).</p>\n<p><strong>Pituitary apoplexy</strong>&nbsp;is a hemorrhagic infarction of large pituitary adenomas or&nbsp;<strong>pituitary infarction</strong>&nbsp;due to traumatic major blood loss. If this blood loss occurs<strong>&nbsp;during delivery,</strong>&nbsp;it is called&nbsp;<strong>Sheehan syndrome.&nbsp;</strong>The hyperplastic enlargement of the pituitary, which occurs normally during pregnancy, increases the risk of hemorrhage and infarction.&nbsp;</p>\n<p>Affected women may have persistent <strong>hypotension</strong>, <strong>tachycardia</strong>, <strong>hypoglycemia</strong>, and lactation failure. The most prominent symptoms are&nbsp;<strong>lactation failure&nbsp;</strong>(due to a deficiency of prolactin)<strong>&nbsp;</strong>and&nbsp;<strong>postpartum amenorrhea&nbsp;</strong>(due to a deficiency of gonadotropins).&nbsp;Because deficiencies of some or all pituitary-responsive hormones may develop after the initial insult, Sheehan syndrome can be heterogeneous and may not be identified for years.</p>\n<div>The acute presentation of <strong>pituitary apoplexy</strong>, an endocrine emergency, is characterized by a sudden onset of <strong>headache</strong>, nausea,<strong> visual deficits,</strong> and in severe cases, severe <strong>hypoglycemia</strong>, <strong>hypotension</strong> and shock, CNS hemorrhage, and death.</div>\n<p>Other&nbsp;features are:</p>\n<ul>\n<li>Loss of pubic and axillary hair</li>\n<li>Hypothyroidism due to decreased TSH secretion&nbsp;</li>\n<li>Adrenal insufficiency due to low ACTH</li>\n</ul>\n<p>Treatment is by hormone replacement: First,&nbsp;<strong>glucocorticoids </strong>and, later, thyroid hormone, sex steroids, vasopressin, and growth hormones are given. If there is evidence of progressive visual loss, cranial nerve involvement, or loss of consciousness, immediate surgical decompression must be carried out.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5624",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old female patient with newly diagnosed class II pulmonary hypertension has a positive vasoreactivity test. Which of the following medications is used in the next step of management?",
      "choices": [
        {
          "id": 1,
          "text": "Iloprost"
        },
        {
          "id": 2,
          "text": "Nifedipine"
        },
        {
          "id": 3,
          "text": "Ambrisentan"
        },
        {
          "id": 4,
          "text": "Epoprostenol"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Nifedipine</strong> is used as the next step in the management of a treatment-naive patient with <strong>class II pulmonary hypertension</strong> and a <strong>positive vasoreactivity test</strong>.</p>\n<p>Pulmonary hypertension is defined as mean pulmonary arterial pressure greater than <strong>20 mmHg </strong>with a pulmonary vascular resistance of ≥3 wood units. Exertional dyspnea, chest pain, fatigue, and lightheadedness are common early symptoms. With the progression of the disease, <strong>right ventricular dysfunction</strong> occurs which can cause syncope, abdominal distention, ascites, and peripheral edema.</p>\n<p>Management<strong> </strong>for pulmonary hypertension:</p>\n<p><strong>Vasoreactivity testing</strong> involves the administration of inhaled nitric oxide, IV epoprostenol, IV adenosine, or inhaled iloprost. The<strong> </strong>test is considered<strong> positive</strong> if the mean pulmonary arterial pressure (mPAH)<strong> decreases by ≥ 10 mmHg</strong> leading to <strong>mPAH ≤ 40 mmHg</strong>, without a decrease in cardiac output (CO).</p>\n<ul>\n<li><strong>Positive vasoreactivity </strong>test: <strong>Calcium channel blockers</strong> are indicated. Long-acting <strong>nifedipine</strong>, diltiazem, or amlodipine are used.<br /><br /></li>\n<li><strong>Negative vasoreactivity</strong> test:\n<ul>\n<li>For patients with <strong>lower risk (class II</strong>,<strong> III) </strong>based on clinical assessment: Oral therapy with <strong>endothelin receptor antagonists</strong> like <strong>ambrisentan</strong>, sitaxsentan, bosentan, or <strong>phosphodiesterase 5 inhibitors </strong>like sildenafil, tadalafil is the first line of therapy.</li>\n<li>For patients with<strong> higher risk (class IV) </strong>based on clinical assessment: Continuous treatment with IV <strong>prostacyclins</strong> (epoprostenol or treprostinil) would be the first line of therapy recommended.<br /><br /></li>\n</ul>\n</li>\n<li>Lung transplantation and/or atrial septostomy are reserved for patients who progress despite optimal medical treatment.</li>\n</ul>\n<p> The image below shows the treatment algorithm for pulmonary hypertension:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e78da2196a8f48dc97e5db27603061c7x1280x1794.JPEG\" alt=\"Explanation Image\"><p><br />The table below provides information on the prognosis of PAH:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Determinants</strong> </td>\n<td><strong>Low risk </strong></td>\n<td><strong>High risk</strong></td>\n</tr>\n<tr>\n<td>Clinical evidence of RV failure</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Progression of symptoms</td>\n<td>Gradual</td>\n<td>\n<p>Rapid</p>\n</td>\n</tr>\n<tr>\n<td>Echocardiography</td>\n<td>Minimal RV dysfunction</td>\n<td>Pericardial effusion, significant RV enlargement/dysfunction, right atrial enlargement</td>\n</tr>\n<tr>\n<td><strong>WHO functional class </strong></td>\n<td><strong>II, III</strong></td>\n<td><strong>IV</strong></td>\n</tr>\n<tr>\n<td>6min walk distance</td>\n<td>Longer (&gt;400 m)</td>\n<td>Shorter (&lt;300 m)</td>\n</tr>\n<tr>\n<td>BNP</td>\n<td>Minimally elevated</td>\n<td>Significantly elevated</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Drugs used in Pulmonary Arterial Hypertension (PAH)</h3><table>\n<tbody>\n<tr>\n<td><strong>Drug Class</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td>Prostacyclin derivative</td>\n<td>\n<p>Epoprostenol</p>\n<p>Iloprost</p>\n<p>Treprostinil</p>\n</td>\n</tr>\n<tr>\n<td>Endothelin receptor antagonist</td>\n<td>\n<p>Bosentan</p>\n<p>Ambrisentan</p>\n<p>Macitentan</p>\n</td>\n</tr>\n<tr>\n<td>PDE5 inhibitor</td>\n<td>\n<p>Sildenafil</p>\n<p>Tadalafil</p>\n</td>\n</tr>\n<tr>\n<td>Soluble guanyl cyclase stimulator</td>\n<td>Riociguat</td>\n</tr>\n<tr>\n<td>Calcium channel blocker</td>\n<td>\n<p>Nifedipine</p>\n<p>Diltiazem</p>\n<p>Amlodipine</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Classification of Pulmonary Hypertension & its Causes</h3><p>Based on underlying mechanisms, the World Health Organization has classified pulmonary hypertension into five groups.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Classification</strong></p>\n</td>\n<td>\n<p><strong>Causes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 1</strong></p>\n<p><strong>Pulmonary arterial hypertension (PAH)</strong></p>\n</td>\n<td>\n<p>Idiopathic PAH</p>\n<p>Hereditary PAH - BMPR2 gene (most common mutation)</p>\n<p>Drug or toxin-induced PAH</p>\n<p>PAH associated with</p>\n<ul>\n<li>Connective tissue disorder (limited systemic sclerosis)</li>\n<li>Portal hypertension</li>\n<li>HIV</li>\n<li>Schistosomiasis</li>\n<li>Congenital heart diseases</li>\n</ul>\n<p>PAH long-term responders to calcium channel blockers</p>\n<p>PAH with overt features of a pulmonary veno-occlusive disease or pulmonary capillary hemangiomatosis</p>\n<p>Persistent pulmonary hypertension of the newborn syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 2</strong></p>\n<p><strong>Pulmonary hypertension associated with left heart disease </strong></p>\n</td>\n<td>\n<p>Left ventricular systolic or diastolic dysfunction</p>\n<p>Valvular heart disease</p>\n<p>Congenital cardiomyopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 3</strong></p>\n<p><strong>Pulmonary hypertension associated with lung</strong> <strong>disease</strong></p>\n</td>\n<td>\n<p>Chronic obstructive pulmonary disease</p>\n<p>Interstitial lung disease</p>\n<p>Sleep-disordered breathing</p>\n<p>Alveolar hypoventilation disorders</p>\n<p>Chronic exposure to high altitude</p>\n<p>Developmental lung disorders</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 4</strong></p>\n<p><strong>Chronic thromboembolic pulmonary hypertension</strong></p>\n</td>\n<td>\n<p>Chronic thromboembolic pulmonary hypertension</p>\n<p>Congenital pulmonary artery stenosis</p>\n<p>Pulmonary arteritis</p>\n<p>Pulmonary angiosarcoma&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 5</strong></p>\n<p><strong>Pulmonary hypertension with unclear and/or multifactorial mechanisms</strong></p>\n</td>\n<td>\n<p>Hematological disorders (chronic hemolytic anemias)</p>\n<p>Metabolic disorders (glycogen storage diseases)</p>\n<p>Systemic disorders (sarcoidosis)</p>\n<p>Others (tumor obstruction, fibrosing mediastinitis)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5673",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is incorrectly paired?",
      "choices": [
        {
          "id": 1,
          "text": "Brenner tumors - Sex cord stromal tumor"
        },
        {
          "id": 2,
          "text": "Immature teratoma - Germ cell tumor"
        },
        {
          "id": 3,
          "text": "Sertoli cell tumor - Sex cord stromal tumor"
        },
        {
          "id": 4,
          "text": "Non-gestational choriocarcinoma - Germ cell tumor"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Brenner</strong> tumor/ <strong>transitional cell tumor</strong> is an <strong>epithelial</strong> tumor not a sex cord-stromal tumor</p>\n<p><strong>Brenner tumors</strong> are uncommon tumors of the ovary. They are typically small to moderate-sized tumors and are mostly benign. However, rarely, if tumors are seen with benign Brenner nests admixed with malignant tumor cells, they are known as malignant Brenner tumors. If it has greater than 50% malignant transitional type epithelium, then it is known as transitional cell carcinomas of the ovary.</p>\n<p>Clinically, they may present with vague abdominopelvic pain in postmenopausal women and are mostly detected incidentally as in this patient. Histopathologically, they are characterized by <strong>fibrous tissue</strong> with interspersed <strong>nests</strong> of <strong>transitional epithelium</strong>. These cells may have <strong>nuclei</strong> with a characteristic <strong>longitudinal groove</strong>. </p><hr><h3>Related Pearl: WHO Classification of Ovarian Tumors</h3><p><strong>I. &nbsp;Epithelial tumors (most common)</strong></p>\n<ul>\n<li>Serous tumors</li>\n<li>Mucinous tumors</li>\n<li>Endometrioid tumors</li>\n<li>Clear cell&nbsp;</li>\n<li>Brenner tumors (transitional cell tumors)</li>\n<li>Seromucinous</li>\n<li>Undifferentiated carcinoma</li>\n</ul>\n<div class=\"page\" title=\"Page 449\"><strong>II. Sex cord-stromal tumors:</strong></div>\n<ul>\n<li>Pure stromal cell tumors-&nbsp;Fibroma, Thecoma,&nbsp;Leydig cell tumor,&nbsp;Steroid cell tumor</li>\n<li>Pure sex cord tumors-&nbsp;Granulosa cell tumor (Adult/Juvenile),&nbsp;Sertoli cell tumor</li>\n<li>Mixed sex cord-stromal tumors- Sertoli&ndash;Leydig cell tumors</li>\n</ul>\n<p><strong>III.&nbsp;Germ cell tumors:</strong></p>\n<ul>\n<li>Dysgerminoma</li>\n<li>Endodermal sinus tumor (Yolk sac tumor)</li>\n<li>Embryonal carcinoma</li>\n<li>Polyembryoma</li>\n<li>Non-gestational choriocarcinoma</li>\n<li>Teratoma (Mature/immature)</li>\n<li>Mixed forms</li>\n</ul>\n<p><strong>IV.&nbsp;Gonadoblastoma</strong></p>\n<ul>\n<li>Pure</li>\n<li>Mixed with dysgerminoma or other germ cell tumors</li>\n</ul>\n<p><strong>V. Soft tissue tumors not specific to ovary</strong><br /><strong>VI. Miscellaneous tumors</strong><br /><strong>VII. Secondary (metastatic) tumors</strong><br /><strong>VIII. Tumor-like conditions</strong></p>\n<div class=\"page\" title=\"Page 449\">&nbsp;</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5637",
      "difficulty": "medium"
    },
    {
      "text": "Arrange the following in ascending order of their normal values<div class='question-desc-html'><ol>\n<li>Total lung capacity</li>\n<li>Vital capacity</li>\n<li>Inspiratory capacity</li>\n<li>Tidal Volume</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-2-3-4"
        },
        {
          "id": 2,
          "text": "4-1-2-3"
        },
        {
          "id": 3,
          "text": "4-3-1-2"
        },
        {
          "id": 4,
          "text": "4-3-2-1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Ascending order of their normal values would be</p>\n<ul>\n<li>Tidal Volume(<span>TV</span>) -&nbsp;500&ndash;750 mL</li>\n<li>Inspiratory capacity (<span>IC</span>) -&nbsp;&sim;3.5 L (<span>TV</span>+ <strong>IRV</strong> -Inspiratory Reserve Volume)</li>\n<li>Vital capacity(<span>VC</span>) -&nbsp;&sim;4.5 L (<span>IRV+TV</span>+<strong>ERV</strong> - Expiratory Reserve Volume)&nbsp;</li>\n<li>Total lung capacity (TLC) -&sim;5.8 L (<span>IRV+TV+ERV</span>+<strong>RV</strong>)&nbsp;</li>\n</ul><p>While this question can be solved if you know the values by heart, you can also solve this if you know the concepts about lung volumes and capacities well, without recollecting the absolute values. INI-CET often asks such seemingly mundane facts which can <strong>also be</strong> solved by just having a solid conceptual understanding.</p><hr><h3>Related Pearl: Lung volumes and capacities</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Measurement</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n<td>\n<p><strong>Normal Value</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Tidal volume (TV)</strong></p>\n</td>\n<td>\n<p>The amount of air that moves into the lungs with each inspiration (or the amount that moves out with each expiration) during quiet breathing</p>\n</td>\n<td>\n<p>500&ndash;750 mL.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inspiratory reserve volume&nbsp;</strong><strong>(IRV)</strong></p>\n</td>\n<td>\n<p>The air inspired with a maximal inspiratory effort in excess of the TV</p>\n</td>\n<td>\n<p>&sim;3 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Expiratory reserve volume (ERV)</strong></p>\n</td>\n<td>\n<p>The volume expelled by an active expiratory effort after passive expiration</p>\n</td>\n<td>\n<p>&sim;1.1 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Residual volume (RV)</strong></p>\n</td>\n<td>\n<p>The air left in the lungs after a maximal expiratory effort</p>\n</td>\n<td>\n<p>&sim;1.2 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total lung capacity (TLC)</strong></p>\n</td>\n<td>\n<p>IRV+TV+ERV+RV</p>\n</td>\n<td>\n<p>&sim;5.8 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Vital capacity (VC)</strong></p>\n</td>\n<td>\n<p>IRV+TV+ERV</p>\n</td>\n<td>\n<p>&sim;4.5 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inspiratory capacity (IC)</strong></p>\n</td>\n<td>\n<p>TV+IRV</p>\n</td>\n<td>\n<p>&sim;3.5 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Expiratory capacity (EC)</strong></p>\n</td>\n<td>\n<p>TV+ERV</p>\n</td>\n<td>\n<p>&sim;1.6 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Functional residual capacity (FRC)</strong></p>\n</td>\n<td>\n<p>ERV+RV</p>\n</td>\n<td>\n<p>&sim;2.3 L</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/06c833b7f0ac40998f328de5bbe2816bx1279x973.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5559",
      "difficulty": "easy"
    },
    {
      "text": "A gardener from the sub-Himalayan region presents to the OPD with the following lesions. On microscopy from tissue biopsy, flower-like clusters of conidia are seen. Which of the following is the drug of choice for the treatment of his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Liposomal Amphotericin B"
        },
        {
          "id": 2,
          "text": "Itraconazole"
        },
        {
          "id": 3,
          "text": "Fluconazole"
        },
        {
          "id": 4,
          "text": "Posaconazole"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The presence of multiple vesicles on hand and multiple eruptions along lymphatics in a gardener from the sub-Himalayan region, and the microscopic finding of flower-like clusters of conidia are suggestive of <strong>lymphocutaneous</strong> <strong>sporotrichosis</strong>. <strong>Itraconazole</strong> is the <strong>drug of choice</strong> for the treatment of lymphocutaneous sporotrichosis.</p>\n<p><em><strong>Sporothrix schenckii </strong></em>causes sporotrichosis, a chronic granulomatous disease, by <strong>traumatic inoculation</strong> into the skin. This is usually followed by spread along the draining lymphatics and lymph nodes. </p>\n<p>It is a thermally <strong>dimorphic fungus. </strong>It is in the yeast phase in tissues and in cultures at 37°C, and in the mycelia phase in nature and cultures at 25°C. When it is cultured, the colonies are blackish-brown and fuzzy. The organism produces branching, septate hyphae, and microconidia clustered at the ends of conidiophores. It exists as cigar-shaped yeast cells. Stains used for identifying yeast forms: </p>\n<ul>\n<li>Gomori methenamine silver - cell wall appears black</li>\n<li>Periodic acid-Schiff stain - cell wall appears red </li>\n<li>Fluorescent antibody staining</li>\n</ul>\n<p>The image given below shows, (A)- (i) culture at 37°C (ii) culture at 25°C. (B) fungi with clustered microconidia with conidiophore.  (C) magnified image showing branching and septate hyphae.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2b67a420432a4dbeaf2720ed90d73553x1280x947.PNG\" alt=\"Explanation Image\"><p>Clinical features: The initial infection develops as a nodule, which may break down to form a necrotic or ulcerative lesion. Untreated, the disease progresses and new nodules develop along the <strong>lymphatics</strong> leading to a chain of nodules. Less commonly it may also cause systemic infection following inhalation, which causes local pulmonary disease or may lead to widely disseminated lesions in joints, meninges, and skin.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e3407e191ba143c6bdfe5f8cba586780x1280x1725.JPEG\" alt=\"Explanation Image\"><p>Treatment:<strong> Itraconazole</strong> is the <strong>drug of choice</strong> for <strong>lymphocutaneous sporotrichosis.</strong> </p>\n<p>Other treatment options for lymphocutaneous sporotrichosis:</p>\n<ul>\n<li>Terbinafine</li>\n<li>SSKI- Saturated solution of potassium iodide</li>\n<li>Fluconazole</li>\n<li>Local hyperthermia</li>\n</ul>\n<p><strong>Pulmonary sporotrichosis &amp; osteoarticular sporotrichosis</strong> are also treated with <strong>itraconazole </strong>in mild to moderate cases. But, <strong>liposomal amphotericin B</strong> can be used in patients that are seriously ill with <strong>severe or life-threatening disease.</strong></p>\n<p><strong>Meningeal sporotrichosis </strong>is treated with <strong>amphotericin B</strong>, as it is the <strong>drug of choice</strong> for meningeal sporotrichosis. Itraconazole is used for step-down therapy in these patients. </p>\n<p> </p><hr><h3>Related Pearl: Classification of fungus based on morphology</h3><p>Fungi are classified into 4 types based on their morphology:</p>\n<ul>\n<li>Yeast</li>\n<li>Yeast-like</li>\n<li>Molds</li>\n<li>Dimorphic fungi</li>\n</ul>\n<p><strong>Yeast:</strong></p>\n<ul>\n<li>Unicellular fungi</li>\n<li>Reproduces by budding</li>\n<li>Oval to round forms</li>\n<li>Example: Cryptococcus,&nbsp;Saccharomyces.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0f583d17fa494e93b42864de8e82507cx597x599.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Yeast like:</strong></p>\n<ul>\n<li>Unicellular fungi</li>\n<li>Reproduces by budding or binary fission</li>\n<li>Spherical or oval forms</li>\n<li>Pseudohyphae may be seen.</li>\n<li>Example: Candida,&nbsp;Malassezia furfur.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bf7e12378e26462194d6b6f9155af000x800x501.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Molds/filamentous fungi:</strong></p>\n<ul>\n<li>Have hyphae which may be septate or aseptate</li>\n<li>Aseptate or coenocytic hyphae &ndash; Rhizopus, mucor,&nbsp;Lichtheimia.</li>\n<li>Septate hyphae &ndash; Penicillium, Dermatophytes, Aspergillus, fusarium.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/129499f438c04855bf91806ab6191d23x800x547.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Dimorphic fungi</strong></p>\n<ul>\n<li>Filamentous forms in the culture at 22<sup>0</sup>C &ndash; 25<sup>0</sup>C and in the environment.</li>\n<li>Yeast form in the culture at 37<sup>0</sup>C and in tissues.</li>\n<li>Examples &ndash; Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis, Paracoccidioides brasiliensis, Talaromyces&nbsp;marneffei, Sporothrix schenckii.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/cf15e7f3ffa74eda970ad035743b1890.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5521",
      "difficulty": "medium"
    },
    {
      "text": "An ultrasound image of the lung would show a seashore sign in case of a _____.",
      "choices": [
        {
          "id": 1,
          "text": "Normal lung"
        },
        {
          "id": 2,
          "text": "Pneumothorax"
        },
        {
          "id": 3,
          "text": "Consolidation"
        },
        {
          "id": 4,
          "text": "Collapse"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>An ultrasound image of the lung would show a <strong>seashore sign</strong> in case of a<strong> normal lung</strong>.</p>\n<p>On M-mode, classical signs for the grayscale imaging are seen:<br />• Seashore sign: normal lung <br />• Barcode/stratosphere sign: pneumothorax</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7c64761fc8cf46f3a5cb55b960e94332x1280x1522.JPEG\" alt=\"Explanation Image\"><p>The M-mode image in the pneumothorax demonstrates a linear, laminar pattern in the tissue superficial to the pleural line and a similar linear pattern deep to the pleural line. This phenomenon, known as the <strong>stratosphere sign</strong> or <strong>barcode sign</strong>, indicates <strong>absent lung sliding</strong> and suggests the presence of <strong>pneumothorax.</strong></p>\n<p>The M-mode image of a normal lung demonstrates a linear, laminar pattern in the tissue superficial to the pleural line and a granular or <strong>sandy</strong> appearance deep to the pleural line. This phenomenon is known as the <strong>seashore sign, </strong>and it indicates <strong>normal lung sliding</strong> and excludes pneumothorax at this interspace.</p>\n<p><strong>Pleural effusion </strong>on ultrasound appears <strong>anechoic</strong> with an <strong>echogenic line at the fluid-lung interface</strong> if it is <strong>transudate</strong>. Exudative and hemorrhagic effusions may appear echogenic with pleural thickening. The fluid shows movement and changes in shape with breathing, along with the presence of septa and fibrous strands.</p>\n<p><strong>Consolidation</strong> on ultrasound appears <strong>hypoechoic with heterogeneous echotexture</strong>. It is isoechoic with the liver and is referred to as <strong>lung hepatization</strong>. </p>\n<p><strong>A collapsed lung</strong> under a large effusion will be seen as a <strong>hyperechoic wedge-shaped area.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5596",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions is associated with box car nuclei seen on histopathological examination of the myocytes?",
      "choices": [
        {
          "id": 1,
          "text": "Hypertension"
        },
        {
          "id": 2,
          "text": "Hypertrophic cardiomyopathy"
        },
        {
          "id": 3,
          "text": "Dilated cardiomyopathy"
        },
        {
          "id": 4,
          "text": "Subendocardial ischemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In<strong> hypertensive heart disease</strong>, the individual myocytes are enlarged and show nucleomegaly. These nuclei are called <strong>box car nuclei.</strong></p>\n<p>The most important histologic features of HOCM myocardium are as follows:</p>\n<ol>\n<li>Massive myocyte hypertrophy</li>\n<li>Haphazard disarray of bundles of myocytes, individual myocytes, and contractile elements in sarcomeres within cells. This is termed&nbsp;<strong>myofiber disarray.</strong></li>\n<li>Interstitial and replacement fibrosis</li>\n</ol>\n<p><strong>Myocyte vacuolization</strong>, also called&nbsp;<strong>myocytolysis</strong>,&nbsp;is associated with <strong>subendocardial ischemia.</strong></p>\n<p><strong>Dilated cardiomyopathy</strong> is also associated with <strong>massive myocyte hypertrophy.</strong></p><p>The best answer for box-car nuclei on histopathological examination is Hypertension&gt; Hypertrophic cardiomyopathy. Box car nuclei are seen in the setting of hypertension resulting in left ventricular hypertrophy even in those without any hypertrophic cardiomyopathy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5666",
      "difficulty": "hard"
    },
    {
      "text": "A patient with hypercholesterolemia and type 2 diabetes is advised to take colesevelam. What is the mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Binding of bile acid in the intestine"
        },
        {
          "id": 2,
          "text": "Inhibit lipolysis in adipose tissues"
        },
        {
          "id": 3,
          "text": "Inhibit HMG-CoA synthase"
        },
        {
          "id": 4,
          "text": "Increased lipolysis of triglycerides"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Colesevelam&nbsp;</strong>is a bile acid&ndash;binding resin that&nbsp;<strong>binds bile acid in the intestine</strong>.</p>\n<p>Colesevelam is the <strong>only&nbsp;bile acid sequestrant specifically approved</strong> for the treatment of type 2 diabetes and is&nbsp;used as an adjunct to diet and exercise. It is also approved for the treatment of <strong>hypercholesterolemia</strong>.&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>HMG-CoA reductase inhibitors (statins)</strong></td>\n<td><strong>Fibrates</strong></td>\n<td><strong>Niacin</strong></td>\n<td><strong>Bile acid&ndash;binding resins</strong></td>\n<td><strong>Ezetimibe</strong></td>\n</tr>\n<tr>\n<td>Important examples</td>\n<td>\n<p class=\"p1\">Lovastatin, atorvastatin, fluvastatin, pravastatin, simvastatin, rosuvastatin, pitavastatin</p>\n</td>\n<td>\n<p class=\"p1\">Gemfibrozil and fenofibrate</p>\n</td>\n<td>Niacin</td>\n<td>&nbsp;\n<p class=\"p1\">Colestipol, cholestyramine, <strong>colesevelam</strong></p>\n</td>\n<td>Ezetimibe</td>\n</tr>\n<tr>\n<td>Mechanism of action</td>\n<td>\n<p class=\"p1\">Inhibits HMG-CoA reductase</p>\n</td>\n<td>\n<p class=\"p1\">PPAR-<span class=\"s1\">&alpha; mediated increased lipolysis</span></p>\n</td>\n<td>Decreases the production of VLDLs and decreases the catabolism of HDLs</td>\n<td>Binds to bile acids in the intestinal lumen and increases excretion. This results in increased conversion of hepatic cholesterol to bile acids, and reduction in hepatic cholesterol content.</td>\n<td>Inhibits intestinal sterol absorption</td>\n</tr>\n<tr>\n<td>Major effects on lipoprotein levels</td>\n<td>\n<p>Reduces LDL levels</p>\n</td>\n<td>\n<p>Reduces triglyceride levels</p>\n<p>A moderate increase in HDL levels</p>\n</td>\n<td>\n<p>Reduces triglycerides,&nbsp; LDL, and lipoprotein a levels</p>\n<p>Significant <strong>increase HDL</strong> levels</p>\n</td>\n<td>Reduces LDL levels&nbsp;</td>\n<td>\n<p>Reduces LDL cholesterol</p>\n<p>Minimal increase in HDL level</p>\n<p>Also decreases the absorption of phytosterols</p>\n</td>\n</tr>\n<tr>\n<td>Important side effects</td>\n<td><strong>Myopathy</strong>\n<p class=\"p1\">Elevations of serum aminotransferase activity</p>\n<p class=\"p1\">Elevation of creatine kinase activity</p>\n</td>\n<td>\n<p class=\"p1\">Rashes, gastrointestinal symptoms, myopathy, arrhythmias</p>\n<p class=\"p1\">Hypokalemia, elevated aminotransferases, or alkaline phosphatase&nbsp;</p>\n</td>\n<td>\n<p>Cutaneous vasodilation</p>\n<p>Elevations in aminotransferases levels&nbsp;</p>\n</td>\n<td>\n<p>Constipation</p>\n<p>Bloating&nbsp;</p>\n<p>May increase plasma triglycerides</p>\n</td>\n<td>\n<p>Reversible hepatic function impairment</p>\n<p>Rarely myositis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5486",
      "difficulty": "easy"
    },
    {
      "text": "You must advise for partner treatment of STD while prescribing all of the following kits, except ____.",
      "choices": [
        {
          "id": 1,
          "text": "Blue kit"
        },
        {
          "id": 2,
          "text": "Red kit"
        },
        {
          "id": 3,
          "text": "White kit"
        },
        {
          "id": 4,
          "text": "Black kit"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Herpetic genital ulcers</strong> are managed using the <strong>red kit</strong> and partner treatment is <strong>not necessary.</strong></p>\n<p>All partners for the past <strong>3 months</strong> need to be treated in those receiving <strong>white or blue kits&nbsp;</strong>(non-herpetic genital ulcer), while all partners for the past <strong>3 weeks</strong> need treatment in case of <strong>black kit</strong> administration (inguinal bubo).</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Syndromic Management of Sexually Transmitted Infections</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1167210a9cd6434a905a98bc64668d41x1280x2612.PNG\" alt=\"Pearl Image\"><p>Partner Management when <strong>asymptomatic</strong> is not required for <strong>Gardenella vaginalis, Candida and Herpes infections</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/60da7b1257d04ca5938ef3340533e6b9x1280x2974.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5508",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following pairs of electron microscopy finding and disease is incorrect?",
      "choices": [
        {
          "id": 1,
          "text": "Linear deposits along the basement membrane - Goodpasture syndrome"
        },
        {
          "id": 2,
          "text": "Basket weave appearance - Membranous nephropathy"
        },
        {
          "id": 3,
          "text": "Mesangial and paramesangial dense deposits - IgA nephropathy"
        },
        {
          "id": 4,
          "text": "Subepithelial humps - Postinfectious glomerulo-nephritis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Basket-weave appearance</strong> of the glomerular basement membrane (GBM) is seen in the case of <strong>Alport syndrome</strong>. </p>\n<p>Alport syndrome or<strong> hereditary nephritis</strong> is a genetic disease caused by mutations in the genes coding for<strong> type IV collagen</strong>. This is a major component of the basement membranes. The majority of the patients have an <strong>X-linked inheritance</strong>. Clinical features include <strong>hematuria</strong>, proteinuria, and <strong>sensorineural hearing loss</strong>. Ocular manifestations include <strong>anterior lenticonus</strong>, macular flecks, and corneal dystrophy.</p>\n<p><strong>Light microscopy </strong>appears <strong>normal</strong> during the first decade of life. Later glomeruli may have mesangial proliferation and capillary wall thickening. This may lead to progressive sclerosis of the glomerulus. <strong>Electron microscopy </strong>shows diffuse thickening and thinning along with splitting of glomerular and tubular basement membranes. It is seen as a characteristic <strong>basket weaving appearance</strong> of lamina densa as shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1ac22e9dc454499d93f15ef3885714f6x720x527.JPEG\" alt=\"Explanation Image\"><p>No specific therapy is recommended to treat Alport syndrome. Proteinuria can be treated with angiotensin-converting enzyme inhibitors or angiotensin 2 receptor blockers.</p>\n<p><strong>Subepithelial deposits</strong> are seen on electron microscopy in cases of <strong>membranous nephropathy</strong>. It typically has a <strong>noninflammatory</strong> pathology. It presents as a <strong>nephrotic syndrome</strong> in most patients. Non-nephrotic proteinuria, hematuria, and mild hypertension can be seen in some cases. </p>\n<p> </p><hr><h3>Related Pearl: Glomerular Pathology in Renal Diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td><strong>Light microscopy</strong></td>\n<td><strong>Fluorescence microscopy</strong></td>\n<td>\n<p><strong>Electron microscopy</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Nephritic syndrome:</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Postinfectious glomerulo-nephritis</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diffuse endocapillary proliferation; leukocytic infiltration</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Granular IgG and C3 in glomerular basement membrane and mesangium,&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Granular IgA in some cases</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Subepithelial humps </strong>Subendothelial deposits in early disease stages</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n<td>Extracapillary proliferation with <strong>crescents</strong>; necrosis</td>\n<td>&nbsp;<strong>Linear </strong>IgG and C3; fibrin in crescents</td>\n<td>\n<p><strong>Linear deposits</strong><strong><strong>&nbsp;</strong></strong>along the basement membrane.&nbsp;</p>\n<p><strong>Disruptions in GBM</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IgA nephropathy (Berger disease)</p>\n</td>\n<td>Focal mesangial proliferative glomerulo-nephritis; mesangial widening</td>\n<td>&nbsp;<strong>IgA</strong> &plusmn; IgG, IgM, and C3 in mesangium</td>\n<td><strong>Mesangial </strong>and paramesangial dense deposits&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alport syndrome</p>\n</td>\n<td>Normal</td>\n<td>Negative</td>\n<td><strong>Basket-weave appearance </strong>of GBM</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Nephrotic syndrome:</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous&nbsp; nephropathy</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diffuse capillary wall thickening</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Granular IgG and C3; diffuse</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Subepithelial deposits </strong>(epimembranous spikes),&nbsp;effacement of podocyte&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal change disease</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal; lipid in tubules</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Negative&nbsp;</td>\n<td>\n<p>No deposits.</p>\n<p>Effacement of podocyte&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal segmental glomerulo-sclerosis&nbsp; (FSGS)</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Glomerular hyalinosis and sclerosis</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Occasional C3 and IgM deposits in the sclerotic areas and the mesangium.</td>\n<td>\n<p>No deposits.</p>\n<p>Effacement of podocyte&nbsp;</p>\n<p>Epithelial denudation.</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Nephrito-nephrotic syndrome:&nbsp;&nbsp;&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membrano-proliferative glomerulo-nephritis</p>\n<p>(MPGN) type I</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mesangial proliferative pattern of proliferation; GBM thickening; splitting</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>C3, C1q, C4 deposits&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\nIgG deposits</td>\n<td>\n<p><strong>Subendothelial deposits</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dense-deposit disease (MPGN type II)</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mesangial proliferative&nbsp; pattern of proliferation; GBM thickening; splitting</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>C3 deposits;</p>\n<p>No C1q and C4 deposits</p>\n<p>No IgG deposits</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Intramembranous </strong>Dense deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fibrillary glomerulo-nephritis</p>\n</td>\n<td>&nbsp;\n<div class=\"page\" title=\"Page 931\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Membrano-proliferative or mesangio-proliferative patterns</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>IgG4 and C3&nbsp;</td>\n<td>Fibrillar deposits in the mesangium and capillary walls</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Note:</p>\n<ul>\n<li>Anionic antigens form subendothelial deposits.</li>\n<li>Cationic antigens form subepithelial deposits.</li>\n<li>Neutral antigens form mesangial deposits.</li>\n</ul>\n<p>&nbsp;</p><hr><h3>Related Pearl: Sites of Deposits in Glomerular diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>Subepithelial</strong></td>\n<td>\n<ul>\n<li>Membranous nephropathy (epimembranous)</li>\n<li>PSGN</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Intramembranous</strong></td>\n<td>\n<ul>\n<li>Dense deposit disease (MPGN type II)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Subendothelial</strong></td>\n<td>\n<ul>\n<li>MPGN Type I</li>\n<li>Lupus nephritis class III and IV</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Mesangial</strong></td>\n<td>\n<ul>\n<li>IgA nephropathy</li>\n<li>Henoch&ndash;Schonlein Purpura</li>\n<li>RPGN&nbsp;</li>\n<li>Lupus nephritis classes I and II</li>\n<li>Resolving postinfectious&nbsp; glomerulonephritis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>No deposits</strong></td>\n<td>\n<ul>\n<li>Minimal change disease</li>\n<li>FSGS</li>\n<li>Alport syndrome</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>MPGN: Membranoproliferative glomerulonephritis</p>\n<p>PSGN: Poststreptococcal glomerulonephritis&nbsp;</p>\n<p>FSGS: Focal segmental glomerulosclerosis</p>\n<p>RPGN: Rapidly progressive glomerulonephritis&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7a297a03f6db49959196ff715d59b609x1280x1685.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Nephrotic and nephritic syndromes</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">&nbsp;</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Nephrotic Syndrome</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Nephritic Syndrome</strong> (Glomerulonephritis)</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Primary pathology</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Damage and dysfunction of glomerular filtration barrier, causing significant leakage of plasma proteins without much glomerular inflammation</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Significant inflammatory injury of the glomerulus resulting in passage of RBCs, inflammatory cells &amp; plasma proteins</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">The principal site of glomerular injury</p>\n</td>\n<td class=\"td1\" valign=\"top\">Visceral epithelial cell (Podocyte)</td>\n<td class=\"td1\" valign=\"top\">Endothelial cells, glomerular basement membrane (GBM), Mesangial cells, Parietal epithelial cells (&gt;Crescents)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Clinical features</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Hallmark: </strong></p>\n<p class=\"p1\"><strong>Heavy Proteinuria: 3.5 g</strong>/24 h or Urine protein:creatinine ratio &gt;3)<span class=\"Apple-converted-space\">&nbsp; </span></p>\n<p class=\"p1\">Hypoalbuminemia,<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p class=\"p1\">Edema</p>\n<p class=\"p1\">Lipiduria, Hyperlipidemia</p>\n<p class=\"p1\">Microscopic hematuria</p>\n<p class=\"p1\">Hypertension</p>\n<p class=\"p1\">Hypercoagulability<span class=\"Apple-converted-space\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Hallmark: </strong></p>\n<p class=\"p1\"><strong>Hematuria</strong> (RBC casts/dysmorphic RBCs)</p>\n<p class=\"p1\">Varying degrees of proteinuria and pyuria</p>\n<p class=\"p1\">Renal dysfunction</p>\n<p class=\"p1\">Hypertension</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Associated Glomerular pathology</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p>Minimal change disease (Primary and secondary)</p>\n<p>Focal segmental glomerulosclerosis (FSGS) (Primary and secondary)</p>\n<p>Membranous-nephropathy (Primary and secondary)</p>\n<p>Diabetic nephropathy</p>\n<p>Amyloidosis</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p>Acute post-streptococcal glomerulonephritis</p>\n<p>Rapidly progressive glomerulonephritis (crescentic)</p>\n<p>IgA nephropathy (Berger disease)</p>\n<p>Membranoproliferative glomerulonephritis</p>\n<p>Alport syndrome</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p1\">These syndromes, however, are <strong>not mutually exclusive</strong>. Some glomerular diseases <strong>may progress from one pattern to another</strong> or&nbsp;may present with considerable<strong> overlap</strong> between them, as&nbsp;a <strong>nephritic&ndash;nephrotic syndrome;</strong>&nbsp;features of nephrotic syndrome can concurrently occur with any form of nephritic syndrome but are most commonly seen with diffuse proliferative glomerulonephritis (seen in systemic lupus erythematosus) and membranoproliferative glomerulonephritis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5660",
      "difficulty": "medium"
    },
    {
      "text": "All of the following conditions show the pattern of inheritance that corresponds to the pedigree chart below except:",
      "choices": [
        {
          "id": 1,
          "text": "Kearn- Sayre Syndrome"
        },
        {
          "id": 2,
          "text": "MELAS"
        },
        {
          "id": 3,
          "text": "Leber hereditary optic neuropathy"
        },
        {
          "id": 4,
          "text": "Tuberous sclerosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The pattern of inheritance shown in the pedigree chart is <strong>mitochondrial inheritance</strong>. <strong>Tuberous sclerosis</strong> is inherited in an <strong>autosomal dominant manner, not by mitochondrial inheritance.</strong> </p>\n<p>The unique feature of mitochondrial inheritance is <strong>maternal inheritance</strong>. The mitochondrial DNA of the zygote is completely derived from the ovum. Therefore, when the <strong>mother</strong> is <strong>affected</strong> and the <strong>father</strong> is <strong>normal</strong>, all their <strong>children</strong> will be <strong>affected</strong>. </p>\n<p>However, children will not be affected if they are born to a normal mother and an affected father. Only the daughters of the affected mother will further transmit the disease to the next generations.</p>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e9d7f0e4ae96444d8fc4a952f9fd5c4bx1280x1242.9901269393513.JPEG\" alt=\"Explanation Image\"><div> </div>\n<div><span class=\"ace-all-bold-hthree\"><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Features of mitochondrial inheritance:</span></span></div>\n<ul class=\"listtype-bullet listindent1 list-bullet1\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The mitochondrial DNA encodes </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">enzymes required for </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">oxidative </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">phosphorylation</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">. The organs of the </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">central nervous system, skeletal muscle, cardiac muscle, liver, and kidneys are affected as they are most dependent on oxidative phosphorylation.</span></li>\n<li><strong>Heteroplasmy</strong> is a phenomenon in which the individual has both wild-type and mutant type of mtDNA. </li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Threshold </strong><strong>effect </strong>is defined as a minimum number of copies of mutant mtDNA to be present in the mitochondria that can lead to oxidative dysfunction to manifest the disease</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">.</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The expression of the disease varies even among different cells of an organ. This is because there is a variable distribution of the normal and mutant mtDNA to the cells.</span></li>\n</ul><hr><h3>Related Pearl: Diseases of mitochondrial inheritance</h3><ul>\n<li><span>Caused by <strong>mutations of the mitochondrial genome</strong></span></li>\n<li><span>Inherited <strong>exclusively from the affected mother</strong></span></li>\n<li><span>These diseases include: (mnemonic: <strong>KLMNOP</strong>)</span></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Disease</strong></span></p>\n</td>\n<td>\n<p><span><strong>Features</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>K</strong>:<strong>&nbsp;</strong>Kearn- Sayre Syndrome (KSS)</span></p>\n</td>\n<td>\n<p><span>Ophthalmoplegia</span></p>\n<p><span>Pigmentary retinopathy</span></p>\n<p><span>Cardiomyopathy</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>L</strong>: Leigh disease</span></p>\n</td>\n<td>\n<p><span>Subacute necrotizing encephalomyelopathy</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>L</strong>: Leber hereditary optic neuropathy</span></p>\n</td>\n<td>\n<p><span>Acute or subacute vision loss due to B/L optic atrophy</span></p>\n<p><span>Cerebellar ataxia</span></p>\n<p><span>Hyperreflexia</span></p>\n<p><span>Babinski sign</span></p>\n<p><span>Psychiatric symptoms</span></p>\n<p><span>Peripheral neuropathy</span></p>\n<p><span>Cardiac conduction abnormalities</span></p>\n<p><span>Some have white matter lesions</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>M</strong>: MELAS</span></p>\n</td>\n<td>\n<p><span>Mitochondrial myopathy</span></p>\n<p><span>Encephalopathy</span></p>\n<p><span>Lactic acidosis</span></p>\n<p><span>Stroke-like episodes</span></p>\n<p><span>(</span><span>MERRF) Myoclonic epilepsy, </span><strong>ragged red fibers</strong><span> in muscle, ataxia, sensorineural deafness</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>N</strong>: NARP (2 clinical patterns)</span></p>\n</td>\n<td>\n<p><span>1. Neuropathy, ataxia, retinitis pigmentosa, dementia</span></p>\n<p><span>2. Severe infantile encephalopathy with lesions in basal ganglia</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>O</strong>: Chronic progressive external&nbsp;<strong>o</strong>phthalmoplegia (CPEO)</span></p>\n</td>\n<td>\n<p><span>Ophthalmoplegia</span></p>\n<p><span>Cardiomyopathy</span></p>\n<p><span>Ptosis</span></p>\n<p><span>Heart block</span></p>\n<p><span>Ataxia</span></p>\n<p><span>Retinal pigmentation</span></p>\n<p><span>Diabetes</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>P</strong>: Pearson&nbsp;syndrome</span></p>\n</td>\n<td>\n<p><span>Pancreatic insufficiency</span></p>\n<p><span>Pancytopenia</span></p>\n<p><span>Lactic acidosis</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p><hr><h3>Related Pearl: Pedigree chart for different inheritance patterns</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b04518e36bdd471daf76691dafd74139x1280x2969.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/195c2ef3907e4d8eac2c909799cbef3ex1280x2742.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Inheritance pattern of important diseases</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington&rsquo;s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher&rsquo;s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don&rsquo;t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch&ndash;Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett&rsquo;s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot&ndash;Marie&ndash;Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on&rsquo;t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott&ndash;Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/851408105e734ac899aa5106c41611ab.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5667",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following occurs during REM sleep?",
      "choices": [
        {
          "id": 1,
          "text": "Somnambulism"
        },
        {
          "id": 2,
          "text": "Night terror"
        },
        {
          "id": 3,
          "text": "Nocturnal penile tumescence"
        },
        {
          "id": 4,
          "text": "Nocturnal enuresis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Nocturnal penile tumescence</strong> occurs during <strong>REM sleep.</strong></p>\n<p>Somnambulism, night terrors, and nocturnal enuresis occur during NREM sleep.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Events occurring in NREM and REM sleep</h3><p>Events occurring during <strong>NREM&nbsp;stages 3 and 4</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Events</strong></span></p>\n</td>\n<td>\n<p><span><strong>Description</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Somnambulism</strong></span></p>\n</td>\n<td>\n<p><span>Sleepwalking</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Sleep terror or Night terror</strong></span></p>\n</td>\n<td>\n<p><span>Also called pavor nocturnus.</span></p>\n<p><span>Awakens with a scream or intense anxiety. Has increased autonomic disturbances.</span></p>\n<p><span>They do not have a memory of this when they wake up.</span></p>\n<p><span>Runs in families and seen more frequently in childhood and boys.</span></p>\n<p><span>Treatment with benzodiazepines is rarely required.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nocturnal enuresis</strong></span></p>\n</td>\n<td>\n<p><span>Behavioral therapy is the mainstay.</span></p>\n<p><span>Drugs like desmopressin and imipramine are used.</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Events occurring in <strong>REM sleep</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Events</strong></span></p>\n</td>\n<td>\n<p><span><strong>Description</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nightmares</strong></span></p>\n</td>\n<td>\n<p><span>Fearful sleep without autonomic disturbances that are well remembered in the morning.</span></p>\n<p><span>TCAs may be used for treatment.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nocturnal penile tumescence</strong></span></p>\n</td>\n<td>\n<p><span>A normal phenomenon that can be used to differentiate between psychogenic and organic impotence.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Narcolepsy</strong></span></p>\n</td>\n<td>\n<p><span>A disorder of the REM sleep characterized by disturbed sleep in the night, leading to excessive sleep in the morning.</span></p>\n<p><span>Associated with symptoms such as cataplexy, hypnogogic and hypnopompic hallucination, and sleep paralysis.</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;<strong>*Hypnogogic hallucinations</strong> are those that occur at the start of sleep and <strong>hypnopompic hallucinations</strong> are those that occur at the end of sleep.</p>\n<p>&nbsp;</p>\n<p>Others:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Events</strong></span></p>\n</td>\n<td>\n<p><span><strong>Description</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bruxism&nbsp;</strong>(teeth grinding)</span></p>\n</td>\n<td>\n<p><span>Occurs in stage 2 NREM sleep.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Frontal lobe epilepsy</strong></span></p>\n</td>\n<td>\n<p><span>Occurs in stage 2 NREM sleep.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Sleep talking</strong></span></p>\n</td>\n<td>\n<p><span>Occurs in all stages of sleep and may accompany night terrors and sleepwalking.</span></p>\n<p><span>Common in children.</span></p>\n<p><span>No treatment is necessary.</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5620",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a contraindication for performing the following procedure in a patient with pancreatic carcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Small liver metastases"
        },
        {
          "id": 2,
          "text": "Celiac lymph node involvement"
        },
        {
          "id": 3,
          "text": "Peripancreatic lymph nodes involvement"
        },
        {
          "id": 4,
          "text": "Hepatic hilar lymph node involvement"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div>The given image shows the <strong>Whipple procedure.</strong>&nbsp;It is not contraindicated in <strong>pancreatic carcinoma patients</strong> with <strong>peripancreatic lymph node involvement.</strong></div>\n<div>&nbsp;</div>\n<div>Contraindications for resection:</div>\n<ul>\n<li>Liver metastases of <strong>any size</strong></li>\n<li><strong>Celiac lymph node</strong> involvement</li>\n<li>Peritoneal implants</li>\n<li><strong>Hepatic hilar lymph node</strong> involvement</li>\n</ul>\n<p>Findings that are not considered contraindications for resection:</p>\n<ul>\n<li>Duodenum or distal stomach invasion</li>\n<li><strong>Peripancreatic lymph node involvement</strong></li>\n<li>Involvement of Lymph nodes along the porta hepatis that can be swept down with the specimen&nbsp;</li>\n</ul>\n<div>&nbsp;</div>\n<div>The&nbsp;<strong>Whipple procedure</strong>&nbsp;is a complex surgery done for carcinomas involving the&nbsp;<strong>head of the pancreas</strong>.</div>\n<p>The following structures are removed during the Whipple procedure:</p>\n<ul>\n<li>Distal stomach</li>\n<li>Duodenum</li>\n<li>Head of the pancreas</li>\n<li>Gallbladder</li>\n<li>Common bile duct (CBD)</li>\n<li>Regional lymphatics</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a3275bb414e24aaaa647618eef47cb23.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5566",
      "difficulty": "medium"
    },
    {
      "text": "What is the drug of choice for the treatment of the severe form of the disease, caused by the organism whose life cycle is shown below?",
      "choices": [
        {
          "id": 1,
          "text": "IV Penicillin G"
        },
        {
          "id": 2,
          "text": "Oral Amoxicillin"
        },
        {
          "id": 3,
          "text": "Oral Azithromycin"
        },
        {
          "id": 4,
          "text": "Oral Ampicillin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The life cycle shown in the above image is suggestive of <strong>leptospirosis</strong>. Severe form of leptospirosis should be treated with IV penicillin administration.</p>\n<p>It is caused by contact with the <strong>urine</strong> or <strong>blood</strong> of an infected organism. It is a <strong>zoonotic disease, </strong>with <strong>rats</strong> being the most well-known <strong>reservoirs.</strong> </p>\n<p>Illness is classically <strong>biphasic</strong> after an incubation period of up to 1 month. The stages are: </p>\n<ul>\n<li><strong>Acute leptospiremic</strong> phase- organism can be cultured from <strong>blood.</strong></li>\n<li><strong>Resolving immune</strong> phase- organism can be cultured from <strong>urine.</strong></li>\n</ul>\n<p>The stages may not be clinically distinguishable.</p>\n<p>Most cases are asymptomatic, but a few may present with severe manifestations. Clinical features include: </p>\n<ul>\n<li>High-grade fever</li>\n<li>Hepatic dysfunction </li>\n<li>Renal impairment</li>\n<li>Hemorrhages- gastrointestinal, pulmonary (most common), petechiae and purpura</li>\n</ul>\n<p>The <strong>severe</strong> form is known as <strong>Weil's disease,</strong> with a triad of <strong>hemorrhage, jaundice,</strong> and <strong>acute kidney injury.</strong> </p>\n<p><strong>Treatment of Leptospirosis</strong></p>\n<ul>\n<li class=\"p1\"><strong>Mild</strong> leptospirosis\n<ul>\n<li class=\"p1\">Doxycycline<span class=\"s1\"> </span>(100 mg PO bid), or</li>\n<li class=\"p1\">Amoxicillin (500 mg PO tid), or</li>\n<li class=\"p1\">Ampicillin (500 mg PO tid)</li>\n</ul>\n</li>\n<li class=\"p1\"><strong>Moderate/severe</strong> leptospirosis\n<ul>\n<li class=\"p1\"><strong>Penicillin</strong> (1.5 million units IV or IM q6h) or</li>\n<li class=\"p1\">Ceftriaxone (2 g/d IV) or</li>\n<li class=\"p1\">Cefotaxime (1 g IV q6h) or</li>\n<li class=\"p1\"><span class=\"s1\">Doxycycline </span>(loading dose of 200 mg IV, then 100 mg IV q12h)</li>\n</ul>\n</li>\n<li class=\"p2\">Chemoprophylaxis\n<ul>\n<li class=\"p1\">Azithromycin (250 mg PO once or twice a week), or</li>\n<li class=\"p1\">Doxycycline<span class=\"s1\"> </span>(200 mg PO once a week)</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/373b21488a604bbd9d0cfae689f9ca20x1279x1329.JPEG\" alt=\"Explanation Image\"><p>Unlike the usual Marrow Image above, the image in the question has lesser clarity so that users get a bit of a taste of the actual INI-CET Exam. This is an image from a previous INI-CET exam and the image was not zoomable in the exam. Those who saw the spirochete-like appearance, rat, and rice field narrowed down the organism by elimination and marked the correct answer. So, pay attention to detail and watch out for any information that you can get from an image to answer questions, even if the image is not clear.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/abc9aa88bcb64ab68a281f4f67e07af4.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5513",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false regarding the role of urea in renal function?",
      "choices": [
        {
          "id": 1,
          "text": "A high-protein diet increases the  kidneys ' ability to concentrate urine"
        },
        {
          "id": 2,
          "text": "High vasopressin increases the urea deposition in the medullary interstitium"
        },
        {
          "id": 3,
          "text": "Urea is transported by urea transport proteins (UT-A) by secondary active transport"
        },
        {
          "id": 4,
          "text": "A low-protein diet reduces the kidneys’ ability to concentrate urine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Urea</strong> is transported by <strong>urea transport proteins </strong>(<strong>UT-A</strong>) by <strong>facilitated diffusion.</strong></p>\n<p>Urea is essential for the establishment of an osmotic gradient in the medullary pyramids and for forming concentrated urine in the collecting ducts.&nbsp;</p>\n<p>During antidiuresis, <strong>high vasopressin increases</strong>&nbsp;<strong>urea deposition in the medullary interstitium</strong>, thus increasing the kidney's concentrating capacity.</p>\n<p>The amount of urea in the medullary interstitium and, consequently, in the urine varies with the amount of urea filtered by the glomerulus, which is dependent on the dietary intake of protein. Therefore, a <strong>high-protein diet increases</strong> the kidney's ability to concentrate urine and a <strong>low-protein diet reduces</strong> the kidneys&rsquo; <strong>ability to concentrate</strong>&nbsp;<strong>urine</strong>.</p><hr><h3>Related Pearl: Renal tubule characteristics</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<p><strong>Segments </strong></p>\n</td>\n<td rowspan=\"2\">\n<p><strong>Active NaCl Transport </strong></p>\n</td>\n<td colspan=\"3\">\n<p><strong>Permeability </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>H<sub>2</sub>0</strong></p>\n</td>\n<td>\n<p><strong>NaCl</strong></p>\n</td>\n<td>\n<p><strong>Urea</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Proximal tubule</p>\n</td>\n<td>\n<p>++</p>\n</td>\n<td>\n<p>++</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thin descending limb</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>++</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thin ascending limb</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thick ascending limb</p>\n</td>\n<td>\n<p>++</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Distal tubule</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+ADH</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cortical collecting duct</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+ADH</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inner medullary collecting duct</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+ADH</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>+ADH</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>KEY:</strong> ADH, antidiuretic hormone; NaCl, sodium chloride; 0, minimal level of active transport or permeability; +, moderate level of active transport or permeability; ++, high level of active transport or permeability; +ADH, permeability to water or urea is increased by ADH.</p><hr><h3>Related Pearl: Summary of Transport Across Proximal and Distal Portions of the Nephron</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>Proximal Tubule</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Reabsorption</strong></td>\n<td>\n<p><strong>Secretion</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>67% of filtered Na<sup>+</sup> actively reabsorbed, not subject to control; Cl<sup>&ndash;</sup> follows passively</p>\n<p>All filtered glucose and amino acids reabsorbed by secondary active transport; not subject to control</p>\n<p>Variable amounts of filtered PO4<sup>3- </sup>and other electrolytes reabsorbed; subject to control</p>\n<p>65% of filtered H<sub>2</sub>O osmotically reabsorbed; not subject to control</p>\n<p>50% of filtered urea passively reabsorbed; not subject to control</p>\n<p>Almost all filtered K<sup>+</sup> reabsorbed; not subject to control</p>\n</td>\n<td>\n<p>Variable H<sup>+</sup> secretion, depending on acid-base status of body</p>\n<p>Organic ion secretion; not subject to control</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Distal tubule</strong></td>\n</tr>\n<tr>\n<td><strong>Reabsorption</strong></td>\n<td><strong>Secretion</strong></td>\n</tr>\n<tr>\n<td>\n<p>Variable Na<sup>+</sup> reabsorption, controlled by aldosterone; Cl<sup>&ndash;</sup> follows passively</p>\n<p>Variable H<sub>2</sub>O reabsorption, controlled by vasopressin</p>\n</td>\n<td>\n<p>Variable H<sup>+ </sup>secretion, depending on acid-base status of body</p>\n<p>Variable K<sup>+</sup> secretion, controlled by aldosterone</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Filtration, Reabsorption, and Excretion Rates of Different Substances by the Kidneys</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Substance</strong></p>\n</td>\n<td>\n<p><strong>Amount Filtered </strong></p>\n</td>\n<td>\n<p><strong>Amount reabsorbed </strong></p>\n</td>\n<td>\n<p><strong>Amount excreted </strong></p>\n</td>\n<td>\n<p><strong>% of Filtered Load Reabsorbed</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose (g/day)</p>\n</td>\n<td>\n<p>180</p>\n</td>\n<td>\n<p>180</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bicarbonate (mEq/day)</p>\n</td>\n<td>\n<p>4320</p>\n</td>\n<td>\n<p>4318</p>\n</td>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>&gt;99.9</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sodium (mEq/day)</p>\n</td>\n<td>\n<p>25,560</p>\n</td>\n<td>\n<p>25410</p>\n</td>\n<td>\n<p>150</p>\n</td>\n<td>\n<p>99.4</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chloride (mEq/day)</p>\n</td>\n<td>\n<p>19440</p>\n</td>\n<td>\n<p>19260</p>\n</td>\n<td>\n<p>180</p>\n</td>\n<td>\n<p>99.1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Potassium (mEq/day)</p>\n</td>\n<td>\n<p>756</p>\n</td>\n<td>\n<p>664</p>\n</td>\n<td>\n<p>92</p>\n</td>\n<td>\n<p>87.8</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Urea (g/day)</p>\n</td>\n<td>\n<p>46.8</p>\n</td>\n<td>\n<p>23.4</p>\n</td>\n<td>\n<p>23.4</p>\n</td>\n<td>\n<p>50</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Creatinine (g/day)</p>\n</td>\n<td>\n<p>1.8</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>1.8</p>\n</td>\n<td>\n<p>0</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5552",
      "difficulty": "medium"
    },
    {
      "text": "A man from Bihar presented with normoanesthetic hypopigmented lesion as shown below. He had a remote history of admission for fever. No thickened nerves are present. What is the best-suited management?",
      "choices": [
        {
          "id": 1,
          "text": "Clotrimazole"
        },
        {
          "id": 2,
          "text": "Steroids"
        },
        {
          "id": 3,
          "text": "MDT"
        },
        {
          "id": 4,
          "text": "Miltefosine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The case scenario suggests a diagnosis of&nbsp;<strong>post-kala-azar dermal leishmaniasis (PKDL)</strong>. According to the NVBDCP, miltefosine is the preferred first-line drug for the management of PKDL.</p>\n<p><strong>Post-kala-azar dermal leishmaniasis (PKDL)</strong>&nbsp;is a condition when <em>Leishmania donovani</em> is found in the skin and manifests as dermal lesions. It is usually seen in the kala-azar-endemic zones, i.e.,&nbsp;<strong>Bihar</strong>, Jharkhand, U.P, and West Bengal (Northeastern states of India).</p>\n<p>These patients present&nbsp;with erythematous rash and hypopigmented macules similar in appearance and distribution to those of lepromatous leprosy but normally less than 1cm. After a variable period of years or months, diffuse nodulation begins to develop in these macules. The rash is <strong>progressive</strong> over many years and seldom heals spontaneously.</p>\n<p>Miltefosine is a relatively safe oral drug for the treatment of PKDL. Oral miltefosine treatment is administered to adults weighing more than 25 kg as 50 mg twice daily for 12 weeks.&nbsp;</p>\n<p>The image below shows post-kala-azar cutaneous leishmaniasis.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c444e1bfdcba4b52bf2413c5443557cfx1280x1092.2425952045135.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/1fa4f72ae35f41ac8d08bd080ae35cb4.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5611",
      "difficulty": "medium"
    },
    {
      "text": "Sequentially arrange the following steps involved in the production of antibodies using the hybridoma technique.<div class='question-desc-html'><ol>\n<li>Culture in HAT medium</li>\n<li>Immunization of mice with the target antigen &amp; wait for few weeks</li>\n<li>Antibody-producing spleen cell &amp; myeloma cell fusion</li>\n<li>Blood sample analysis to analyze serum target antibody levels</li>\n<li>Mice euthanization &amp; spleen removal</li>\n<li>Harvesting of monoclonal antibodies</li>\n</ol>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "2-1-5-3-4-6"
        },
        {
          "id": 2,
          "text": "2-4-5-3-1-6"
        },
        {
          "id": 3,
          "text": "2-1-3- 4-5-6"
        },
        {
          "id": 4,
          "text": "4- 3-2-5-1-6"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct sequence of steps involved in the production of antibodies using the hybridoma technique is as follows:</p>\n<ol>\n<li>Immunization of mice with the target antigen&nbsp;&amp; wait for few weeks</li>\n<li>Blood sample analysis to analyze serum target antibody levels</li>\n<li>Mice euthanization &amp; spleen removal</li>\n<li>Antibody-producing spleen cell &amp; myeloma cell fusion</li>\n<li>Culture in HAT medium</li>\n<li>Harvesting of monoclonal antibodies</li>\n</ol>\n<p><strong>Hybridoma technology</strong> is a method for producing large numbers of identical antibodies <strong>(monoclonal antibodies).</strong></p>\n<p>Hybridomas are somatic cell hybrids produced by fusing the antibody-forming spleen cells with myeloma cells. The resultant <strong>hybrid</strong> thus has both the <strong>antibody-producing</strong> ability of the <strong>B-cell</strong> and the ability to <strong>multiply indefinitely</strong> of the <strong>myeloma.</strong></p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>The following are the&nbsp;<strong>steps</strong>&nbsp;involved in hybridoma technology:</p>\n<ul>\n<li><strong>Mice</strong>&nbsp;are&nbsp;<strong>immunized</strong>&nbsp;with an antigen.</li>\n<li>After several weeks of immunization, blood samples are obtained from mice for measurement of serum antibodies.</li>\n<li>When the antibody titer is high enough, mice are commonly boosted by injecting antigen without adjuvant, intraperitoneally or intravenously.</li>\n<li>Then the mice are euthanized and their&nbsp;<strong>spleens removed</strong>&nbsp;for in vitro hybridoma cell production.</li>\n<li><strong>Fusing antibody-producing spleen cells</strong>, which have a limited life span,&nbsp;<strong>with myeloma cells</strong>&nbsp;(derived from an immortal tumor of lymphocytes) results in a hybridoma that is capable of unlimited growth.</li>\n<li>The cells are&nbsp;<strong>cultured in</strong>&nbsp;a medium containing hypoxanthine, aminopterin, and thymidine&nbsp;<strong>(HAT medium)</strong>&nbsp;which allows only the fused cells to survive in culture.</li>\n<li><strong>Monoclonal antibodies</strong>&nbsp;are then&nbsp;<strong>harvested.</strong></li>\n</ul>\n</div>\n<div class=\"ng-scope\">&nbsp;</div>\n</div>\n<div class=\"ng-scope\">&nbsp;</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9e63ab1d55834789ba2fdb2d3de3641ex1280x2037.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5475",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following diseases occurs as a consequence of genomic imprinting?",
      "choices": [
        {
          "id": 1,
          "text": "Cri du chat disease"
        },
        {
          "id": 2,
          "text": "Prader-Willi syndrome"
        },
        {
          "id": 3,
          "text": "Patau syndrome"
        },
        {
          "id": 4,
          "text": "Noonan syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The phenomenon of a <strong>differential effect of the same gene from different parents</strong> is called <strong>genomic imprinting</strong>. Prader-Willi syndrome occurs as a result of genomic imprinting.</p>\n<p>Genomic imprinting refers to gene <strong>silencing</strong>/ inactivation. Here either the maternal or the paternal allele is inactivated resulting in only one functional allele. It occurs via the process of <strong>epigenetics</strong>, where gene expression is lowered by:</p>\n<ul>\n<li>DNA methylation</li>\n<li>Histone deacetylation</li>\n</ul>\n<p>Genomic imprinting is best illustrated by two uncommon genetic disorders: <strong>Prader-Willi syndrome</strong> and <strong>Angelman syndrome</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><span><strong>P</strong>rader-Willi syndrome</span></td>\n<td><span>&nbsp;Angel<strong>M</strong>an syndrome</span></td>\n</tr>\n<tr>\n<td>\n<p><strong>Deletion&nbsp;</strong></p>\n<p>(most common)</p>\n</td>\n<td>\n<p><strong>P</strong>aternal chromosome 15</p>\n</td>\n<td>\n<p><strong>M</strong>aternal chromosome 15</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Uniparental disomy&nbsp;</strong></p>\n<p>(less common)</p>\n</td>\n<td><strong>Maternal disomy</strong> (duplication)&nbsp;</td>\n<td><strong>Paternal disomy</strong> (duplication)&nbsp;</td>\n</tr>\n<tr>\n<td>Clinical features</td>\n<td>\n<p>Elevated ghrelin levels - hyperphagia</p>\n<p>Truncal obesity</p>\n<p>Severe hypotonia</p>\n<p>Short stature</p>\n<p>Small hands and feet with hypotonia</p>\n<p>Hypogonadotropic hypogonadism</p>\n<p>Cognitive impairment</p>\n</td>\n<td>\n<p>Short stature</p>\n<p>Severe <strong>mental retardation</strong> with a lack of speech</p>\n<p>Stiff arm movements</p>\n<p>Spastic, uncoordinated walk (<strong>ataxia</strong>)</p>\n<p><strong>Seizures</strong></p>\n<p>Inappropriate outbursts of laughter (<strong>happy puppets</strong>)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The image given below is a child with Prader-Willi syndrome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9ac6945a0df343399e08619a6d47eb54x572x903.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The image given below is a child with Angelman syndrome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/67e865e6f6f4430aaf61cff4d23c52b7x938x998.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Diagnosis of these syndromes is based on the assessment of the methylation status of marker genes and fluorescence in-situ hybridization (<strong>FISH</strong>).</p>\n<p><strong>Mnemonic:</strong></p>\n<p>Prader<strong>&ndash;</strong>Willi Syndrome: Paternal gene deletion - <strong>P for P</strong><br />Angelman syndrome: Maternal gene deletion (Mothers are Angels, Maternal gene deletion leads to Angelman syndrome)</p><p>&nbsp;</p>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Patau</strong>&nbsp;syndrome - Trisomy 13-&nbsp;Atrial septal defect, ventricular septal defect, valve abnormalities</li>\n<li><strong>Cri du chat</strong>&nbsp;- Partial aneuploidy/ deletion of chromosome 5p15.2- Atrial septal defect, ventricular septal defect, tetralogy of Fallot</li>\n<li><strong>Noonan</strong>&nbsp;syndrome - Pulmonic stenosis, atrial septal defect, hypertrophic cardiomyopathy</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5641",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following women would not be diagnosed as having polycystic ovarian syndrome as per the  Rotterdam criteria?",
      "choices": [
        {
          "id": 1,
          "text": "29-year-old woman with Alopecia & acne and cycles of length 40 days"
        },
        {
          "id": 2,
          "text": "31-year-old woman with an ovary measuring 12 cm and cycles of length 42 days"
        },
        {
          "id": 3,
          "text": "23-year-old woman with ovaries showing 7 follicles of 1-2 mm diameter and hirsutism"
        },
        {
          "id": 4,
          "text": "27-year-old-woman with severe hirsutism, acne and a cycle length of 38 days"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Polycystic ovaries is defined as <strong>≥ 12 follicles measuring 2‐9 mm in diameter</strong> and/or an <strong>ovarian volume &gt; 10 mL</strong> in <strong>at least one ovary</strong> as per the <strong>Rotterdam criteria</strong>.</p>\n<p>Polycystic ovarian syndrome is the most common endocrine disorder in a <strong>reproductive-age</strong> woman. <strong>Rotterdam criteria</strong> is used to diagnose PCOS. It is an algorithm and diagnosis is made only after excluding other causes. To diagnose both of the following criteria should be present:</p>\n<p>1) <strong><strong>Irregular menstrual cycles </strong></strong>is defined as</p>\n<ul>\n<li>normal cycles in the first year post menarche (due to pubertal transition).</li>\n<li>&lt; 21 or &gt; 45 days in 1-3 years post menarche</li>\n<li>&lt; 21 or &gt; 35 days or &lt; 8 cycles per year &gt; 3 years post menarche to perimenopause.</li>\n<li> &gt; 90 days for any one cycle &gt; 1-year post menarche</li>\n<li>Primary amenorrhea by age 15 or &gt; 3 years post thelarche (breast development).</li>\n</ul>\n<div class=\"page\" title=\"Page 193\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>2)<strong> </strong><strong>Clinical/Biochemical hyperandrogenism </strong>characterised by alopecia, acne, hirsutism</p>\n</div>\n</div>\n</div>\n</div>\n<p>If only one of the criteria can be established, then an endovaginal/transabdominal <strong>ultrasound </strong>to demonstrate <strong>polycystic ovaries</strong> should be done (confirmatory).</p>\n<p>PCOS can increase the risk for:</p>\n<ul>\n<li><strong>Cardiovascular disease </strong></li>\n<li><strong>Obstructive sleep apnea</strong></li>\n<li>Gestational and <strong>type 2 diabetes mellitus</strong></li>\n<li><strong>Endometrial cancer</strong></li>\n<li><strong>Hirsutism</strong></li>\n<li><strong>Acanthosis nigricans</strong></li>\n</ul><hr><h3>Related Pearl: Endocrinological changes of PCOD</h3><ol>\n<li>Elevated Estrone/E1 levels.</li>\n<li>LH level is raised over 10 IU/mL. FSH level remains normal to low, but<strong> FSH/LH ratio falls.</strong></li>\n<li>Testosterone and epi-androstenedione levels rise.<br />\n<ul>\n<li><strong>Testosterone elevated but &lt; 200 ng/dL </strong>(normal range 20 -80 ng/dL)</li>\n<li>Testosterone &gt; 200 ng/dL suggests androgen-secreting ovarian tumor</li>\n<li>DHEA-S values may be normal or slightly elevated</li>\n<li>DHEA &gt;700 ng/mL suggests adrenal tumour</li>\n</ul>\n</li>\n<li>Serum SHBG is reduced.</li>\n<li><strong>Triglyceride level &gt;150 mg/dL</strong>-hyperlipidaemia HDL &lt;50 mg/dL.</li>\n<li>Fasting blood glucose/fasting insulin &lt;4.5 suggests insulin resistance</li>\n<li>Prolactin is mildly raised in 15% cases</li>\n<li><strong>Fasting insulin is more than 10 mIU/L in PCOS in 50–70%cases</strong></li>\n<li>Thyroid function tests may be abnormal (hypothyroidism)</li>\n<li>17-a-hydroxyprogesterone in the follicular phase &gt;300 ng/dL suggests adrenal hyperplasia due to 21-hydroxylase deficiency.</li>\n<li><strong>Urinary cortisol &lt;50 μg/24 h.</strong></li>\n</ol><hr><h3>Related Pearl: Management of PCOD</h3><table>\n<tbody>\n<tr>\n<td><strong>Complaint</strong></td>\n<td><strong>Management</strong> &nbsp;</td>\n</tr>\n<tr>\n<td>Irregular periods</td>\n<td>OCPs</td>\n</tr>\n<tr>\n<td>Obesity</td>\n<td>Lifestyle modification</td>\n</tr>\n<tr>\n<td>Insulin resistance</td>\n<td>Metformin</td>\n</tr>\n<tr>\n<td>Hirsutism /acne</td>\n<td>OCPs with cyproterone acetate</td>\n</tr>\n<tr>\n<td>Infertility</td>\n<td>Clomiphene</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Letrozole is as effective as Clomiphene in treating infertility in PCOD with fewer side effects. However, it's pending FDA approval and is used off-label.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5635",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is incorrectly paired?",
      "choices": [
        {
          "id": 1,
          "text": "3 - Tobacco mosaic virus"
        },
        {
          "id": 2,
          "text": "4 - Rabies virus"
        },
        {
          "id": 3,
          "text": "1 - Rotavirus"
        },
        {
          "id": 4,
          "text": "2 - Adenovirus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Image 3 shows a <strong>brick-shaped</strong> virus corresponding to the <strong>poxvirus</strong>.&nbsp;<strong>Tobacco mosaic virus </strong>is rod-shaped, as shown below</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6802e03a08cd43b68e7b58c40adfc682x675x675.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Option B -<strong> Adenovirus</strong> contains <strong>double-stranded DNA</strong>. They have an <strong>icosahedral symmetry</strong> with structures known as <strong>fibers</strong> extruding from the vertices.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8dee85296ad74c20ac31b2c2c67a0b7fx1280x1177.JPEG\" alt=\"Explanation Image\"><p>Option A - Rotaviruses appear as <strong>cartwheel-shaped</strong> structures with short spokes radiating from them.&nbsp;</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7970be4356354a158051a39c78e5d09bx720x551.JPEG\" alt=\"Explanation Image\"><p>Option D - <strong>Rabies viruses,</strong> belonging to the family Rhabdoviridae, are <strong>bullet-shaped</strong> viruses with <strong>nonsegmented single-stranded RNA</strong>.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1aac9ca34ba5436896852c07a52480e9x1280x1179.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Important Shapes of Some Viruses</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>VIRUS</strong></p>\n</td>\n<td>\n<p><strong>SHAPE</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rabies virus</p>\n</td>\n<td>\n<p>Bullet shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pox virus</p>\n</td>\n<td>\n<p>Brick shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tobacco mosaic virus</p>\n</td>\n<td>\n<p>Rod shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ebola virus</p>\n</td>\n<td>\n<p>Filamentous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Astro virus</p>\n</td>\n<td>\n<p>Star shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adenovirus</p>\n</td>\n<td>\n<p>Space vehicle shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotavirus</p>\n</td>\n<td>\n<p>Wheel shaped</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f6d5f3c3f8bf492ea6205638895ac069.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5510",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following suturing techniques would yield the best cosmetic results?",
      "choices": [
        {
          "id": 1,
          "text": "4"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "1"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Subcuticular suturing,&nbsp;</strong>seen in image 4, would yield the best cosmetic results.</p>\n<p><strong>Subcuticular sutures:</strong>&nbsp;</p>\n<p>It is used for a <strong>better cosmetic appearance</strong>. It is also employed in situations where the edges of the wound are <strong>easily approximated</strong>. In this technique, small bites of the subcuticular tissues are taken on alternate sites of the wound, and then, they are gently pulled together. This causes approximation of the wound edges <strong>without the risk of the cross-hatched markings of interrupted sutures.</strong></p>\n<p>Both absorbable and non-absorbable suture materials can be used in this technique. A buried knot is secured with the ends of absorbable sutures when used. When non-absorbable sutures are used, a collar and bead are used to secure the ends of the suture.</p>\n<p>In <strong>interrupted sutures, </strong>the needle should be <strong>inserted at right angles</strong>&nbsp;to the incision and should exit at a right angle with the skin. The needle should be rotated through the tissue and should not be dragged through to avoid unnecessary enlargement of the needle hole.&nbsp;If 'x' is the depth of the wound, then the distance&nbsp;from the entry point of the suture to the edge of the wound must be 'x'. Distance between 2 consecutive sutures must be '2x'.&nbsp;</p>\n<p>The following image shows interrupted suture:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/317460039b4e4de3a162f6ae85845d20x720x631.JPEG\" alt=\"Explanation Image\"><p><strong>Continuous suture technique:</strong>&nbsp;The first suture is inserted in a manner identical to that in an interrupted suture. The remaining sutures are inserted in a continuous manner until the far end of the wound is reached. Care should be taken to maintain the tension of the suture to avoid excessive tension or leaving it too slack; hence, the use of an assistant is warranted. An Aberdeen knot is used to secure the end of the suture.</p>\n<p>The image below shows continuous sutures:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4b94a68f08d746ba84a6a6797d990e7dx1280x1143.JPEG\" alt=\"Explanation Image\"><p><strong>Mattress sutures:</strong>&nbsp;They can be vertical or horizontal and are used to create either an eversion or inversion of the wound edges. The initial suture is inserted in the same way as an interrupted suture, but then, the needle either moves horizontally or vertically and traverses both edges of the wound once again, as seen in the figure. The main advantage of the mattress suture is that it produces an accurate approximation of wound edges, especially in settings where the edges are not easily approximated.</p>\n<p>The following image shows the mattress suture technique:&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c64dc6b67f0448feb8760ebdd82f185ex1280x1238.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4348b938dba54638b3edfb0c8307b206.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5573",
      "difficulty": "easy"
    },
    {
      "text": "Sequentially arrange the following structures that are involved in the production & conduction of otoacoustic emissions(OAEs).<div class='question-desc-html'><ol>\n<li>\n<div class=\"p1\">Outer hair cells</div>\n</li>\n<li>\n<div class=\"p1\">Basilar membrane</div>\n</li>\n<li>Oval window</li>\n<li>\n<div class=\"p1\">Perilymph</div>\n</li>\n<li>\n<div class=\"p1\">Ossicles</div>\n</li>\n<li>\n<div class=\"p1\">Tympanic membrane</div>\n</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-2-4-5-3-6"
        },
        {
          "id": 2,
          "text": "1-2-4-3-5-6"
        },
        {
          "id": 3,
          "text": "1-4-2-3-6-5"
        },
        {
          "id": 4,
          "text": "1-4-2-5-3-6"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The structures involved in the production &amp; transmission of otoacoustic emission in order of their involvement are:</p>\n<ul>\n<li>\n<div class=\"p1\">Outer hair cells</div>\n</li>\n<li>\n<div class=\"p1\">Basilar membrane</div>\n</li>\n<li>\n<div class=\"p1\">Perilymph</div>\n</li>\n<li>\n<div class=\"p1\">Oval window</div>\n</li>\n<li>\n<div class=\"p1\">Ossicles</div>\n</li>\n<li>\n<div class=\"p1\">Tympanic membrane</div>\n</li>\n<li>\n<div class=\"p1\">Ear canal</div>\n</li>\n</ul>\n<p><strong>Otoacoustic emissions (OAE)</strong> are used in the universal neonatal hearing <strong>screening</strong> protocol. <strong>Universal Newborn Hearing Screening (UNHS)</strong> has become a standard practice in most developed countries. The identification of all newborns with hearing loss before 6 months has become an attainable and realistic goal. The goal is to <strong>screen</strong> newborn babies <strong>before 1 month</strong> of age, diagnose hearing loss before 3 months of age and <strong>start intervention</strong> as early as possible, or by <strong>6 months</strong> of age.</p><hr><h3>Related Pearl: OAEs - Otoacoustic emissions</h3><p>It is an <strong>objective test</strong> that records the low-intensity&nbsp;sounds produced by&nbsp;the<strong> outer hair cells</strong> of a<strong> normal cochlea</strong>.</p>\n<p>It is of two types:</p>\n<ul>\n<li><strong>Spontaneous </strong>type- it is generated spontaneously and is present in 50% of normal individuals.</li>\n<li><strong>Evoked </strong>types- also called<strong>&nbsp;</strong>Kemp echoes or cochlear echoes, are generated <strong>in response to sound stimulus</strong> and found in <strong>all individuals</strong> with<strong> normal hearing</strong>. The two subtypes are transient evoked and distortion product.</li>\n</ul>\n<p>The applications are as follows:</p>\n<ul>\n<li><strong>Screening test</strong> for<strong>&nbsp;neonates</strong>,<strong> infants</strong>,<strong>&nbsp;</strong>and <strong>small children</strong>&nbsp;for deafness due to inner ear causes.</li>\n<li>Helps to <strong>differentiate cochlear and retrocochlear hearing loss-</strong>&nbsp;normal OAE indicates normal cochlea and hence retrocochlear pathology in a patient with sensorineural deafness.</li>\n<li><strong>Early detection</strong> of<strong> noise-induced hearing loss</strong>-<strong>&nbsp;</strong>since it is generated by outer hair cells that are prone to damage by noise trauma.</li>\n</ul><hr><h3>Related Pearl: BERA (Brainstem Evoked Response Audiometry) or ABR (Auditory Brainstem Response)</h3><p>It is an<strong>&nbsp;objective test </strong>that<strong> r</strong><strong>ecords electrical activity </strong>occurring in the auditory pathway.</p>\n<p>Normally, 7 waves are produced in the first 10ms.&nbsp;</p>\n<ul>\n<li>Wave I &ndash; distal part of the cochlear nerve</li>\n<li>Wave II &ndash;proximal part of the cochlear nerve</li>\n<li>Wave III &ndash; cochlear nucleus</li>\n<li>Wave IV &ndash; superior olivary complex</li>\n<li><strong>Wave V &ndash; lateral lemniscus</strong></li>\n<li>Wave VI &amp; VII &ndash; inferior colliculus</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1f9167544929446482f04a6b10c3109dx1280x851.JPEG\" alt=\"Pearl Image\"><p>Findings:</p>\n<ul>\n<li>Conductive or cochlear pathology- delayed wave-I but inter-peak latency of I-V is normal</li>\n<li>Retrocochlear pathology- wave-I present, rest of the waves absent</li>\n<li><strong>Acoustic neuroma</strong> or vestibular schwannoma- increased inter-peak latency of wave I-V and increased inter-aural latency of wave <strong>V &gt; 0.2ms.</strong></li>\n</ul>\n<p>Uses:</p>\n<ul>\n<li>To objectively find hearing threshold- <strong>wave-V</strong> appears 10dB above the hearing level obtained through PTA</li>\n<li>Best audiometric test for:\n<ul>\n<li>Confirming <strong>hearing loss in infants</strong></li>\n<li>Diagnosing <strong>acoustic neuroma</strong></li>\n</ul>\n</li>\n<li>\n<ul>\n<li>Differentiating cochlear and retro-cochlear hearing loss</li>\n<li>Diagnosing non-organic hearing loss.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5543",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements regarding hematological changes in pregnancy is false?",
      "choices": [
        {
          "id": 1,
          "text": "Protein C, protein S, and antithrombin decrease"
        },
        {
          "id": 2,
          "text": "Clotting time and bleeding time are unaffected."
        },
        {
          "id": 3,
          "text": "The normal albumin: globulin ratio of 1.7:1 is diminished to 1:1"
        },
        {
          "id": 4,
          "text": "The viscosity of blood increases"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>viscosity</strong> of blood <strong>decreases</strong> due to <strong>relative hemodilution.</strong></p>\n<p><strong>Pregnancy</strong> is a <strong>hypercoagulable</strong> state. This is in order to control bleeding and help in hemostasis after placental separation. <strong>Hematological changes</strong> in pregnancy include:</p>\n<ul>\n<li>All <strong>clotting</strong> <strong>factors</strong> are <strong>increased</strong>, <strong>except factors 11 and 13</strong>. The levels return to normal within 2 weeks of delivery.</li>\n<li>Anticoagulants <strong>p</strong><strong>rotein C</strong>,<strong> protein S</strong>, and antithrombin <strong>decrease</strong> during pregnancy.</li>\n<li><strong>Fibrinogen</strong> levels are also <strong>increased</strong> by 50 %.</li>\n<li>Clotting time and bleeding time are<strong> unaffected</strong>.</li>\n<li>The<strong> viscosity</strong> of blood <strong>decreases</strong> due to relative hemodilution (relatively higher increase in plasma volume as compared to the increase in RBC mass).</li>\n<li><strong>ESR</strong> is raised due to an <strong>increase</strong> in <strong>fibrinogen</strong> and <strong>globulin</strong> levels.</li>\n<li>Because of a <strong>marked fall </strong>in<strong> albumin </strong>level and only a slight rise of globulin, the normal <strong>albumin: globulin ratio</strong> of 1.7:1 is <strong>diminished </strong>to 1:1.</li>\n<li>Platelet counts remain the same or fall by a small amount (15%).</li>\n</ul>\n<p>The most common cause of decreased platelet count in pregnancy is <strong>benign gestational thrombocytopenia</strong>. This is due to <strong>hemodilution</strong> and increased platelet consumption and the women are generally <strong>asymptomatic</strong>.</p><hr><h3>Related Pearl: Cardiovascular changes in pregnancy</h3><ul>\n<li class=\"p1\">The resting pulse rate increases by <strong>10 beats</strong>/<strong>min</strong></li>\n<li class=\"p1\">The apex is moved laterally&nbsp;</li>\n<li class=\"p1\">Cardiac output remains elevated throughout (maximum in the immediate postpartum period)</li>\n<li class=\"p1\">X-Ray shows a larger cardiac silhouette (due to benign pericardial effusion and shifted apex)</li>\n<li class=\"p1\">ECG: Slight&nbsp;<strong>left axis </strong>deviation</li>\n</ul>\n<p><strong>Heart sounds:</strong></p>\n<ul>\n<li class=\"p1\">First heart sound: Loud with an exaggerated split</li>\n<li class=\"p1\">Second heart sound: Normal but loud</li>\n<li class=\"p1\">Third heart sound: Loud and easily heard</li>\n</ul>\n<p><strong>Murmurs:</strong></p>\n<ul>\n<li>A systolic murmur<strong>&nbsp;</strong>that was intensified during inspiration or expiration</li>\n<li class=\"p1\">A soft diastolic murmur (in 20%)</li>\n<li class=\"p1\">Continuous murmur&nbsp;arising from the breast vasculature (in 10%)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5631",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following finding is unlikely to be seen in a patient with radial nerve injury due to elbow dislocation?",
      "choices": [
        {
          "id": 1,
          "text": "Loss of extension of the metacarpophalangeal joints of the hand"
        },
        {
          "id": 2,
          "text": "Weakness of thumb extension and retroposition"
        },
        {
          "id": 3,
          "text": "Loss of wrist extension"
        },
        {
          "id": 4,
          "text": "Radial deviation of the wrist"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In a patient with&nbsp;radial nerve injury due to elbow dislocation,&nbsp; <strong>wrist extension is preserved</strong> because the <strong>branch to the extensor carpi radialis longus</strong> arises <strong>proximal to the elbow.</strong></p><p>&nbsp;</p>\n<p><strong>Radial nerve injuries</strong></p>\n<p>In very high lesions like the lesions around the shoulder joint &amp; axilla and crutch palsy - there is loss of extension of the elbow, wrist, and hand.</p>\n<p>In high lesions like fractures of the humerus and&nbsp;prolonged tourniquet pressure, there is&nbsp;<strong>wrist drop</strong>, due to weakness of the radial extensors of the wrist, as well as&nbsp;<strong>inability&nbsp;</strong>to&nbsp;<strong>extend&nbsp;</strong>the<strong>&nbsp;metacarpophalangeal joints&nbsp;</strong>and and <strong>inability to elevate&nbsp;the thumb</strong>. They will also have a&nbsp;<strong>sensory loss</strong>&nbsp;on the skin over the&nbsp;<strong>anatomical snuff box.</strong></p>\n<p><strong>Low lesions</strong>&nbsp;occur due to the fracture or dislocations of the elbow. The<strong> wrist and elbow extension are preserved</strong> but the patient&nbsp;<strong>cannot extend</strong>&nbsp;the&nbsp;<strong>metacarpophalangeal joint</strong>. There is also a weakness in <strong>extension and retroposition of the thumb</strong>. These patients have a&nbsp;<strong>radial deviation of the wrist</strong>&nbsp;due to the lack of balancing action of the <strong>extensor carpi radialis brevis.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bbbb84f8af2b4b4e9038c07a2003fdcex1280x2560.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Upper limb nerve integrity tests</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Nerve</strong></td>\n<td>\n<p>&nbsp; <strong>&nbsp; Test</strong></p>\n</td>\n<td>\n<p>&nbsp; &nbsp;<strong> Muscle</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Ulnar&nbsp; &nbsp;nerve</td>\n<td>\n<p>&nbsp;1.Book test</p>\n<p>&nbsp;2.Card test</p>\n<p>&nbsp;3.Froment's sign</p>\n<p>&nbsp;4.Egawa test</p>\n</td>\n<td>\n<p>&nbsp;1.Adductor&nbsp; &nbsp;pollicis</p>\n<p>&nbsp;2.Palmar&nbsp; &nbsp;interossei</p>\n<p>&nbsp;3.Flexor pollicis&nbsp; &nbsp;substitutes for&nbsp; &nbsp;adductor pollicis</p>\n<p>&nbsp;4.Dorsal&nbsp; &nbsp;interossei</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Median&nbsp; &nbsp;nerve</td>\n<td>\n<p>&nbsp;1.Ape thumb</p>\n<p>&nbsp;2.Pen test</p>\n<p>&nbsp;3.Pincer grasp&nbsp; &nbsp;(Kiloh Nevin&nbsp; &nbsp;Sign)</p>\n<p>&nbsp;4.Pointing index&nbsp; &nbsp;(ochners&nbsp; clasp/Benediction&nbsp; &nbsp;test)</p>\n</td>\n<td>\n<p>&nbsp;1.Thenar&nbsp; &nbsp;muscles</p>\n<p>&nbsp;2. Abductor&nbsp; &nbsp;pollicis brevis</p>\n<p>&nbsp;3. Flexor&nbsp; &nbsp;digitorum&nbsp; &nbsp;profundus+&nbsp; &nbsp;Flexor pollicis&nbsp; &nbsp;longus (Ant.&nbsp; &nbsp;interosseous&nbsp; &nbsp;nerve)</p>\n<p>&nbsp;4.Flexor&nbsp; &nbsp;Digitorum&nbsp; &nbsp;superficialis+&nbsp; &nbsp;Lateral half of&nbsp; &nbsp;Flexor&nbsp; &nbsp;digitorum&nbsp; &nbsp;profundus</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Radial&nbsp; &nbsp;nerve</td>\n<td>\n<p>&nbsp;1.Thumb and&nbsp; &nbsp;finger drop</p>\n<p>&nbsp;2. Wrist drop</p>\n</td>\n<td>\n<p>&nbsp;1.Extensors(Post.&nbsp; &nbsp;interosseous&nbsp; &nbsp;nerve)</p>\n<p>&nbsp;2.Extensors of&nbsp; &nbsp;wrist.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5530",
      "difficulty": "hard"
    },
    {
      "text": "What is the characteristic nail examination finding that would be seen in a patient whose peripheral smear shows microcytic hypochromic anemia, poikilocytes,  elliptocytes, and target cells?",
      "choices": [
        {
          "id": 1,
          "text": "Terry’s nails"
        },
        {
          "id": 2,
          "text": "Koilonychia"
        },
        {
          "id": 3,
          "text": "Muehrcke’s lines"
        },
        {
          "id": 4,
          "text": "Azure lunula"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Microcytic hypochromic</strong> cells will be seen on the <strong>peripheral smear</strong> of patients with <strong>iron-deficiency anemia (IDA)</strong>. The characteristic nail finding associated with this condition is <strong>koilonychia</strong>. </p>\n<p>Iron deficiency is the <strong>most common</strong> nutritional disorder in the world. IDA results from dietary deficiency, impaired absorption, increased requirement, and chronic blood loss. The cause of IDA in an <strong>older man</strong> or <strong>post-menopausal woman</strong> is always <strong>gastrointestinal cancer</strong>, until proven otherwise.</p>\n<p>Clinical presentation may include <strong>fatigue</strong>, pallor, <strong>dyspnea</strong>, cheilosis (fissures at the corners of the mouth), and <strong>koilonychia</strong> (spooning of the fingernails).</p>\n<p>Peripheral smear in IDA shows</p>\n<ul>\n<li><strong> Microcytic hypochromic</strong> red blood cells with an enlarged zone of <strong>central one-third pallor</strong>.</li>\n<li>Poikilocytes: <strong>pencil-shaped</strong> RBCs and, <strong>target cells.</strong></li>\n</ul>\n<p>The image given below shows a microcytic hypochromic blood picture in a peripheral smear:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3ba9cf4b7d9c4f8583c3b31986cdf6a7x1280x852.JPEG\" alt=\"Explanation Image\"><p>IDA is treated by giving oral, parenteral and packed cell transfusions depending on the severity of anaemia.</p>\n<p>For oral iron replacement therapy,</p>\n<ul>\n<li>Up to <strong>200mg of elemental iron</strong> is given.</li>\n<li>According to the Anemia Mukt Bharat initiative, <strong>adult women</strong> need to take <strong>60 mg elemental iron + 500 mcg folic acid</strong> tablets <strong>once a week.</strong></li>\n</ul>\n<p>For parenteral iron therapy, the amount of iron needed by an individual is calculated by the formula:</p>\n<p><strong>Body weight(kg) x 2.3 x (15 - patient's hemoglobin, g/dL) + 500 or 1000mg (for stores)</strong></p><hr><h3>Related Pearl: Nail findings and associated systemic conditions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Nail finding</strong></p>\n</td>\n<td><strong>Associated systemic condition</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Clubbing</strong></p>\n</td>\n<td>\n<ul>\n<li>Inflammatory bowel disease</li>\n<li><span>Lung cancer</span></li>\n<li>Idiopathic pulmonary fibrosis</li>\n<li><span>Complicated tuberculosis</span></li>\n<li><span>Suppurative lung disease (lung abscess, empyema, bronchiectasis, cystic fibrosis)</span></li>\n<li>Mesothelioma</li>\n<li>Cirrhosis</li>\n<li>Congenital heart disease, Endocarditis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Koilonychia</strong></p>\n</td>\n<td>\n<p>Iron-deficiency anemia, hemochromatosis, Raynaud&rsquo;s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Onycholysis</strong></p>\n</td>\n<td>\n<p>Psoriasis, onychomycosis, hyperthyroidism, sarcoidosis, trauma, amyloidosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pitting</strong></p>\n</td>\n<td>\n<p>Psoriasis, Reiter&rsquo;s syndrome, Alopecia areata</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Beau&rsquo;s lines</strong></p>\n</td>\n<td>\n<p>Any severe systemic illness that disrupts nail growth, Raynaud&rsquo;s disease, pemphigus, trauma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Yellow nail</strong></p>\n</td>\n<td>\n<p>Lymphedema, pleural effusion, immunodeficiency, bronchiectasis, sinusitis, rheumatoid arthritis, nephrotic syndrome, thyroiditis, tuberculosis, Raynaud&rsquo;s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nail Pterygium</strong></p>\n</td>\n<td>\n<p>Dorsal: Lichen Planus</p>\n<p>Ventral: trauma, systemic sclerosis, Raynaud phenomenon, lupus erythematosus</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"heading\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Nail finding</strong></p>\n</td>\n<td>\n<p><strong>Associated systemic condition</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Terry&rsquo;s (white) nails</strong></p>\n</td>\n<td>\n<p>Hepatic failure, cirrhosis, diabetes mellitus, CHF, hyperthyroidism, malnutrition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Azure lunula</strong></p>\n</td>\n<td>\n<p>Hepatolenticular degeneration (Wilson&rsquo;s disease), silver poisoning, quinacrine therapy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Half-and-half nails</strong></p>\n</td>\n<td>\n<p>Specific for renal failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Muehrcke&rsquo;s lines</strong></p>\n</td>\n<td>\n<p>Specific for hypoalbuminemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mees&rsquo; lines</strong></p>\n</td>\n<td>\n<p>Arsenic poisoning, Hodgkin&rsquo;s disease, CHF, leprosy, malaria, chemotherapy, carbon monoxide poisoning, other systemic insults</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Dark longitudinal streaks</strong></p>\n</td>\n<td>\n<p>Melanoma, benign nevus, chemical staining, normal variant in darkly pigmented people</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Splinter hemorrhage</strong></p>\n</td>\n<td>\n<p>Subacute bacterial endocarditis, SLE, rheumatoid arthritis, antiphospholipid syndrome, peptic ulcer disease, malignancies, oral contraceptive use, pregnancy, psoriasis, trauma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Telangiectasia</strong></p>\n</td>\n<td>\n<p>Rheumatoid arthritis, SLE, dermatomyositis, scleroderma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Features of Peripheral Blood Smear in Different Anemias</h3><p><strong>Type of anemia </strong></p>\n<p><strong>Microcytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thalassemia trait</p>\n</td>\n<td>\n<p>Basophilic stippling, target cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron-deficiency</p>\n</td>\n<td>\n<p>Elliptocytes, target cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sideroblastic anemia</p>\n</td>\n<td>\n<p>Pappenheimer bodies, RBC dimorphism, ringed sideroblasts (Perl&rsquo;s stain)&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Macrocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myelodysplastic syndrome</p>\n</td>\n<td>\n<p>Hypogranular or hypolobulated neutrophils, blast cells, giant or hypogranular platelets, Pappenheimer bodies</p>\n<p>Minor population of hypochromic / microcytic cells (dimorphic), poikilocytosis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Megaloblastic anemia</p>\n</td>\n<td>\n<p>Hypersegmented neutrophils (&gt;5 lobes), ovalocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemolysis</p>\n</td>\n<td>\n<p>Polychromasia (purple reticulocyte) +/- spherocytes&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic liver disease</p>\n</td>\n<td>\n<p>Target cells&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Normocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemolytic anemia&nbsp;</p>\n</td>\n<td>\n<p>Anisocytosis, poikilocytosis, polychromasia, nucleated red cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hereditary spherocytosis</p>\n</td>\n<td>\n<p>RBC lack central zone of pallor, reticulocytosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency&nbsp;</p>\n</td>\n<td>\n<p>Heinz bodies (revealed by special staining),&lsquo;Bite&rsquo; cells</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Differential Diagnosis of Microcytic Anaemia</h3><table>\n<tbody>\n<tr>\n<td>Investigation</td>\n<td><strong>Iron- Deficiency Anemia</strong></td>\n<td><strong>Alpha or beta thalassemia</strong></td>\n<td><strong>Anemia of Chronic Disease</strong></td>\n</tr>\n<tr>\n<td><strong>Serum Iron</strong></td>\n<td>&lt;60 &micro;g/dL</td>\n<td>Normal/Increased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Serum Ferritin</strong></td>\n<td>&lt;20 &micro;g/L</td>\n<td>Normal/Increased</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td><strong>TIBC</strong></td>\n<td>Increased</td>\n<td>Normal</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Transferrin saturation</strong></td>\n<td>&lt;15%</td>\n<td>Normal</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>MCV</strong></td>\n<td>Decreased</td>\n<td>&nbsp;Decreased</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>RBC count</strong></td>\n<td>Decreased</td>\n<td>Normal/Increased</td>\n<td>Normal/Increased</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>TIBC: Total iron-binding capacity&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5644",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is true regarding maple syrup urine disease?",
      "choices": [
        {
          "id": 1,
          "text": "Urine, sweat, and cerumen have a characteristic burnt sugar odor"
        },
        {
          "id": 2,
          "text": "Strict dietary methionine restriction is advised on diagnosis"
        },
        {
          "id": 3,
          "text": "It is inherited in an autosomal dominant manner"
        },
        {
          "id": 4,
          "text": "Untreated individuals have motor delay, but otherwise normal IQ levels."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Urine, sweat, and cerumen have a characteristic burnt sugar odor/maple syrup-like odor in maple syrup urine disease (MSUD).</p>\n<p>Only <strong>branched-chain amino acids</strong> need to be restricted; hence, methionine does not need any restriction in diet.</p>\n<p>Branched-chain amino acids are</p>\n<ul>\n<li><strong>Leucine</strong>&nbsp;(L)</li>\n<li><strong>Isoleucine&nbsp;</strong>(I)</li>\n<li><strong>Valine&nbsp;</strong>(V)</li>\n</ul>\n<p>MSUD is an <strong>autosomal recessive</strong> disorder in which there is a partial or complete deficiency of&nbsp;<strong>branched-chain alpha-ketoacid dehydrogenase</strong>&nbsp;complex (BCKD). This impairs the metabolism of branched-chain amino acids.&nbsp;These amino acids, particularly leucine and its metabolite accumulate in the blood, causing toxic effects on the brain.&nbsp;Features include feeding problems, vomiting, ketosis, and a characteristic&nbsp;<strong>burnt sugar</strong>&nbsp;<strong>odor</strong>/<strong>maple syrup-like odor</strong> found in&nbsp;<strong>urine</strong>,&nbsp;sweat, and&nbsp;cerumen.</p>\n<p>Infants with <strong>untreated classic maple syrup urine disease</strong> have <strong>significant developmental delay</strong> and <strong>die</strong> within the first few&nbsp;<strong>months</strong> of life.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2b61ae3b601a4b78b29862ed1e28df01x1279x1324.JPEG\" alt=\"Explanation Image\"><p>Laboratory investigations will show increased&nbsp;<strong>levels&nbsp;</strong>of&nbsp;<strong>branched-chain amino acids</strong>&nbsp;in the plasma and urine. <strong>Leucine</strong> levels are usually higher than isoleucine and valine levels.</p>\n<p>Treatment involves <strong>restricted intake</strong> of <strong>branched-chain amino acids</strong> using commercially available formulas and judicious supplementation of isoleucine and valine. Very high levels of leucine are removed by&nbsp;<strong>hemodialysis.</strong></p><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5478",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following conditions is unlikely to result in type II respiratory failure?",
      "choices": [
        {
          "id": 1,
          "text": "Gastric Aspiration"
        },
        {
          "id": 2,
          "text": "Opioid overdose"
        },
        {
          "id": 3,
          "text": "Myasthenia gravis"
        },
        {
          "id": 4,
          "text": "Severe hypothyroidism"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Patients with <strong>Gastric Aspiration</strong> develop <strong>type 1 respiratory failure</strong>. It is characterized by <strong>low pO<sub>2</sub></strong> and <strong>normal/low pCO<sub>2</sub></strong>.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Types of Respiratory Failure</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Name</td>\n<td>Mechanism</td>\n<td>Associated conditions</td>\n</tr>\n<tr>\n<td>I</td>\n<td>Acute <strong>hypoxemic</strong> respiratory failure</td>\n<td>\n<p>Alveolar flooding and subsequent intrapulmonary shunt physiology.</p>\n<p>Low pO2</p>\n<p>Normal/ low pCO2</p>\n<p>High (pAO2-paO2)</p>\n</td>\n<td>\n<p>Sepsis</p>\n<p>Gastric aspiration</p>\n<p>Pneumonia</p>\n<p>Near-drowning</p>\n<p>Multiple blood transfusions</p>\n<p>Pancreatitis</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td>\n<p>Hypoxemia with <strong>hypercapnia</strong></p>\n</td>\n<td>\n<p>Results from the inability to eliminate carbon dioxide effectively.</p>\n<p>Low pO2</p>\n<p>High pCO2</p>\n<p>Normal (pAO2-paO2)</p>\n</td>\n<td>\n<p>Drug overdose</p>\n<p>Brainstem injury</p>\n<p>Sleep-disordered breathing</p>\n<p>Severe hypothyroidism</p>\n<p>Myasthenia gravis</p>\n<p>Guillain-Barre syndrome</p>\n<p>Amyotrophic lateral sclerosis</p>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td>Peri-operative respiratory failure</td>\n<td>Results from lung atelectasis.</td>\n<td>After general anesthesia.</td>\n</tr>\n<tr>\n<td>IV</td>\n<td>Shock</td>\n<td>Results from hypoperfusion of respiratory muscles in patients with shock</td>\n<td>Cardiogenic shock.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><p>pO2- partial pressure of oxygen</p>\n<p>pCO2- partial pressure of carbon dioxide</p>\n<p>(pAO2-paO2)- alveolar- arterial oxygen gradient</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5674",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements regarding the first-dose phenomenon seen with alpha-1 blockers usage is false?",
      "choices": [
        {
          "id": 1,
          "text": "Occurs within 30-90 minutes of administration first dose"
        },
        {
          "id": 2,
          "text": "Subsequent dose increases will not cause this effect"
        },
        {
          "id": 3,
          "text": "Occurs in upto 50% of patients, especially in those with concomitant diuretic intake"
        },
        {
          "id": 4,
          "text": "Initiating low doses at bedtime helps minimise this phenomenon"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Subsequent dose increases</strong> will <strong>also be associated</strong> with this effect.</p>\n<p>Prazosin is a <strong>selective alpha-1</strong>&nbsp;<strong>antagonist.</strong> It acts by blocking the alpha-1 receptors in the arterioles and veins, thereby decreasing peripheral vascular resistance. It has <strong>little or no alpha-2-blocking effect.</strong></p>\n<p><strong>First-dose phenomenon:&nbsp;</strong></p>\n<p>Within <strong>30&ndash;90 minutes</strong> of the initial dose of prazosin <strong>or when the dosage is increased,</strong> there is <strong>marked</strong> <strong>orthostatic hypotension </strong>or <strong>syncope</strong>. This is known as the first-dose phenomenon. After a few initial doses, tolerance develops to this adverse effect.<strong> Initiating low doses at bedtime</strong> is recommended to minimize this phenomenon.&nbsp;</p>\n<p>Uses of prazosin:</p>\n<ul>\n<li>Hypertension</li>\n<li>Congestive cardiac failure</li>\n<li>Benign prostatic hyperplasia</li>\n<li>In vasospastic disorders like Raynaud's disease</li>\n</ul>\n<p>Other adverse effects are headache, dizziness, and asthenia.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5588",
      "difficulty": "medium"
    },
    {
      "text": "While assisting the chief medical examiner during the autopsy of victims of a mass casualty event, you are asked to collect blood samples for biochemical examination. Arrange the blood collection site that you can use, in descending order of preference.<div class='question-desc-html'><ol>\n<li>Heart</li>\n<li>Root of aorta</li>\n<li>Femoral vessels</li>\n<li>Subclavian vessels</li>\n<li>Pulmonary artery</li>\n<li>Superior vena cava</li>\n</ol>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "3-4-2-5-6-1"
        },
        {
          "id": 2,
          "text": "1-5-3-4-2-6"
        },
        {
          "id": 3,
          "text": "1-5-6-3-4-2"
        },
        {
          "id": 4,
          "text": "3-1-6-4-2-5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>sites</strong>&nbsp;for collection of <strong>blood samples for biochemical analysis</strong>&nbsp;in <strong>descending order of preference</strong> are:</p>\n<ol>\n<li>Femoral vessels</li>\n<li>Subclavian vessels</li>\n<li>Root of aorta</li>\n<li>Pulmonary artery</li>\n<li>Superior vena cava</li>\n<li>Heart</li>\n</ol>\n<p>Blood sample collection for<strong> volatile substances</strong> should be done using small glass bottles that are <strong>aluminum foil lined</strong>. These should be filled up to the brim and stored at 4&deg;C. <strong>CSF</strong> can be collected by <strong>lumbar puncture or cisternal puncture.</strong>&nbsp;The samples are <strong>best collected within 4-6 hours after death</strong>, but no later than 12 hours.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Autopsy Techniques</h3><ul>\n<li><strong>Virchow's</strong>&nbsp;<strong>technique</strong>: Organs are removed <strong>one by one</strong> from the body to be examined. Here the cranial cavity is opened first, then the spinal cord, followed by thoracic, cervical, and abdominal organs in that order.</li>\n<li><strong>Ghon's technique</strong>: Here the organs are removed<strong> 'en bloc</strong>'. The thoracic, cervical, pelvic, and abdominal organs are removed as organ blocks.</li>\n<li><strong>Rokitansky's technique</strong>: This is characterized by <strong>'in situ'</strong> dissection in part combined with<strong><em> en bloc</em>&nbsp;</strong>removal like Ghon's technique. The dissection begins at the neck and slowly works its way down the body and the organ is removed as a bloc. A cut is first made at the larynx to separate the esophagus from the pharynx. The larynx and trachea are pulled downward and using a scalpel, the chest organs are cut. The diaphragm is cut to expose the abdominal organs. Other organs like the bladder and rectum are separated from the body by using a scalpel to cut the pelvic ligaments.</li>\n<li><strong>Letulle's technique</strong>: Thoracic, cervical, abdominal, and pelvic organs are removed <strong>'en masse'</strong> meaning as one big organ block. It allows the body to be made available for examination in less than 30 minutes as the process of removing the organs is much quicker.</li>\n</ul><hr><h3>Related Pearl: Autopsy: Types Of Incision</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of incision</strong></td>\n<td><strong>Procedure</strong></td>\n<td><strong>Indication</strong></td>\n<td><strong>Advantage</strong></td>\n</tr>\n<tr>\n<td><strong>I-Shaped Incision</strong></td>\n<td>Extends from <strong>symphysis menti to symphysis pubis</strong>, taking a curve towards the left around the umbilicus.</td>\n<td>It is used routinely in practice</td>\n<td>It is <strong>simple and convenient</strong>.</td>\n</tr>\n<tr>\n<td><strong>Y-Shaped Incision</strong></td>\n<td>Commences at the <strong>acromial process</strong> on the shoulder on either side of the chest, runs downwards and anteriorly <strong>beneath the breasts</strong> as to meet at the xiphisternum and then run downwards as in the \"I\"-shaped incision  </td>\n<td>Preferred in <strong>females</strong></td>\n<td>It <strong>prevents cutting of the chest</strong> skin in the midline.</td>\n</tr>\n<tr>\n<td><strong>Modified Y-Shaped Incision</strong></td>\n<td>Commences at the <strong>angle of mandible</strong> on either side, brought forwards, downwards to meet at the suprasternal notch . It is then run downwards as a midline incision up to the pubic symphysis.</td>\n<td>Preferred when a <strong>detailed study of neck structures</strong> required, e.g. asphyxial death due to neck compression. </td>\n<td>It has better exposure and allows the study of neck structures. </td>\n</tr>\n<tr>\n<td><strong>Elongated X-shaped Incision</strong></td>\n<td>Used to dissect out <strong>subcutaneous structures</strong> in the back to identify and evaluate the extent of blunt injuries. </td>\n<td>Should be practiced in cases of custodial death. </td>\n<td>Helpful in the <strong>reconstruction of events</strong> prior to death. </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b50f95de210f4d069f005b0844c8e10ex1264x1306.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/49bf2290516345ddbf128a1ea88ec8e3x1267x1297.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f798ddeaaa0f45c292cb0be7ab3f3a40x1262x1293.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e036f4fc17f1412ca5f8b027908a66a8x1261x1287.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5527",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old male patient presents with a pelvic fracture following blunt abdominal trauma. No blood is seen at the meatus. Catheterization does not produce significant urine output. The radiological image is given below. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Ureteral rupture"
        },
        {
          "id": 2,
          "text": "Pelvic hematoma"
        },
        {
          "id": 3,
          "text": "Extra-peritoneal rupture of the bladder"
        },
        {
          "id": 4,
          "text": "Intra-peritoneal rupture of the bladder"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario of blunt abdominal trauma, minimal urine output on catheterization, and the&nbsp;pattern of contrast extravasation in the given image indicates&nbsp;<strong>extraperitoneal bladder rupture</strong>.&nbsp;</p>\n<p><strong>Extraperitoneal bladder rupture</strong>&nbsp;leads to extravasation of the contrast material into the <strong>perivesical space and the fascial planes</strong> <strong>anterior to the peritoneum</strong>. The image shows extraperitoneal bladder rupture, with contrast material in the perivesical and the retro-pubic space (no contrast can be seen within the peritoneal cavity).</p>\n<p>Bladder rupture may be extraperitoneal or intraperitoneal. The type of bladder rupture depends on the location of the injury and its relationship with the peritoneal reflection.&nbsp;</p>\n<p>As seen in the image below, the bladder is related to the peritoneum only on its superior surface. Therefore, if the bladder rupture is towards the superior surface, the urine leaks into the peritoneal cavity, i.e. urine extravasation will be&nbsp;<strong>intraperitoneal. </strong>Whereas, bladder rupture due to injury to the anterior or lateral surfaces does not rupture the peritoneum. In such cases, the urine leaks into the perivesical space but does not enter the peritoneum, i.e.&nbsp;urine extravasation will be&nbsp;<strong>extraperitoneal.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/16dac046f56341f2a1cd035f230b2c91x800x485.JPEG\" alt=\"Explanation Image\"><p class=\"p1\"><strong>Intraperitoneal</strong>&nbsp;bladder rupture is caused by a blow or fall on the&nbsp;<strong>distended bladder</strong>. Intraperitoneal bladder rupture manifests as sudden severe pain in the hypogastrium and syncope. There will be an associated increase in BUN and creatinine levels due to systemic absorption of the extravasated urine, and it may also lead to chemical peritonitis.</p>\n<p>Investigations:</p>\n<p><strong>CT</strong>&nbsp;scan can be done to&nbsp;diagnose bladder rupture. A plain erect&nbsp;<strong>X-ray</strong>&nbsp;may show a&nbsp;<strong>ground-glass</strong>&nbsp;appearance. Intravenous urography (<strong>IVU</strong>) may confirm a&nbsp;<strong>leak</strong>.&nbsp;<strong>Retrograde cystography</strong>&nbsp;will&nbsp;<strong>confirm</strong>&nbsp;the diagnosis.&nbsp;</p>\n<p><strong>Intraperitoneal bladder rupture</strong> leads to extravasation of the contrast material into the peritoneal cavity, around the bowel loops and paracolic gutters. Hence, the outline of bowel loops can be seen.</p>\n<p>The image below shows intraperitoneal bladder rupture, with arrows showing contrast material in the peritoneal cavity:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a86446460d145879c7811859d0600e9x625x750.JPEG\" alt=\"Explanation Image\"><p>Treatment :&nbsp;</p>\n<ul>\n<li>Extravesical injury&ndash; catheter drainage for 10 days</li>\n<li>Intraperitoneal injury&ndash; laparotomy, repair, and bladder drainage (suprapubic and urethral catheter). Laparoscopic approaches are also now being used.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0309c32b0a2045d4a0fd9247d4b04785.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5565",
      "difficulty": "medium"
    },
    {
      "text": "Sequentially arrange the following fractures in ascending order of their severity as per the Gustilo-Anderson classification for open fractures.<div class='question-desc-html'><ol>\n<li>A 16 cm open wound with comminuted fractures but intact soft tissue coverage</li>\n<li>A 14 cm open wound with comminuted fractures that require concomitant soft tissue reconstructive surgery</li>\n<li>A 11 cm open wound with comminuted fracture and arterial injury requiring vascular repair</li>\n<li>A 6 cm open wound with a moderately comminuted fracture and some muscle damage.</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "4312"
        },
        {
          "id": 2,
          "text": "4321"
        },
        {
          "id": 3,
          "text": "4213"
        },
        {
          "id": 4,
          "text": "4123"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>As per Gustilo and Anderson's classification, the respective grades are</p>\n<p>A 16 cm open wound with comminuted fractures but intact soft tissue coverage - <strong>IIIA</strong><br />A 14 cm open wound with comminuted fractures that require concomitant soft tissue reconstructive surgery - <strong>IIIB</strong><br />A 11 cm open wound with comminuted fracture and arterial injury requiring vascular repair - <strong>IIIC</strong><br />A 6 cm open wound with a moderately comminuted fracture and some muscle damage - <strong>II</strong></p>\n<p><strong>Gustilo and Anderson's classification</strong> is the most commonly followed classification for <strong>open fractures</strong>. An<strong> open fracture,</strong> with an<strong> arterial injury, </strong>that requires repair <strong>regardless of the size of the soft tissue wound,</strong> belongs to classification<strong> IIIC.</strong></p><hr><h3>Related Pearl: Gustilo and Anderson classification for open fracture</h3><table>\n<tbody>\n<tr>\n<td colspan=\"5\"><strong>Gustilo-Anderson's classification for open injuries</strong>&nbsp;&nbsp;&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Wound</strong></td>\n<td><strong>Level of contamination</strong></td>\n<td><strong>Soft tissue injury</strong></td>\n<td><strong>Bone injury</strong></td>\n</tr>\n<tr>\n<td><strong>I</strong></td>\n<td>&lt;1 cm</td>\n<td>Clean</td>\n<td>Minimal</td>\n<td>Simple, minimal comminution</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>&gt;1 cm</td>\n<td>Moderate</td>\n<td>Moderate; some muscle damage</td>\n<td>Moderate comminution</td>\n</tr>\n<tr>\n<td><strong>IIIA</strong></td>\n<td>usually &gt;10 cm</td>\n<td>High</td>\n<td>Severe with crushing</td>\n<td>Usually comminuted; soft tissue coverage of bone possible</td>\n</tr>\n<tr>\n<td><strong>IIIB</strong></td>\n<td>usually &gt;10 cm</td>\n<td>High</td>\n<td>Very severe loss of cover</td>\n<td>Bone cover poor; usually requires soft tissue reconstructive surgery</td>\n</tr>\n<tr>\n<td><strong>IIIC</strong></td>\n<td>usually &gt;10 cm</td>\n<td>High</td>\n<td>Very severe loss of cover; <strong>vascular injury</strong> requiring repair</td>\n<td>Bone cover poor; usually requires soft tissue reconstructive surgery</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p><span><br />Management according to Gustilo-Anderson's classification:</span></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Types</strong></td>\n<td><strong>Methods of fixation</strong></td>\n</tr>\n<tr>\n<td><strong>Grade &nbsp;I &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong></td>\n<td>A technique that is suitable for closed fracture management i.e, debridement and internal fixation by intramedullary nail and plate&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Grade II, IIIA</strong></td>\n<td>\n<p>Within 6hr same as grade I and after 6hr same as IIIB, IIIC</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade IIIB, IIIC</strong></td>\n<td>\n<p>Debridement and external fixation</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5651",
      "difficulty": "easy"
    },
    {
      "text": "What is the drug of choice for prophylaxis of chronic cluster headaches?",
      "choices": [
        {
          "id": 1,
          "text": "Oral sumatriptan"
        },
        {
          "id": 2,
          "text": "Oral Verapamil"
        },
        {
          "id": 3,
          "text": "Sumatriptan nasal spray"
        },
        {
          "id": 4,
          "text": "Gabapentin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The drugs used in the <strong>prophylaxis</strong> of chronic cluster headaches are:</p>\n<ul>\n<li><strong>Verapamil - drug of choice</strong></li>\n<li>Prednisone</li>\n<li>Lithium</li>\n<li>Topiramate</li>\n<li>Gabapentin</li>\n<li>Melatonin</li>\n<li>Greater occipital nerve injection with lidocaine and glucocorticoids</li>\n</ul>\n<p><strong>Cluster headache</strong> is a <strong>periodic</strong> headache characterized by daily attacks of short-duration unilateral headache lasting 8-10 weeks a year. It presents as severe, <strong>unilateral retro-orbital pain</strong> with <strong>autonomic features</strong>, such as unilateral lacrimation, nasal congestion, and conjunctival injection. The pain, though severe, is characteristically brief (15-180 minutes). Patients are usually perfectly well in between episodes.</p>\n<p>The most suitable treatment is pharmacologic prevention of future bouts of headaches. An acute episode can be treated with<strong> </strong></p>\n<ul>\n<li><strong>Sumatriptan </strong>6 mg <strong>subcutaneous </strong>injection</li>\n<li><strong>100% O2 </strong>at<strong> 10 -12 L/min </strong>for 15 - 20 mins</li>\n<li>Sumatriptan (20 mg) and zolmitriptan (5 mg)<strong> nasal spray.</strong></li>\n<li>Noninvasive vagus nerve stimulation (nVNS) is also approved by the FDA for the treatment of acute episodes of cluster headaches.</li>\n</ul>\n<p>Other options:</p>\n<p><strong>Oral</strong> sumatriptan is <strong>not effective</strong> for the treatment or prevention of acute cluster headaches. The <strong>nasal spray</strong> form of <strong>sumatriptan</strong> is used in the <strong>management of acute attacks. </strong>Gabapentin is not the drug of choice, though it has a role in prophylaxis of cluster headaches. </p>\n<p> </p><hr><h3>Related Pearl: Trigeminal Autonomic Cephalalgia</h3><p><strong>Types of trigeminal autonomic cephalalgia:</strong></p>\n<ul>\n<li>Cluster headache</li>\n<li>Paroxysmal hemicranias</li>\n<li>Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT)</li>\n<li>Short-lasting unilateral neuralgiform&nbsp;<em>headache</em>&nbsp;attacks with cranial autonomic features (SUNA)</li>\n<li>Hemicrania continua</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>&nbsp;Cluster headache</strong></td>\n<td><strong>Paroxysmal hemicrania&nbsp;</strong></td>\n<td><strong>&nbsp;SUNCT/SUNA</strong></td>\n</tr>\n<tr>\n<td>Gender&nbsp;</td>\n<td>Males&gt;females</td>\n<td>Female=Males</td>\n<td>Female=Males</td>\n</tr>\n<tr>\n<td>Character of pain&nbsp;</td>\n<td>Stabbing /boring</td>\n<td>Throbbing pain&nbsp;/stabbing /boring</td>\n<td>Burning /stabbing/sharp</td>\n</tr>\n<tr>\n<td>Severity of pain&nbsp;</td>\n<td>Excruciating&nbsp;</td>\n<td>Excruciating</td>\n<td>Severe to excruciating</td>\n</tr>\n<tr>\n<td>Site of pain&nbsp;</td>\n<td>Orbit, temple</td>\n<td>Orbit, temple</td>\n<td>Periorbital</td>\n</tr>\n<tr>\n<td>Attack frequency&nbsp;</td>\n<td>1-8 /day</td>\n<td>1-20/day</td>\n<td>3-200/day</td>\n</tr>\n<tr>\n<td>Duration</td>\n<td>15min-3 hours</td>\n<td>2-30 min</td>\n<td>5-240seconds</td>\n</tr>\n<tr>\n<td>Migraneous feature&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Alcohol trigger&nbsp;</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Cutaneous trigger</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Response to indomethacin</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Abortive treatment</td>\n<td>\n<p>100% oxygen</p>\n<p>Sumatriptan injection</p>\n</td>\n<td>\n<p>No effective treatment</p>\n</td>\n<td>\n<p>IV lidocaine&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Prophylaxis</td>\n<td>\n<p>Chronic cluster</p>\n<ul>\n<li>Lithium</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n<p>Episodic cluster&nbsp;</p>\n<ul>\n<li>Steroids&nbsp;</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Indomethacin</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n<li>Topiramate</li>\n<li>Gabapentin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Indomethacin</strong> is effective in paroxysmal hemicrania,hemicrania continuum, and primary sexual/ exercise headache</li>\n<li>Cutaneous trigger is also seen in trigeminal neuralgia, however, <strong>trigeminal neuralgia</strong> is a <strong>separate entity </strong>and not a part of trigeminal autonomic cephalalgia&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5581",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following conditions do you see a 'headlight-in-fog' appearance, as seen below?",
      "choices": [
        {
          "id": 1,
          "text": "Posterior staphyloma"
        },
        {
          "id": 2,
          "text": "Fundal coloboma"
        },
        {
          "id": 3,
          "text": "Congenital rubella"
        },
        {
          "id": 4,
          "text": "Toxoplasmosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The \"<strong>headlight-in-fog'</strong>&nbsp;appearance is seen in <strong>toxoplasmosis.&nbsp;</strong></p>\n<p>Toxoplasmosis is a parasitic infestation due to <strong><em>Toxoplasma gondii</em></strong><em>.&nbsp;</em>It primarily affects the central nervous system and retina. In humans, it occurs as congenital, acquired, or recurrent.</p>\n<p><strong>Toxoplasmosis</strong>&nbsp;has a <strong>variable presentation</strong>.&nbsp;Congenital toxoplasmosis is acquired by the transplacental route. Infants are usually born with inactive disease.&nbsp;<strong>Iridocyclitis</strong>&nbsp;can be granulomatous or non-granulomatous. There is focal superficial necrotizing retinochoroiditis along with vitritis, which gives the '<strong>headlight-in-fog' appearance</strong>&nbsp;as in the image in question.<strong>&nbsp;</strong>Fundoscopy shows deep retinitis and papillitis with granulomas.&nbsp;</p>\n<p><strong>Old choroid</strong>&nbsp;lesions of toxoplasmosis are <strong>punched-out lesions with pigmented borders</strong>&nbsp;as in the image below<strong>.</strong>&nbsp;<strong>Bilateral healed punched-out</strong> chorioretinal lesions in the <strong>macular</strong> area are usually seen. In acquired toxoplasmosis, punched-out lesions similar to congenital toxoplasmosis are seen. In addition, punctate outer retinal toxoplasmosis (PORT) may also be seen.&nbsp;</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/96b3261505f24644ad2ef07e66c2d03dx662x661.PNG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A - <strong>Posterior staphyloma</strong> is used to describe a bulge in the <strong>sclera </strong>with the <strong>choroid</strong> behind the equator. On ophthalmoscopy, there is an <strong>excavated area</strong> with r<strong>etinal vessels</strong> dipping in it.&nbsp;</p>\n<p>Option B - <strong>Fundal coloboma</strong> occurs due to a defect in the closure of the embryonic cleft. It appears as a <strong>comet-shaped</strong> defect with the apex towards the disc which may or may not be involved. A few choroidal or retinal vessels may also be seen on the surface.&nbsp;</p>\n<p>Option C - <strong>Congenital rubella</strong> typically produces a <strong>salt and pepper</strong> appearance of the fundus.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/1255430567934a5bb15a1cb46b3bafef.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5536",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following factors causes an increase in the minimum alveolar concentration of an inhaled anesthetic agent?",
      "choices": [
        {
          "id": 1,
          "text": "Hypoxia"
        },
        {
          "id": 2,
          "text": "Hypothermia"
        },
        {
          "id": 3,
          "text": "Hypernatremia"
        },
        {
          "id": 4,
          "text": "Hyperthyroidism"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Minimum alveolar concentration (MAC)<strong>&nbsp;increases</strong>&nbsp;in&nbsp;<strong>hypernatremia</strong>&nbsp;(total serum sodium level: &gt;145 mmol/L)</p>\n<p>MAC is defined as the inhaled anesthetic atmospheric pressure required to prevent movement in response to a defined noxious stimulus in 50% of subjects. MAC is <strong>unique</strong> to each inhaled anesthetic.&nbsp;It is used to express the potency of anesthetic agents. Thus, the <strong>lower the MAC</strong>, the <strong>higher the potency</strong>.&nbsp;</p>\n<p>&nbsp;</p>\n<p><strong>Hyperthyroidism</strong> and hypothyroidism have <strong>no effect on MAC.</strong></p><hr><h3>Related Pearl: Factors affecting Minimum Alveolar Concentration (MAC)</h3><table>\n<tbody>\n<tr>\n<td><strong>Factors increasing MAC</strong></td>\n<td><strong>Factors decreasing MAC</strong></td>\n<td><strong>No change in MAC</strong></td>\n</tr>\n<tr>\n<td>Hyperthermia &gt;42°C</td>\n<td>Acute alcohol intoxication </td>\n<td>Hyperthyroidism</td>\n</tr>\n<tr>\n<td>Chronic alcohol abuse</td>\n<td>Hypothermia and hyperthermia up to 42°C</td>\n<td>Hypothyroidism</td>\n</tr>\n<tr>\n<td>Acute amphetamine use </td>\n<td>Older age (&gt;6 months MAC decreases 6% per decade)</td>\n<td> </td>\n</tr>\n<tr>\n<td>Drugs: Cocaine, Ephedrine</td>\n<td>Chronic amphetamine abuse</td>\n<td> </td>\n</tr>\n<tr>\n<td>Hypernatremia </td>\n<td>Drugs: Opioids, Ketamine, Barbiturates, Benzodiazepines, Sympatholytics </td>\n<td> </td>\n</tr>\n<tr>\n<td>Young age (&lt;6 months; MAC is maximum at 6 months)</td>\n<td>Hyponatremia, Hypercalcemia</td>\n<td> </td>\n</tr>\n<tr>\n<td> </td>\n<td>Hypotension</td>\n<td> </td>\n</tr>\n<tr>\n<td> </td>\n<td>Hypercarbia, Hypoxia, Metabolic acidosis</td>\n<td> </td>\n</tr>\n<tr>\n<td> </td>\n<td>Pregnancy </td>\n<td> </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><hr><h3>Related Pearl: Minimum alveolar concentration (MAC)</h3><p><strong><span class=\"topic-highlight\">Minimum alveolar concentration</span>&nbsp;(MAC)</strong> is the minimum concentration of an inhaled anesthetic at 1&nbsp;atm of pressure that<strong> prevents skeletal muscle movement</strong> in response to a<strong> surgical incision </strong>in<strong> 50% of patients.&nbsp;</strong></p>\n<p><strong>MAC of inhaled anesthetics</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Anesthetic Agents</strong></td>\n<td>\n<p><strong>MAC&nbsp;</strong><strong>(Potency)</strong></p>\n</td>\n<td>\n<p><strong>Blood-gas coefficient&nbsp;</strong><strong>(Solubility)</strong></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Halothane</strong></span></td>\n<td><strong>0.75</strong></td>\n<td>&nbsp;2.4</td>\n</tr>\n<tr>\n<td><span><strong>Isoflurane</strong></span></td>\n<td>1.2</td>\n<td>1.4&nbsp;</td>\n</tr>\n<tr>\n<td><span><strong>Enflurane</strong></span></td>\n<td>1.7</td>\n<td>1.9&nbsp;</td>\n</tr>\n<tr>\n<td><span><strong>Sevoflurane</strong></span></td>\n<td>2</td>\n<td>0.65&nbsp;</td>\n</tr>\n<tr>\n<td><span><strong>Desflurane</strong></span></td>\n<td>6</td>\n<td><strong>0.42</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><span><strong>Nitrous oxide</strong></span></td>\n<td><strong>104</strong></td>\n<td>0.47&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>MAC is an indicator of potency. The <strong>lower</strong> the <strong>MAC,</strong>&nbsp;the <strong>higher</strong> is the <strong>potency.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2b4742a236574d888df15bbc175acb5dx1280x1280.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5609",
      "difficulty": "hard"
    },
    {
      "text": "Difficulty in eversion of the upper lid seen in Graves ophthalmopathy is known as _________",
      "choices": [
        {
          "id": 1,
          "text": "Enroth sign"
        },
        {
          "id": 2,
          "text": "Gifford's sign"
        },
        {
          "id": 3,
          "text": "Stellwag's sign"
        },
        {
          "id": 4,
          "text": "Gellineck sign"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Difficulty in eversion of the upper lid seen in Graves ophthalmopathy is known as<strong> Gifford's sign</strong>.</p>\n<p><strong>Graves ophthalmopathy:</strong> Most frequently affected extra ocular muscle in Grave's ophthalmopathy is Inferior Rectus.</p>\n<p>Classification: Acronym ‘NOSPECS’:</p>\n<ul>\n<li>Class 0 : No signs and symptoms</li>\n<li>Class 1 : Only signs, no symptoms. Signs are limited to lid retraction with or without lid lag and mild proptosis</li>\n<li>Class 2 : Soft tissue involvement with signs of class 1 and symptoms including lacrimation, photophobia, lid or conjunctival swelling</li>\n<li>Class 3 : Proptosis is well established</li>\n<li>Class 4 : Extraocular muscle involvement (limitation of movements and diplopia)</li>\n<li>Class 5 : Corneal involvement (exposure keratitis)</li>\n<li>Class 6 : Sight loss due to optic nerve involvement with disc pallor or papilloedema</li>\n</ul>\n<p>EARLY Graves : class 1 and 2</p>\n<p>Late Graves : class 3 to 6</p><hr><h3>Related Pearl: Signs in Grave’s ophthalmopathy</h3><div>\n<table>\n<tbody>\n<tr>\n<td><strong>Sign</strong></td>\n<td><strong>Feature</strong></td>\n</tr>\n<tr>\n<td>Dalrymple's sign</td>\n<td>Retraction of the upper lids</td>\n</tr>\n<tr>\n<td>von Graefe's sign</td>\n<td>Lid lag, i.e., when the globe is moved downward, the upper lid lags behind</td>\n</tr>\n<tr>\n<td>Griffith Sign</td>\n<td>Lower lid lag on upward gaze</td>\n</tr>\n<tr>\n<td>Enroth's sign</td>\n<td>Fullness of the eyelids</td>\n</tr>\n<tr>\n<td>Stellwag's sign</td>\n<td>Infrequent blinking</td>\n</tr>\n<tr>\n<td>Gifford's sign</td>\n<td>Difficulty in eversion of the upper lid</td>\n</tr>\n<tr>\n<td>Mobius&rsquo; sign</td>\n<td>Convergence weakness</td>\n</tr>\n<tr>\n<td>Joffroy&rsquo;s sign</td>\n<td>Lack of wrinkling of the forehead on superior gaze</td>\n</tr>\n<tr>\n<td>Jellinek's Sign</td>\n<td>Abnormal pigmentation of the upper lid</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The image given below shows Dalrymple's sign in the right eye.</p>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0a484751a2e640e7906b3d75f752f5b5x450x224.PNG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5676",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following pairs of sphingolipidoses and deficient enzymes is incorrect?",
      "choices": [
        {
          "id": 1,
          "text": "Sandhoff disease - Hexosaminidase A and B"
        },
        {
          "id": 2,
          "text": "Fabry disease - β-Galactosidase"
        },
        {
          "id": 3,
          "text": "Gaucher disease - β-Glucosidase"
        },
        {
          "id": 4,
          "text": "Niemann–Pick disease - Sphingomyelinase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Fabry disease</strong> is due to the deficiency of <strong>α-galactosidase. β-Galactosidase deficiency</strong> results in <strong>Krabbe disease.</strong></p>\n<p><strong>Fabry disease</strong> is an <strong>X-linked</strong>, multisystem,<strong> lysosomal storage disorder</strong> caused by the deficiency of <strong>α-galactosidase. </strong>This leads to the accumulation of <strong>globotriaosylceramide</strong>. It is seen in both men and women (less severe). It usually manifests in childhood or adolescence, with symptoms of <strong>severe agonizing pain</strong> in the palms of hands, soles of feet, and proximal extremities called <strong>acroparesthesia.</strong></p>\n<p><strong>Angiokeratomas,</strong> as seen in the image below are present,<strong> </strong>which are lesions that are dark-red to blue-black, flat or slightly raised, punctate, and usually seen between the umbilicus and the knees (called the '<strong>bathing suit area'</strong>) and the trunk.</p>\n<p>Late presentations include <strong>renal failure</strong>, and cardiovascular or cerebrovascular disease, which are the leading causes of death in these patients. Urinalysis shows <strong>proteinuria </strong>and<strong> Maltese cross structures. </strong>An enzyme assay, genetic testing, or a skin or kidney biopsy showing <strong>glycolipid deposits</strong> helps establish the diagnosis. Treatment is with <strong>enzyme replacement therapy</strong> (recombinant alpha-Gal A or migalastat).</p>\n<p><strong>Krabbe disease</strong> or <strong>globoid cell</strong> leukodystrophy is a neurodegenerative disorder with severe myelin loss and the presence of globoid bodies in white matter. It is an <strong>autosomal recessive leukodystrophy</strong> due to the deficiency of galactocerebroside <strong>β-galactosidase</strong>. β-galactosidase helps in the catabolism of galactocerebroside to ceramide and galactose.</p>\n<p>As a result, an alternative catabolic pathway shunts galactocerebroside to <strong>galactosylsphingosine</strong>.<strong> </strong>Elevated levels of these compounds are cytotoxic and cause the destruction of oligodendroglia. The onset of symptoms is between 3 and 6 months of age, dominated by motor signs such as stiffness and weakness. They often do not survive beyond the age of 2 years. The brain shows <strong>loss of myelin and oligodendrocytes </strong>with a similar process affecting the<strong> peripheral nerves.</strong></p>\n<p>The <strong>aggregation of engorged macrophages </strong>called<strong> globoid cells </strong>in the brain parenchyma and around blood vessels is the characteristic and diagnostic feature of Krabbe disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6edbd12d870149bf8c283016aeb7a862x512x336.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5476",
      "difficulty": "medium"
    },
    {
      "text": "What is the maximum flow rate of the cannula shown in the below image?",
      "choices": [
        {
          "id": 1,
          "text": "30 ml/min"
        },
        {
          "id": 2,
          "text": "36 ml / min"
        },
        {
          "id": 3,
          "text": "13 ml/min"
        },
        {
          "id": 4,
          "text": "20 ml/min"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given cannula is a <strong>26-</strong><strong>gauge IV cannula</strong> as its color is <strong>violet</strong>.<strong> </strong>The maximum flow rate in the cannula of this gauge is <strong>13 mL/min</strong>.</p><hr><h3>Related Pearl: Color Coding of Intravenous Cannulae</h3><table>\n<tbody>\n<tr>\n<td><strong>Size</strong></td>\n<td><strong>Color Coding</strong></td>\n<td><strong>Flow Rate</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td><span>14G</span></td>\n<td><strong><span>Orange</span></strong></td>\n<td>270ml/min</td>\n<td>Trauma Patients, Rapid, Large Volume replacement</td>\n</tr>\n<tr>\n<td>16G</td>\n<td><strong><span>Grey</span></strong></td>\n<td>236ml/min</td>\n<td>Trauma Patients, Major Surgery, Intra Partum/Post Partum, GI bleeds, Multiple blood transfers, High volume of Fluids</td>\n</tr>\n<tr>\n<td>17G</td>\n<td><strong>White</strong></td>\n<td>125ml/min</td>\n<td>Newly added</td>\n</tr>\n<tr>\n<td>18G</td>\n<td><span><strong><span>Green</span></strong></span></td>\n<td>103 ml/min</td>\n<td>Blood products, delivery of irritant medications, major surgery, contrast study</td>\n</tr>\n<tr>\n<td>20G</td>\n<td><strong><span>Pink</span></strong></td>\n<td>67ml/min</td>\n<td>General use IV maintenance, IV antibiotics, IV analgesics</td>\n</tr>\n<tr>\n<td>22G</td>\n<td><span><strong><span>Blue</span></strong></span></td>\n<td>42 ml/min</td>\n<td>Small or Fragile veins, Cytotoxic Therapy</td>\n</tr>\n<tr>\n<td>24G</td>\n<td><strong><span>Yellow</span></strong></td>\n<td>20ml/min</td>\n<td>For pediatric Usage</td>\n</tr>\n<tr>\n<td>26G</td>\n<td><span><strong><span>Violet</span></strong></span></td>\n<td>13ml/min</td>\n<td>Newly added</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/339cb813cd714385ac6ad69260bb3fe4.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5576",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a history of multiple abdominal surgeries is taken up for a laparoscopic procedure. Your senior resident asks you to insert the port at the palmer's point. Where would you insert the Veress needle?",
      "choices": [
        {
          "id": 1,
          "text": "3 cm below the left costal margin at the mid-clavicular line"
        },
        {
          "id": 2,
          "text": "7 cm below the left costal margin at the mid-clavicular line"
        },
        {
          "id": 3,
          "text": "3 cm below the left costal margin at the mid-axillary line"
        },
        {
          "id": 4,
          "text": "7 cm below the right costal margin at the mid-clavicular line"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Palmer's point is 3 cm</strong> <strong>below</strong> the <strong>left costal margin</strong> at the <strong>mid-clavicular line.</strong></p>\n<p>Most common site of insertion of port for creation of pneumoperitoneum is <strong>infraumbilical</strong>. But in patients with multiple adhesions, this is not preferred due to suspected adhesions.</p>\n<p>In routine laparoscopy, there are two methods for establishing abdominal access during laparoscopic surgeries. One is the direct puncture technique and the other is the direct peritoneal access technique. Veress needle is used in&nbsp;<strong>direct puncture laparoscopy.</strong></p>\n<p><strong>Direct puncture laparoscopy</strong>, the abdominal wall is grasped with towel clips or fingers to elevate the abdominal wall away from the underlying structures. Then a small incision is made in the umbilicus and insufflation is done with a veress needle. While introducing the veress needle, two distinct pops can be felt as the needle pierces the abdominal wall fascia and the peritoneum.</p>\n<p>The umbilicus is the preferred location for introducing a veress needle because the abdominal wall is thin at this location. Laparoscopic surgeries can be done under general anesthesia or local anesthesia however, general anesthesia is preferred.&nbsp;<strong>Carbon dioxide(CO2)</strong>&nbsp;gas is usually used and the maximum pressure is in the range of 14-15 mm Hg. But&nbsp;<strong>N2O</strong>&nbsp;is used if the procedure is done under&nbsp;<strong>local anesthesia</strong>. Insufflation with N2O is stopped at a pressure of 10 mmHg or when 2L of gas is insufflated.</p>\n<p>The&nbsp;<strong>direct peritoneal access technique</strong>&nbsp;<strong>(Hasson technique)</strong>&nbsp;is done only occasionally. It is preferred for patients who have undergone previous abdominal surgeries as the small bowel may be adherent to the undersurface of the abdominal wound in such cases.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5561",
      "difficulty": "medium"
    },
    {
      "text": "What is the intermediate host for the organism shown in the image below?",
      "choices": [
        {
          "id": 1,
          "text": "Freshwater fish"
        },
        {
          "id": 2,
          "text": "Pig"
        },
        {
          "id": 3,
          "text": "Cattle"
        },
        {
          "id": 4,
          "text": "No intermediate host"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given image shows&nbsp;<strong><em>Ascaris lumbricoides</em></strong><em>&nbsp;</em>(roundworm). It has <strong>no intermediate host.</strong></p>\n<p>It is the most common of human helminths and is distributed worldwide. Adult worms live in the small intestine (85% in the jejunum and 15% in the ileum). It is the largest nematode parasite in the human intestine.</p>\n<p>The adult worms are large<strong> cylindrical </strong>worms, with<strong> tapering ends</strong>, the anterior end being more pointed than the posterior end.&nbsp;<strong>Man</strong> is the <strong>natural host</strong>. There is <strong>no intermediate host.</strong></p>\n<p>Infection&nbsp;occurs through food or water contaminated with nightsoil or human feces containing eggs of <em>Ascaris</em>. The eggs contain the infective&nbsp;rhabditiform larva.</p><hr><h3>Related Pearl: Definitive and intermediate hosts of various parasites</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Parasite</strong></p>\n</td>\n<td>\n<p><strong>Definitive host</strong></p>\n</td>\n<td>\n<p><strong>Intermediate host</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Protozoa</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasmodium spp.</p>\n</td>\n<td>\n<p>Female Anopheles mosquito</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Babesia</p>\n</td>\n<td>\n<p>Tick</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leishmania</p>\n</td>\n<td>\n<p>Man, dog</p>\n</td>\n<td>\n<p>Sandfly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trypanosoma brucei</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Tsetse fly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trypanosoma cruzi</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Triatomine bug</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Toxoplasma gondii</p>\n</td>\n<td>\n<p>Cat</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cestodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Taenia solium</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Pig</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Taenia saginata</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Cattle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Echinococcus granulosus</p>\n</td>\n<td>\n<p>Dog</p>\n</td>\n<td>\n<p>Sheep, horses.</p>\n<p>Man is the accidental intermediate host.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Trematodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fasciola hepatica</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fasciolopsis buski</p>\n</td>\n<td>\n<p>Man, pig</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Schistosoma spp.</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nematodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trichinella spiralis</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Pig</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Wuchereria bancrofti</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Mosquito</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Brugia malayi</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Mosquito</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dracunculus medinensis</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Cyclops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Infective form and diagnostic forms - Worms</h3><table dir=\"ltr\"><colgroup><col /><col /><col /></colgroup>\n<tbody>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Parasite&quot;}\"><strong>Parasite</strong></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Infective form&quot;}\"><strong>Infective form</strong></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Diagnostic form&quot;}\"><strong>Diagnostic form</strong></td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\" data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cestode&quot;}\"><strong>Cestode</strong></td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Diphyllobothrium latum&quot;}\"><em>Diphyllobothrium latum</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Plerocercoid larva&quot;}\">Plerocercoid larva</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;eggs or segments of the tapeworm&quot;}\">Eggs or segments of the tapeworm</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Taenia saginata&quot;}\"><em>Taenia saginata</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cysticercus bovis&quot;}\">Cysticercus bovis</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Egg&quot;}\">Egg</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Taenia solium&quot;}\"><em>Taenia solium</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cysticercus cellulosae&quot;}\">Cysticercus cellulosae</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Egg (for intestital taeniasis ) / cysticercus cellulosae larva (for cysticercosis)&quot;}\">Egg (for intestinal taeniasis ) / cysticercus cellulosae larva (for cysticercosis)</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Echinococcus granulosus&quot;}\"><em>Echinococcus granulosus</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Egg&quot;}\">Egg</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;protoscolices and brood capsules&quot;}\">Protoscolices and brood capsules</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Hymenolepsis nana&quot;}\"><em>Hymenolepsis nana</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Egg&quot;}\">Egg</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Egg&quot;}\">Egg</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\" data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;TREMATODE&quot;}\"><strong>Trematode</strong></td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Schistosoma&quot;}\"><em>Schistosoma spp</em>.</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cercariae&quot;}\">Cercariae</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Nonoperculated Eggs&quot;}\">Nonoperculated Eggs</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Other trematodes  - Fasciola hepatica, Fasciolopsis buski, Paragonimus westermani, Clonorchis sinensis&quot;}\">Other trematodes - <em>Fasciola hepatica, Fasciolopsis buski, Paragonimus westermani, Clonorchis sinensis</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Metacercaria larva&quot;}\">Metacercaria larva</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Operculated Eggs&quot;}\">Operculated Eggs</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\" data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;NEMATODE&quot;}\"><strong>Nematode</strong></td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Ascaris lumbricoides&quot;}\"><em>Ascaris lumbricoides</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Egg&quot;}\">Egg</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Unembryonated eggs in stool&quot;}\">Unembryonated eggs in stool</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Hookworm&quot;}\">\n<p><em>Ancylostoma duodenale</em></p>\n<p><em>Necator americanus</em></p>\n</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Filariform larva&quot;}\">Filariform larva</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;eggs (in fresh stool), larva ( in old stool )&quot;}\">Eggs (in fresh stool), larva ( in old stool )</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Strongyloides&quot;}\"><em>Strongyloides stercoralis</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Filariform larva&quot;}\">Filariform larva</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Rhabditiform larva&quot;}\">Rhabditiform larva</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trichuris&quot;}\"><em>Trichuris trichuria</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Egg&quot;}\">Embryonated Egg</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Eggs &quot;}\">Unembryonated Egg</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Enterobius&quot;}\"><em>Enterobius vermicularis</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Egg&quot;}\">Egg</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Eggs from perianal skin&quot;}\">Eggs from perianal skin</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Filarial nematodes &quot;}\">Filarial nematodes</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Filarial larva (L3)&quot;}\">Third stage Filarial larva (L3)</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Microfilariae&quot;}\">Microfilariae</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trichinella spiralis&quot;}\"><em>Trichinella spiralis</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;First stage larva (L1)&quot;}\">First stage larva (L1)</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trichinella antibody test&quot;}\">Trichinella antibody test</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Drancunculus medinensis&quot;}\"><em>Dracunculus medinensis</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Third stage filariform larva (L3)&quot;}\">Third stage filariform larva (L3)</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Guinea worm &quot;}\">Adult worm</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\" data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;HINT : Usually parasites causing AUTOINFECTION, infective and diagnostic forms are same&quot;}\"><strong>Hint</strong>: The infective and diagnostic forms are usually the same in the parasites causing <strong>autoinfection</strong>.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b118390f68d0456190f304ea3c081ab4.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5514",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is a serotonin partial agonist–reuptake inhibitor (SPARI)?",
      "choices": [
        {
          "id": 1,
          "text": "Lurasidone"
        },
        {
          "id": 2,
          "text": "Vilazodone"
        },
        {
          "id": 3,
          "text": "Asenapine"
        },
        {
          "id": 4,
          "text": "Blonanserin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Vilazodone</strong> is a novel antidepressant that is considered a <strong>serotonin partial agonist–reuptake inhibitor (SPARI).</strong></p>\n<p id=\"__p9\">The antidepressant effect of vilazodone is due to its <strong>enhancement</strong> of <strong>serotonergic activity</strong> in the CNS through selective inhibition of serotonin reuptake. It binds with <strong>high affinity</strong> to the serotonin reuptake site <strong>but not</strong> to the norepinephrine or dopamine reuptake site. As a result, vilazodone <strong>potently</strong> and <strong>selectively inhibits</strong> the reuptake of serotonin.</p>\n<p>Vilazodone is also a <strong>partial agonist</strong> at serotonergic <strong>5-HT<sub>1A</sub></strong> receptors. The result of this activity on serotonergic transmission also plays a role in its antidepressant effect.</p>\n<p>Thus it offers a <strong>novel</strong> combination of <strong>selective serotonin reuptake inhibition (SSRI)</strong> and serotonergic (<strong>5-HT<sub>1A</sub></strong>) receptor <strong>partial agonist</strong> activity. Because of these characteristics, vilazodone has been termed a serotonin partial agonist–reuptake inhibitor (<strong>SPARI</strong>).</p>\n<p>Vilazodone is never combined with a <strong>monoamine oxidase</strong> (<strong>MAO</strong>) inhibitor or given within <strong>14 days</strong> of discontinuing or initiating MAO inhibitor therapy due to the serious risk of <strong>serotonin toxicity</strong>.</p>\n<p>Other options:</p>\n<p>Option A:<strong> Lurasidone </strong>is a second-generation antipsychotic that is a <strong>5-HT<sub>2A </sub></strong>and <strong>D</strong><sub><strong>2</strong> </sub>receptor antagonist. it is used in the treatment of schizophrenia and bipolar depression (as monotherapy or as an adjunct).</p>\n<p>Option C:<strong> Asenapine </strong>is a second-generation antipsychotic which is also a <strong>5-HT<sub>2A </sub></strong>and <strong>D</strong><sub><strong>2</strong> </sub>receptor antagonist, used in the management of schizophrenia and acute mania.</p>\n<p>Option D: <strong>Blonanserin</strong> is a second-generation antipsychotic, which acts as an antagonist at <strong>D<sub>2</sub></strong>, <strong>D<sub>3</sub></strong>, and <strong>5-HT<sub>2A</sub></strong> receptors. Blonanserin has a low affinity for 5-HT<sub>2C</sub>, adrenergic α<sub>1</sub>, histamine H<sub>1</sub>, and muscarinic M<sub>1</sub> receptors, but displays a relatively high affinity for 5-HT<sub>6</sub> receptors. It is used in the management of schizophrenia.</p><hr><h3>Related Pearl: Neurotransmitters</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Neuro-transmitters</strong></td>\n<td><strong>&nbsp;Major source</strong></td>\n<td><strong>&nbsp;Function</strong></td>\n<td><strong>&nbsp;Increased in</strong></td>\n<td><strong>&nbsp;Decreased in</strong></td>\n</tr>\n<tr>\n<td><strong>Serotonin</strong></td>\n<td><span>Midline Raphe Nucleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Regulation of mood, sleep, appetite, sexual behavior, decreases anxiety</span></p>\n<p><span>Inhibits the dopaminergic function</span></p>\n</td>\n<td><span>Serotonin syndrome</span></td>\n<td>\n<p><span>Depression</span></p>\n<p><span>OCD</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Dopamine</strong></td>\n<td>&nbsp;<span>Substantia Nigra</span></td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Motor movement and alertness</span></p>\n<p><span>Reward seeking, pleasure, motivation</span></p>\n<p><span>Major neurotransmitter in the basal ganglia</span></p>\n</td>\n<td>\n<p><span>Schizophrenia</span></p>\n<p><span>OCD</span></p>\n<p><span>Mania</span></p>\n<p><span>Delirium</span></p>\n</td>\n<td>\n<p><span>Parkinson's disease</span></p>\n<p><span>Depression</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Endorphins</strong></td>\n<td>&nbsp;<span>Pituitary gland</span></td>\n<td><span>Pain control, feelings of pleasure, stress reduction, \"natural opium\"</span></td>\n<td><span>Addiction</span></td>\n<td><span>Inability to combat pain</span></td>\n</tr>\n<tr>\n<td><strong>Acetylcholine</strong></td>\n<td>&nbsp;<span>Nucleus Basalis (of Meynert)</span></td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Motor movement, learning and memory</span></p>\n</td>\n<td><span>Parkinson's disease</span></td>\n<td>\n<p><span>Alzheimer's disease</span></p>\n<p><span>Delirium</span></p>\n<p><span>Dementia</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>GABA</strong></td>\n<td>&nbsp;\n<p>&nbsp;</p>\n</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Decreases anxiety and reduces insomnia</span></p>\n<p><span>Interacts with dopamine, inhibits dopaminergic neurons</span></p>\n</td>\n<td>&nbsp;</td>\n<td>\n<p><span>Anxiety</span></p>\n<p><span>Seizure disorder</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Norepinephrine</strong></td>\n<td><span>Locus ceruleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory:</strong></span></p>\n<p><span>\"Fight or flight\"</span></p>\n</td>\n<td><span>Mania</span></td>\n<td><span>Lack of energy, anhedonia in Schizophrenia,&nbsp;</span><span>Depression</span></td>\n</tr>\n<tr>\n<td><strong>Glutamate</strong></td>\n<td>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Links between neurons for learning and long term memory</span></p>\n</td>\n<td><span>Seizures</span></td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5587",
      "difficulty": "medium"
    },
    {
      "text": "Clinical examination of a patient with suspected anterior dislocation of the shoulder reveals that the vertical circumference of the axilla on the side of suspected dislocation is greater than that on the contralateral side. Which of the following tests gives this result?",
      "choices": [
        {
          "id": 1,
          "text": "Callaway test"
        },
        {
          "id": 2,
          "text": "Bryant test"
        },
        {
          "id": 3,
          "text": "Hamilton ruler test"
        },
        {
          "id": 4,
          "text": "Dugas test"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In a patient with anterior dislocation of the shoulder, the <strong>vertical circumference of the axilla on the side of dislocation is greater</strong> than that on the contralateral side. This is the <strong>Callaway test.&nbsp;</strong><strong>&nbsp;</strong></p>\n<p><strong>Four tests</strong>&nbsp;can be used to diagnose <strong>anterior dislocation </strong>of&nbsp;the<strong> shoulder</strong>:</p>\n<ul>\n<li>Bryant's test</li>\n<li>Dugas test</li>\n<li>Hamilton ruler test&nbsp;</li>\n<li>Callaway test &nbsp;&nbsp;</li>\n</ul><hr><h3>Related Pearl: Tests for anterior shoulder dislocation</h3><p><strong>Bryant&rsquo;s test:&nbsp;</strong>Anterior axillary fold is at a lower level on the dislocated side.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f233d810676246f6a010e89a0a5a0bddx1280x1412.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Dugas test: </strong>The patient is made to place the hand on the opposite shoulder. The examiner then applies gentle pressure on the flexed elbow to make it touch the chest. In shoulder dislocation, the elbow cannot be made to touch the chest.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/993e9fb89e9346deaebb6a42ea3bd38ex600x749.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Hamilton ruler test:&nbsp;</strong>In a&nbsp;normal shoulder, a ruler (scale) placed on the lateral side of the arm will not touch the lateral condyle of the humerus and the acromion at the same time.</p>\n<p>In anterior shoulder dislocation, the ruler will simultaneously touch the lateral condyle of the humerus and the acromion.&nbsp;</p>\n<p class=\"p1\">&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4b10dd054e604dde8a83037dfb07e741x1280x1526.JPEG\" alt=\"Pearl Image\"><p class=\"p1\">&nbsp;</p>\n<p class=\"p1\"><strong>Callway Test:&nbsp;</strong>The vertical circumference of the axilla is increased on the dislocated side as compared to the normal side.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/be589ce9527049c88a0adac7b0f18aa4x1280x1412.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5652",
      "difficulty": "medium"
    },
    {
      "text": "During the analysis of a crime scene in a bathroom, you notice a fingerprint impression made on a soap bar. What would this type of fingerprint be called?",
      "choices": [
        {
          "id": 1,
          "text": "Chance print"
        },
        {
          "id": 2,
          "text": "Latent print"
        },
        {
          "id": 3,
          "text": "Visible print"
        },
        {
          "id": 4,
          "text": "Plastic print"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A<strong> fingerprint</strong> impression made on a<strong> soft surface</strong> such as <strong>soap</strong> would be called&nbsp;<strong>plastic print.</strong></p>\n<p><strong>Types of fingerprints:</strong></p>\n<ul>\n<li><strong>Latent print/Chance print</strong> are&nbsp;<strong>invisible or barely visible</strong>&nbsp;fingerprint impressions that are left on a <strong>smooth surface</strong>.</li>\n<li><strong>Visible prints</strong> are <strong>clearly seen</strong> fingerprints that are formed by <strong>fingers stained with blood or ink</strong> or other similar media.</li>\n<li><strong>Plastic print</strong> is a fingerprint impression made <strong>on a soft surface.</strong>&nbsp;Examples of such soft surfaces include:\n<ul>\n<li>Soap</li>\n<li>Cheese</li>\n<li>Mud</li>\n<li>Candles</li>\n<li>Thick dried blood</li>\n<li>Adhesives</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p>\n<p><strong>Dactylography/Fingerprint system/Dermatoglyphics/Galton system</strong>&nbsp;is the&nbsp;<strong>most reliable method</strong>&nbsp;in establishing the identity of an individual. It was&nbsp;<strong>first used in India</strong>&nbsp;by&nbsp;<strong>William Herschel</strong>&nbsp;and systematized by&nbsp;<strong>Sir Francis Galton</strong>.</p>\n<p>Fingerprints can be obtained up to a&nbsp;<strong>depth of 0.6 mm</strong>&nbsp;from the surface of the skin. The pattern is&nbsp;<strong>not inherited</strong>&nbsp;and hence,&nbsp;<strong>paternity cannot be proved</strong>&nbsp;with the help of fingerprints, and are not&nbsp;<strong>even similar in identical twins (Quetelet&rsquo;s law of biological variation)</strong>.</p>\n<p><strong>Permanent </strong>impairment&nbsp;of fingerprints is seen in&nbsp;<strong>leprosy, electric injury,&nbsp;</strong>and<strong> irradiation,&nbsp;</strong>while <strong>atrophy</strong> of the ridges is seen in&nbsp;<strong>celiac disease and dermatitis</strong>.</p>\n<p><strong>Patterns</strong>&nbsp;of fingerprints:</p>\n<ul>\n<li><strong>Loops</strong> (60&ndash;70%)\n<ul>\n<li>Radial</li>\n<li>Ulnar</li>\n</ul>\n</li>\n<li><strong>Whorls</strong>&nbsp;\n<ul>\n<li>Concentric</li>\n<li>Spiral</li>\n<li>Double spiral</li>\n<li>Almond shaped</li>\n</ul>\n</li>\n<li><strong>Arches</strong>&nbsp;\n<ul>\n<li>Plain</li>\n<li>Tented</li>\n</ul>\n</li>\n<li><strong>Composite</strong>\n<ul>\n<li>Central pocket loop</li>\n<li>Lateral pocket loop</li>\n<li>Twinned loop</li>\n<li>Accidentals</li>\n</ul>\n</li>\n</ul>\n<p>The image given below shows the different patterns of fingerprints.&nbsp;</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0083bc4e75414aa9ba31670d17732a15x1280x2223.PNG\" alt=\"Explanation Image\"><p>Classification of fingerprints into different patterns is based on&nbsp;<strong>delta</strong>&nbsp;and&nbsp;<strong>core&nbsp;</strong>formation.&nbsp;<strong>Delta</strong>&nbsp;is a&nbsp;<strong>triangular</strong>&nbsp;arrangement formed where three separate ridge line flows come together.&nbsp;<strong>Core</strong>&nbsp;is the&nbsp;<strong>centermost</strong>&nbsp;portion of a ridge flow pattern.&nbsp;</p>\n<p>&nbsp;</p><p><strong>Edgeoscopy&nbsp;</strong>is a method of identification through the examination of the unique details and characteristics found along the&nbsp;<strong>edges</strong>&nbsp;of individual&nbsp;<strong>fingerprint ridges</strong>.&nbsp;</p>\n<p>Methods of<strong>&nbsp;identification</strong>&nbsp;using different&nbsp;<strong>prints</strong>:</p>\n<ul>\n<li>Dactylography - evaluation of fingerprints</li>\n<li>Poroscopy - evaluation of sweat pore openings on fingerprint ridges</li>\n<li>Cheiloscopy - evaluation of lip prints</li>\n<li>Podography - evaluation of foot prints</li>\n<li>Rugoscopy - evaluation of palatal rugae</li>\n<li>Ridgeology - evaluation of friction ridges on fingerprints</li>\n</ul>\n<p>Dactylography or dermatoglyphics is the study of fingerprint patterns. The first fingerprint bureau in India was established in Kolkata.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5522",
      "difficulty": "hard"
    },
    {
      "text": "How would you manage a case of pedunculated umbilical adenoma presenting for the first time?",
      "choices": [
        {
          "id": 1,
          "text": "Appy silver nitrate solution"
        },
        {
          "id": 2,
          "text": "Tie a firm ligature around the base of the peduncle"
        },
        {
          "id": 3,
          "text": "Umbillectomy"
        },
        {
          "id": 4,
          "text": "Oral antibiotics"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Tying a firm ligature around the base of the peduncle </strong>is the best management for a case of <strong>pedunculated umbilical adenoma</strong> presenting for the <strong>first time.</strong></p>\n<p><strong>Umbilical adenoma</strong> is also known as a <strong>raspberry tumor. </strong>It is due to a partially <strong>unobliterated vitellointestinal duct</strong>. It is mostly seen in <strong>infants. </strong>The <strong>prolapsing mucosa </strong>gives a raspberry appearance, and it <strong>bleeds on touch.</strong></p>\n<p>A ligature is tied around its base, and it falls off after a few days. <strong>Recurrent</strong> cases can be treated by <strong>umbillectomy</strong>.</p><img src=\"https://cdn1.dailyrounds.org/uploads/74809153814f4827ba56c023887ab4c2x213x246.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5571",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following measures are recommended for the delivery room thermoregulation management of very preterm neonates?<div class='question-desc-html'><ol>\n<li>Maintain delivery room temperature of at least 26&deg;C&nbsp;</li>\n<li>Prewarm the radiant warmer to 50% heater output for at least 5 minutes prior to delivery</li>\n<li>Use polythene bags/ wraps for all neonates&nbsp;</li>\n<li>Do not dry the neonate</li>\n<li>Do not remove plastic bag wrap until the neonate is transferred to the NICU and normal temperature is recorded</li>\n<li>Do not cover the head of the baby&nbsp;</li>\n</ol>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 5, 6"
        },
        {
          "id": 2,
          "text": "2, 3, 4, 6"
        },
        {
          "id": 3,
          "text": "1, 3, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 2, 3, 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Very preterm refers to babies delivered between&nbsp;<strong>28 to 32 weeks </strong>of gestation.</p>\n<p>The measures that are recommended for the <strong>delivery room</strong> <strong>thermoregulation</strong> management of <strong>very preterm</strong> neonates are as follows:</p>\n<ol>\n<li>Maintain <strong>delivery room temperature</strong> of <strong>at least 26&deg;C</strong> for all deliveries<strong>.</strong></li>\n<li>Prewarm the radiant warmer to <strong>100% heater output</strong> for at least <strong>10 minutes prior</strong> to delivery.</li>\n<li>Use <strong>polythene bags/ wraps for all neonates</strong>.</li>\n<li><strong>Do not dry</strong> the neonate.</li>\n<li><strong>Do not remove the bag</strong> until the neonate is transferred to the NICU and normal temperature is recorded.</li>\n<li><strong>Cover the head</strong> of the neonate with a <strong>plastic bag/ hat.</strong></li>\n<li><strong>Use a transport incubator</strong> to transfer neonates from DR to NICU. Prewarm the baby boundaries and the transport incubator prior to use.</li>\n</ol>\n<p>The axillary temperature of the neonate should be recorded within 10 minutes of NICU admission of the baby.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5444",
      "difficulty": "hard"
    },
    {
      "text": "A child with nephrotic syndrome is started on steroid therapy. She would be classified as steroid-resistant if",
      "choices": [
        {
          "id": 1,
          "text": "There is no remission despite 2 weeks of weekly-once steroid therapy"
        },
        {
          "id": 2,
          "text": "There is no remission despite 4 weeks of daily steroid therapy"
        },
        {
          "id": 3,
          "text": "There is no remission despite 4 weeks of weekly-once steroid therapy"
        },
        {
          "id": 4,
          "text": "There is no remission despite 2 weeks of daily steroid therapy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>No remission</strong> despite <strong>4 weeks </strong>of <strong>daily steroid therapy</strong> is considered as <strong>steroid resistance.</strong></p>\n<p>Important definitions regarding steroid therapy in nephrotic syndrome:</p>\n<ul>\n<li><strong>Response:</strong> Attainment of remission within the initial 4 weeks of corticosteroid therapy.</li>\n<li><strong>Remission:</strong> It consists of a <strong>urine protein:creatinine ratio </strong>of<strong> &lt; 0.2</strong> or<strong> &lt; 1+ protein</strong> on urine dipstick testing for<strong> 3 consecutive days</strong>. </li>\n<li><strong>Relapse:</strong> It is an increase in the first-morning <strong>urine protein:creatinine ratio &gt; 0.2</strong> or reading of <strong>2+ </strong>and<strong> higher</strong> for<strong> 3 consecutive days</strong> on urine protein testing.\n<ul>\n<li><strong>Frequently relapsing:</strong> It is <strong>two </strong>or <strong>more</strong> relapses <strong>within 6 months</strong> after the initial therapy or <strong>four relapses</strong> in a 12-month period.</li>\n</ul>\n</li>\n<li><strong>Steroid dependence:</strong> It is a<strong> relapse</strong> during<strong> steroid tapering</strong> or <strong>relapse within 2 weeks </strong>of the <strong>discontinuation</strong> of therapy.</li>\n<li><strong>Steroid resistance:</strong> It is the <strong>inability</strong> to<strong> </strong>induce <strong>remission </strong>within<strong> 4 weeks</strong> of daily steroid therapy.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/21351171e95f4d01a44ca923200b040fx1280x2264.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Glomerular Pathology in Renal Diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td><strong>Light microscopy</strong></td>\n<td><strong>Fluorescence microscopy</strong></td>\n<td>\n<p><strong>Electron microscopy</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Nephritic syndrome:</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Postinfectious glomerulo-nephritis</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diffuse endocapillary proliferation; leukocytic infiltration</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Granular IgG and C3 in glomerular basement membrane and mesangium,&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Granular IgA in some cases</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Subepithelial humps </strong>Subendothelial deposits in early disease stages</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n<td>Extracapillary proliferation with <strong>crescents</strong>; necrosis</td>\n<td>&nbsp;<strong>Linear </strong>IgG and C3; fibrin in crescents</td>\n<td>\n<p><strong>Linear deposits</strong><strong><strong>&nbsp;</strong></strong>along the basement membrane.&nbsp;</p>\n<p><strong>Disruptions in GBM</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IgA nephropathy (Berger disease)</p>\n</td>\n<td>Focal mesangial proliferative glomerulo-nephritis; mesangial widening</td>\n<td>&nbsp;<strong>IgA</strong> &plusmn; IgG, IgM, and C3 in mesangium</td>\n<td><strong>Mesangial </strong>and paramesangial dense deposits&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alport syndrome</p>\n</td>\n<td>Normal</td>\n<td>Negative</td>\n<td><strong>Basket-weave appearance </strong>of GBM</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Nephrotic syndrome:</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous&nbsp; nephropathy</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diffuse capillary wall thickening</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Granular IgG and C3; diffuse</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Subepithelial deposits </strong>(epimembranous spikes),&nbsp;effacement of podocyte&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal change disease</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal; lipid in tubules</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Negative&nbsp;</td>\n<td>\n<p>No deposits.</p>\n<p>Effacement of podocyte&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal segmental glomerulo-sclerosis&nbsp; (FSGS)</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Glomerular hyalinosis and sclerosis</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Occasional C3 and IgM deposits in the sclerotic areas and the mesangium.</td>\n<td>\n<p>No deposits.</p>\n<p>Effacement of podocyte&nbsp;</p>\n<p>Epithelial denudation.</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Nephrito-nephrotic syndrome:&nbsp;&nbsp;&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membrano-proliferative glomerulo-nephritis</p>\n<p>(MPGN) type I</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mesangial proliferative pattern of proliferation; GBM thickening; splitting</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>C3, C1q, C4 deposits&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\nIgG deposits</td>\n<td>\n<p><strong>Subendothelial deposits</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dense-deposit disease (MPGN type II)</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mesangial proliferative&nbsp; pattern of proliferation; GBM thickening; splitting</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>C3 deposits;</p>\n<p>No C1q and C4 deposits</p>\n<p>No IgG deposits</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Intramembranous </strong>Dense deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fibrillary glomerulo-nephritis</p>\n</td>\n<td>&nbsp;\n<div class=\"page\" title=\"Page 931\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Membrano-proliferative or mesangio-proliferative patterns</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>IgG4 and C3&nbsp;</td>\n<td>Fibrillar deposits in the mesangium and capillary walls</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Note:</p>\n<ul>\n<li>Anionic antigens form subendothelial deposits.</li>\n<li>Cationic antigens form subepithelial deposits.</li>\n<li>Neutral antigens form mesangial deposits.</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5535",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following findings would you not see in a patient with central cord syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Marked upper extremity weakness compared to the lower extremities"
        },
        {
          "id": 2,
          "text": "Loss of vibration sense over the shoulders, lower neck, and upper trunk"
        },
        {
          "id": 3,
          "text": "Loss of pain and temperature sensations over the shoulders, lower neck, and upper trunk"
        },
        {
          "id": 4,
          "text": "Preservation of light touch, and joint position sense over the shoulders, lower neck, and upper trunk"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"page\" title=\"Page 3564\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In central cord syndrome, there is <strong>preservation of light touch, joint position sense, as well as vibration sense</strong> over the <strong>shoulders, lower neck, and upper trunk (cape distribution).</strong></p>\n<p>This condition affects the cervical cord producing <strong>arm weakness &gt; leg weakness</strong>. A <strong>dissociated sensory loss</strong>, i.e. loss of pain and temperature with <strong>preservation</strong> of light touch, joint position, and vibration sensations, is seen over the shoulders, lower neck, and upper trunk (<strong>cape distribution</strong>).</p>\n<p>It results from <strong>selective damage to the gray matter</strong> nerve cells and the <strong>decussating spinothalamic tracts</strong> surrounding the central canal. These decussating fibers carry crude touch, pain, and temperature sensations.</p>\n<p>Spinal trauma, syringomyelia, and intrinsic cord tumors are the main causes.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/630f2145c3d8493cb318ddb82937b538x536x938.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5668",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs is not useful for the treatment of a  patient with graft rejection?",
      "choices": [
        {
          "id": 1,
          "text": "Cyclosporine"
        },
        {
          "id": 2,
          "text": "Alemtuzumab"
        },
        {
          "id": 3,
          "text": "Muromonab"
        },
        {
          "id": 4,
          "text": "Corticosteroids"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cyclosporine</strong> is <strong>not useful</strong> in the <strong>treatment</strong> of a patient with graft rejection. It can only be used for prophylaxis against graft rejection. Once graft rejection has set in, management would require <strong>agents that can act on activated lymphocytes</strong>.</p>\n<p>Calcineurin is a calcium/calmodulin-dependent phosphatase required for the induction of T cell lymphokine production and proliferation. <strong>Cyclosporine</strong> is an immunomodulatory drug that <strong>inhibits calcineurin activity</strong> by<strong> </strong>forming a complex with <strong>cyclophilin</strong>, a cytoplasmic-receptor protein present in target cells, to form a <strong>cyclosporine-cyclophilin complex</strong>.</p>\n<p>This drug-receptor complex specifically and competitively binds to and <strong>inhibits calcineurin</strong>, a calcium and calmodulin-dependent phosphatase. This, in turn, inhibits the translocation of a family of transcription factors (NF-AT), leading to reduced transcriptional activation of cytokine genes for interleukin (IL)-2, tumor necrosis factor (TNF)-alpha, IL-3, IL-4, CD40L, granulocyte-macrophage colony-stimulating factor, and interferon-gamma. Ultimately, the proliferation of T lymphocytes is reduced, resulting in <strong>immunomodulation.</strong></p>\n<p>Its uses are as follows:</p>\n<ul>\n<li aria-level=\"1\">In solid organ transplantation, to prevent organ rejection in kidney, liver, and heart allogeneic transplants</li>\n<li aria-level=\"1\">In patients with rheumatoid arthritis, when the disease has not adequately responded to methotrexate</li>\n<li aria-level=\"1\">It is approved to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig disease) and its variants.</li>\n<li aria-level=\"1\">In nephrotic syndrome, to treat focal segmental glomerulosclerosis not responding to corticosteroids</li>\n</ul>\n<p>Adverse effects of cyclosporine include a <strong>decrease</strong> in glomerular filtration rate (<strong>GFR</strong>) and <strong>metabolic disturbances</strong> like hypomagnesemia, hyperkalemia, dyslipidemia, gynecomastia, hypertrichosis; <strong>neurotoxicity</strong> in the form of convulsions. There is an increased risk of developing skin and lymphoproliferative malignancies in cyclosporine-treated psoriasis patients.</p>\n<p> </p>\n<p> </p>\n<p>Alemtuzumab is a monoclonal antibody directed against the CD52 antigen. Muromonab is a monoclonal antibody that acts on T cell–receptor complex, blocking antigen recognition.</p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5616",
      "difficulty": "hard"
    },
    {
      "text": "A 48-year-old woman presented with yellowish discoloration of the toenails. The discoloration spread proximally as a streak in the nail, and later, the entire nail separated from the nailbed, prompting a diagnosis of onychomycosis. What is the site of action of the drug of choice for her?",
      "choices": [
        {
          "id": 1,
          "text": "4"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>drug of choice</strong> for <strong>onychomycosis</strong> is<strong>&nbsp;</strong>oral<strong> terbinafine</strong>,&nbsp;which acts by&nbsp;<strong>inhibiting</strong><strong>&nbsp;ergosterol synthesis</strong>.&nbsp;</p>\n<p>Terbinafine acts as a <strong>non-competitive inhibitor</strong> of <strong>squalene epoxidase</strong>, an early step enzyme in the synthesis of fungal ergosterol. This results in the accumulation of sterol squalene, which is toxic to the organism.</p>\n<p>The efficacy of terbinafine in onychomycosis is improved when<strong> combined </strong>with amorolfine<strong> 5% nail lacquer</strong>.</p><hr><h3>Related Pearl: Mechanism of action of Antifungal drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e48d5ad74a9b48c6baa33c90914e13cbx1280x2560.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/cbe4d37e6b0347c4ba3aa9facca4ebdf.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5487",
      "difficulty": "medium"
    },
    {
      "text": "Your newlywed friend asks you for advice regarding what dose of folic acid supplements she should take, as she is planning her first pregnancy. As per the Anemia Mukt Bharat Program, what should you recommend?",
      "choices": [
        {
          "id": 1,
          "text": "500 mcg of folic acid weekly"
        },
        {
          "id": 2,
          "text": "4 mg of folic acid daily"
        },
        {
          "id": 3,
          "text": "800 mcg of folic acid daily"
        },
        {
          "id": 4,
          "text": "400 mcg of folic acid daily"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>As per the <strong>Anemia Mukt Bharat Program</strong>, during the period of <strong>pre-conception</strong> up to the first trimester, women are advised to have <strong>400 mcg of folic acid tablets daily</strong>&nbsp;to reduce the incidence of neural tube defects in the fetus.</p>\n<p>Note that, non-pregnant, non-lactating Women of reproductive age (20&ndash;49 years) who are not actively planning a pregnancy in near term should receive&nbsp;1 iron and folic acid tablet containing 60 mg elemental iron + 500 mcg folic acid.&nbsp;</p><hr><h3>Related Pearl: Prophylactic Iron and Folic Acid (IFA) Supplementation</h3><p>According to the&nbsp;<strong>Anemia Mukt Bharat 2018 scheme,</strong>&nbsp;giving<strong> IFA</strong> to children, adolescents, women of reproductive age, and pregnant women,&nbsp;irrespective of their anemia status, is a key intervention.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age group</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Frequency</strong></td>\n<td><strong>Tablet Color</strong></td>\n</tr>\n<tr>\n<td><span>Children</span><br /><span>6-59 months of age</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 mL iron and folic acid syrup</p>\n<p>Each mL contains&nbsp;<strong>20 mg</strong> elemental<strong> iron </strong>+<strong> 100 mcg</strong> of<strong> folic&nbsp;acid</strong></p>\n</td>\n<td>\n<p>Bi-weekly</p>\n</td>\n<td>&nbsp;Syrup</td>\n</tr>\n<tr>\n<td><span>Children </span><br /><span>5-9 years of age</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 Iron and folic&nbsp;acid tablet</p>\n<p><strong>45 mg</strong> elemental iron +<strong> 400 mcg</strong> folic acid,</p>\n<p>Sugar-coated</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Pink</td>\n</tr>\n<tr>\n<td>\n<p><span>School-going adolescent girls and Boys</span><br /><span>10-19 years of age</span></p>\n<p><span>Out-of-school adolescent girls</span><br /><span>10-19 years of age</span></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet</p>\n<p><strong>60&nbsp;mg&nbsp;</strong>elemental iron +<strong> 500 mcg </strong>folic acid,&nbsp;</p>\n<p>Sugar-coated</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Blue</td>\n</tr>\n<tr>\n<td>\n<p><span>Women of reproductive age (non-pregnant, non-lactating) </span><br /><span>20-49 years</span></p>\n<p><span>(Under Mission Parivar Vikas)</span></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet</p>\n<p><strong>60</strong>&nbsp;<strong>mg</strong> elemental iron +<strong> 500 mcg </strong>folic acid,&nbsp;</p>\n<p>Sugar-coated&nbsp;</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Red</td>\n</tr>\n<tr>\n<td><span>Pregnant Women and Lactating Mothers </span><br /><span>of 0-6 months child</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet starting from the <strong>fourth month</strong> of pregnancy is continued throughout pregnancy (minimum 180 days). It should also be continued for 180 days post-partum.</p>\n<p><strong>60</strong>&nbsp;<strong>mg </strong>elemental iron +<strong> 500 mcg </strong>folic acid,</p>\n<p>Sugar-coated and red color</p>\n</td>\n<td>Daily&nbsp;</td>\n<td>Red&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note 1:<strong> Prophylaxis with iron</strong> should be <strong>withheld</strong> in case of <strong>acute illness</strong> (fever, diarrhea, pneumonia, etc.) and in a known case of <strong>thalassemia major</strong>/ history of <strong>repeated blood transfusion</strong>. In cases of children with severe acute malnutrition (SAM), IFA supplementation should be continued as per the SAM management protocol.</p>\n<p>Note 2: All women in the reproductive age group in the pre-conception period and up to the first trimester of the pregnancy are advised to have 400 mcg of folic acid tablets, daily, to reduce the incidence of neural tube defects in the fetus.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5590",
      "difficulty": "easy"
    },
    {
      "text": "A 35-year-old farmer presented with a 6-month history of soft tissue swelling on the right jaw. On examination, a discharging sinus was found as seen below. On microscopic examination of the pus, sulfur granules appearance was seen. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Actinomycosis"
        },
        {
          "id": 2,
          "text": "Chromoblastomycosis"
        },
        {
          "id": 3,
          "text": "Cutaneous anthrax"
        },
        {
          "id": 4,
          "text": "Sporotrichosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A farmer with a lumpy jaw &amp; discharging sinuses, with the pus having a sulfur granule appearance is characteristic of <strong>cervicofacial</strong> <strong>actinomycosis</strong>.</p>\n<p>Actinomycosis typically presents as a <strong>painless nodule that indurates,</strong> with<strong> purulent discharge</strong> that contains <strong>sulfur granules. </strong>Sulfur granules are composed of a matrix of <strong>bacteria, calcium phosphate, and host tissue. </strong>It is an indolent, slowly progressive, suppurative, and granulomatous infection that produces pyogenic lesions, with interconnecting sinus tracts that contain <strong>sulfur granules.</strong></p>\n<p>It is caused by <strong>anaerobic or microaerophilic</strong> bacteria, primarily of the genus <em><strong>Actinomyces. </strong></em>It presents as one of the following clinical types:</p>\n<ul>\n<li class=\"p1\"><strong>Cervicofacial actinomycosis</strong>- (<strong>most common site)</strong> fluctuant mass in the jaw area producing draining fistulas. (<strong>lumpy jaw)</strong></li>\n<li class=\"p1\"><strong>Thoracic actinomycosis</strong>- pulmonary infection with fever, cough, and purulent sputum. </li>\n<li class=\"p1\"><strong>Abdominal actinomycosis</strong>- following ruptured appendix or ulcer. It may involve multiple organs.</li>\n<li class=\"p1\"><strong>Pelvic</strong> <strong>actinomycosis</strong>- due to the colonization of intrauterine contraceptive device.</li>\n<li class=\"p1\">Actinomycosis can spread to<strong> bones</strong> and surrounding tissue, and produce <strong>multiple discharging sinuses.</strong></li>\n</ul>\n<p class=\"p1\">Diagnosis:</p>\n<ul>\n<li class=\"p1\">Gram staining of sulfur granules shows a dense network of thin <strong>gram-positive filaments</strong>, surrounded by <strong>club-shaped</strong> structures (<strong>Sunray appearance</strong>).</li>\n<li class=\"p1\">Culture shows a <strong>molar tooth</strong> appearance of the colonies.</li>\n</ul>\n<p>The image below shows the <strong>molar tooth</strong> appearance of <em>Actinomyces</em> colonies.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/60a07fef674445a1b03aca863f115365x720x483.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>Image below shows <strong>gram-positive filaments</strong> of <em>Actinomyces. </em></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0a214151e0274bdf9a5b60fd78fadde1x1024x768.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>The given image shows a patient with multiple cutaneous lesions caused by actinomycosis:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6cd1e7fd1059438a9449713b38605fcex700x460.JPEG\" alt=\"Explanation Image\"><p>Treatment:</p>\n<ul>\n<li><strong>Penicillin G</strong> is the <strong>drug of choice.</strong></li>\n<li><strong>Duration</strong> of therapy:<strong> 6-12 months.</strong></li>\n<li>Other drugs that can be used: Amoxicillin, Erythromycin, Tetracycline, Doxycycline, Clindamycin, Minocycline.</li>\n</ul>\n<p>Other options:</p>\n<p>Option B: <strong>Chromoblastomycosis</strong> is commonly seen in<strong> tropical</strong> areas among <strong>agricultural workers</strong> and woodcutters who walk barefooted. <strong>Traumatic</strong> implantation is the mode of infection. Patients present with warty <strong>cauliflower-like</strong> cutaneous nodules on the feet and lower legs. Species of the fungal genera <strong>Fonsecaea</strong> are implicated as the causative agents. Diagnosis is by demonstration of <strong>sclerotic bodies</strong> (<strong>copper-penny bodies</strong>) in tissue sections. Sclerotic bodies appear as round or irregular, <strong>dark brown</strong> bodies with <strong>septae</strong>.</p>\n<p>Option C: <em>Bacillus anthracis</em> infection manifests as <strong>cutaneous anthrax</strong>. The typical lesion has a characteristic <strong>central black eschar</strong> with marked edema. Microscopy shows <strong>Gram-positive rods</strong> and culture on blood agar produce non-hemolytic gray to white, tenacious colonies with a <strong>ground-glass appearance</strong>. Comma-shaped outgrowths may project from the colony.</p>\n<p>Option D: <strong>Sporotrichosis </strong>caused by the dimorphic fungus <em><strong>Sporothrix schenckii</strong>, </em>is commonly seen in gardeners following minor <strong>trauma</strong>. Patients present with <strong>skin nodules</strong> or lymph node ulceration. Microscopy shows <strong>asteroid bodies</strong>. It can be seen as an oval, basophilic structure with <strong>eosinophilic</strong> radiation.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e200615dfbe84e568a38b7abada8aaea.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5515",
      "difficulty": "easy"
    },
    {
      "text": "A patient who is being worked up for suspected laryngeal carcinoma is asked to undergo a direct laryngoscopy to visualize the hidden areas of the larynx. All of the following are considered hidden areas of the larynx, except",
      "choices": [
        {
          "id": 1,
          "text": "Infrahyoid epiglottis"
        },
        {
          "id": 2,
          "text": "Suprahyoid epiglottis"
        },
        {
          "id": 3,
          "text": "Anterior commissure"
        },
        {
          "id": 4,
          "text": "Subglottis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Hidden areas</strong> of the larynx are <strong>infrahyoid epiglottis, anterior commissure, subglottis,</strong> and <strong>ventricle.</strong></p>\n<p>Direct Laryngoscopy is done during the workup of patients with laryngeal ca to see the hidden areas of the larynx and to determine the extent of disease. Hidden areas may not be clearly seen by laryngeal mirror examination making direct laryngoscopy essential.</p>\n<p><strong>Indirect laryngoscopy</strong> is done using a<strong> laryngeal mirror,</strong> which appears as below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6c48720a421242ada67892223e54f052x720x542.PNG\" alt=\"Explanation Image\"><p>Structures that are seen during indirect laryngoscopy (in order):</p>\n<ul>\n<li>The base of the tongue (posterior one-third of the tongue)</li>\n<li>Vallecula</li>\n<li>Median and lateral glossoepiglottic folds</li>\n<li>Epiglottis</li>\n<li>Pharyngoepiglottic folds</li>\n<li>Aryepiglottic folds</li>\n<li>Arytenoids</li>\n<li>False vocal cords</li>\n<li>True vocal cords</li>\n</ul>\n<p>A<strong> posterior rhinoscopy mirror </strong>has<strong> two bends</strong> in the shaft and is <strong>bayonet shaped </strong>and appears as below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2c4ed2e65fd04d33817cc021aa222143x720x643.JPEG\" alt=\"Explanation Image\"><p>The structures seen in posterior rhinoscopy are:</p>\n<ul>\n<li>Adenoids</li>\n<li>Posterior ends of nasal turbinates</li>\n<li>Opening of the eustachian tube</li>\n<li>The posterior border of the nasal septum</li>\n<li>Fossa of Rosenmuller</li>\n<li>Torus tubarius</li>\n<li>The upper surface of the soft palate</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5547",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant woman has delivered a baby in the middle of a flood zone with limited medical help. According to WHO, what dose of misoprostol is recommended for use in such a setting for the prevention of postpartum hemorrhage?",
      "choices": [
        {
          "id": 1,
          "text": "500 mcg/ 800 mcg  administered per oral"
        },
        {
          "id": 2,
          "text": "500 mcg/ 800 mcg  administered per vaginal"
        },
        {
          "id": 3,
          "text": "400 mcg/ 600 mcg  administered per vaginal"
        },
        {
          "id": 4,
          "text": "400 mcg/ 600 mcg  administered per oral"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>400 mcg/ 600 mcg of misoprostol administered per oral</strong>&nbsp;is recommended for the prevention of PPH in such a setting. The administration of oral misoprostol can be done by community health workers or even lay health workers.</p>\n<p>To effectively <strong>prevent</strong> PPH, the WHO recommends the use of <strong>only one</strong> of the following uterotonic agents:</p>\n<ul>\n<li>Oxytocin - (10 IU - IM/IV)</li>\n<li>Carbetocin - (100 &mu;g - IM/IV)</li>\n<li>Misoprostol - (400 &mu;g or 600 &mu;g, per-oral)</li>\n<li>Ergometrine/methylergometrine - (200 &mu;g - IM/IV)</li>\n<li>Oxytocin and ergometrine fixed-dose combination - (5 IU,500&mu;g - IM)</li>\n</ul>\n<p>Of these, <strong>oxytocin is used as the first-line agent in preventing postpartum hemorrhage</strong>. When oxytocin is not available, the other drugs mentioned above can be used based on the clinical condition and availability of the drug.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5638",
      "difficulty": "hard"
    },
    {
      "text": "A 19-year-old girl is wheeled into the emergency following blunt trauma to the abdomen while traveling on her 2-wheeler.  CECT reveals the presence of splenic vascular injury with active bleeding extending well into the peritoneum. As per the AAST Spleen Injury Scale, you would grade this injury as?",
      "choices": [
        {
          "id": 1,
          "text": "Grade V"
        },
        {
          "id": 2,
          "text": "Grade IV"
        },
        {
          "id": 3,
          "text": "Grade III"
        },
        {
          "id": 4,
          "text": "Grade VI"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Any injury in the presence of<strong> splenic vascular injury</strong> with active <strong>bleeding</strong> extending beyond the spleen <strong>into the peritoneum</strong> is considered grade V as per the&nbsp;AAST Spleen Injury Scale.</p>\n<p>This or a shattered spleen are both considered Grade V injuries and require splenectomy.</p>\n<p><strong>Management of Splenic trauma:</strong></p>\n<p><strong>Grade I and II injuries:</strong></p>\n<ul>\n<li>They are usually hemodynamically stable and are managed non-operatively.</li>\n<li>Initially, these patients are managed conservatively with regular monitoring of vitals and serial CECT.</li>\n<li>If the grade of injury is found to increase, then&nbsp;<strong>angiography</strong>&nbsp;and&nbsp;<strong>embolization</strong>&nbsp;of the bleeding vessel are done to achieve hemostasis.</li>\n<li>If angiography and embolization fail to achieve hemostasis, or if the patient becomes hemodynamically unstable or if there is a contrast blush, then a&nbsp;<strong>splenorrhaphy</strong>&nbsp;is done.</li>\n</ul>\n<p><strong>Grade III injuries</strong>&nbsp;that are hemodynamically stable are managed like that of Grades I and II, while those that are hemodynamically unstable are managed like that of Grades IV and V.</p>\n<p><strong>Grade IV and V injuries:&nbsp;</strong>These patients are usually hemodynamically unstable and splenectomy is done.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: American Association for the Surgery of Trauma (AAST) Spleen Injury Scale</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/304d125090cf41f5b2ac0b5561d350dfx1280x2558.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Indications for Selective Non-Operative Management (SNOM) in splenic trauma</h3><p>Indications :</p>\n<ul>\n<li>Patient younger than <strong>55 years</strong></li>\n<li>Grade I, II, or III (in selective cases) splenic injury</li>\n<li>Physiologic stability, as indicated by normal blood pressure, lack of tachycardia, absence of physical examination findings indicating shock, and absence of metabolic acidosis.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5564",
      "difficulty": "hard"
    },
    {
      "text": "Match the following variants of Reed-Sternberg cell with the corresponding subtype of Hodgkin's lymphoma.<div class='question-desc-html'><ol>\n<li aria-level=\"1\">Lacunar</li>\n<li aria-level=\"1\">L&amp;H Popcorn cells </li>\n<li aria-level=\"1\">Pleomorphic</li>\n<li aria-level=\"1\">Mononuclear</li>\n</ol>\n<ol>\n<li>Nodular sclerosis</li>\n<li>Lymphocyte predominant</li>\n<li>Lymphocyte depleted</li>\n<li>Mixed cellularity and lymphocyte rich</li>\n</ol>\n<p> </p>\n<p> </p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-D, 2-B, 3-C, 4-A"
        },
        {
          "id": 2,
          "text": "1-B, 2-D, 3-C, 4-A"
        },
        {
          "id": 3,
          "text": "1-A, 2-C, 3-B, 4-D"
        },
        {
          "id": 4,
          "text": "1-A, 2-B, 3-C, 4-D"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The correctly matched pairs are as follows:</p>\n<ol>\n<li aria-level=\"1\">Lacunar - Nodular sclerosis</li>\n<li aria-level=\"1\">L&amp;H popcorn cells - Lymphocyte predominant</li>\n<li aria-level=\"1\">Pleomorphic - Lymphocyte depleted</li>\n<li aria-level=\"1\">Mononuclear - Mixed cellularity and lymphocyte rich</li>\n</ol>\n<p> </p>\n<p><strong>Reed-Sternberg cell</strong> (RS cell) is the characteristic tumor giant cell of <strong>Hodgkin Lymphoma</strong>. It is derived from the <strong>germinal center B cell</strong>. It has a classic <strong>owl-eyed</strong> appearance due to the presence of a symmetric or mirror-image bilobed nucleus, with prominent nucleoli surrounded by a clear space. It has the following variants:</p>\n<ul>\n<li aria-level=\"1\">Lacunar</li>\n<li aria-level=\"1\">Classic </li>\n<li aria-level=\"1\">L&amp;H popcorn cells </li>\n<li aria-level=\"1\">Pleomorphic</li>\n<li aria-level=\"1\">Mononuclear</li>\n</ul>\n<p>RS cells should be present in a background of non-neoplastic inflammatory cells like lymphocytes, plasma cells, and eosinophils, to make a diagnosis of Hodgkin’s lymphoma.</p>\n<p>The image given below shows the diagnostic<strong> Reed-Sternberg cell</strong>, with two nuclear lobes, large inclusion-like nucleoli, and abundant cytoplasm, surrounded by lymphocytes, macrophages, and an eosinophil.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a9297574836480594e30b18e11a8924x794x469.PNG\" alt=\"Explanation Image\"><p>The image below shows <strong>Reed-Sternberg cell, mononuclear variant</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/998f2aa5dbdf4c12b377ad82297e9c3ex1280x1137.JPEG\" alt=\"Explanation Image\"><p>The image below shows <strong>Reed-Sternberg cell, lacunar variant. </strong>This variant has a folded or multilobated nucleus and lies within an open space, which is an artefact created by disruption of the cytoplasm during tissue sectioning.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59533bc81f554e9895747b88a67b508dx1280x1137.JPEG\" alt=\"Explanation Image\"><p>The image below shows the <strong>Reed-Sternberg cell, lymphohistiocytic variant</strong>. Several such variants with multiple infolded nuclear membranes, small nucleoli, fine chromatin, and abundant pale cytoplasm are present.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/defeb4af37944c8f92db6c0c23b27a35x530x397.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Important Features of the Different Types of Hodgkin's Lymphoma (HL)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8f432ebab66e464e8027d857e46694c8x827x650.PNG\" alt=\"Pearl Image\"><p><strong>Classic subtypes</strong></p>\n<ul>\n<li>Nodular sclerosis&nbsp;</li>\n<li>Mixed cellularity&nbsp;</li>\n<li>Lymphocyte-rich</li>\n<li>Lymphocyte depletion</li>\n</ul>\n<p><strong>Non-Classical subtype</strong></p>\n<ul>\n<li>Lymphocyte predominant</li>\n</ul>\n<p>Note: <strong>Mixed cellularity</strong> is most commonly associated with HIV due to its high incidence.&nbsp;</p><hr><h3>Related Pearl: Variants of Reed Sternberg Cells</h3><p><strong>Variant Reed–Sternberg cells and the corresponding subtype of Hodgkin's Lymphoma</strong></p>\n<ul>\n<li><strong>Lacunar Variant:</strong> Nodular Sclerosis</li>\n<li><strong>Mononuclear variant:</strong> Mixed cellularity and Lymphocyte rich </li>\n<li><strong>Pleomorphic/Necrotic/Mummified Variant:</strong> Lymphocyte depleted </li>\n<li><strong>L&amp;H/Lymphohistiocytic/Popcorn Variant:</strong> Lymphocyte predominant</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5647",
      "difficulty": "medium"
    },
    {
      "text": "The following deformity is seen in a patient with a history of spinal tuberculosis. What is this deformity called as?",
      "choices": [
        {
          "id": 1,
          "text": "Kyphosis"
        },
        {
          "id": 2,
          "text": "Gibbus"
        },
        {
          "id": 3,
          "text": "Concertina collapse"
        },
        {
          "id": 4,
          "text": "Knuckle"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>The <strong>skeletal deformity</strong> seen in the patient above with <strong>significant sagittal curvature</strong> of the thoracic spine is<strong> kyphosis.</strong></p>\n<p><strong>Spinal tuberculosis</strong> may present with the following<strong> skeletal deformities</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>Deformity</td>\n<td>Mechanism</td>\n<td>Description</td>\n</tr>\n<tr>\n<td>Knuckle</td>\n<td>Collapse of a single vertebra</td>\n<td>Prominence of a single spinous process</td>\n</tr>\n<tr>\n<td>Gibbus/Kyphus</td>\n<td>Collapse of 2-3 vertebral levels</td>\n<td>Sharp posterior angulation</td>\n</tr>\n<tr>\n<td>Kyphosis</td>\n<td>Collapse of anterior vertebral bodies</td>\n<td>Exaggerated curvature of the vertebral column</td>\n</tr>\n<tr>\n<td>Concertina collapse / vertebra plana</td>\n<td>Collapse of the entire vertebral body</td>\n<td>Seen in tuberculosis of the central vertebral body</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p><strong>Tb spine</strong> occurs <strong>secondary</strong> to a pulmonary or gastrointestinal primary and <strong>spreads</strong> through the Batson's plexus of veins (paravertebral plexus). It most commonly involves the <strong>dorso-lumbar</strong> region. </p>\n<div class=\"page\" title=\"Page 204\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Types of vertebral tuberculosis:</p>\n<ul>\n<li><strong>Paradiscal </strong>- contiguous areas of two adjacent vertebrae and the middle intervening disc are affected. This is due to the <strong>high oxygen requirements</strong> of tubercular bacteria and the corresponding high blood supply in this region by the segmental vessels.</li>\n<li><strong> Central </strong>- the body of the vertebra is involved leading to <strong>collapse</strong> (causing wedging or concertina) of the affected vertebra. This leads to spinal deformities such as kyphosis and gibbus.</li>\n<li><strong>Anterior </strong>- the anterior part of body is affected and spreads through anterior longitudinal ligament.</li>\n<li><strong>Posterior </strong>- the posterior complex (pedicle, lamina, spinous process and transverse process) is affected.</li>\n</ul>\n<p>Image showing various parts and patterns of involvement in Pott's spine. </p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/aff31a53e9934371b590fdbb68b7cea3x1280x1484.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/87631c3ed5714b1aae6168264ce61530x1280x3667.JPEG\" alt=\"Explanation Image\"><p><strong>Clinical features</strong> of spinal tuberculosis:</p>\n<ul>\n<li>Back <strong>pain,</strong> <strong>stiffness </strong>and reduced movements are the usual early complaints</li>\n<li><strong>Cautious</strong> <strong>gait </strong>- a person with spinal TB will walk carefully with short steps to avoid pain resulting from movement</li>\n<li>Pott's paraplegia</li>\n<li>Cold abscess</li>\n<li><strong>Concertina collapse</strong> - a type of compression fracture without involvement of the interverterbral disc</li>\n<li>Deformity - <strong>kyphus</strong> and <strong>gibbus</strong> (gradually increasing prominence).</li>\n</ul>\n<p>Images showing concertina collapse and the deformities seen TB spine.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b0a4667442254fe5a6f12e50518ddbdbx1280x1968.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/81202c7073ea417a9ce53137a562baaex1279x2309.JPEG\" alt=\"Explanation Image\"><p>The image below shows <strong>gibbus</strong> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eb695ee54ff549798f7046c3e4d80e25x720x1166.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/98d683e251ed4d9f88dd060596f81ee0.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5649",
      "difficulty": "hard"
    },
    {
      "text": "The cell marked in the image below predominantly plays a role in which of the following hypersensitivity reactions?",
      "choices": [
        {
          "id": 1,
          "text": "Type I"
        },
        {
          "id": 2,
          "text": "Type II"
        },
        {
          "id": 3,
          "text": "Type III"
        },
        {
          "id": 4,
          "text": "Type IV"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The cell marked in the image is a <strong>mast cell </strong>stained with<strong> toluidine blue. Mast cells</strong> play an important role in <strong>type-I hypersensitivity reactions</strong>.</p>\n<p>Mast cell granules contain <strong>acid proteoglycan</strong> that binds <strong>basic blue</strong> such as toluidine blue. Mast cells may be difficult to differentiate from lymphocytes in routine, hematoxylin, and eosin-stained sections, and special metachromatic stains (<strong>toluidine blue or Giemsa</strong>) are used to visualize their granules.</p>\n<p>Mast cells are a part of <strong>innate</strong> immunity and are widely distributed in connective tissues. They play an important role in <strong>immediate hypersensitivity</strong> and both acute and chronic inflammation.</p>\n<p>Mast cells express a receptor on their surface that binds to the Fc portion of <strong>the IgE</strong> antibody. When an antigen binds to IgE antibodies on the surface of the mast cell, they get activated and degranulate. This results in the release of the following:</p>\n<ul>\n<li>Granule contents: <strong>Histamine</strong>, chymase, <strong>tryptase</strong>, heparin.</li>\n<li>Lipid mediators: <strong>Leucotriene C4, D4</strong>, prostaglandin D2, platelet-activating factor.</li>\n<li>Cytokines: <strong>Tumor necrosis factor</strong>, interleukin-1</li>\n</ul>\n<p>These mediators released from mast cells play an important role in the pathogenesis of immediate/<strong>type 1</strong> hypersensitivity.</p>\n<p>The image given below shows the sequence of events in immediate (type 1) hypersensitivity.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/05afb970bbf44923a9051559614f82e1x1280x2558.JPEG\" alt=\"Explanation Image\"><p>Some of the important disorders associated with mast cell activity are bronchial asthma, urticaria, <strong>mastocytosis</strong>, interstitial cystitis and neurofibroma.</p><hr><h3>Related Pearl: Mechanisms of Hypersensitivity Reactions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Immune Mechanisms</strong></p>\n</td>\n<td>\n<p><strong>Histopathological lesions</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immediate </strong><br /><strong>&nbsp;hypersensitivity<br />(type I)<br /></strong></p>\n<ul>\n<li>Anaphylaxis</li>\n<li>Allergies</li>\n<li>Bronchial asthma</li>\n<li>Atopic dermatitis</li>\n</ul>\n</td>\n<td>\n<p>Production of IgE antibody &rarr;immediate release of vasoactive amines from mast cells</p>\n</td>\n<td>\n<p>Vascular dilatation, edema, smooth muscle contraction, mucus production, tissue injury, inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Antibody-mediated hypersensitivity<br />(type II)<br /></strong></p>\n<ul>\n<li>Autoimmune hemolytic anemia</li>\n<li>Goodpasture syndrome</li>\n</ul>\n</td>\n<td>\n<p>Production of IgG, IgM &rarr; binds to antigen on target cell or tissue &rarr; phagocytosis or lysis of target cell by activated complement or Fc receptors; recruitment of leukocytes</p>\n</td>\n<td>\n<p>Phagocytosis and lysis of cells; inflammation;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immune complex-mediated hypersensitivity<br /> (type III)<br /></strong></p>\n<ul>\n<li>SLE</li>\n<li>Serum sickness</li>\n<li>Arthus reaction</li>\n</ul>\n</td>\n<td>\n<p>Deposition of antigen-antibody complexes &rarr; complement activation &rarr;recruitment of leukocytes by complement products and Fc receptors &rarr; release of enzymes and other toxic molecules</p>\n</td>\n<td>\n<p>Inflammation, necrotizing vasculitis (fibrinoid necrosis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-mediated hypersensitivity<br />(type IV)</strong></p>\n<ul>\n<li>Contact dermatitis</li>\n<li>Multiple sclerosis</li>\n<li>Type 1 diabetes</li>\n<li>Tuberculosis</li>\n</ul>\n</td>\n<td>\n<p>Activated T lymphocytes &rarr;</p>\n<p>1. Release of cytokines, inflammation, and macrophage activation</p>\n<p>2. T-cell-mediated cytotoxicity</p>\n</td>\n<td>\n<p>Perivascular cellular infiltrates; edema; granuloma formation; cell destruction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f55cab6c8fd44a7abfe8a663dde3980ex1280x2567.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2a98b94d6a9479b8e6e885ee59366cex1280x2089.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d92e092ef5874477a6da091ca3b1234ax1280x1360.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/56fc1dfb49434818b5057534a97d6621x1280x4218.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Various stains and their applications in Pathology and Microbiology</h3><table>\n<tbody>\n<tr>\n<td><strong>Staining technique</strong></td>\n<td><strong>Cells/inclusions stained</strong></td>\n<td><strong>Disorders</strong></td>\n</tr>\n<tr>\n<td><strong>H&amp;E</strong></td>\n<td>Most common stain used in routine&nbsp;<strong>histopathology</strong></td>\n<td>Commonly used for all slides</td>\n</tr>\n<tr>\n<td><strong>Papanicolaou stain</strong></td>\n<td>Universal stain for <strong>cytological</strong> preparations</td>\n<td>Cytological studies</td>\n</tr>\n<tr>\n<td><strong>PAS</strong></td>\n<td>Demonstrate&nbsp;<strong>glycogen,&nbsp;mucin,&nbsp;fungi, </strong>macrophages&nbsp;</td>\n<td>Whipple's disease, adenocarcinomas,&nbsp;and glycogen-positive tumors (Ewings sarcoma, renal cell carcinoma)</td>\n</tr>\n<tr>\n<td><strong><strong>PTAH (</strong></strong><strong>Phosphotungstic acid hematoxylin)</strong></td>\n<td>Fibrin</td>\n<td>Gliosis, Ependymomas, Tumours of skeletal muscles, Fibrin deposits</td>\n</tr>\n<tr>\n<td><strong>Alcian blue</strong></td>\n<td>For <strong>acid mucins</strong>: Positive stain for mucins of the intestinal mucosa and negative stain for mucins of gastric mucosa and Brunner's gland</td>\n<td>Barrett's esophagus, Gastric disorders</td>\n</tr>\n<tr>\n<td><strong>Perl's Prussian blue</strong></td>\n<td>Demonstrate&nbsp;<strong>hemosiderin and iron</strong></td>\n<td>Hemochromatosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson&ndash;Fontana stain</strong></td>\n<td>Demonstrate <strong>melanin</strong></td>\n<td>Nevus and malignant melanoma</td>\n</tr>\n<tr>\n<td><strong>von Kossa method</strong></td>\n<td>Demonstrate&nbsp;<strong>calcium</strong></td>\n<td>Calcification of tissues</td>\n</tr>\n<tr>\n<td><strong>Van Gieson stain</strong></td>\n<td>\n<p>Demonstrate <strong>collagen </strong>in; Differentiate amyloid from collagen</p>\n</td>\n<td>Spindle-cell neoplasm; Delineate extent of fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson trichrome stain</strong></td>\n<td>Demonstrate <strong>collagen and muscle</strong></td>\n<td>Connective tissue disorders, muscle and fibroblast tumors, liver cirrhosis, neuromuscular diseases&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Reticulin stain</strong></td>\n<td>Demonstrate <strong>reticulin fibers</strong></td>\n<td>Distinguish epithelial from non-epithelial neoplasm, Hodgkin's lymphoma, early cirrhosis of the&nbsp;liver, myelofibrosis</td>\n</tr>\n<tr>\n<td><strong>Verhoeff's method</strong></td>\n<td>Demonstrate <strong>elastic fibers</strong></td>\n<td>Malignant hypertension, arteriovenous malformation aneurysms, Marfan's syndrome, emphysema lung</td>\n</tr>\n<tr>\n<td><strong>Oil red O</strong> <strong>Sudan Black</strong> <strong>Sudan III/IV</strong></td>\n<td>Demonstrate&nbsp;<strong>fat/lipids</strong></td>\n<td>Fatty liver-fat embolism-fibroma vs. thecoma of the&nbsp;ovary-liposarcoma&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Microbiology stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>&nbsp;Uses</strong></td>\n</tr>\n<tr>\n<td><strong>Ziehl&ndash;Neelsen Stain</strong></td>\n<td>Mycobacteria (all species, including <em>Mycobacterium leprae</em>), <em>Nocardia </em>spp. Cyst of&nbsp;<em>Cryptosporidium parvum</em>, <em>Isospora </em>spp., and&nbsp;<em>Cyclospora</em>&nbsp;spp., Head of sperms</td>\n</tr>\n<tr>\n<td><strong>Masson&rsquo;s Fontana</strong></td>\n<td>Melanin and argentaffin Cells</td>\n</tr>\n<tr>\n<td><strong>Gomori Methenamine Silver</strong></td>\n<td>Fungi</td>\n</tr>\n<tr>\n<td><strong>Luxol Fast Blue (LFB)</strong></td>\n<td>Myelin</td>\n</tr>\n<tr>\n<td><strong>Phosphotungstic Acid-hematoxylin</strong></td>\n<td>Cross striations of skeletal muscle, fibrin</td>\n</tr>\n<tr>\n<td><strong>Toluidine blue</strong></td>\n<td>Mast cells</td>\n</tr>\n<tr>\n<td><strong>Warthin&ndash;Starry</strong></td>\n<td>Helicobacter pylori, spirochetes</td>\n</tr>\n<tr>\n<td><strong>Van Gieson</strong></td>\n<td>Collagen fibres</td>\n</tr>\n<tr>\n<td><strong>Mucicarmine</strong></td>\n<td>Mucin, <em>Cryptococcus</em> capsule</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/fd9b7fad1a6948ac979334a064f7d0e8.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5643",
      "difficulty": "medium"
    },
    {
      "text": "Autoantibodies against Dsg3 would typically be seen in patients with which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Pemphigus foliaceus"
        },
        {
          "id": 2,
          "text": "Bullous pemphigoid"
        },
        {
          "id": 3,
          "text": "Pemphigus Vulgaris"
        },
        {
          "id": 4,
          "text": "Dermatitis herpetiformis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Autoantibodies against <strong>Dsg3</strong> would typically be seen in patients with <strong>pemphigus vulgaris</strong>.</p>\n<p>In <strong>pemphigus vulgaris, Anti-Dsg 3 antibodies</strong> predominate. As Dsg 3 is present in all the layers of the mucosa, but is found only in the basal and immediate suprabasal layers of skin, the&nbsp;<strong>oral epithelium is primarily affected with relative sparing of skin remaining</strong>.</p>\n<p>In the case of <strong>pemphigus foliaceus</strong>, Anti-Dsg1 antibodies predominate. Hence, the skin is primarily affected with sparing of oral mucosa.</p><hr><h3>Related Pearl: Vesiculobullous Disorders</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Clinical Manifestations</strong></td>\n<td><strong>Histology</strong></td>\n<td><strong>Immuno-pathology</strong></td>\n<td><strong>Autoantigens</strong></td>\n</tr>\n<tr>\n<td>Pemphigus vulgaris <strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Flaccid blisters, denuded skin,oro-mucosal lesions</td>\n<td>Acantholytic blister formed in&nbsp;<strong>suprabasal layer</strong> of epidermis&nbsp;</td>\n<td>Cell surface deposits of IgG on keratinocytes- fish net pattern</td>\n<td><strong>Dsg3, Dsg1</strong> in patients with skin involvement</td>\n</tr>\n<tr>\n<td>Pemphigus foliaceus <strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Crusts and shallow erosions on the scalp, central face, upper chest, and back</td>\n<td>Acantholytic blister formed in&nbsp;<strong>superficial layer</strong> of epidermis&nbsp;</td>\n<td>Cell surface deposits of IgG onkeratinocytes</td>\n<td><strong>Dsg1</strong></td>\n</tr>\n<tr>\n<td>Bullous pemphigoid <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Large tense blisters on flexor surfaces and trunk&nbsp;</td>\n<td><strong>Subepidermal </strong>blister with <strong>eosinophil-rich</strong> infiltrate</td>\n<td>Linear band of IgG and/or C3 in epidermal BMZ&nbsp;</td>\n<td><strong>BPAG1, BPAG2</strong></td>\n</tr>\n<tr>\n<td>Dermatitis herpetiformis<strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Extremely pruritic small papules and vesicles on elbows, knees, buttocks, and posterior neck</td>\n<td><strong>Subepidermal </strong>blister with <strong>neutrophils </strong>in dermal papillae&nbsp;</td>\n<td>Granular deposits of IgA at the tips of dermal papillae</td>\n<td><strong>Epidermal trans-glutaminase</strong></td>\n</tr>\n<tr>\n<td>Linear IgA disease <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Pruritic small papules on extensor surfaces; occasionally larger, arciform blisters&nbsp;</td>\n<td><strong>Subepidermal </strong>blister with <strong>neutrophil</strong>-rich infiltrate&nbsp;</td>\n<td>Linear band of IgA in epidermalBMZ</td>\n<td><strong>BPAG2</strong></td>\n</tr>\n<tr>\n<td><strong>Epidermo-lysis bullosa acquisita</strong></td>\n<td>Tense bullae and erosions&nbsp;</td>\n<td>Subepidermal blister&nbsp;</td>\n<td>IgG and C3 DEJ &ndash; Continous and linear&nbsp;</td>\n<td><strong>Type VII collagen</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;The images below shows clinical pictures of pemphigus patients.</p>\n<ul>\n<li>Image A - oral erosions in a patient with <strong>pemphigus vulgaris</strong></li>\n<li>Image B - heavily clotted and crusted lesions around the mouth in a patient with <strong>paraneoplastic pemphigus</strong></li>\n<li>Image C - skin lesions found on the trunk in a patient with <strong>pemphigus vulgaris</strong></li>\n<li>Image D - skin lesions on the trunk in a patient with <strong>pemphigus foliaceus</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9f91eeb50e144e818c6d6e857996c593x443x358.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Classification of Vesiculobullous Disorders</h3><p><strong>According to Pathology</strong></p>\n<ul>\n<li><strong>Immunobullous disorders/ Primary blistering disease: </strong>occur due to autoimmunity</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Intraepidermal</strong></p>\n</td>\n<td>\n<p><strong>Subepidermal</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus vulgaris</p>\n</td>\n<td>\n<p>Bullous pemphigoid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus foliaceous</p>\n</td>\n<td>Dermatitis herpetiformis</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus vegetans</p>\n</td>\n<td>Epidermolysis bullous acquisita</td>\n</tr>\n<tr>\n<td>&nbsp;Pemphigus erythematosus</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Mechanobullous disorders:</strong> Due to defect in the structure of epidermis\n<ul>\n<li>Epidermolysis bullosa</li>\n<li>Bullous ichthyosiform erythroderma</li>\n</ul>\n</li>\n<li><strong>Other disorders</strong>\n<ul>\n<li>Infections - VZV, HSV, Bullous impetigo, SSSS</li>\n<li>Metabolic - Porphyria, Diabetes, Hemodialysis</li>\n<li>Drug eruptions - Fixed drug eruption, Steven Johnson Syndrome, Erythema Multiforme</li>\n</ul>\n</li>\n</ul>\n<p><strong>According to Site</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Intraepidermal</strong></p>\n</td>\n<td>\n<p><strong>Sub-epidermal (Dermo-epidermal)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>1. Subcorneal (granular layer)</strong></p>\n<ul>\n<li>Pemphigus foliaceous &amp; erythematosus</li>\n<li>Staphylococcal scalded skin syndrome</li>\n<li>Miliaria crystalina</li>\n<li>Bullous impetigo</li>\n<li>Friction blister</li>\n<li>Subcorneal pustular dermatosis</li>\n</ul>\n<p><strong>2. Spinous layer</strong></p>\n<ul>\n<li>Eczematous (atopic) dermatitis</li>\n<li>HSV/VZV infection</li>\n<li>Molluscum contagiosum</li>\n<li>Familial benign pemphigus (Hailey-hailey disease)</li>\n</ul>\n<p><strong>3. Suprabasal</strong></p>\n<ul>\n<li>Pemphigus vulgaris</li>\n<li>Darrier&rsquo;s disease</li>\n</ul>\n<p><strong>4. Basal layer</strong></p>\n<ul>\n<li>Erythema multiforme</li>\n<li>Epidermolysis bullosa simplex</li>\n</ul>\n</td>\n<td>\n<p><strong>1. Junctional (at basal lamina)</strong></p>\n<ul>\n<li>Junctional epidermolysis bullosa</li>\n<li>Bullous pemphigoid</li>\n<li>Toxic epidermal necrolysis</li>\n</ul>\n<p><strong>2. Dermolytic (below basal lamina)</strong></p>\n<ul>\n<li>Epidermolysis bullosa acquisita</li>\n<li>Epidermolysis bullosa dystrophicans</li>\n<li>Deep burns</li>\n<li>Porphyria cutanea tarda</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Differences between pemphigus vulgaris and bullous pemphigoid</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Pemphigus vulgaris</strong></td>\n<td><strong>Bullous pemphigoid</strong></td>\n</tr>\n<tr>\n<td>Age</td>\n<td>30-40 years</td>\n<td>70-80 years</td>\n</tr>\n<tr>\n<td>Antibody</td>\n<td>Anti-desmoglein</td>\n<td>Anti-hemidesmosome</td>\n</tr>\n<tr>\n<td>Location of target antigens</td>\n<td>Intraepidermal</td>\n<td>Subepidermal</td>\n</tr>\n<tr>\n<td>Immuno-fluorescence</td>\n<td>Fish-net pattern</td>\n<td>Linear, shoreline pattern</td>\n</tr>\n<tr>\n<td>Bullae</td>\n<td>Thin and fragile</td>\n<td>Deep and tense</td>\n</tr>\n<tr>\n<td>Mouth involved</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Nikolsky&rsquo;s sign</td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>Symptom</td>\n<td>Painful</td>\n<td>Pruritic</td>\n</tr>\n<tr>\n<td>Severity</td>\n<td>Life threatening</td>\n<td>Resolves</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5610",
      "difficulty": "easy"
    },
    {
      "text": "All of the following result in the change of gene frequencies in a population except:",
      "choices": [
        {
          "id": 1,
          "text": "Occurrence of population movement"
        },
        {
          "id": 2,
          "text": "Breeding structure in population"
        },
        {
          "id": 3,
          "text": "Hardy-Weinberg equilibrium state"
        },
        {
          "id": 4,
          "text": "Public health measures"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In a <strong>Hardy-Weinberg equilibrium state</strong>, there is <strong>no change in gene frequencies.</strong>&nbsp;</p>\n<p>The<strong> Hardy-Weinberg law</strong> states that the <strong>relative frequencies</strong> of each gene allele tend to <strong>remain constant</strong> from generation to generation in the <strong>absence of forces that change the gene frequencies.</strong> A population in Hardy-Weinberg equilibrium would not have any change in the gene frequencies.</p>\n<p>But, this is a <strong>theoretical concept</strong>, and in practice, the human population is never in an equilibrium state because of the action of the following forces that result in the change of gene frequencies from generation to generation:</p>\n<ul>\n<li>Mutation</li>\n<li>Natural Selection</li>\n<li>Population movements</li>\n<li>Breeding structure resulting in nonrandom mating</li>\n<li>Public health measures</li>\n</ul><hr><h3>Related Pearl: Hardy-Weinberg Law</h3><ul>\n<li>The Hardy-Weinberg Law is related to <strong>population genetics</strong>.</li>\n<li>It is based on the principle founded by G.H. Hardy and Wilhelm Weinberg.</li>\n<li>The law states that the relative <strong>frequencies of each gene allele</strong>&nbsp;tends to remain <strong>constant</strong> from generation to generation in the absence of other evolutionary influences.</li>\n<li>It is also called the Hardy-Weinberg<strong> equilibrium</strong> or principle.</li>\n<li>It is only applicable for <strong>infinitely large, static</strong> populations which <strong>randomly mate</strong>.</li>\n<li>This law fails in the following conditions:\n<ul>\n<li>Small and dynamic populations</li>\n<li>Non random or assortative mating</li>\n<li>Mutations</li>\n<li>Gene outflow and genetic drift</li>\n<li>Migration</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5497",
      "difficulty": "medium"
    },
    {
      "text": "What type of MRI image is given below?",
      "choices": [
        {
          "id": 1,
          "text": "Susceptibility-weighted image"
        },
        {
          "id": 2,
          "text": "Proton density–weighted image"
        },
        {
          "id": 3,
          "text": "Gradient echo image"
        },
        {
          "id": 4,
          "text": "Inversion recovery image"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image shown is a <strong>proton density (PD)-weighted image</strong> as the <strong>CSF fluid appears similar in density to fat.  </strong></p>\n<p><strong>A PD-weighted image</strong> is based on the <strong>number of nuclei</strong> in the area that is imaged. In PD-weighted imaging, tissues with a higher density of protons produce stronger signals and appear brighter. PD-weighted images can be identified by comparing fluid with the fat signal: <strong>fluids</strong> in these images <strong>appear greyish white</strong>, similar or the appearance of fat in the body.</p>\n<p>Other options:</p>\n<p>Susceptibility-weighted imaging is a form of MRI sequence that is especially sensitive to substances that <strong>distort the local magnetic field</strong>. Compounds with <strong>diamagnetic, paramagnetic, and ferromagnetic</strong> properties will interact with the local magnetic field and produce distraction. This would lead to a loss of signal in these areas.</p>\n<p><strong>Deoxyhemoglobin, hemosiderin</strong>, and <strong>ferritin</strong> are paramagnetic. <strong>Bone minerals</strong> and <strong>dystrophic calcifications</strong> are diamagnetic in nature. The main clinical use is the identification of microhemorrhages/blood products or calcium that are not detected in other MRI sequences.</p>\n<p>The image shown below is a <strong>susceptibility-weighted image (SWI)</strong> as it clearly demonstrates <strong>microhemorrhages as hypointense foci.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ddd99e4172884e61a8d790af5bd44acex720x835.JPEG\" alt=\"Explanation Image\"><p><strong>Gradient echo sequences (GRE):</strong> </p>\n<p>It uses gradient fields to <strong>generate transverse magnetization.</strong> In areas of hemorrhage, the iron that is present in the hemoglobin produces its own local magnetic field and dephases the spinning nuclei. This is useful to <strong>identify hemorrhagic contusions</strong> in the brain and pigmented villonodular synovitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b5e21cf3e2bc4873bc0cde15d1120611x140x160.PNG\" alt=\"Explanation Image\"><p><strong>Inversion recovery sequences:</strong></p>\n<p>This MRI sequence is used to <strong>selectively null certain tissues</strong>. It can be</p>\n<ul>\n<li><strong>Short tau inversion recovery (STIR)</strong> where <strong>fat is nulled</strong>. Fluids appear bright and fat appears dark in these images.</li>\n<li><strong>Fluid attenuated inversion recovery (FLAIR)</strong> or double inversion recovery (DIR), where fluid is nulled. The fluid (CSF) normally appears dark and lesions appear to be brighter in these images.</li>\n</ul>\n<p>FLAIR image:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/aba533b9ffc54180be8c46ea2692d2cfx512x512.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: T1 vs T2 MRI</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Structure</strong></div>\n</td>\n<td>\n<div><strong>T1 image</strong></div>\n</td>\n<td>\n<div><strong>T2 image</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Grey matter</strong></div>\n</td>\n<td>\n<div>Darker</div>\n</td>\n<td>Lighter</td>\n</tr>\n<tr>\n<td>\n<div><strong>White matter</strong></div>\n</td>\n<td>Lighter </td>\n<td>Darker</td>\n</tr>\n<tr>\n<td>\n<div><strong>CSF/ Fluids</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Bright</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Fat</strong></div>\n</td>\n<td>\n<div>White</div>\n</td>\n<td>\n<div>Less white</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Air</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Cortical bone</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Tendons and ligaments</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Calcification</strong></div>\n</td>\n<td>Variable</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Flowing blood and hemosiderin</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3c066751d79648d68cd8b72597f1d710.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5593",
      "difficulty": "hard"
    },
    {
      "text": "During the antenatal assessment of a mother, you would suspect probable fetal asphyxia if the biophysical profile score is ________.<div class='question-desc-html'><p>AFI- Amniotic fluid index</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "8/10 with decreased AFV"
        },
        {
          "id": 2,
          "text": "6/10"
        },
        {
          "id": 3,
          "text": "4/10"
        },
        {
          "id": 4,
          "text": "8/10 with normal AFV"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Fetal asphyxia</strong> would be suspected when the <strong>biophysical profile&nbsp;</strong>(BPP)<strong> score is 4/10.</strong></p>\n<p>BPP is a multi-parametric,&nbsp;<strong>screening test</strong>&nbsp;to assess uteroplacental insufficiency. It consists of&nbsp;<strong>five components</strong>/ variables and the observations are made in a&nbsp;<strong>30-minute</strong>&nbsp;time period.</p>\n<p>Components of BPP: (Mnemonic: BATMaN)</p>\n<ul>\n<li>B -&nbsp;<strong>Breathing movements</strong> of the fetus</li>\n<li>A - Amniotic fluid volume (<strong>AFI</strong>)</li>\n<li>T - <strong>Tone</strong> of the fetus</li>\n<li>M -&nbsp;Movements of the fetus</li>\n<li>N - Non-stress test (NST)</li>\n</ul>\n<p>Each parameter has a&nbsp;<strong>maximum score of 2</strong>&nbsp;and a&nbsp;<strong>minimum score of 0.&nbsp;</strong>So the total maximum score will be 10. A <strong>score of 4 or less</strong> indicates fetal <strong>acidemia</strong>.</p>\n<p>Interpretation of the BPP scores and the corresponding management:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>BPP score</strong></td>\n<td><strong>Fetal asphyxia</strong></td>\n<td><strong>Management</strong></td>\n</tr>\n<tr>\n<td><strong>10</strong></td>\n<td><br />No <br /><br /></td>\n<td>Repeat test weekly&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>8</strong>&nbsp;<br />with<strong> <br />normal <br /></strong><strong>AFV</strong></p>\n</td>\n<td>No <br /><br /></td>\n<td>Repeat test weekly&nbsp;</td>\n</tr>\n<tr>\n<td><strong>8 <br /></strong>with<strong> decreased AFV</strong></td>\n<td>Suspicion of chronic asphyxia</td>\n<td>Deliver, if&nbsp;<br />&ge;36 weeks</td>\n</tr>\n<tr>\n<td><strong><strong>6<br /></strong></strong>with&nbsp;<strong><strong><br />normal <br />AFV</strong></strong></td>\n<td>&nbsp;Equivocal</td>\n<td>Deliver, if &ge;37 weeks, <br />if &lt;37 weeks, repeat test in 24 hours</td>\n</tr>\n<tr>\n<td><strong><strong>6<br /></strong></strong>with<strong> decreased AFV<br /></strong></td>\n<td>Possible <br /><br /></td>\n<td>\n<p>Deliver, if 36-37 weeks</p>\n</td>\n</tr>\n<tr>\n<td><strong>4</strong></td>\n<td><strong>Probable</strong>&nbsp;</td>\n<td>Deliver, if&nbsp;<br />&ge;32 weeks</td>\n</tr>\n<tr>\n<td><strong>0-2</strong></td>\n<td>Almost <strong>certain</strong>&nbsp;</td>\n<td>Delivery&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>BPP is directly related to <strong>fetal pH</strong> and <strong>fetal outcome</strong>. A lower BPP score is associated with a poor outcome (stillbirth, perinatal mortality) and <strong>lower APGAR scores</strong> at birth.</p>\n<p>A score of 8-10 is associated with a normal&nbsp;<strong>pH </strong>and a <strong>score of 0</strong> is associated with significant<strong>&nbsp;fetal acidemia</strong>.</p>\n<p>Note: The<strong>&nbsp;modified biophysical score&nbsp;</strong>has only 2 components i.e&nbsp;<strong>NST</strong>&nbsp;and&nbsp;<strong>amniotic fluid index</strong>&nbsp;only. It<strong>&nbsp;</strong>is considered abnormal (nonreassuring) when the NST is non-reactive and/or the AFI is &lt;5.</p><hr><h3>Related Pearl: Change in the amniotic fluid volume through gestation</h3><table>\n<tbody>\n<tr>\n<td><strong>Period of gestation </strong> &nbsp;</td>\n<td><strong>Amniotic fluid volume </strong></td>\n</tr>\n<tr>\n<td>10 weeks</td>\n<td>10-20 mL</td>\n</tr>\n<tr>\n<td>16 weeks</td>\n<td>250 mL</td>\n</tr>\n<tr>\n<td>33 weeks</td>\n<td>800 mL</td>\n</tr>\n<tr>\n<td>38-39 weeks</td>\n<td>plateaus at 1000 mL</td>\n</tr>\n<tr>\n<td>40 weeks</td>\n<td>&nbsp;800</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: The average volume increases with gestational age, peaking at <strong>800-1000 mL</strong>, which coincides with <strong>36-37</strong> weeks' gestation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5626",
      "difficulty": "medium"
    },
    {
      "text": "A 19-year-old trekking enthusiast embarks on a month-long trek across the Himalayas. Which of the following physiological adaptations would you expect to see in him at high altitudes following acclimatization?<div class='question-desc-html'><p class=\"p1\">&nbsp;</p>\n<ol>\n<li class=\"p2\">Erythropoietin secretion increases<span class=\"Apple-converted-space\">&nbsp;</span></li>\n<li class=\"p2\"><span class=\"Apple-converted-space\">Tissue mitochondria increase in number</span></li>\n<li class=\"p2\"><span class=\"Apple-converted-space\">Tissue myoglobin decreases</span></li>\n<li class=\"p2\"><span class=\"Apple-converted-space\">Tissue content of cytochrome oxidase also increases</span></li>\n<li class=\"p2\"><span class=\"Apple-converted-space\">pH of blood increases</span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3 & 5"
        },
        {
          "id": 2,
          "text": "2, 3, & 5"
        },
        {
          "id": 3,
          "text": "1, 2, 4, & 5"
        },
        {
          "id": 4,
          "text": "1, 2, 3, & 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Myoglobin increases</strong> to facilitate the movement of O<sub>2</sub> into the tissues in high altitudes following acclimatization.</p>\n<p>Compensatory mechanisms that are carried out to increase altitude tolerance are called <strong>acclimatization</strong>.&nbsp;</p>\n<p>Following are the physiological changes that occur during acclimatization:</p>\n<ul>\n<li aria-level=\"1\">Hyperventilation leads to&nbsp;respiratory alkalosis&nbsp;and&nbsp;shift&nbsp;of the&nbsp;oxygen&ndash;hemoglobin dissociation curve&nbsp;to the&nbsp;left&nbsp;(and shifts to right after aclimitization).</li>\n<li aria-level=\"1\"><strong>Increased erythropoietin</strong>&nbsp;secretion, leading to an increase in circulating red blood cells</li>\n<li aria-level=\"1\"><strong>Increased number of mitochondria</strong></li>\n<li aria-level=\"1\"><strong>Increased myoglobin</strong> to facilitate the movement of O<sub>2</sub> into the tissues</li>\n<li aria-level=\"1\"><strong>Increased tissue cytochrome oxidase</strong></li>\n<li aria-level=\"1\">Increased sympathetic tone</li>\n<li aria-level=\"1\">Renal suppression of carbonic anhydrase and excretion of dilute alkaline urine brings the pH of the blood to normal.</li>\n<li aria-level=\"1\">Decreased maximal exercise capacity (by ~1% for every 100 meters gained above 1500 meters)&nbsp;</li>\n</ul>\n<p><br /><br /></p><hr><h3>Related Pearl: Acclimatization to high altitude</h3><img src=\"https://cdn1.dailyrounds.org/uploads/07859b7f9cce4e0ab7654ab13244b120x1061x606.PNG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Characteristics of different types of Hypoxia</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Hypoxic</strong></p>\n</td>\n<td>\n<p><strong>Anaemic</strong></p>\n</td>\n<td>\n<p><strong>Stagnant</strong></p>\n</td>\n<td>\n<p><strong>Histotoxic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Etiology</strong></p>\n</td>\n<td>\n<p>&darr; in paO<sub>2</sub></p>\n</td>\n<td>\n<p>&darr; in available Hb</p>\n</td>\n<td>\n<p>O<sub>2</sub> carrying capacity is normal but O<sub>2</sub> delivery is decreased</p>\n</td>\n<td>\n<p>No O<sub>2</sub> utilization at tissue level</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Examples</strong></p>\n</td>\n<td>\n<p>High altitude, lung disease</p>\n</td>\n<td>\n<p>Anemia, CO poisoning</p>\n</td>\n<td>\n<p>Heart failure, shock, Haemorrhage</p>\n</td>\n<td>\n<p>Cyanide Poisoning</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>paO<sub>2</sub></strong></p>\n</td>\n<td>\n<p>&darr;</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Dissolved O<sub>2 </sub>content</strong></p>\n</td>\n<td>\n<p>&darr;</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>O<sub>2</sub> combined with Hb</strong></p>\n</td>\n<td>\n<p>&darr;</p>\n</td>\n<td>\n<p>&darr;</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chemoreceptor stimulation</strong></p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>Not stimulated</p>\n</td>\n<td>\n<p>+++</p>\n</td>\n<td>\n<p>+++</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Amount of reduced Hb</strong></p>\n</td>\n<td>\n<p>&uarr;</p>\n</td>\n<td>\n<p>Total Hb&darr;, HHb&uarr;</p>\n</td>\n<td>\n<p>&uarr;&uarr;&uarr;</p>\n</td>\n<td>\n<p>&darr;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cyanosis </strong></p>\n</td>\n<td>\n<p>Can be present</p>\n</td>\n<td>\n<p>Unlikely</p>\n</td>\n<td>\n<p>Can be present</p>\n</td>\n<td>\n<p>unlikely</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5554",
      "difficulty": "medium"
    },
    {
      "text": "Match the following radionuclide dye with its indication:<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>1. Tc-99m DTPA (diethylene-triamine-pentaacetate)</td>\n<td>A. CEA-expressing cancers</td>\n</tr>\n<tr>\n<td>2. Tc-99m DMSA (dimercaptosuccinic acid)</td>\n<td>B. Vesicoureteral reflux</td>\n</tr>\n<tr>\n<td>3. Tc-99m pertechnetate</td>\n<td>C. Renal structure and morphology</td>\n</tr>\n<tr>\n<td>4. Tc-99m Arcitumomab</td>\n<td>D. Direct measurement of GFR</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-D, 2-C, 3-B, 4-A"
        },
        {
          "id": 2,
          "text": "1-A, 2-C, 3-B, 4-D"
        },
        {
          "id": 3,
          "text": "1-A, 2-B, 3-C, 4-D"
        },
        {
          "id": 4,
          "text": "1-D, 2-B, 3-C, 4-A"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correctly matched pairs are <strong>1-D, 2-C, 3-B, 4-A.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Radionuclide dye</strong></td>\n<td><strong>Indication</strong></td>\n</tr>\n<tr>\n<td>Tc-99m DTPA (diethylene-triamine-pentaacetate)</td>\n<td>Direct measurement of glomerular filtration rate (GFR)</td>\n</tr>\n<tr>\n<td>Tc-99m DMSA (dimercaptosuccinic acid)</td>\n<td>Renal structure and morphology</td>\n</tr>\n<tr>\n<td>Tc-99m pertechnetate</td>\n<td>Vesicoureteral reflux</td>\n</tr>\n<tr>\n<td>Tc-99m Arcitumomab</td>\n<td>CEA-expressing cancers</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong><br />Tc-99m DTPA (diethylene-triamine-pentaacetate)</strong> is cleared only via glomeruli with no tubular excretion and hence used for<strong> direct measurement of GFR.</strong></p>\n<p><strong>Tc-99m DMSA (dimercaptosuccinic acid)</strong> is used in renal imaging to evaluate <strong>renal structure and morphology,</strong> particularly in pediatric imaging for the detection of scarring and pyelonephritis. DMSA is an ideal agent for the assessment of the renal cortex as it binds to the <strong>sulfhydryl groups in proximal tubules</strong> at the renal cortex with longer retention than other agents. It allows for a better assessment of differential renal function. It is a <strong>static scan</strong> as opposed to dynamic DTPA or MAG3 scans.</p>\n<p>Assessment of VUR can be done by<strong> direct isotope cystography</strong> using <strong>99m Tc-pertechnetate. </strong>Other uses of Tc-99m pertechnetate:</p>\n<ul>\n<li>Thyroid imaging for thyroid nodules and ectopic thyroid</li>\n<li>Salivary gland imaging</li>\n<li>Meckel scan</li>\n<li>Gastric emptying studies, intestinal and rectal functional studies.</li>\n<li>Vesicoureteral reflux imaging.</li>\n</ul>\n<p><strong>99mTc-Arcitumomab</strong>, which is formed by the conjugation of 99mTc with a <strong>murine anti-carcinoembryonic antigen (CEA) monoclonal antibody</strong> <strong>(MAb)</strong> Fab fragment, can be used for <strong>imaging CEA-expressing cancers</strong>.</p><hr><h3>Related Pearl: Radionuclide agents and their uses</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Radionuclide agent</strong></p>\n</td>\n<td>\n<p><strong>Use</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Medronate (MDP) (most common)</p>\n<p>Tc-99m Oxidronate (HMDP)</p>\n<p>Tc-99m HEDP</p>\n</td>\n<td>\n<p>Bone imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Apcitide</p>\n</td>\n<td>\n<p>Peptide imaging of DVT</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Arcitumomab</p>\n</td>\n<td>\n<p>Monoclonal antibody for colorectal cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m albumin colloid</p>\n</td>\n<td>\n<p>Imaging of RES (liver/spleen)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m bicisate (ECD)</p>\n<p>Tc-99m exametazine (HMPAO</p>\n</td>\n<td>\n<p>Cerebral perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Depreotide</p>\n</td>\n<td>\n<p>Somatostatin receptor-bearing pulmonary masses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m disofenin (DISIDA)</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Glucepatate</p>\n<p>Tc-99m Meriatide</p>\n<p>Tc-99m Succimer (DMSA)</p>\n</td>\n<td>\n<p>Renal imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Human Serum Albumin(HAS)</p>\n</td>\n<td>\n<p>Imaging of cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Lidofenin (HIDA)</p>\n<p>Tc-99m Mebrofenin</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m nofetumomab Merpentan NR-LU-10</p>\n</td>\n<td>\n<p>Monoclonal antibody Fab fragment for imaging small cell lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pentetate (DTPA)</p>\n</td>\n<td>\n<p>Renal imaging and functional studies; radioaerosol ventilation imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pyrophosphate (PYP)</p>\n</td>\n<td>\n<p>Avid infarct imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Red Blood Cells (RBCs)</p>\n</td>\n<td>\n<p>Imaging of GI bleeds, cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sestamibi</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging; breast tumor imaging, parathyroid gland</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sulfur colloid (SC)</p>\n</td>\n<td>\n<p>Imaging of RES( liver/spleen), gastric emptying, GI bleeds</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Teboroxime</p>\n<p>Tc-99m Tetrofosmin</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><sup>68</sup>Gallium</p>\n</td>\n<td>\n<p>Binds to somatostatin receptors</p>\n<p>Detection of new neuroendocrine tumors</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5594",
      "difficulty": "medium"
    },
    {
      "text": "According to the 2020 revised CEAP classification, C6r is used to denote a patient with ____.",
      "choices": [
        {
          "id": 1,
          "text": "Recurrent varicose vein"
        },
        {
          "id": 2,
          "text": "Corona phlebectasia"
        },
        {
          "id": 3,
          "text": "Recurrent active venous ulcer"
        },
        {
          "id": 4,
          "text": "Lipodermatosclerosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Recurrent active venous ulcer</strong> is classified as <strong>C6r</strong> according to the recent 2020 update in the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification system. </p>\n<p>Varicose veins are subcutaneous dilated, tortuous veins with diameter of <strong>3 mm or more</strong>. They commonly present with a sensation of <strong>dragging pain</strong>, <strong>heaviness, itching, </strong>or <strong>burning</strong> over the affected area or the whole limb, and swelling of the feet. These symptoms increase throughout the day or with prolonged standing and are relieved by <strong>elevation or compression hosiery.</strong></p>\n<p><strong>Risk factors</strong>:</p>\n<ul>\n<li aria-level=\"1\">Female gender</li>\n<li aria-level=\"1\">Increasing age</li>\n<li aria-level=\"1\">Increasing body mass and height</li>\n<li aria-level=\"1\">Pregnancy</li>\n<li aria-level=\"1\">Family history</li>\n<li aria-level=\"1\">Smoking</li>\n<li aria-level=\"1\">Occupations involving prolonged standing</li>\n</ul>\n<p> According to the CEAP classification, venous disease is classified as follows:  </p>\n<ul>\n<li aria-level=\"1\">C0: No signs of venous disease</li>\n<li aria-level=\"1\">C1: Telangiectasia or reticular veins</li>\n<li aria-level=\"1\">C2: Varicose veins</li>\n</ul>\n<ul>\n<li><strong>C2r: recurrent varicose veins </strong></li>\n</ul>\n<ul>\n<li aria-level=\"1\">C3: Edema</li>\n<li aria-level=\"1\">C4: Skin changes due to chronic venous disease</li>\n</ul>\n<ul>\n<li>C4a: Pigmentation or eczema (including malleolar flare)</li>\n<li>C4b: Lipodermatosclerosis or atrophie blanche</li>\n<li><strong>C4c: Corona phlebectatica </strong></li>\n</ul>\n<ul>\n<li aria-level=\"1\">C5: Healed venous ulcer</li>\n<li aria-level=\"1\">C6: Active venous ulcer</li>\n</ul>\n<ul>\n<li><strong>C6r: Recurrent active venous ulcer</strong></li>\n</ul>\n<p>The images below show C5 and C6—<strong>healed </strong>and <strong>active venous ulcers</strong>, respectively.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/41ed85da6a2441e8a6c75c3540d63742x1280x960.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/efaaf4764bc4444f850d8b1a61aa99b1x495x375.PNG\" alt=\"Explanation Image\"><p><strong>Telangiectasia/thread veins/spider veins</strong> (C1) are intradermal venules with diameter &lt; 1 mm.</p>\n<p>A <strong>reticular vein</strong> (C1) is a subdermal vein with diameter 1–3 mm.</p>\n<p><strong>Atrophie blanche</strong> (C4b) refers to localized areas of white, atrophic skin, often surrounded by telangiectasia and pigmentation.</p>\n<p>The image below shows atrophie blanche:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ad6f864205fb4c4587111b739e300698x720x959.JPEG\" alt=\"Explanation Image\"><p><strong>Lipodermatosclerosis</strong> (C4b) is pigmentation, chronic inflammation, and induration of the skin and subcutaneous tissues in the calf and around the ankle. <strong>Champagne bottle sign/inverted beer bottle</strong> sign is seen in lipodermatosclerosis, as shown in the image below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c793be0741d04b6892abf41117b4fa48x1279x1142.JPEG\" alt=\"Explanation Image\"><p><strong>Malleolar flare/Corona phlebectatica</strong> (C4c) is fan-shaped telangiectasia on the ankle or foot.</p>\n<p><strong>Duplex ultrasound</strong> is the investigation of choice for varicose veins.</p>\n<p>Management of varicose veins</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Incompetence</strong></td>\n<td><strong>Management</strong></td>\n</tr>\n<tr>\n<td>Great saphenous vein (GSV) and saphenofemoral (SFJ) </td>\n<td>\n<ul>\n<li><strong>Endothermal ablation</strong> (<strong>gold standard</strong> treatment for varicose veins). It includes:</li>\n</ul>\n<ul>\n<li><strong>Endovenous laser ablation</strong> (<strong>EVLA</strong>)</li>\n<li>Radiofrequency ablation (RFA)</li>\n</ul>\n<ul>\n<li><strong>Trendelenburg procedure</strong> (<strong>Flush Ligation</strong> of Saphenofemoral Junction (<strong>SFJ</strong>) after ligation of 6 tributaries) ± <strong>stripping</strong> (retrogradely <strong>up to the knee</strong>, to prevent<strong> saphenous</strong> nerve injury.)     </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Short saphenous vein (SSJ) and saphenopopliteal (SPJ)</td>\n<td>\n<ul>\n<li><strong>Flush ligation</strong> of <strong>SPJ</strong> (<strong>Stripping</strong> is <strong>not done</strong> to prevent <strong>sural nerve</strong> injury)</li>\n<li><strong>Endothermal ablation:</strong></li>\n</ul>\n<ul>\n<li><strong>Endovenous laser ablation (EVLA)</strong></li>\n<li>Radiofrequency ablation (RFA)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Perforator </td>\n<td>\n<ul>\n<li>Dodd and Crockett surgery - Multiple subfascial ligations</li>\n<li><strong>Subfascial endoscopic perforator surgery (SEPS)</strong> - smaller incision, so cosmetically better</li>\n<li><strong>Endothermal ablation:</strong></li>\n</ul>\n<ul>\n<li><strong>Endovenous laser ablation (EVLA)</strong></li>\n<li>Radiofrequency ablation (RFA)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>New treatment modalities:</p>\n<ul>\n<li aria-level=\"1\"><strong>Foam sclerotherapy -</strong> The Tessari method is a widely used method to prepare foam for sclerotherapy. Sclerosant: air ratio taken is 1:3 or 1:4.</li>\n<li aria-level=\"1\"><strong>Endovenous glue therapy</strong> - endoluminal application of cyanoacrylate adhesive </li>\n<li aria-level=\"1\"><strong>TriVex</strong> - Transilluminated powered phlebectomy</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5577",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following tests is useful for detecting bile salts in urine?",
      "choices": [
        {
          "id": 1,
          "text": "Ehrlich's test"
        },
        {
          "id": 2,
          "text": "Hay's test"
        },
        {
          "id": 3,
          "text": "Fouchet's test."
        },
        {
          "id": 4,
          "text": "Rothera test"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Hay's test </strong>is used for the detection of<strong> bile salts </strong>in<strong>&nbsp;urine.&nbsp;</strong>Normally, bile salts (sodium salts of taurocholic acid and glycocholic acid) are not present in urine. Thus, <strong>positive Hay's test</strong> indicates an <strong>obstructive</strong> pathology in the biliary system, leading to the backflow of bile into the circulation. This obstruction may be associated with either obstructive jaundice or hepatic jaundice.</p><p><strong><span data-preserver-spaces=\"true\">Fouchet's test</span></strong><span data-preserver-spaces=\"true\">&nbsp;is used for detecting the presence of&nbsp;<strong>b</strong></span><strong><span data-preserver-spaces=\"true\">ile pigments in urine.&nbsp;</span></strong>Here, urine is heated with barium sulfate, which adsorbs bilirubin. Ferric chloride is added, which oxidizes the adsorbed bilirubin to biliverdin which produces a green color. Principle for all tests to detect bile pigments: Oxidizing agents readily&nbsp;<strong>oxidize bilirubin</strong>&nbsp;to&nbsp;<strong>biliverdin</strong>&nbsp;to form a<strong>&nbsp;green color.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cf1c3da8f64d48b38a366217ba3d46e8x720x452.JPEG\" alt=\"Explanation Image\"><p><strong>Ehrlich's test&nbsp;</strong>is used to determine urinary&nbsp;and fecal<strong> urobilinogen.</strong>&nbsp;Porphobilinogens form a <strong>red aldehyde compound</strong>&nbsp;with Ehrlich reagent, which is insoluble in chloroform. A red color remaining after chloroform extraction is indicative of porphobilinogens. This test is&nbsp;positive in acute intermittent porphyria and hemolytic jaundice. It is negative in hepatic jaundice (later stages) and obstructive jaundice. The earliest sign of recovery in obstructive jaundice is the re-appearance of urobilinogen in urine.</p>\n<p><strong>Rothera&rsquo;s test</strong>&nbsp;by&nbsp;<strong>nitroprusside reagent</strong>&nbsp;is a specific test used to detect whether&nbsp;<strong>acetone</strong>&nbsp;or&nbsp;<strong>acetoacetate</strong>&nbsp;is present in the given sample of urine. A&nbsp;<strong>purple ring</strong>&nbsp;at the junction of two liquids indicates a positive test. Rothera's test does&nbsp;<strong>not detect</strong>&nbsp;&beta;-hydroxybutyrate.&nbsp;&nbsp;</p>\n<p>The other test used for the purpose of detecting <strong>acetoacetate</strong> <strong>only</strong> is the <strong>ferric chloride test</strong>. It shows a burgundy red color that is graded from +1 to +4. False-positive results occur with drugs like salicylates and phenols.&nbsp;</p>\n<p>The image below shows the purple ring formed by a positive Rothera test.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/45d79805c8fd433d9f6a6f65cb004ca2x720x540.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Rothera's Test Procedure</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/73b9ba92c9384966a6760940ce51d4fcx287x140.JPEG\" alt=\"Pearl Image\"><p>Rothera's test, positive for ketone bodies.</p><hr><h3>Related Pearl: Color of urine  in different conditions</h3><p>Normal color of urine is <strong>pale straw</strong> due to presence of <strong>urochrome.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Smokey or cloudy</td>\n<td>\n<ul>\n<li>AGN</li>\n<li>Nephrotic syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Gross blood</td>\n<td>\n<ul>\n<li>Urological causes&nbsp; &nbsp; &nbsp;</li>\n<li>Nephro causes</li>\n<li>Hematological causes, e.g. PNH</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Red without blood [brownish tinge]</td>\n<td>\n<ul>\n<li>Rhabdomyolysis&nbsp; &nbsp;</li>\n<li>Beetroot ingestion&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Tea- or cola-colored urine</td>\n<td>Hemoglobinuria</td>\n</tr>\n<tr>\n<td>High-colored urine</td>\n<td>Bilirubinuria</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>Alkaptonuria</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;Due to Drugs:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality&nbsp;</strong></td>\n<td><strong>Drugs&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Orange</td>\n<td>\n<ul>\n<li>Rifamycins (rifampicin, rifabutin, rifapentine)</li>\n<li>B-complex&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Blue</td>\n<td>\n<ul>\n<li>Amitriptyline</li>\n<li>Methylene blue</li>\n<li>Copper poisoning</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Brown</td>\n<td>\n<ul>\n<li>Chloroquine</li>\n<li>Quinine</li>\n<li>Primaquine</li>\n<li>Nitrofurantoin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Yellow</td>\n<td>Tetracycline&nbsp;</td>\n</tr>\n<tr>\n<td>Pinkish</td>\n<td>Deferoxamine</td>\n</tr>\n<tr>\n<td>Green</td>\n<td>Triamterene</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>\n<ul>\n<li>Metronidazole</li>\n<li>Methyldopa</li>\n<li>Imipenem-cilastin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5477",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common ocular manifestation of SLE?",
      "choices": [
        {
          "id": 1,
          "text": "Conjunctivitis"
        },
        {
          "id": 2,
          "text": "Sicca syndrome"
        },
        {
          "id": 3,
          "text": "Episcleritis"
        },
        {
          "id": 4,
          "text": "Panophthalmitis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most common ocular </strong>manifestation of <strong>SLE</strong> is <strong>Sicca syndrome.</strong></p>\n<p>The most common manifestations of different systems involved in SLE are:</p>\n<ul>\n<li>Musculoskeletal- arthritis and arthralgia</li>\n<li>Skin- photosensitivity</li>\n<li>Kidneys- proteinuria</li>\n<li>Neurologic- cognitive impairment</li>\n<li>Cardiac- pericarditis</li>\n<li>Pulmonary- pleuritis</li>\n<li>Hematologic- anemia</li>\n</ul><hr><h3>Related Pearl: Antibodies in Systemic lupus erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates  with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP <br />More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br />More common in blacks and whites </td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br />Primarily 60kDA and 52kDA</td>\n<td>Not Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased  risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br />(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp; β2 G1,<br />Sensitive prothrombin time (DRVVT)<br />Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane </td>\n<td> Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br />This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br />(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5681",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is incorrect regarding prophylaxis in contacts of a patient with leprosy?",
      "choices": [
        {
          "id": 1,
          "text": "Prophylaxis is recommended for pregnant females also"
        },
        {
          "id": 2,
          "text": "Prophylaxis is contraindicated if contact is confirmed with TB"
        },
        {
          "id": 3,
          "text": "Prophylaxis is contraindicated if contact has possible signs and/or symptoms of TB"
        },
        {
          "id": 4,
          "text": "Chemoprophylaxis must be initiated only 4 weeks after initiation of treatment for the patient"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Prophylaxis</strong> is <strong>contraindicated</strong> during <strong>pregnancy</strong>. Chemoprophylaxis with single-dose rifampicin can be administered after delivery.</p>\n<p>Chemoprophylaxis for leprosy should be given to the following contacts:</p>\n<ul>\n<li class=\"p1\">A person who has been in close contact with the index case for <strong>20 hours</strong> or more <strong>per week</strong> for <strong>more than 3 months</strong>.</li>\n<li class=\"p1\"><strong>Close contact</strong> if the <strong>age</strong> is more than <strong>2 years</strong></li>\n</ul>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Chemoprophylaxis cannot be given if there is/are:</span></p>\n<ul>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Possible signs of leprosy</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Signs or confirmed tuberculosis</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Liver or kidney disease</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Pregnancy</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Received rifampicin in the last 2 years</span></li>\n</ul>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">A <strong>single dose </strong>of<strong> rifampicin</strong> is used in chemoprophylaxis. Chemoprophylaxis must be initiated <strong>only 4 weeks after treatment for leprosy has begun</strong> in the patient so as to ensure the patient is non-infectious. </span></p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Dose of rifampicin in chemoprophylaxis of leprosy</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Dose</strong></td>\n</tr>\n<tr>\n<td>Children 2-5 years</td>\n<td>10-15 mg/kg</td>\n</tr>\n<tr>\n<td>Children 6-9 years (less than 20kg)</td>\n<td>150 mg</td>\n</tr>\n<tr>\n<td>Children 6-9 years (more than 20kg)</td>\n<td>300 mg</td>\n</tr>\n<tr>\n<td>10-14 years</td>\n<td>450 mg</td>\n</tr>\n<tr>\n<td>15 years and above</td>\n<td>600 mg</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p2\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5614",
      "difficulty": "hard"
    },
    {
      "text": "Starting a patient on propranolol would be contraindicated if he has a history of ______.<div class='question-desc-html'><ol>\n<li>Migraine</li>\n<li>Asthma</li>\n<li>Uncompensated congestive heart failure</li>\n<li>Essential tremor</li>\n<li>Hypertrophic Subaortic Stenosis</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3"
        },
        {
          "id": 2,
          "text": "2, 3, 4"
        },
        {
          "id": 3,
          "text": "1, 2, 5"
        },
        {
          "id": 4,
          "text": "3, 4, 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Asthma &amp; uncompensated congestive heart failure</strong> are <strong>contraindications</strong> for starting a patient on propranolol, a non-selective beta-blocker.</p>\n<p>Migraine, essential tremor, and hypertrophic subaortic stenosis are indications for which propranolol can be prescribed. Other labeled indications of propranolol are as follows:</p>\n<ul>\n<li>Hypertension</li>\n<li>Angina</li>\n<li>Pheochromocytoma</li>\n<li>Myocardial infarction</li>\n<li>Supraventricular arrhythmia</li>\n</ul>\n<p><strong>Contraindications</strong> of propranolol include:</p>\n<ul>\n<li>Asthma, COPD</li>\n<li>Severe sinus bradycardia or second- or third-degree heart block without a pacemaker</li>\n<li>Cardiogenic shock</li>\n<li>Uncompensated congestive heart failure</li>\n</ul>\n<p> </p>\n<p>Note:</p>\n<p>Portal hypertension and prevention of variceal bleeding is an off-label indication for propranolol, not a labeled indication.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5489",
      "difficulty": "medium"
    },
    {
      "text": "Match the following milestones with their corresponding age of occurrence<div class='question-desc-html'><ol>\n<li>Immature pincer grasp</li>\n<li>Monosyllables sounds</li>\n<li>Recognizes mother</li>\n<li>Stands without support</li>\n</ol>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<ol>\n<li>12 Months</li>\n<li>6 Months</li>\n<li>3 Months</li>\n<li>9 months</li>\n</ol>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-B, 2-D, 3-C, 4-A"
        },
        {
          "id": 2,
          "text": "1-D, 2-B, 3-C, 4-A"
        },
        {
          "id": 3,
          "text": "1-D, 2-C, 3-B, 4-A"
        },
        {
          "id": 4,
          "text": "1-D, 2-A, 3-B, 4- C"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The corresponding milestones are:</p>\n<ul>\n<li>3 months - Recognizes mother</li>\n<li>6 months - Monosyllables sounds (ma, ba)</li>\n<li>9 months - Immature pincer grasp</li>\n<li>12 months - Stands without support</li>\n</ul>\n<p><strong>Social and adaptive milestones</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<div><strong>Age</strong></div>\n</td>\n<td>\n<div><strong>Milestone</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>2 months</div>\n</td>\n<td>\n<div>Social smile</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>3 months</strong></div>\n</td>\n<td>\n<div><strong>Recognizes mother</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>6 months</div>\n</td>\n<td>\n<div>Stranger anxiety</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>9 months</div>\n</td>\n<td>\n<div>Waves bye-bye</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>12 months</div>\n</td>\n<td>\n<div>Comes when called</div>\n<div>Plays simple ball game</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>15 months</div>\n</td>\n<td>\n<div>Jargon</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>18&nbsp;months</div>\n</td>\n<td>\n<div>Copies parents in the task</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>2 years</div>\n</td>\n<td>\n<div>Asks for food, drink, toilet</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3 years</div>\n</td>\n<td>\n<div>Shares toys</div>\n<div>Knows full name and gender</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>4 years</div>\n</td>\n<td>\n<div>Plays cooperatively in a group and goes to the toilet alone</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>5 years</div>\n</td>\n<td>\n<div>Helps in household tasks and can dress and undress on its own</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Fine motor milestones</h3><table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Reaches out for objects with both hands (Bidextrous reach)</td>\n</tr>\n<tr>\n<td>\n<div>6 months</div>\n</td>\n<td>\n<div>Reaches out for objects with one hand (Unidextrous reach) and transfers objects</div>\n</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Immature pincer grasp</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>Mature pincer grasp</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>Imitates scribbling and builds a tower of 2 blocks</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Scribbles and builds a tower of 3 blocks</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Builds a tower of 6 blocks</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>Builds a tower of 9 blocks and copies a circle</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>Builds a bridge with blocks and copies a cross</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Copies a triangle and&nbsp;builds a gate with blocks</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4773a150d41047a29789e417bb2993e1x1280x936.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Language milestones</h3><div>\n<table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>1 month</td>\n<td>Alerts to sound</td>\n</tr>\n<tr>\n<td>2 months</td>\n<td>Coos (musical vowel sound)</td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Laughs aloud</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Monosyllables sounds (ma, ba)</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Bisyllables (mama, baba)</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>1-2 words with meaning</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>8-10 word vocabulary</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>2-3 word sentences (uses pronouns like I, me, you)</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>Asks questions and knows name and gender</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>Sings songs, poems and tells stories</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Asks meaning of words</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div><hr><h3>Related Pearl: Gross motor milestones</h3><table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>3 months</td>\n<td>Neck holding</td>\n</tr>\n<tr>\n<td>5 months</td>\n<td>Rolls over</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Sits with support</td>\n</tr>\n<tr>\n<td>8 months</td>\n<td>Sits without support</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Stands with support</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>\n<p>Stands without support</p>\n<p>Creeps well</p>\n<p>Walks but falls</p>\n</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>\n<p>Walks without support</p>\n<p>Creeps upstairs</p>\n</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Runs</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Walks upstairs and downstairs (2 feet/step)</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>\n<p>Walks upstairs with alternate foot</p>\n<p>Rides tricycle</p>\n</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>\n<p>Walks downstairs with alternate foot</p>\n<p>Hopping on 1 foot</p>\n</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Can skip without falling to either side</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5532",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following arteries are usually the branches of the mandibular part of the maxillary artery?<div class='question-desc-html'><ol>\n<li>Middle meningeal</li>\n<li>Masseteric artery</li>\n<li>Infra-orbital artery</li>\n<li>Inferior alveolar</li>\n<li>Deep auricular </li>\n<li>Anterior tympanic arteries.</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 4, 5, 6"
        },
        {
          "id": 2,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 3,
          "text": "2, 3, 4, 6"
        },
        {
          "id": 4,
          "text": "1, 3, 5, 6"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Branches from the <strong>mandibular division</strong> of the <strong>maxillary artery</strong>:</p>\n<ol>\n<li>Middle meningeal</li>\n<li>Inferior alveolar</li>\n<li>Deep auricular </li>\n<li>Anterior tympanic arteries</li>\n</ol>\n<p>The <strong>masseteric artery</strong> is a branch of the <strong>pterygoid part</strong>, and the <strong>infra-orbital artery</strong> is a branch of the <strong>pterygopalatine part.</strong></p><hr><h3>Related Pearl: Divisions of Maxillary Artery and Its Branches</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a2303ab13e0649d5b993147ad8be02c9x1280x1346.JPEG\" alt=\"Pearl Image\"><p><strong>1st part/Mandibular part:</strong>&nbsp;</p>\n<ul>\n<li>Extend - Neck of the mandible to lower border of Lateral pterygoid</li>\n<li>Common Pattern - All branches from this part enter the bone.</li>\n<li>Branches\n<ul>\n<li>middle meningeal,</li>\n<li>accessory meningeal,</li>\n<li>inferior alveolar,</li>\n<li>deep auricular&nbsp;</li>\n<li>anterior tympanic arteries.</li>\n</ul>\n</li>\n</ul>\n<p><strong>2nd part/Pterygoid part</strong>:</p>\n<ul>\n<li>Location - In the infratemporal fossa</li>\n<li>Common Pattern - All are muscular branches.</li>\n<li>Branches\n<ul>\n<li>Artery to lateral pterygoid,</li>\n<li>medial pterygoid,</li>\n<li>Masseteric artery</li>\n<li>2 deep temporal arteries.</li>\n</ul>\n</li>\n</ul>\n<p><strong>3rd part/Pterygopalatine part</strong>:</p>\n<ul>\n<li>Location - pterygopalatine fossa</li>\n<li>Branches\n<ul>\n<li>Artery of pterygoid canal,</li>\n<li>Infra-orbital artery,</li>\n<li>Greater palatine,</li>\n<li>Sphenopalatine artery,</li>\n<li>pharyngeal artery,</li>\n<li>posterior superior alveolar artery.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5603",
      "difficulty": "hard"
    },
    {
      "text": "The absence of fetal pole in a gestational sac of diameter 35mm would be termed as",
      "choices": [
        {
          "id": 1,
          "text": "Threatened miscarriage"
        },
        {
          "id": 2,
          "text": "Missed abortion"
        },
        {
          "id": 3,
          "text": "Incomplete abortion"
        },
        {
          "id": 4,
          "text": "Silent miscarriage"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>absence of a fetal pole</strong> in a <strong>gestational sac of diameter 35mm</strong> would be termed as a <strong>blighted ovum/ silent miscarriage</strong></p>\n<p><strong>Blighted ovum</strong> (<strong>silent miscarriage</strong>) occurs&nbsp;<strong>when a fertilized egg implants in the uterus but doesn't develop into an embryo.&nbsp;</strong>It is a sonographic diagnosis where there is an absence of a fetal pole in a gestational sac with a diameter of 3 cm or more.</p><hr><h3>Related Pearl: Clinical classification of Spontaneous Abortion</h3><table>\n<tbody>\n<tr>\n<td><strong>Clinical type</strong></td>\n<td><strong>Description</strong>/<strong> Clinical picture</strong></td>\n<td><strong>USG/ Investigations</strong></td>\n</tr>\n<tr>\n<td><strong>Threatened&nbsp;</strong></td>\n<td>\n<div class=\"page\" title=\"Page 373\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bloody vaginal discharge or bleeding</p>\n<p><strong>Closed</strong> cervical os</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 374\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Gestational sac/&nbsp;pseudo-gestational sac present</p>\n<p>Fetal cardiac activity present</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Inevitable&nbsp;</strong></td>\n<td>\n<div class=\"page\" title=\"Page 375\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Gush of vaginal fluid or bleeding</p>\n<p>Cramping or fever</p>\n<p><strong>Dilated</strong> cervical os</p>\n<p>Gross rupture of membranes</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>Low lying sac</p>\n<p>Oligohydramnios</p>\n</td>\n</tr>\n<tr>\n<td><strong>Incomplete&nbsp;</strong></td>\n<td>\n<div class=\"page\" title=\"Page 375\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Vaginal bleeding</p>\n<p>Partial or complete placental separation</p>\n<p><strong>Dilated</strong> cervical os</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>Retained products of conception</p>\n</td>\n</tr>\n<tr>\n<td><strong>Complete&nbsp;</strong></td>\n<td>\n<div class=\"page\" title=\"Page 375\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Heavy vaginal bleeding with cramps</p>\n<p>Complete placental separation with the passage of tissue or a fetus&nbsp;</p>\n<p><strong>Closed</strong> cervical os</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 375\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Minimally thickened endometrium</p>\n<p>Gestational sac absent</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong><strong>Missed /</strong></strong><strong>early pregnancy failure or loss</strong></td>\n<td>\n<div class=\"page\" title=\"Page 375\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dead products of conception that were retained for days, weeks or months in the uterus</p>\n<p><strong>Closed</strong> cervical os</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 375\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Large anechoic sac consistent with an anembryonic gestation</p>\n<p><strong>Serial&nbsp;&beta;-hCG</strong> assays</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Septic</strong>&nbsp;</td>\n<td>\n<div class=\"page\" title=\"Page 375\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 375\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Pelvic infection and sepsis syndrome</p>\n<p>Seen in 1-2% of women with threatened or incomplete miscarriage</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>&nbsp;-</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5634",
      "difficulty": "hard"
    },
    {
      "text": "What is the time taken for peak response in IgM-mediated immune response?",
      "choices": [
        {
          "id": 1,
          "text": "2-3 Days"
        },
        {
          "id": 2,
          "text": "2-3 Weeks"
        },
        {
          "id": 3,
          "text": "5-7 Days"
        },
        {
          "id": 4,
          "text": "7-10 Days"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Primary immune response is IgM mediated. This peaks at 7-10 Days.&nbsp;</p>\n<p>An <strong>immune response</strong>&nbsp;occurs as a result of an antigenic stimulus.&nbsp;It is of two types: Humoral or antibody-mediated response, and cellular or cell-mediated response. The response to the antigenic stimulus can be primary or secondary. The features of the primary and secondary immune responses are:</p>\n<table>\n<tbody>\n<tr>\n<td>Features</td>\n<td>Primary immune response</td>\n<td>Secondary immune response</td>\n</tr>\n<tr>\n<td>1. Lag period</td>\n<td>4-10 days</td>\n<td>\n<p>1-3 days</p>\n</td>\n</tr>\n<tr>\n<td>2. Peak response time&nbsp;</td>\n<td><strong>7-10 days</strong></td>\n<td>\n<p>3-5 days</p>\n</td>\n</tr>\n<tr>\n<td>3. Antibody response&nbsp;</td>\n<td>Depends on the antigen</td>\n<td>More potent than the primary immune response</td>\n</tr>\n<tr>\n<td>4. Isotype generate</td>\n<td><strong>IgM</strong></td>\n<td>IgG</td>\n</tr>\n<tr>\n<td>5. Antigens</td>\n<td>Both thymus-dependent and independent</td>\n<td>Depends only on the thymus</td>\n</tr>\n<tr>\n<td>6. Antibody affinity</td>\n<td><strong>Lower</strong></td>\n<td><strong>Higher</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5509",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following depicts the life cycle of Diphyllobothrium latum?",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Image 1 corresponds to the life cycle of&nbsp;<em>Diphyllobothrium latum</em>.</p>\n<p><strong><em>Diphyllobothrium latum</em>&nbsp;</strong>infection is acquired by eating raw or undercooked fish, containing third-stage <strong>plerocercoid larva</strong>. The organism usually causes <strong>diphyllobothriasis </strong>(transient abdominal discomfort, diarrhea, nausea, weakness, weight loss)&nbsp;and <strong>vitamin B12 deficiency&nbsp;</strong>by absorbing large quantities of&nbsp;vitamin B12&nbsp;and interfering with the ileal absorption.</p>\n<div class=\"page\" title=\"Page 139\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Definitive hosts: Man, dog, and cat;&nbsp;<strong>Man</strong> is the optimal host.</li>\n<li>First intermediate host: <em><strong>Cyclops</strong></em> or <em>Diaptomus</em></li>\n<li>Second intermediate host: <strong>Freshwater fish</strong> (<strong>salmon</strong>, trout, etc.).</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p>Treatment for <em>D. latum</em> infection is<strong>&nbsp;Praziquantel</strong>.</p>\n<p>The image below shows the life cycle of&nbsp;<em>Diphyllobothrium latum</em>:&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3fbfb1d2841a443aba784298c77a8e67x720x561.PNG\" alt=\"Explanation Image\"><p><em><strong>Paragonimus westermani</strong></em>&nbsp;(lung fluke) infection is acquired by consuming <strong>freshwater crab/crayfish</strong>&nbsp;containing metacercariae. It&nbsp;causes pulmonary symptoms similar to pulmonary tuberculosis (<strong>coughing and hemoptysis</strong>).</p>\n<ul>\n<li><strong>Definitive host</strong>: Man,&nbsp;cats, tigers, leopards, foxes, dogs, pigs, beavers, and domestic animals</li>\n<li>First intermediate host:&nbsp;<strong>Freshwater snail</strong></li>\n<li>Second intermediate host:&nbsp;<strong>Freshwater crab</strong>&nbsp;or crayfish</li>\n</ul>\n<div class=\"page\" title=\"Page 178\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The&nbsp;<strong>adult</strong>&nbsp;<strong>worms</strong>&nbsp;live in the&nbsp;<strong>respiratory tract</strong>&nbsp;of the definitive host in&nbsp;<strong>cystic spaces</strong>&nbsp;surrounded by a fibrous capsule formed by the host tissues. Unembryonated eggs escape into the bronchi and are coughed up and voided in sputum or swallowed and passed in feces.</p>\n<p><strong>Praziquantel</strong> (25 mg/kg TDS for 1&ndash;2 days) is the drug of choice.</p>\n<p>The given image shows the life cycle of&nbsp;<em>Paragonimus westermani</em>:</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f6a840f7261f4b29b43c096320075246x519x435.GIF\" alt=\"Explanation Image\"><p><strong><em>Fasciola hepatica</em>&nbsp;</strong>is a&nbsp;<strong>liver fluke</strong>&nbsp;that resides in the liver and the lumen of the biliary passages and causes <strong>fascioliasis</strong>. It mainly affects sheep and other <strong>domestic</strong> <strong>animals</strong>. Infection in sheep and man is acquired by ingestion of <strong>metacercariae</strong> encysted on<strong> aquatic vegetation</strong>.</p>\n<div class=\"page\" title=\"Page 169\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Definitive host: <strong>Sheep</strong>, goat, cattle, and man.</li>\n<li>Intermediate host: <strong>Snails</strong> of the genus <em><strong>Lymnaea</strong></em> and <em><strong>Succinea</strong></em>. Encystment occurs on <strong>aquatic plants</strong>, which act as the second intermediate host.</li>\n</ul>\n<div class=\"page\" title=\"Page 170\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Oral <strong>triclabendazole</strong> (10 mg/kg once) is the treatment of choice</p>\n<p>Life cycle of <em>Fasciola hepatica:</em></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fff369912ec649c296a3296acdb7cc54x568x435.GIF\" alt=\"Explanation Image\"><p><em><strong>Brugia malayi </strong></em>causes filariasis in <strong>man</strong>. The&nbsp;intermediate hosts of <em>Brugia</em> are vectors of genera <em><strong>Mansonia</strong></em>, <em>Anopheles</em>, and <em>Aedes</em>. In India, the main vectors are <em>Mansonia annulifera</em> and&nbsp;<em>Mansonia</em>&nbsp;<em>uniformis</em>.</p>\n<div class=\"page\" title=\"Page 232\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Diethylcarbamazine</strong> is the drug of choice. It is given orally in a dose of 6 mg/kg body weight daily, for a period of 12 days.</p>\n<p>Life cycle of <em>Brugia malayi:</em></p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a1eb8354b0d74fedaa354fcf5626f9f1x496x416.GIF\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Definitive and intermediate hosts of various parasites</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Parasite</strong></p>\n</td>\n<td>\n<p><strong>Definitive host</strong></p>\n</td>\n<td>\n<p><strong>Intermediate host</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Protozoa</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasmodium spp.</p>\n</td>\n<td>\n<p>Female Anopheles mosquito</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Babesia</p>\n</td>\n<td>\n<p>Tick</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leishmania</p>\n</td>\n<td>\n<p>Man, dog</p>\n</td>\n<td>\n<p>Sandfly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trypanosoma brucei</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Tsetse fly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trypanosoma cruzi</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Triatomine bug</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Toxoplasma gondii</p>\n</td>\n<td>\n<p>Cat</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cestodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Taenia solium</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Pig</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Taenia saginata</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Cattle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Echinococcus granulosus</p>\n</td>\n<td>\n<p>Dog</p>\n</td>\n<td>\n<p>Sheep, horses.</p>\n<p>Man is the accidental intermediate host.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Trematodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fasciola hepatica</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fasciolopsis buski</p>\n</td>\n<td>\n<p>Man, pig</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Schistosoma spp.</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nematodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trichinella spiralis</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Pig</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Wuchereria bancrofti</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Mosquito</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Brugia malayi</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Mosquito</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dracunculus medinensis</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Cyclops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/09fb2d7919c345299f4b8c791f34c0ac.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5511",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following structures pass through the marked foramen?<div class='question-desc-html'><ol>\n<li>Inferior petrosal sinus</li>\n<li>Spinal accessory nerve</li>\n<li>Vagus nerve</li>\n<li>Hypoglossal nerve</li>\n<li>Middle meningeal branch of the occipital artery</li>\n<li>Deep petrosal nerve</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, 5, & 6"
        },
        {
          "id": 2,
          "text": "1, 2, 3, & 5"
        },
        {
          "id": 3,
          "text": "1, 2,  4 & 6"
        },
        {
          "id": 4,
          "text": "2, 3, 4, & 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The marked foramen is the <strong>jugular foramen.</strong>&nbsp;Option B is the correct answer. The&nbsp;structures passing through it are as follows:</p>\n<ol>\n<li>Inferior petrosal sinus</li>\n<li>Meningeal branch of ascending pharyngeal artery</li>\n<li>Glossopharyngeal Nerve - IX</li>\n<li>Vagus Nerve - X&nbsp;</li>\n<li>Spinal Accessory Nerve - XI</li>\n<li>Sigmoid Sinus continuing as internal jugular vein</li>\n<li>Middle meningeal branch of the occipital artery</li>\n</ol>\n<p>&nbsp;The <strong>hypoglossal nerve</strong> passes via the <strong>hypoglossal canal</strong>.</p>\n<p>The deep petrosal nerve carries postganglionic sympathetic fibers from the pterygopalatine ganglion. It then joins with the <strong>greater petrosal nerve</strong> to form the nerve of the&nbsp;<strong>pterygoid</strong> (<strong>Vidian</strong>) <strong>canal.</strong>&nbsp;</p><hr><h3>Related Pearl: Structures passing through skull foramina</h3><table>\n<tbody>\n<tr>\n<td><strong>Opening</strong></td>\n<td><strong>Transmits</strong></td>\n</tr>\n<tr>\n<td><strong>Optic canal</strong></td>\n<td>\n<ul>\n<li>Optic nerves</li>\n<li>Ophthalmic arteries</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Superior orbital fissure</strong></td>\n<td>\n<ul>\n<li>Lacrimal nerve (V1)</li>\n<li>Frontal nerve (V1)</li>\n<li>Nasociliary nerve (V1)</li>\n<li>CNs III, IV, VI</li>\n<li>Superior ophthalmic vein</li>\n<li>Inferior ophthalmic vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen rotundum</strong></td>\n<td>\n<ul>\n<li>Maxillary division of CN V (V2)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen ovale</strong></td>\n<td>\n<ul>\n<li><strong>M</strong>andibular division of CN V (V3)</li>\n<li><strong>A</strong>ccessory meningeal artery</li>\n<li><strong>L</strong>esser petrosal nerve</li>\n<li><strong>E</strong>missary veins</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen spinosum</strong></td>\n<td>\n<ul>\n<li>Middle meningeal artery</li>\n<li>Nervus spinosus</li>\n<li>Middle meningeal vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen lacerum</strong></td>\n<td>\n<ul>\n<li>Deep petrosal nerve</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>Emissary vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Carotid canal</strong></td>\n<td>\n<ul>\n<li>Internal carotid artery</li>\n<li>Venous and sympathetic plexus around artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Jugular foramen</strong></td>\n<td>\n<ul>\n<li>Inferior petrosal sinus</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>CNs IX,X &amp; XI</li>\n<li>Sigmoid Sinus continuing as IJV&nbsp;</li>\n<li>Middle meningeal branch of occipital artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Hypoglossal canal</strong></td>\n<td>\n<ul>\n<li>Hypoglossal nerve (CN XII)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen magnum</strong></td>\n<td>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li class=\"ng-binding\">Osseo-ligamentous (anterior) compartment:&nbsp;\n<ul>\n<li>Apical ligament and tip of dens</li>\n<li>Upper band of cruciate ligament</li>\n<li>Membrana tectoria</li>\n</ul>\n</li>\n<li>Neuro-vascular (posterior)&nbsp;compartment:\n<ul>\n<li>Lower end of the medulla oblongata with meninges</li>\n<li>Fourth part of vertebral artery surrounded by sympathetic plexus of nerves</li>\n<li>Spinal roots of accessory nerves</li>\n<li>Anterior and posterior spinal arteries</li>\n<li>Tonsil of cerebellum.</li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n<div class=\"ng-scope\">&nbsp;</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59dee8c948d642d8b7e732620bd2e2a7x600x1522.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Origins of cranial nerves at the base of the brain</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/521c0fb7637a49bc98549d02ec59d22dx600x618.JPEG\" alt=\"Pearl Image\"><p>Cranial nerve origins as seen in gross anatomy:</p>\n<ul>\n<li>III cranial nerve: Midbrain at the level of the superior colliculus. &nbsp;</li>\n<li>IV cranial nerve: Midbrain at the level of inferior colliculus - the only nerve the <strong>exits from the dorsal aspect</strong></li>\n<li>V cranial nerve: The substance of pons&nbsp;</li>\n<li>VI, VII, and VIII cranial nerves:&nbsp; Pontomedullary junction</li>\n<li>IX, X, and XI cranial nerves(nucleus ambiguus): Posterolateral sulcus&nbsp; &nbsp;</li>\n<li>XII cranial nerve: Anterolateral sulcus (between pyramid and olive)</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/026d9e203cbf403582341ba0903d3914.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5604",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions warrants treatment with oral corticosteroids?",
      "choices": [
        {
          "id": 1,
          "text": "Chronic Plaque Psoriasis"
        },
        {
          "id": 2,
          "text": "Erythrodermic Psoriasis"
        },
        {
          "id": 3,
          "text": "Psoriatic Arthritis"
        },
        {
          "id": 4,
          "text": "Impetigo Herpetiformis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The&nbsp;<strong>only indication</strong>&nbsp;for using&nbsp;<strong>systemic</strong>&nbsp;steroids in psoriasis is generalized pustular psoriasis in pregnancy (<strong>impetigo herpetiformis</strong>). In fact, the <strong>drug of choice</strong> for<strong> impetigo herpetiformis</strong>&nbsp;is <strong>systemic steroids</strong>.&nbsp;</p>\n<p><strong>Impetigo herpetiformis</strong> typically presents during the <strong>last trimester</strong> of pregnancy. It may persist until the delivery of the child; however, it may even persist longer. Clinical features include the following:</p>\n<ul>\n<li>Characteristic <strong>erythematous patches</strong> with marginal grouped <strong>sterile</strong> pustules</li>\n<li><strong>Flexures</strong> affected, symmetrical</li>\n<li><strong>Centrifugal</strong> extension from the inguino-genital region</li>\n<li>Grouping of areas of pustulation</li>\n<li><strong>Erosions</strong> and <strong>crusts</strong> may be present</li>\n<li>Residual <strong>reddish-brown pigmentation</strong> as healing occurs.</li>\n<li>Nail, mucosal lesions in tongue, mouth, and oesophagus</li>\n<li>May be associated with hypothyroidism and hypocalcemia</li>\n</ul>\n<p>The mainstay of treatment is <strong>systemic corticosteroids</strong>. If the patient is unresponsive to corticosteroids, <strong>cyclosporine</strong> may also be started. <strong>Antibiotics</strong>&nbsp;like cephalosporins are found to be effective as an <strong>additive</strong> treatment, even though the pustules are sterile. <strong>Narrowband UVB</strong> is considered another safe treatment when there is no adequate response to steroids.</p>\n<p>Complications like IUGR, PROM, and placental insufficiency are also seen. Death of the mother may occur due to cardiac or renal failure.&nbsp;<strong>Recurrence</strong> is common.</p><hr><h3>Related Pearl: Drug of choice for different types of psoriasis</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Drug of choice</strong></td>\n</tr>\n<tr>\n<td>Chronic Plaque Psoriasis</td>\n<td>Methotrexate</td>\n</tr>\n<tr>\n<td>Erythrodermic Psoriasis</td>\n<td>Methotrexate&nbsp;</td>\n</tr>\n<tr>\n<td>Psoriatic Arthritis</td>\n<td>Methotrexate / Apremilast</td>\n</tr>\n<tr>\n<td>Pustular Psoriasis</td>\n<td>Acitretin</td>\n</tr>\n<tr>\n<td>Psoriasis in HIV patients</td>\n<td>Acitretin</td>\n</tr>\n<tr>\n<td>Impetigo Herpetiformis</td>\n<td>\n<p>1. Systemic Corticosteroids</p>\n<p>2. Cyclosporine</p>\n</td>\n</tr>\n<tr>\n<td>Erythrodermic Psoriasis in Pregnancy</td>\n<td>Systemic Corticosteroids&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5613",
      "difficulty": "medium"
    },
    {
      "text": "Cardiac edema and neuropathy are seen to be present in a patient with suspected nutritional deficiency.  Which of the following biochemical assays would you advise?",
      "choices": [
        {
          "id": 1,
          "text": "RBC glutathione reductase"
        },
        {
          "id": 2,
          "text": "RBC Trans-ketolase"
        },
        {
          "id": 3,
          "text": "RBC transaminase"
        },
        {
          "id": 4,
          "text": "Glucose-6-phosphate dehydrogenase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Cardiac edema and neuropathy</strong> are associated with a deficiency of <strong>thiamine (vitamin B1).&nbsp;</strong>Measurement of <strong>erythrocyte</strong>&nbsp;<strong>transketolase&nbsp;</strong>provides an index of&nbsp;<strong>vitamin B1&nbsp;nutritional status</strong>.&nbsp;</p>\n<p><strong>Thiamine diphosphate (Vit B1)</strong>&nbsp;is the&nbsp;<strong>cofactor</strong> of <strong>transketolase</strong> which is <span>involved in the <strong>pentose phosphate pathway</strong></span>, <span><strong>pyruvate dehydrogenase </strong></span><span>which is </span><span>involved </span><span>in <strong>carbohydrate metabolism</strong></span><span>, </span><span><strong>&alpha;-ketoglutarate dehydrogenase</strong> which is involved </span><span>in the <strong>citric acid cycle</strong></span><span>, and </span><strong><span>branched-chain keto acid </span></strong><span><strong>dehydrogenase</strong> which is involved </span><span>in the <strong>metabolism of leucine, isoleucine, and valine.</strong></span></p>\n<p><strong>Wet beriberi (cardiac)</strong> is associated with tachycardia, cardiomegaly, cardiac failure, and edema. It is commonly seen in the&nbsp;<strong>refugee camps</strong>&nbsp;where people consume&nbsp;<strong>polished rice</strong>-based monotonous diets. Diagnosis of thiamine deficiency can be established by&nbsp;<strong>erythrocyte transketolase</strong>&nbsp;activity assessment.</p>\n<p><strong>Dry beriberi</strong> is associated with neurological deficits such as peripheral neuropathy, optic atrophy, ataxia, and irritability. Complications include&nbsp;<strong>lactic acidosis</strong>&nbsp;and Wernicke encephalopathy in adults.</p><hr><h3>Related Pearl: Biochemical Assay for Vitamin Deficiency State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Assay and test</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B1 (Thiamine)</p>\n</td>\n<td>\n<p>RBC Trans-ketolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B2 (Riboflavin)</p>\n</td>\n<td>\n<p>RBC glutathione reductase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 (Pyridoxine)</p>\n</td>\n<td>\n<p>RBC transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B9 (Folic acid)</p>\n</td>\n<td>\n<p>FIGLU excretion/Histidine load test</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B12 (Cobalamine)</p>\n</td>\n<td>\n<p>Serum methyl malonate level</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5484",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following infants would not be considered high risk as per the NACO guidelines?",
      "choices": [
        {
          "id": 1,
          "text": "An infant born to HIV-positive mother who is not on ART"
        },
        {
          "id": 2,
          "text": "An infant born to a mother with maternal viral load not done after 32 weeks of pregnancy"
        },
        {
          "id": 3,
          "text": "An infant born to a mother with maternal viral load not suppressed after 32 weeks of pregnancy"
        },
        {
          "id": 4,
          "text": "An infant born to a mother who is newly identified as HIV-positive 11 weeks after delivery"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>An infant born to a mother who is <strong>newly</strong> identified as <strong>HIV-positive</strong> <strong>within 6 weeks of delivery </strong>should be considered as<strong> high risk</strong>,<strong>&nbsp;</strong>as per the <strong>NACO guidelines.</strong></p>\n<p>&nbsp;High-risk infants include</p>\n<ul>\n<li>infants born to HIV-positive mothers who are not on ART</li>\n<li>maternal viral load not done after 32 weeks of pregnancy</li>\n<li>maternal viral load not suppressed after 32 weeks of pregnancy</li>\n<li>mother is newly identified HIV-positive within 6 weeks of delivery</li>\n</ul>\n<p>Low-risk infants are infants born to mothers with suppressed viral load (&lt;1000 copies/mL) done any time after 32 weeks of pregnancy up to delivery</p>\n<p>According to the National AIDS Control Organization (NACO),<strong> antiretroviral therapy </strong>(ART) should be given to <strong>all pregnant women,</strong> including during labor hours and breastfeeding. They are started on a <strong>triple-drug ART</strong>. ART should be given irrespective of the CD4 count and clinical stage, and treatment should be continued lifelong.</p>\n<p>Immediate care of HIV-exposed infants includes wiping of baby's mouth and nostrils, handling of infants with gloves, immediate cord clamping, and initiation of feeding.&nbsp;An infant born to an HIV-positive mother should be <strong>breastfed exclusively</strong> or by <strong>replacement feeds</strong> exclusively for <strong>6 months</strong> of age.</p>\n<p>Infants should receive <strong>ARV prophylaxis.</strong>&nbsp;A single drug or dual drug regimen is followed depending on the risk of transmission, which can be low or high risk.</p>\n<ul>\n<li><strong>Low-risk infants</strong> are those born to mothers with a low viral load which is detected after 32 weeks of pregnancy till delivery.&nbsp;</li>\n<li><strong>High-risk infants</strong> are those born to HIV-positive mothers, not on ART, with viral load not estimated beyond 32 weeks, viral load not suppressed after 32 weeks, or diagnosed with HIV within 6 weeks of delivery.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>HIV Risk&nbsp;</strong></td>\n<td><strong>ARV prophylaxis</strong></td>\n<td><strong>Duration</strong></td>\n</tr>\n<tr>\n<td>Low-risk infants</td>\n<td><strong>Syrup nevirapine or Syrup zidovudine</strong><br /><br /></td>\n<td>Birth to <strong>6 weeks</strong> of age <strong>irrespective of feeding&nbsp;</strong></td>\n</tr>\n<tr>\n<td>High-risk infants</td>\n<td><strong>Syrup nevirapine + syrup zidovudine</strong></td>\n<td>\n<p><strong>If exclusive replacement feeding: Birth to 6 weeks</strong></p>\n<p>If exclusive breastfeeding: Birth till 12 weeks&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5498",
      "difficulty": "easy"
    },
    {
      "text": "A 10-year-old boy presents with fever, joint pain, and a lesion over his hand, as seen in the image below. Histopathological examination would most likely reveal?",
      "choices": [
        {
          "id": 1,
          "text": "Perimysial CD4+ cellular infiltrates, perivascular infiltrates and perifascicular atrophy"
        },
        {
          "id": 2,
          "text": "Endomysial CD8+ cellular infiltrates  and perivascular infiltrates"
        },
        {
          "id": 3,
          "text": "Perivascular infiltrates with amyloid inclusion bodies and rimmed vacuoles"
        },
        {
          "id": 4,
          "text": "Perimysial CD8+ cellular infiltrates with amyloid inclusion bodies and rimmed vacuoles"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given scenario, the patient has arthritis and skin lesions pointing to<strong> Gottron's papules </strong>and highly suggestive of<strong> dermatomyositis. </strong><strong>Perimysial CD4+</strong> cellular infiltrates, perivascular infiltrates, and <strong>perifascicular</strong> atrophy are characteristic histopathological findings that would be seen in this condition.</p>\n<p><strong>Dermatomyositis</strong> (DM) is an autoimmune disorder predominantly affecting the <strong>skin</strong> and <strong>skeletal muscle</strong>. The following are various manifestations of dermatomyositis:</p>\n<ul>\n<li><strong>Gottron's papules</strong>: Violaceous, erythematous papules overlying the dorsal interphalangeal or metacarpophalangeal, elbow, or knee joints, as shown in the image below</li>\n<li><strong>Gottron's sign</strong>: Symmetric, non-scaling, violaceous, erythematous macules or plaques, often atrophic, in the same distribution as Gottron's papules.</li>\n<li><strong>Shawl sign/V-sign: </strong>Fixed macular erythema across the shoulders and outer arms(Shawl distribution)</li>\n<li><strong>Periungual telangiectasias: </strong>Dilated capillaries of the nail folds</li>\n<li><strong>Mechanic's hand:</strong> Roughening and cracking of the skin of the tips and sides of the fingers, resulting in irregular, dirty-appearing lines that resemble those of a mechanic or manual labourer</li>\n<li>Proximal myopathy: Patients have trouble performing everyday activities like climbing stairs, getting up, and lifting their arms above their heads.</li>\n<li>Less common manifestations include: Facial swelling, malignancy, erythroderma, lichen planus</li>\n</ul>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>Laboratory evaluation of patients with dermatomyositis will reveal <strong>elevated serum creatinine kinase</strong> and <strong>antinuclear antibodies</strong>. Electromyography will reveal features of myopathy. Histology will show <strong>perifascicular atrophy.</strong> Immunohistochemical staining will reveal <strong>myxovirus resistance protein A</strong>, a sensitive and specific marker. </p>\n<p>Treatment of dermatomyositis includes:</p>\n<ul>\n<li>Immunotherapy with <strong>high-dose glucocorticoids</strong> - first-line drug</li>\n<li><strong>Methotrexate</strong> - <strong>second-line</strong> drug. Indications include -\n<ul>\n<li>When a patient presents with severe weakness or other organ system involvement</li>\n<li>Patients with a risk of steroid complications, like patients with diabetes, osteoporosis, or postmenopausal women</li>\n<li>Patients who do not show improvement after 2-4 months of treatment with prednisone or those who cannot be maintained on a low dose </li>\n</ul>\n</li>\n<li><strong>Triple therapy</strong> with <strong>intravenous immunoglobulin </strong>or<strong> rituximab</strong> may be required</li>\n</ul>\n</div>\n</div><hr><h3>Related Pearl: Antibodies in Dermatomyositis</h3><ul>\n<li><strong>Anti-Mi2 antibodies</strong> (directed against a helicase implicated in nucleosome remodeling) show a strong association with prominent Gottron papules and heliotrope rash.</li>\n<li><strong>Anti-Jo1 antibodies</strong> (directed against the enzyme histidyl t-RNA synthetase) are associated with interstitial lung disease, nonerosive arthritis, and a skin rash described as &ldquo;mechanic&rsquo;s hands.&rdquo;</li>\n<li><strong>Anti-P155/P140 antibodies</strong> (directed against several transcriptional regulators) are associated with paraneoplastic and juvenile cases of dermatomyositis.</li>\n</ul><hr><h3>Related Pearl: Inflammatory myopathy</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Dermatomyositis</strong></td>\n<td><strong>Polymyositis</strong></td>\n<td><strong>Inclusion Body Myositis</strong></td>\n</tr>\n<tr>\n<td>Age of onset</td>\n<td>Adulthood and childhood</td>\n<td>&gt;18 years</td>\n<td>&gt;50 years  </td>\n</tr>\n<tr>\n<td>Familial Association</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Skin Manifestation</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Muscle involvement</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Asymmetric</p>\n</td>\n</tr>\n<tr>\n<td>Histopathological Findings</td>\n<td>\n<p><strong>Perimysial</strong> <strong>CD4+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates and <strong>perifascicular atrophy</strong></p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates </p>\n<p>Perivascular infiltrates  </p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates with amyloid inclusion bodies and rimmed vacuoles   </p>\n</td>\n</tr>\n<tr>\n<td>Association with connective tissue disease</td>\n<td>Scleroderma and mixed connective tissue only</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Association with other autoimmune diseases</td>\n<td>Infrequent</td>\n<td>Frequent</td>\n<td> Infrequent</td>\n</tr>\n<tr>\n<td>Association with malignancy</td>\n<td>Yes (breast, ovarian, lung) and ILD</td>\n<td> Yes (incidence much lesser than dermatomyositis)</td>\n<td> No</td>\n</tr>\n<tr>\n<td>Immunotherapy</td>\n<td> Responsive</td>\n<td> Responsive</td>\n<td> Resistant</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5ada624d71d247a191ec2f2ca3d3f97a.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5612",
      "difficulty": "medium"
    },
    {
      "text": "What is the action of the muscle supplied by the structure marked in the image?",
      "choices": [
        {
          "id": 1,
          "text": "Extorsion, abduction, depression"
        },
        {
          "id": 2,
          "text": "Intorsion, adduction, elevation"
        },
        {
          "id": 3,
          "text": "Intorsion, abduction, depression"
        },
        {
          "id": 4,
          "text": "Extorsion, adduction, elevation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The arrow in the given image shows the&nbsp;<strong>trochlear nerve (CN IV)</strong>. It is identified easily as it is the <strong>only cranial nerve to emerge from the dorsal surface of the brainstem.&nbsp;</strong>It supplies the&nbsp;<strong>superior oblique muscle</strong><strong>.&nbsp;</strong>The actions carried out by the superior oblique muscle are <strong>intorsion, depression, and abduction.&nbsp;</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/20a5f71341754bf6bf0e4e8fd32c9831x1280x1196.JPEG\" alt=\"Explanation Image\"><ul>\n<li><strong>Lateral rectus</strong> is supplied by the <strong>abducens nerve</strong>&nbsp;(CN VI).</li>\n<li><strong>Medial rectus and inferior oblique</strong>&nbsp;are supplied by the&nbsp;<strong>oculomotor nerve (CN III).</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5e381c4e2d724dd08a1a52835556093ax1280x1688.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Structures passing through skull foramina</h3><table>\n<tbody>\n<tr>\n<td><strong>Opening</strong></td>\n<td><strong>Transmits</strong></td>\n</tr>\n<tr>\n<td><strong>Optic canal</strong></td>\n<td>\n<ul>\n<li>Optic nerves</li>\n<li>Ophthalmic arteries</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Superior orbital fissure</strong></td>\n<td>\n<ul>\n<li>Lacrimal nerve (V1)</li>\n<li>Frontal nerve (V1)</li>\n<li>Nasociliary nerve (V1)</li>\n<li>CNs III, IV, VI</li>\n<li>Superior ophthalmic vein</li>\n<li>Inferior ophthalmic vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen rotundum</strong></td>\n<td>\n<ul>\n<li>Maxillary division of CN V (V2)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen ovale</strong></td>\n<td>\n<ul>\n<li><strong>M</strong>andibular division of CN V (V3)</li>\n<li><strong>A</strong>ccessory meningeal artery</li>\n<li><strong>L</strong>esser petrosal nerve</li>\n<li><strong>E</strong>missary veins</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen spinosum</strong></td>\n<td>\n<ul>\n<li>Middle meningeal artery</li>\n<li>Nervus spinosus</li>\n<li>Middle meningeal vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen lacerum</strong></td>\n<td>\n<ul>\n<li>Deep petrosal nerve</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>Emissary vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Carotid canal</strong></td>\n<td>\n<ul>\n<li>Internal carotid artery</li>\n<li>Venous and sympathetic plexus around artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Jugular foramen</strong></td>\n<td>\n<ul>\n<li>Inferior petrosal sinus</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>CNs IX,X &amp; XI</li>\n<li>Sigmoid Sinus continuing as IJV&nbsp;</li>\n<li>Middle meningeal branch of occipital artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Hypoglossal canal</strong></td>\n<td>\n<ul>\n<li>Hypoglossal nerve (CN XII)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen magnum</strong></td>\n<td>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li class=\"ng-binding\">Osseo-ligamentous (anterior) compartment:&nbsp;\n<ul>\n<li>Apical ligament and tip of dens</li>\n<li>Upper band of cruciate ligament</li>\n<li>Membrana tectoria</li>\n</ul>\n</li>\n<li>Neuro-vascular (posterior)&nbsp;compartment:\n<ul>\n<li>Lower end of the medulla oblongata with meninges</li>\n<li>Fourth part of vertebral artery surrounded by sympathetic plexus of nerves</li>\n<li>Spinal roots of accessory nerves</li>\n<li>Anterior and posterior spinal arteries</li>\n<li>Tonsil of cerebellum.</li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n<div class=\"ng-scope\">&nbsp;</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59dee8c948d642d8b7e732620bd2e2a7x600x1522.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Extraocular Muscles and Their Actions</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0bb7d5876bda4f169609e47a0090c446x1280x3287.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f5174c28481a4e95a7ab824e3ecae9a3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5538",
      "difficulty": "medium"
    },
    {
      "text": "While explaining the side effects of sulfasalazine to a patient with rheumatoid arthritis, you would be correct to mention all of the following, except _____.",
      "choices": [
        {
          "id": 1,
          "text": "In males, it decreases the number and motility of sperm in a reversible manner."
        },
        {
          "id": 2,
          "text": "Most common side effects are headache, dyspepsia and skin rash."
        },
        {
          "id": 3,
          "text": "In females, it does not cause any impairment of fertility."
        },
        {
          "id": 4,
          "text": "It does not cross the placenta, but harms the fetus due to impaired folate absorption."
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Sulfasalazine <strong>crosses</strong> the placenta, but has <strong>not</strong> been shown to <strong>harm the fetus.&nbsp;</strong>It is associated with impaired <strong>intestinal</strong> folate absorption, because of which it is generally administered with folate.</p>\n<p><strong>Sulfasalazine</strong> is a prodrug. In the distal GI tract, it is metabolized to 5-aminosalicylic acid (<strong>5-ASA</strong>)&nbsp;and <strong>sulfonamide</strong>. Oral sulfasalazine is effective in patients with mild or moderately active <strong>ulcerative colitis. </strong>It is also used as add-on therapy in the case of <strong>moderate to severe rheumatoid arthritis</strong>.&nbsp;</p>\n<p><strong>Adverse effects</strong> of sulfasalazine:</p>\n<ul>\n<li><strong>Headache, dyspepsia, and skin rash</strong> are the <strong>most common</strong> side effects.&nbsp;</li>\n<li>Side effects of sulfasalazine are mostly related to the <strong>sulfa moiety</strong>. <strong>Allergic reactions</strong> include:\n<ul>\n<li>Rash</li>\n<li>Fever</li>\n<li>Stevens-Johnson syndrome</li>\n<li>Hepatitis</li>\n<li>Pneumonitis</li>\n<li>Hemolytic anemia</li>\n<li>Bone marrow suppression</li>\n</ul>\n</li>\n<li>Sulfasalazine <strong>reversibly decreases</strong> the <strong>number and motility of sperm</strong> but does <strong>not impair female fertility. </strong></li>\n<li>Sulfasalazine inhibits intestinal folate absorption and is usually administered with folate.</li>\n<li>Nephrotoxicity may rarely be seen. So, <strong>renal function</strong>&nbsp;monitoring is recommended&nbsp;in all patients receiving it.</li>\n<li>Though sulfasalazine and its metabolites <strong>cross the placenta</strong>, they have <strong>not</strong> been shown to <strong>harm the fetus</strong>.</li>\n</ul><hr><h3>Related Pearl: Important drugs for rheumatoid arthritis</h3><p><strong>1) NSAIDs - </strong>analgesic and anti-inflammatory, used as <strong>adjunctive</strong> for management of uncontrollable <strong>symptoms</strong> and in acute <strong>flares.</strong></p>\n<p dir=\"ltr\"><strong>2) Glucocorticoids - </strong>used in acute <strong>flare</strong> for rapid control and as <strong>initial therapy</strong> before the onset of action of DMARDs. Chronic administration of low doses is needed in patients with inadequate response to DMARDs.</p>\n<ul>\n<li dir=\"ltr\">\n<p>Prednisolone - oral</p>\n</li>\n<li dir=\"ltr\">\n<p>Triamcinolone - intraarticular<br /> </p>\n</li>\n</ul>\n<p><strong><span>3) DMARDs - </span></strong><span>disease-modifying anti-rheumatoid drugs:</span></p>\n<p> </p>\n<p><strong>- Conventional DMARDs:</strong></p>\n<ul>\n<li dir=\"ltr\">Methotrexate (MTX)- is an antifolate drug. The DMARD of <strong>choice</strong> and the anchor drug for combination therapy. Regular <strong>LFT</strong> monitoring is required.</li>\n<li dir=\"ltr\">Hydroxychloroquine- is used as <strong>monotherapy</strong> for <strong>early</strong> and <strong>mild</strong> disease and in combination with other DMARDs for severe cases.</li>\n<li dir=\"ltr\">Sulfasalazine- is a salicylate. It <strong>reduces</strong> the radiographic <strong>progression</strong> of the disease.</li>\n<li dir=\"ltr\">Leflunomide- is a pyrimidine synthase inhibitor used as an <strong>alternative</strong> to MTX.</li>\n</ul>\n<p><span><strong>- Biologicals:</strong></span></p>\n<ul>\n<li>TNF-α antagonists- used in combination with MTX. Has a risk of serious bacterial infections, opportunistic fungal infection &amp; reactivation of latent TB. The TNF-α inhibitors are <strong>adalimumab,</strong> golimumab, etanercept, infliximab, and certolizumab.</li>\n<li>Abatacept- a T-cell costimulation inhibitor, used in combination with MTX, leflunomide, etc.</li>\n<li>Rituximab- an <strong>anti-CD20</strong> antibody. Used in refractory disease in combination with MTX.</li>\n<li>Anakinra- an<strong> IL-1</strong> receptor <strong>antagonist</strong>. It should not be combined with anti-TNF alpha.</li>\n<li><strong>IL-6</strong> receptor <strong>antagonists</strong>- tocilizumab and sarilumab are used as monotherapy or combination therapy in moderate to severe disease.  </li>\n</ul>\n<p><span><strong>- Small molecules: </strong></span></p>\n<ul>\n<li>Janus kinase inhibitors: <strong>Tofacitinib</strong>, baricitinib, and upadacitinib are used as monotherapy or combination therapy.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5485",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following statements regarding monkey pox is false?",
      "choices": [
        {
          "id": 1,
          "text": "Patient needs to wear a triple layer mask during isolation."
        },
        {
          "id": 2,
          "text": "Contact monitoring must be done for a period of 21 days from day of contact."
        },
        {
          "id": 3,
          "text": "During ambulance transfer, the accompanying personnel should wear long-sleeved gowns, N95 Mask, gloves, and goggles."
        },
        {
          "id": 4,
          "text": "It is caused by an enveloped, single-stranded DNA virus."
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>All the statements mentioned above are true about monkeypox, except that it is caused by an enveloped, single-stranded DNA virus.</p>\n<p><strong>Monkeypox</strong> is caused by an <strong>enveloped double-stranded DNA virus,</strong> which belongs to the <em>O</em><em>rthopoxvirus</em> genus of the Poxviridae family.</p>\n<p>The natural reservoir is unknown. The <strong>incubation period</strong> can range from<strong> 5 to 21 days</strong>. The period of communicability is 1–2 days prior to the onset of the rash until all scabs fall off/ subside. Both human-to-human and animal-to-human transmission is known to occur.</p>\n<p>People with monkeypox get a <strong>rash</strong> that may be located on or <strong>near the genitals</strong> (penis, testicles, labia, and vagina) or anus and could be on other areas like the hands, feet, chest, face, or mouth.</p>\n<p>At first, the rash may resemble acne or <strong>blister</strong> and may be <strong>painful</strong> or <strong>itchy</strong>. Before the rash heals, it will go through a number of stages, including <strong>scabs</strong>.</p>\n<p>The image given below shows the stages of the monkeypox lesion.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/71b0b57c0c8742fdb06d24d19c1796e6x851x560.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4900b4b22e4e4d78bf03c065c706bde9x506x539.PNG\" alt=\"Explanation Image\"><p>Other signs and symptoms of monkeypox include fever with chills, enlarged lymph nodes, back, and muscle aches, headache, and respiration symptoms like sore throat, nasal congestion, or cough.</p>\n<p>Management includes patient isolation, protection of compromised skin and mucous membranes, rehydration therapy, and nutritional support.</p>\n<p><strong>Patient Isolation</strong></p>\n<ul>\n<li>Isolate the patient in a room with separate ventilation.</li>\n<li>The patient should <strong>wear a triple-layer mask</strong>.</li>\n<li>Cover skin lesions as much as possible, with measures such as using long sleeves and long pants, to minimize the risk of contact.</li>\n<li>Continue isolation until all lesions resolve and scabs completely fall off.</li>\n</ul>\n<p><strong>Contact monitoring</strong></p>\n<ul>\n<li>Contact monitoring must be done for a period of <strong>21 days</strong> from the day of contact.</li>\n<li>Asymptomatic exposed health workers do not need to be excluded from work but should be under active surveillance for 21 days.</li>\n</ul>\n<p>During <strong>ambulance transfer,</strong> accompanying personnel should wear<strong> long-sleeved gowns, N95 masks, gloves,</strong> and<strong> goggles</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5659",
      "difficulty": "easy"
    },
    {
      "text": "An incidentally found Meckel's diverticulum can be left alone if",
      "choices": [
        {
          "id": 1,
          "text": "it has a wide mouth and is not thickened"
        },
        {
          "id": 2,
          "text": "it has a narrow mouth and is not thickened"
        },
        {
          "id": 3,
          "text": "it has a narrow mouth and is thickened"
        },
        {
          "id": 4,
          "text": "it has a wide mouth and is thickened"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>If an incidentally found Meckel's diverticulum has a <strong>wide mouth </strong>and is <strong>not thickened, </strong>it can safely be <strong>left alone.</strong></p>\n<p> When Meckel's diverticulum is found in the course of abdominal surgery,</p>\n<ul>\n<li>In cases of <strong>narrow-mouthed</strong>, thickened Meckel’s diverticulum, <strong>resection</strong> of the diverticulum is the treatment of choice.</li>\n<li>If it has a <strong>wide mouth </strong>and is <strong>not thickened, </strong>it can safely be <strong>left alone.</strong></li>\n</ul>\n<p>As there is the risk of stricture and of leaving heterotopic epithelium behind, a broad-based Meckel’s diverticulum should not be amputated at its base and invaginated like the procedure done for an appendix. The diverticulum should be <strong>excised</strong> either by resecting it and suturing the defect at its base or with a linear stapler-cutter.</p>\n<p>Rarely, Meckel's diverticulum is <strong>complicated</strong> by a <strong>meso-diverticular</strong> <strong>band</strong>, which is believed to be a remnant of a vitelline artery. In such <strong>symptomatic</strong> cases, the treatment is <strong>diverticulectomy </strong>with the<strong> removal of associated bands</strong> connecting the diverticulum to the abdominal wall or intestinal mesentery.</p>\n<div class=\"page\" title=\"Page 1191\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Segmental resection of the ileum</strong> that includes both the diverticulum and the adjacent ileal peptic ulcer should be performed if</p>\n<ul>\n<li> There is bleeding from the diverticulum,</li>\n<li> The base is inflamed or perforated, and/or</li>\n<li> The diverticulum contains a tumor.</li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5570",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding varenicline?",
      "choices": [
        {
          "id": 1,
          "text": "It is an antagonist at α4β2 receptor"
        },
        {
          "id": 2,
          "text": "It interacts with nicotinic ACh receptors"
        },
        {
          "id": 3,
          "text": "Its use is associated with mood and behavioral changes"
        },
        {
          "id": 4,
          "text": "It is useful in decreasing craving"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Varenicline</strong> is a <strong>partial agonist</strong> at the&nbsp;<strong>&alpha;4&beta;2 receptor,</strong> not an antagonist.</p>\n<p><strong>Nicotine</strong> is the principal constituent of tobacco responsible for its addictive behavior. One of the newest agents introduced to aid in smoking cessation is <strong>varenicline</strong>.</p>\n<p>Varenicline works by blocking the effects of nicotine on the brain. It <strong>blocks</strong> &alpha;-4, &beta;-2 <strong>nicotinic acetylcholine receptor</strong> subtypes.</p>\n<p>It&nbsp;<strong>inhibits dopaminergic activation</strong> produced by smoking through its&nbsp;<strong>partial agonism</strong>&nbsp;and&nbsp;<strong>decreases the craving</strong> and withdrawal syndrome that occurs with cessation attempts. It prevents nicotine stimulation of the mesolimbic dopamine system associated with nicotine addiction, thus helping to occlude the \"rewarding\" effect of smoking.</p>\n<p>Varenicline is prescribed only to patients 18 years or older. Varenicline is taken orally at a starting dose of 0.5 mg once daily on days 1 to 3, which is increased to 0.5 mg twice daily on days 4 through 7, followed by 1 mg twice daily after day 8 for 11 weeks. Therapy should start one week before the target quit date. It can be continued for another 12 weeks (1 mg BD) to maintain abstinence.</p>\n<p>The adverse effects include nausea, which can be mitigated by starting at lower doses and gradually increasing the dose. Other symptoms include disturbed sleep, sleepwalking, agitation, drowsiness, and constipation; it may also increase the risk of pancreatitis. Varenicline has also been implicated in specific skin syndromes such as <strong>Stevens-Johnson&nbsp;syndrome</strong>, erythema multiforme, and photosensitivity. Varenicline can cause renal failure and kidney stones, and therefore, renal function must be monitored.</p>\n<p>The FDA has issued a warning about <strong>mood</strong> and <strong>behavioral changes</strong> associated with its use, and there is some evidence of <strong>increased cardiovascular risk.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5585",
      "difficulty": "medium"
    },
    {
      "text": "A patient who is set to travel to a typhoid endemic region in 10 days seeks your advice on vaccination. What should you recommend?",
      "choices": [
        {
          "id": 1,
          "text": "Vi Polysaccharide vaccine"
        },
        {
          "id": 2,
          "text": "Ty21a Vaccine"
        },
        {
          "id": 3,
          "text": "Either Vi Polysachharide vaccine or Ty21a Vaccine"
        },
        {
          "id": 4,
          "text": "Ask the patient to delay the travel plan, as both vaccines need at least 28 days for conferring protection"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Vi Polysaccharide vaccine</strong> should be recommended for this patient as it requires <strong>only one injectable dose</strong> and <strong>confers protection 7 days after the injection.&nbsp;</strong></p>\n<p><strong>Vi Polysaccharide vaccine</strong> is composed of purified Vi capsular polysaccharide from the Ty2 Typhi strain. The vaccine is administered <strong>subcutaneously or intramuscularly</strong>. It is <strong>licensed</strong> for use in <strong>ages &gt;2 years</strong>. <strong>Revaccination</strong> is recommended <strong>every 3 years</strong> to maintain protection.</p>\n<p>This vaccine can be <strong>co-administered</strong> with other vaccines relevant for international travelers, such as <strong>yellow fever and hepatitis A</strong>, as well as with vaccines of the <strong>routine childhood immunization</strong> programs.</p>\n<p><strong>Ty21a</strong> is a <strong>live-attenuated oral</strong> vaccine for individuals &ge;5 years of age. The regimen is 1st, 3rd, and 5th day - 3 doses. Here, <strong>protective immunity</strong> is achieved <strong>7 days after the last dose&nbsp;</strong>(i.e. 5+7 = 12th Day).</p>\n<p>Repeat doses are recommended every 3 years for endemic areas, and every year for traveling individuals.&nbsp;<strong>Not recommended</strong> in:</p>\n<ul>\n<li>Patients on antimitotic drugs and immunosuppressants</li>\n<li>Acute febrile illness</li>\n<li>Acute intestinal infestation</li>\n<li>Congenital or acquired immunodeficiency</li>\n</ul>\n<p>Ty21a vaccine can be administered in an HIV-positive <strong>asymptomatic patient</strong> as long as the <strong>CD4+ count is &gt;200/ cubic mm.&nbsp;</strong>Proguanil and antibacterial drugs should be stopped <strong>from 3 days before to 3 days after the vaccine.&nbsp;&nbsp;</strong>The vaccine is unlikely to be effective if it is administered at the time of ongoing diarrhea.</p><hr><h3>Related Pearl: Types of Vaccines</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Vaccines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Live attenuated</p>\n<p>(<strong>M</strong>ost<strong>&nbsp;</strong><strong>B</strong>eautiful&nbsp;<strong>P</strong>lace&nbsp;<strong>I</strong>n&nbsp;<strong>T</strong>he <strong>W</strong>orld<strong>&nbsp;</strong>-<strong> ROME)</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>M</strong>umps</p>\n<p><strong>B</strong>CG</p>\n<p><strong>P</strong>lague</p>\n<p><strong>I</strong>nfluenza (cold-adapted)</p>\n<p><strong>T</strong>yphoid (oral)</p>\n<p>Yello<strong>W&nbsp;</strong>fever</p>\n<p><strong>R</strong>ubella and&nbsp;<strong>R</strong>otavirus</p>\n<p><strong>O</strong>ral Polio (Sabin)</p>\n<p><strong>M</strong>easles</p>\n<p>Japanese&nbsp;<strong>E</strong>ncephalitis</p>\n<p>Varicella</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Killed whole organism</p>\n<p>(<strong>RIP</strong> <strong>ACE</strong>)</p>\n</td>\n<td>\n<p><strong>R</strong>abies</p>\n<p><strong>I</strong>nfluenza</p>\n<p><strong>P</strong>olio (IPV, Salk)</p>\n<p>Hep <strong>A</strong></p>\n<p><strong>C</strong>holera</p>\n<p><strong>E</strong>ncephalitis</p>\n<p>Typhoid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Toxoid/Protein</p>\n</td>\n<td>\n<p>Diphtheria</p>\n<p>Tetanus</p>\n<p>Acellular Pertussis</p>\n<p>Anthrax</p>\n<p>Influenza subunit&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Polysaccharide</p>\n</td>\n<td>\n<p>Pneumococcus</p>\n<p>Meningococcus</p>\n<p>Hemophilus influenza type b (Hib)</p>\n<p>Typhoid (Vi)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Glycoconjugate</p>\n</td>\n<td>\n<p>Hib</p>\n<p>Pneumococcus</p>\n<p>MenACWY(meningococcal vaccine)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Recombinant</p>\n</td>\n<td>\n<p>Hepatitis B vaccine</p>\n<p>Lyme disease</p>\n<p>Cholera toxin B</p>\n<p>HPV&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5500",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is false regarding Ewing's sarcoma?",
      "choices": [
        {
          "id": 1,
          "text": "Histopathological examination would reveal Homer-Wright rosettes."
        },
        {
          "id": 2,
          "text": "It has a slight female predominance."
        },
        {
          "id": 3,
          "text": "Immunohistochemistry is positive for synaptophysin and mic-2."
        },
        {
          "id": 4,
          "text": "X-Ray shows characteristic onion-skin appearance."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ewing's</strong> sarcoma has a slight <strong>male</strong> preponderance.</p>\n<p>Ewing's sarcoma<strong> </strong>is the <strong>2nd most common</strong> bone sarcoma in children. The majority of the patients affected are usually <strong>&lt;20 years</strong> of age. It has a slight <strong>male</strong> predominance. </p>\n<p>It commonly involves the <strong>diaphysis</strong> of the <strong>long bones</strong>, like the <strong>femur</strong>,<strong> tibia</strong>, fibula, and humerus, and <strong>flat bones</strong> of the <strong>pelvis</strong>. The majority of Ewing's sarcomas have a balanced translocation between the <em>EWSR1</em> gene on <strong>chromosome 22</strong> and the <em>FLI1</em> gene on <strong>chromosome 11</strong>. </p>\n<p>Patients present with <strong>painful enlarging mass</strong>, fever, and anemia. The affected area is usually tender, swollen, and warm. Laboratory findings may show an elevated WBC count and erythrocyte sedimentation rate (ESR). </p>\n<p>A histopathological examination of Ewing's sarcoma shows sheets of<strong> uniform, round cells </strong>arranged in<strong> Homer-Wright rosettes.</strong><strong> </strong>These cells are of neuroectodermal origin and have minimal cytoplasm and abundant glycogen. When they are arranged around a central fibrillary core in the form of clusters, the appearance is termed <strong>Homer-Wright rosettes. </strong>Immunohistochemistry is usually positive for<strong> synaptophysin </strong>and<strong> mic-2.</strong></p>\n<p>Given below is the histopathological appearance of Ewing's sarcoma. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9003f86ee1384b5c938b3096d52cc98cx1280x960.JPEG\" alt=\"Explanation Image\"><p>The tumor cells stain positive for periodic acid–Schiff (<strong>PAS</strong>) stain, as they are rich in <strong>glycogen, </strong>but they stain negatively for <strong>reticulin</strong>.</p>\n<p>The image given below shows PAS staining done in Ewing's sarcoma:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6a40fa82d61e43fe834545ba3e782885x1279x1048.JPEG\" alt=\"Explanation Image\"><p>Radiological examination of Ewing's sarcoma shows a destructive lesion in the <strong>diaphysis</strong> of long bones. Deposition of <strong>periosteal reaction</strong> in layers gives an <strong>onion-peel </strong>appearance (shown below). </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f99343856f124715846432a4a29e62b6x720x1363.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Classical Radiological Appearance of Bone Tumors</h3><table>\n<tbody>\n<tr>\n<td><strong>RADIOLOGICAL APPEARANCE&nbsp;</strong></td>\n<td>\n<p><strong>TUMORS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sunray appearance / Codman&rsquo;s triangle</p>\n</td>\n<td>\n<p>Osteosarcoma (but can be seen in any malignant lesion)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Onion peel appearance&nbsp;</p>\n</td>\n<td>\n<p>Ewing&rsquo;s sarcoma (but can be seen in any malignant lesion or chronic osteomyelitis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Soap bubble appearance&nbsp;</p>\n</td>\n<td>\n<p>Giant cell tumor, adamantinoma&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ground glass appearance / Shepherd's</p>\n<p>crook deformity&nbsp;</p>\n</td>\n<td>\n<p>Fibrous dysplasia&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Patchy calcification&nbsp;</p>\n</td>\n<td>\n<p>Chondrogenic tumors (chondrosarcoma and chondroblastoma)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Popcorn, punctate or comma-shaped calcification</p>\n</td>\n<td>\n<p>Chondrosarcoma&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stippled or Punctate calcification</p>\n</td>\n<td>\n<p>Chondroblastoma&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homogeneous calcification&nbsp;</p>\n</td>\n<td>\n<p>Osteogenic tumors (osteosarcoma)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fallen fragment / Trap door sign</p>\n</td>\n<td>\n<p>Simple bone cyst</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Double-density fluid levels and intra-lesional septation</p>\n</td>\n<td>\n<p>Aneurysmal bone cyst</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Winking owl sign</p>\n</td>\n<td>\n<p>Vertebral metastasis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polka dot sign / Corduroy / Jailhouse sign</p>\n</td>\n<td>\n<p>Vertebral hemangioma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Moth eaten bone</p>\n</td>\n<td>\n<p>Multiple myeloma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Summary of Bone Tumors</h3><table>\n<tbody>\n<tr>\n<td><strong>Bone tumor</strong></td>\n<td><strong>Most common site</strong></td>\n<td><strong>Age</strong></td>\n</tr>\n<tr>\n<td>Simple bone cyst</td>\n<td>Proximal Humeral Metaphysis</td>\n<td>&lt;20years</td>\n</tr>\n<tr>\n<td>Enchondroma</td>\n<td>\n<p>Hand bones</p>\n<p>(Metaphysis of small bones of hand)</p>\n</td>\n<td>\n<p>4<sup>th</sup>&nbsp;&amp; 5<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteochondroma</p>\n<p>(Exostosis)</p>\n</td>\n<td>Distal Femoral Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteoid osteoma</td>\n<td>Diaphysis of Femur</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>Osteoblastoma</td>\n<td>Posterior column of vertebra</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteoclastoma (GCT)</p>\n</td>\n<td>Distal femoral epiphysis</td>\n<td>\n<p>2<sup>nd</sup> -4<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>Aneurysmal Bone Cyst</td>\n<td>Long bone Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteosarcoma</td>\n<td>Distal Femoral Metaphysis</td>\n<td>\n<p>BIMODAL</p>\n<p>Primary- 2<sup>nd</sup> Decade Secondary-6<sup>th</sup> and 7<sup>th</sup> Decade</p>\n</td>\n</tr>\n<tr>\n<td>Ewings sarcoma</td>\n<td>Diaphysis of Femur</td>\n<td>5-25 years</td>\n</tr>\n<tr>\n<td>Chondrosarcoma</td>\n<td>Any site in the bone - mc in proximal femur</td>\n<td>3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Clear cell chondrosarcoma</td>\n<td>Proximal femoral epiphysis</td>\n<td>&nbsp;3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Adamantinoma</td>\n<td>Diaphysis of Tibia</td>\n<td>&nbsp;20-40 years</td>\n</tr>\n<tr>\n<td>&nbsp;Fibrous dysplasia</td>\n<td>&nbsp;The upper end of femur &gt; tibia</td>\n<td>&nbsp;1st to 3rd decade</td>\n</tr>\n<tr>\n<td>&nbsp;Chordoma</td>\n<td>&nbsp;Sacrum</td>\n<td>&nbsp;5th to 7th decade</td>\n</tr>\n<tr>\n<td>Multiple myeloma</td>\n<td>Vertebrae</td>\n<td>5th to 7th decade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5645",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are new components that have been added to the MELD 3.0 scoring system except<div class='question-desc-html'><p>MELD- Model for end-stage liver disease</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Female sex as a variable"
        },
        {
          "id": 2,
          "text": "Serum albumin as a variable"
        },
        {
          "id": 3,
          "text": "An upper bound for creatinine at 3.0 mg/dL."
        },
        {
          "id": 4,
          "text": "Serum bilirubin as a variable"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Serum bilirubin</strong> as a variable was <strong>present</strong> even in the <strong>previously recommended MELDNa scoring system.</strong></p>\n<p>The Model for End-Stage Liver Disease (MELD) is used as an indicator of short-term survival in patients with end-stage liver disease, and to determine organ allocation priorities for liver transplantation. According to the <strong>previous model, MELDNa</strong>, the <strong>components</strong> of the scoring system were:</p>\n<ul>\n<li>Serum creatinine</li>\n<li>Serum bilirubin</li>\n<li>Serum sodium, and</li>\n<li>INR (international normalized ratio)</li>\n</ul>\n<p>The <strong>updated MELD 3.0</strong> scoring system has made the following major changes: </p>\n<ul>\n<li>Additional variables of female sex and serum albumin,</li>\n<li>Interactions between bilirubin and sodium and between albumin and creatinine, and</li>\n<li>An upper bound for creatinine at 3.0 mg/dL</li>\n</ul>\n<p>The addition of these two components and certain adjustments made in the other components has led to a better scoring system. MELD 3.0 allows for a <strong>more accurate prediction of mortality</strong> than the previous MELDNa scoring system. An important improvement is that it addresses factors that can affect wait-list outcomes such as <strong>sex disparity</strong>. MELD 3.0 is able to <strong>correctly reclassify</strong> almost 9% of <strong>patients </strong>to a<strong> higher MELD tier,</strong> giving them a much <strong>better chance of transplantation,</strong> particularly in women. </p>\n<p>It is estimated that almost 20 waitlist deaths can be reduced per year with the new MELD 3.0 scoring system.</p><hr><h3>Related Pearl: Revised Model for End-stage liver disease  (MELD) scoring system: MELD 3.0</h3><p>MELD 3.0 score has the following components (Mnemonic <strong>F BASIC</strong>)</p>\n<ul>\n<li>Female sex</li>\n<li>Bilirubin</li>\n<li>Albumin</li>\n<li>Serum sodium (mEq/L)</li>\n<li>INR (International Normalized ratio)</li>\n<li>Creatinine</li>\n</ul>\n<p><strong>Uses:</strong></p>\n<ul>\n<li>Predict short-term prognosis in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) insertion</li>\n<li>Assess and <strong>prioritize patients</strong> awaiting <strong>liver transplantation</strong></li>\n<li>Assess prognosis in cirrhosis</li>\n</ul>\n<p class=\"bulletIndent1\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5680",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following suture materials retains its tensile strength in vivo for the longest duration?",
      "choices": [
        {
          "id": 1,
          "text": "Plain catgut"
        },
        {
          "id": 2,
          "text": "Chromic catgut"
        },
        {
          "id": 3,
          "text": "Polyglyconate"
        },
        {
          "id": 4,
          "text": "Polyglactin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Amongst the given suture materials, polyglyconate retains its tensile strength&nbsp;in vivo for the longest duration.&nbsp;</p>\n<p>&nbsp;</p>\n<p>Absorbable suture materials:</p>\n<table>\n<tbody>\n<tr>\n<td>Suture</td>\n<td>Types</td>\n<td>Raw material</td>\n<td>Uses</td>\n<td>Absorption Rate</td>\n<td>Contraindications</td>\n</tr>\n<tr>\n<td><strong>Catgut</strong></td>\n<td><strong>Plain</strong></td>\n<td>Collagen from healthy sheep or cattle</td>\n<td>Ligate superficial vessels ,suture subcutaneous tissue ,stomas and other tissuses that heal rapidly.</td>\n<td>\n<p><strong>7-10 days</strong></p>\n<p>Phagocytosis and enzymatic degradation</p>\n</td>\n<td>Not used for tissuses that heal slowly and require prolonged support.</td>\n</tr>\n<tr>\n<td><strong>Catgut</strong></td>\n<td><strong>Chromic</strong></td>\n<td>Tanned with chromium salts</td>\n<td>As for plaingut</td>\n<td>\n<p><strong>90 days</strong></p>\n<p>Phagocytosis and enzymatic degradation&nbsp;</p>\n</td>\n<td>Same as above</td>\n</tr>\n<tr>\n<td>Polydioxanone</td>\n<td>Monofilament</td>\n<td>Polyster polymer</td>\n<td>Uses as for other absorabable sutures ,in particular where slightly longer wound support is required.</td>\n<td>Hydrolysis minimal at 8-9 weeks complete by 180 days</td>\n<td>Not for use in association with heart valves or synthetic grafts or in situation in which prolonged tissue approximation under stress is require.</td>\n</tr>\n<tr>\n<td>Polyglycolic acid (dexon)</td>\n<td>Multifilament&nbsp;</td>\n<td>Polymer of polyglycolic acid</td>\n<td>Uses as for other absorable sutures , in particular where slightly longer wound support is required.</td>\n<td>Hydrolysis minimal at 2 weeks;significant at 4 weeks;complete by 60-90 days</td>\n<td>Not used when prolonged tissue approximation under stress is required. &nbsp;</td>\n</tr>\n<tr>\n<td>Polyglactin (vicryl)</td>\n<td>Multifilament</td>\n<td>Copolymer of glycolide and lactide in ratio 90:10</td>\n<td>\n<p>Has become the workhorse suture for many applications in most general surgical practices ,including undyed for subcuticular wound closure , opthalmic surgery.</p>\n</td>\n<td>Hydrolysis minimal until 5-6 weeks;&nbsp;<strong>complete by 60-90 days</strong></td>\n<td>Not used when prolonged tissue approximation under stress is required.</td>\n</tr>\n<tr>\n<td>Polyglyconate</td>\n<td>Monofilament</td>\n<td>Copolymer of glycolic acid and trimethylene carbonate</td>\n<td>Popular in some centers as an alternative to vicryl</td>\n<td>Hydrolysis minmal at 8-9 weeks; <strong>Complete by 180 days</strong></td>\n<td>Not used when prolonged tissue approximation under stress is required. &nbsp;</td>\n</tr>\n<tr>\n<td>Polyglycaprone</td>\n<td>Monofilament</td>\n<td>Copolymer of glycolite and caprolactone</td>\n<td>&nbsp;Subcuticular in skin ligation,gastrointestinal and muscle surgery</td>\n<td>90-120 days</td>\n<td>Not used in extended support</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Suture materials</h3><table>\n<tbody>\n<tr>\n<td><strong>Suture</strong></td>\n<td><strong>Types</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p class=\"p1\"><strong>Absorbable&nbsp;</strong><strong>suture materials</strong></p>\n</td>\n</tr>\n<tr>\n<td>Catgut</td>\n<td>Plain/Chromic</td>\n<td>\n<p class=\"p1\">Ligate superficial vessels</p>\n<p class=\"p1\">Suture subcutaneous tissues, stomas and other tissues that heal rapidly</p>\n</td>\n</tr>\n<tr>\n<td>Polyglactin (Vicryl)</td>\n<td>Braided multifilament</td>\n<td>\n<p class=\"p1\">Gut and biliary anastomoses</p>\n<p class=\"p1\">Vascular ligatures</p>\n<p class=\"p1\">Kidney and ureter surgeries.</p>\n<p class=\"p1\">Subcuticular wound</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Polydioxanone</p>\n</td>\n<td>\n<p class=\"p1\">Monofilament</p>\n<p class=\"p1\">Dyed or&nbsp;undyed</p>\n</td>\n<td>\n<p class=\"p1\">Used in tissues where slightly longer wound support is required</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Poliglecaprone (Monocryl)</p>\n</td>\n<td>Monofilament</td>\n<td>\n<p class=\"p1\">Subcuticular suturing of skin</p>\n<p class=\"p1\">Soft tissue ligation</p>\n<p class=\"p1\">Gastrointestinal and muscle surgery</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\"><strong>Non-absorbable suture materials</strong></td>\n</tr>\n<tr>\n<td>Silk</td>\n<td>\n<p class=\"p1\">Braided or twisted multifilament</p>\n<p class=\"p1\">Coated (with wax or silicon) or uncoated</p>\n</td>\n<td>\n<p class=\"p1\">Ligation and suturing when long-term tissue support is necessary</p>\n<p class=\"p1\">For securing drains externally, two-layer bowel anastomoses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Surgical steel</p>\n</td>\n<td>\n<p class=\"p1\">Monofilament or multifilament</p>\n</td>\n<td>\n<p class=\"p1\">Closure of sternotomy wounds</p>\n</td>\n</tr>\n<tr>\n<td>Nylon</td>\n<td>\n<p class=\"p1\">Monofilament or braided multifilament</p>\n</td>\n<td>\n<p class=\"p1\">Skin closure</p>\n<p class=\"p1\">Abdominal wall closure</p>\n<p class=\"p1\">Hernia repair</p>\n<p class=\"p1\">Neurosurgery</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Polybutester</p>\n</td>\n<td>\n<p class=\"p1\">Monofilament</p>\n</td>\n<td>\n<p class=\"p1\">Exhibits elasticity. Favoured&nbsp;for use in plastic surgery</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p class=\"p1\">Polypropylene (Prolene)</p>\n</td>\n<td>Monofilament&nbsp;</td>\n<td>&nbsp;\n<p class=\"p1\">Cardiovascular surgery and vascular anastomosis&nbsp;</p>\n<p class=\"p1\">Plastic surgery</p>\n<p class=\"p1\">General surgical subcuticular skin closure</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5572",
      "difficulty": "hard"
    },
    {
      "text": "Artificial insemination is least likely to be useful in _______.",
      "choices": [
        {
          "id": 1,
          "text": "Oligospermia after sperm washout"
        },
        {
          "id": 2,
          "text": "Antispermal antibodies in the cervical mucus"
        },
        {
          "id": 3,
          "text": "Impotency or ejaculatory failure"
        },
        {
          "id": 4,
          "text": "Non-obstructive azoospermia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the given options, <strong>artificial insemination</strong> is <strong>least </strong>likely to be<strong> useful</strong> in <strong>non-obstructive azoospermia.</strong></p>\n<div class=\"page\" title=\"Page 490\">&nbsp;</div><hr><h3>Related Pearl: Indications for various procedures in Infertility treatment</h3><p><strong>Indications of artificial insemination with husband's semen</strong>:</p>\n<ul>\n<li>Chronic medical disorder</li>\n<li>Oligospermia after sperm washout</li>\n<li>Impotency or ejaculatory failure</li>\n<li>Premature ejaculation, retrograde ejaculation</li>\n<li>Hypospadias</li>\n<li>Antisperm&nbsp;antibodies in the cervical mucus</li>\n<li>Unexplained infertility</li>\n<li>Frozen sperm: If the husband needs to undergo radiotherapy or chemotherapy or is not available at the time of ovulation</li>\n<li>X&ndash;Y fractionation of sperms for sex selection, in a genetic and chromosomal abnormality</li>\n<li>HIV positive male or female</li>\n</ul>\n<p><strong>Indications for </strong>Intra-cytoplasmic sperm injection<strong> (ICSI) </strong>and&nbsp;gamete intra-fallopian transfer<strong> (GIFT)</strong>:</p>\n<ul>\n<li>Sperm count&nbsp;of less than 5 million/mL</li>\n<li>Absent or reduced sperm motility</li>\n<li>Abnormal sperm morphology</li>\n<li>Previous failed IVF</li>\n<li>Unexplained infertility</li>\n<li>Failure to penetrate zona by sperm as seen in IVF</li>\n</ul><hr><h3>Related Pearl: Causes of Male Infertility</h3><p><strong>Pre-testicular causes:</strong></p>\n<p>Endocrine cause</p>\n<ul>\n<li>Gonadotropin deficiency</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperprolactinemia</li>\n</ul>\n<p>Psychosexual</p>\n<ul>\n<li>Impotence</li>\n<li>Erectile dysfunction</li>\n</ul>\n<p>Drugs</p>\n<ul>\n<li>Antihypertensives</li>\n<li>Antipsychotics</li>\n</ul>\n<p>Genetics</p>\n<ul>\n<li>47XXY</li>\n<li>Y chromosome deletions</li>\n</ul>\n<p><strong>Testicular causes:</strong></p>\n<ul>\n<li>Immotile cilia syndrome</li>\n<li>Cryptorchidism</li>\n<li>Orchitis (mumps, Tb, gonorrhoea, traumatic)</li>\n<li>Toxins(Drugs,radiation)</li>\n<li>Primary testicular failure</li>\n<li>Sertoli cell-only syndrome</li>\n<li>Oligoasthenoteratozoospermia</li>\n</ul>\n<p><strong>Post-testicular causes:</strong></p>\n<p>Obstruction of efferent duct&nbsp;</p>\n<p>Congenital</p>\n<ul>\n<li>Absence of Vas deferens</li>\n<li>Youngs syndrome</li>\n</ul>\n<p>Acquired (Inflammatory block)</p>\n<ul>\n<li>Tuberculosis</li>\n<li>Gonorrhea</li>\n</ul>\n<p>Surgical</p>\n<ul>\n<li>Vasectomy</li>\n</ul>\n<p>Others</p>\n<ul>\n<li>Ejaculatory failure</li>\n<li>Bladder neck surgery</li>\n<li>Retrograde ejaculation&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5627",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements about sugammadex is false?",
      "choices": [
        {
          "id": 1,
          "text": "Sugammadex is a reversal agent for rocuronium and vecuronium."
        },
        {
          "id": 2,
          "text": "Sugammadex does not reverses the effect of succinylcholine."
        },
        {
          "id": 3,
          "text": "It is safe for use in patients with renal impairment"
        },
        {
          "id": 4,
          "text": "Side effects include dysgeusia and rarely hypersensitivity"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Sugammadex is essentially <strong>eliminated unchanged via the kidneys</strong>. It is <strong>not recommended</strong> for use in patients who have <strong>severe renal impairment. </strong></p>\n<p><strong>Sugammadex</strong> is a<strong> reversal agent </strong>for <strong>rocuronium</strong> and <strong>vecuronium. </strong>Sugammadex is a <strong>cyclodextrin. </strong>It is the first selective relaxant binding agent. It exerts its reversal effect by forming tight complexes in a 1:1 ratio with <strong>steroidal non-depolarizing agents</strong> (<strong>rocuronium &gt; vecuronium &gt;&gt; pancuronium</strong>). Since rocuronium is a steroidal agent, it is specifically bound by sugammadex.</p>\n<p>Sugammadex binds to plasma rocuronium and thus decreases the plasma concentration of rocuronium. This forms a concentration gradient of rocuronium due to which it moves from the neuromuscular junction back into the circulation where it is quickly bound by free sugammadex. </p>\n<p>Sugammadex is essentially <strong>eliminated unchanged</strong> via the kidneys. It is not recommended to be used in patients who have severe renal impairment. Side effects include dysgeusia and, rarely, hypersensitivity.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5607",
      "difficulty": "medium"
    },
    {
      "text": "A 21-year-old student presents with ocular redness, foreign body sensation, and excessive tearing, following the use of a contact lens. An interface contrast microscopy from his corneal scraping is shown below. Which of the following is false regarding the treatment of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Topical steroid therapy should be started immediately to prevent scarring"
        },
        {
          "id": 2,
          "text": "Debridement of epithelium is done to help penetration of eye drops"
        },
        {
          "id": 3,
          "text": "Topical polyhexamethylene biguanide (PHMB) and chlorhexidine are used"
        },
        {
          "id": 4,
          "text": "Oral NSAIDs can be administered for pain management"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical history of redness, watering and foreign body sensation in a contact lens wearer along with the demonstration of polygonal cysts in interface contrast microscopy are suggestive of <strong>amoebic keratitis</strong> caused by <strong>acanthamoeba. Topical steroids</strong> should be <strong>avoided</strong> if possible.</p>\n<p>If there is persistent inflammation even after 2 weeks after starting anti-amoebic treatment, low-dose steroid therapy may be useful. But, it is important to note that amoebicidal treatment should be continued in simultaneously with and for several weeks after steroids.</p>\n<p><em>Acanthamoeba</em> is an opportunistic protozoan pathogen. It exists as a <strong>trophozoite</strong> form and resistant <strong>cystic</strong> form. <strong>Both</strong> these forms are <strong>infective.</strong> The trophozoite is large and characterized by spine-like pseudopodia called acanthopodia.</p>\n<p>Human beings acquire the infection by <strong>inhalation</strong> of cysts or trophozoites, directly through traumatized <strong>skin</strong> or <strong>eyes</strong>, or <strong>ingestion</strong> of cysts.</p>\n<p>It chiefly presents as two chronic conditions:</p>\n<ul>\n<li><strong><em>Acanthamoeba</em> keratitis</strong></li>\n<li><strong>Granulomatous amoebic encephalitis</strong></li>\n</ul>\n<p><em>Acanthamoeba</em> keratitis is an infection of the eyes that typically develops from the entry of the amebic cyst through abrasions on the cornea. Most of the cases are associated with the use of contact lenses. </p>\n<p>Patients usually present with photophobia, <strong>excessive tearing, redness, </strong>and <strong>foreign body sensation</strong> and it can be<strong> bilateral in contact lens</strong> users.</p>\n<p>Diagnosis of amoebic keratitis is made by the demonstration of the cyst in corneal scrapings by wet mount, histology, and culture. The cysts are smaller (12–25 micrometer) and <strong>polygonal</strong> or star-shaped.</p>\n<p>Management:</p>\n<ul>\n<li><strong>Debridement</strong> of the involved epithelium may facilitate <strong>eye drop penetration</strong>.</li>\n<li>Administer topical <strong>biguanides or chlorhexidine,</strong> with or without diamidine agents.</li>\n<li>Oral NSAIDs can be used for pain management</li>\n<li>In severe cases, <strong>penetrating keratoplasty</strong> can be done.</li>\n</ul>\n<p>The below image shows the ring lesion seen in acanthamoeba keratitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/31760f83cf9745cface31b4d7e1bc0bbx720x488.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Clinical differential diagnosis of corneal ulcer</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Bacterial</strong></td>\n<td><strong>Fungal</strong></td>\n<td><strong>Viral</strong></td>\n<td><strong>Parasitic</strong></td>\n</tr>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td>\n<p>Contact lens wear</p>\n<p>Trauma</p>\n<p>Chronic steroid use</p>\n<p>Anesthetic cornea</p>\n<p>Dry eyes</p>\n<p>Exposure keratopathy</p>\n</td>\n<td>Trauma with<strong> vegetative matter</strong></td>\n<td>\n<p>Low immunity</p>\n<p>Recurrent attacks</p>\n</td>\n<td>\n<p>Contact lens wear</p>\n<p>Exposure to contaminated water (acanthamoeba)</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td>\n<p>Hypopyon is<strong> fluid and mobile</strong></p>\n<p><em><strong>Pseudomonas aeruginosa</strong> </em>is likely to have a <strong>rapid course,</strong> with deep corneal necrosis.</p>\n</td>\n<td>\n<p><strong>Less pain</strong> and watering compared to the extent of vision loss and signs.&nbsp;</p>\n<p>Tend to be <strong>indolent</strong> but <strong>progressive</strong></p>\n<p><strong>Hypopyon</strong> is <strong>thick</strong>, <strong>immobile.</strong></p>\n</td>\n<td>\n<p>Relatively <strong>more&nbsp;pain</strong> and watering compared to the extent of vision loss and signs.&nbsp;</p>\n<p><strong>Recurrences</strong> are characteristic.</p>\n</td>\n<td>\n<p><strong>Disproportionately severe pain</strong> is a characteristic feature.</p>\n<p><strong>Indolent course</strong> and in&nbsp;<strong>initial&nbsp;stages,&nbsp;</strong>often <strong>mistaken</strong> to be<strong>&nbsp;viral/ fungal infection,</strong> leading to a delay in diagnosis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Infective form and diagnostic forms of various protozoa</h3><table dir=\"ltr\"><colgroup><col /><col /><col /></colgroup>\n<tbody>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Parasite&quot;}\"><strong>Parasite</strong></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Infective form&quot;}\"><strong>Infective form</strong></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Diagnostic form&quot;}\"><strong>Diagnostic form</strong></td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Entamoeba histolytica&quot;}\"><em>Entamoeba histolytica</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Mature quadrinucleate cyst&quot;}\">Mature quadrinucleate cyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites, quadrinucleate cyst&quot;}\">Trophozoites, quadrinucleate cyst</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Giardia lamblia&quot;}\"><em>Giardia lamblia</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Quadrinucleate cyst&quot;}\">Quadrinucleate cyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites, cyst&quot;}\">Trophozoites, cyst</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trichomonas vaginalis&quot;}\"><em>Trichomonas vaginalis</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites&quot;}\">Trophozoites</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites&quot;}\">Trophozoites</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Naegleria fowleri&quot;}\"><em>Naegleria fowleri</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoite&quot;}\">Trophozoite</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoite in CSF&quot;}\">Trophozoite in CSF</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Acanthamoeba&quot;}\"><em>Acanthamoeba</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites and cysts&quot;}\">Trophozoites and cysts</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoite in CSF&quot;}\">Trophozoite in CSF</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Leishmania donovani &quot;}\"><em>Leishmania donovani</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Promastigote&quot;}\">Promastigote</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;amastigotes in macrophage&quot;}\">amastigotes in macrophage</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trypanosoma cruzi&quot;}\"><em>Trypanosoma cruzi</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Metacyclic Trypomastigote&quot;}\">Metacyclic Trypomastigote</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trypomastigote&quot;}\">Trypomastigote</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trypanosoma brucei&quot;}\"><em>Trypanosoma brucei</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Metacyclic Trypomastigote&quot;}\">Metacyclic Trypomastigote</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trypomastigote&quot;}\">Trypomastigote</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Balantidium coli&quot;}\"><em>Balantidium coli</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cysts&quot;}\">Cysts</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cysts&quot;}\">Cysts</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Plasmodium&quot;}\"><em>Plasmodium </em>spp.</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporozoites&quot;}\">Sporozoites</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Schizont, immature trophozoite, mature trophozoite, gametocyte&quot;}\">Schizont, immature trophozoite, mature trophozoite, gametocyte</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Babesia&quot;}\"><em>Babesia </em>spp.</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporozoites&quot;}\">Sporozoites</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Maltese cross form&quot;}\">Maltese cross form</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Toxoplasma gondii&quot;}\"><em>Toxoplasma gondii</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;All 3 morphological forms - oocyst, tachyzoite, bradyzoite&quot;}\">All 3 morphological forms - oocyst, tachyzoite, bradyzoite</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Tissue cysts&quot;}\">Tachyzoites, tissue cysts</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cryptosporidium&quot;}\"><em>Cryptosporidium parvum</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporulated oocyst&quot;}\">Sporulated oocyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporulated oocyst&quot;}\">Sporulated oocyst</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cyclospora&quot;}\"><em>Cyclospora cayetanensis</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporulated oocyst&quot;}\">Sporulated oocyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;unsporulated oocyst&quot;}\">unsporulated oocyst</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Isospora&quot;}\"><em>Isospora belli</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporulated oocyst&quot;}\">Sporulated oocyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;unsporulated oocyst&quot;}\">unsporulated oocyst</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3f8671b0a20c4293a8daced3fff88752.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5537",
      "difficulty": "hard"
    },
    {
      "text": "While prescribing which of the following antidiabetic drugs should you warn the patient about the risk of weight gain?",
      "choices": [
        {
          "id": 1,
          "text": "Metformin"
        },
        {
          "id": 2,
          "text": "Empagliflozin"
        },
        {
          "id": 3,
          "text": "Pramlintide"
        },
        {
          "id": 4,
          "text": "Glyburide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>While prescribing the antidiabetic drug<strong> glyburide</strong>, a <strong>sulfonylurea</strong>, the doctor should warn the patient about the risk of <strong>weight gain</strong>.</p>\n<p>By inhibiting the activity of a specific location on the<strong> β cell K <sub>ATP</sub> channel complex</strong> in the cell, <strong>sulfonylureas</strong> promote the release of insulin. Inhibiting K<sub>ATP</sub> channels results in <strong>cell membrane depolarization </strong>and the series of events that trigger the production of insulin.</p>\n<div class=\"page\" title=\"Page 880\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>First-generation sulfonylureas</strong>: tolbutamide, tolazamide, and chlorpropamide (rarely used now in the treatment of diabetes) </p>\n<div class=\"page\" title=\"Page 880\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Second-generation sulfonylureas</strong>: glyburide (glibenclamide), glipizide, and glimepiride</p>\n<div class=\"page\" title=\"Page 888\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Important side effects are <strong>hypoglycemia </strong>and<strong> weight gain</strong>. They can induce a disulfiram-like reaction.</p>\n<p><strong>Other options:</strong></p>\n<p>Option A:<strong> Metformin</strong> is considered <strong>weight neutral</strong>. Other advantages of this drug are that it does not cause hypoglycemia and is inexpensive. Side effects may include diarrhea, nausea, and lactic acidosis. Prolonged use leads to <strong>vitamin B12 deficiency.</strong></p>\n<p>Option B:<strong> Empagliflozin</strong> is an <strong>SGLT-2 inhibitor</strong> and is known to cause <strong>mild weight loss</strong>. It also causes blood pressure reduction and does not cause hypoglycemia. They increase the risk of <strong>urinary tract infections</strong> and can increase the risk of <strong>fractures.</strong></p>\n<p>Option C:<strong> Pramlintide</strong> is an <strong>amylin agonist</strong>. It reduces postprandial glycemia and leads to <strong>weight loss</strong>.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5583",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a cause of exudative pleural effusion?",
      "choices": [
        {
          "id": 1,
          "text": "Cirrhosis"
        },
        {
          "id": 2,
          "text": "Peritoneal dialysis"
        },
        {
          "id": 3,
          "text": "Myxedema"
        },
        {
          "id": 4,
          "text": "Dressler syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Dressler syndrome</strong> causes <strong>exudative pleural effusion.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Transudative Pleural Effusion</strong></td>\n<td><strong>Exudative Pleural Effusion</strong></td>\n</tr>\n<tr>\n<td>Alteration in <strong>systemic factors</strong> that influence the formation and absorption of pleural fluid.</td>\n<td>Alteration in <strong>local</strong> <strong>factors</strong> that influence the formation and absorption of pleural fluid.</td>\n</tr>\n<tr>\n<td>Causes include congestive cardiac failure, cirrhosis, nephrotic syndrome, peritoneal dialysis, SVC obstruction, myxedema.</td>\n<td>Causes include neoplastic conditions like <strong>mesothelioma</strong>; infectious diseases like <strong>tuberculosis</strong>; pulmonary embolization; GI conditions like esophageal perforation, pancreatic diseases; collagen vascular diseases like SLE; asbestosis, sarcoidosis; drug-induced; hemothorax and <strong>chylothorax</strong>, etc.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Types of pleural effusion</h3><p><strong>Transudative Pleural effusion</strong></p>\n<ul>\n<li>Congestive heart failure (most common)</li>\n<li>Cirrhosis</li>\n<li>Nephrotic syndrome</li>\n<li>Myxedema&nbsp;</li>\n<li>Peritoneal dialysis</li>\n<li>Urinothorax</li>\n<li>Hypoalbuminemia</li>\n<li>Constrictive pericarditis</li>\n<li>Superior vena cava obstruction</li>\n</ul>\n<p><strong>Exudative Pleural effusion&nbsp;</strong></p>\n<ul>\n<li aria-level=\"1\">Infections:&nbsp;Tuberculosis, pneumonia,&nbsp;intraabdominal abscess (like- liver abscess)</li>\n<li aria-level=\"1\">Malignancy:&nbsp;Pleural mesothelioma,&nbsp;metastasis,&nbsp;lymphoma</li>\n<li aria-level=\"1\">Connective tissue diseases:&nbsp;SLE,&nbsp;rheumatoid arthritis</li>\n<li aria-level=\"1\">Drugs:&nbsp;Amiodarone,&nbsp;bromocriptine,&nbsp;dantrolene,&nbsp;dasatinib,&nbsp;methysergide,&nbsp;nitrofurantoin</li>\n<li aria-level=\"1\">Others:\n<ul>\n<li aria-level=\"1\">Pancreatitis</li>\n<li aria-level=\"1\">Asbestosis</li>\n<li aria-level=\"1\">Pulmonary embolism</li>\n<li aria-level=\"1\">Hemothorax</li>\n<li aria-level=\"1\">Chylothorax</li>\n<li aria-level=\"1\">Meigs' syndrome&nbsp;</li>\n<li aria-level=\"1\">Dressler syndrome (post-myocardial infarction or cardiac surgery)</li>\n<li aria-level=\"1\">Yellow nail syndrome&nbsp;</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Causes of predominantly unilateral pleural effusion</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Predominantly right-</strong><strong>sided pleural </strong><strong>effusion</strong></p>\n</td>\n<td>\n<p><strong>Predominantly </strong><strong>left-sided pleural </strong><strong>effusion</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cirrhosis of the liver</p>\n<p>(hepatic hydrothorax)</p>\n</td>\n<td>Acute pancreatitis</td>\n</tr>\n<tr>\n<td>\n<p>Amebic liver abscess</p>\n</td>\n<td>Aortic dissection</td>\n</tr>\n<tr>\n<td>&nbsp;Meig&rsquo;s syndrome</td>\n<td>Esophageal rupture</td>\n</tr>\n<tr>\n<td>\n<p>Cardiac failure</p>\n<p>( B/L&gt;&gt;right-sided)</p>\n</td>\n<td>\n<p>Dressler&rsquo;s syndrome</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5682",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following investigations is considered the gold standard for diagnosing sphincter of Oddi dysfunction?",
      "choices": [
        {
          "id": 1,
          "text": "MRCP"
        },
        {
          "id": 2,
          "text": "HIDA scan"
        },
        {
          "id": 3,
          "text": "ERCP with manometry"
        },
        {
          "id": 4,
          "text": "CECT"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The<strong> gold standard for diagnosing sphincter of Oddi dyskinesia or dysfunction (SOD)</strong> is<strong> ERCP</strong> with manometry of the biliary and pancreatic sphincters.</p>\n<p>SOD is a clinical syndrome in which pain, biochemical abnormalities, and the dilatation of the bile duct and/or pancreatic duct are attributed to abnormal function of the sphincter of Oddi. &nbsp;It may be a result of stenosis of the sphincter or dysfunction of the sphincter.&nbsp;There are two clinical types of SOD:</p>\n<ul>\n<li>Biliary SOD: characterized by a mix of biliary pain, abnormally raised liver enzymes, dilation of the bile duct &amp; evidence of delayed emptying on biliary scintigraphy.&nbsp;It may be a cause of persistent post-cholecystectomy symptoms.</li>\n<li>Pancreatic SOD: characterized by recurrent episodes of acute pancreatitis</li>\n</ul>\n<p><strong>HIDA</strong> scan may be used to <strong>demonstrate delayed biliary transit</strong>.</p>\n<p>But, the<strong> gold standard for diagnosing SOD</strong> is<strong> ERCP</strong>, with manometry of the biliary and pancreatic sphincters.&nbsp;</p>\n<p class=\"p1\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5578",
      "difficulty": "easy"
    },
    {
      "text": "Match the following drugs-receptor combination with their respective graphical representations.<div class='question-desc-html'><ol>\n<li>Salbutamol at beta-2 receptor</li>\n<li>Naloxone at opioid receptors</li>\n<li>Buprenorphine at opioid receptor</li>\n<li>&beta;-Carboline at benzodiazepine site of GABA-A receptor</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "A-2, B-4, C-1, D-3"
        },
        {
          "id": 2,
          "text": "A-4, B-3, C-2, D-1"
        },
        {
          "id": 3,
          "text": "A-1, B-3, C-2, D-4"
        },
        {
          "id": 4,
          "text": "A-1, B-2, C-3, D-4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correctly matched pairs are as follows:</p>\n<ul>\n<li>Salbutamol at beta-2 receptor - Graph 1</li>\n<li>Naloxone at opioid receptors - Graph 3&nbsp;</li>\n<li>Buprenorphine at opioid receptor - Graph 2</li>\n<li>&beta;-Carboline at benzodiazepine site of GABA-A receptor - Graph 4</li>\n</ul>\n<p>&nbsp;</p>\n<div><strong>Graph 1 </strong>represents the <strong>agonist: </strong>An agonist is an agent which initiates the <strong>normal</strong> <strong>physiological response</strong> when combined with a receptor.</div>\n<div>Example: <strong>Salbutamol</strong> is a beta-2 receptor agonist.</div>\n<div>&nbsp;</div>\n<div><strong>Graph 2</strong> represents a <strong>partial agonist</strong>: An agent which produces a <strong>submaximal or partial effect</strong> when combined with a receptor.</div>\n<div>Example: <strong>B</strong><span class=\"ILfuVd\" lang=\"en\"><span class=\"hgKElc\"><strong>uprenorphine</strong> and butorphanol are partial agonists at opioid receptors.</span></span></div>\n<div>&nbsp;</div>\n<div><strong>Graph 3 </strong>represents the <strong>competitive</strong>&nbsp;<strong>antagonist</strong>: An agent which blocks or reduces the action of an agonist on a receptor, but does not have any effect of its own.</div>\n<div>Example: N<span class=\"ILfuVd\" lang=\"en\"><span class=\"hgKElc\">altrexone and <strong>naloxone</strong> are antagonists at opioid receptors</span></span></div>\n<div>&nbsp;</div>\n<div><strong>Graph 4</strong> represents an<strong> inverse agonist</strong>: An agent which activates a receptor to produce an effect in the opposite direction to that of the agonist.</div>\n<div>Example: &beta;-<strong>Carboline</strong> is an inverse agonist at benzodiazepine site of GABA-A receptor.</div>\n<p>The image given below shows the action of various types of selective receptor modulators:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8d7167c153aa42a5bdc0787fd454473ex1280x1252.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e92db6bfe3d1445887b58ce7103cde72.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5445",
      "difficulty": "medium"
    },
    {
      "text": "A patient recovered from hepatitis B infection. Which of the following curve represents antibodies seen 4 weeks post-recovery?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-HBs"
        },
        {
          "id": 2,
          "text": "Anti-HBc"
        },
        {
          "id": 3,
          "text": "HBeAg"
        },
        {
          "id": 4,
          "text": "HBsAg"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The serological marker marked in the image is <strong>anti-HBs antibody</strong>. In typical cases of resolving hepatitis B, HBsAg becomes undetectable 1-2 months after the appearance of clinical features. After this, anti-HBs becomes detectable in the serum.</p>\n<p>After a person is infected with the hepatitis B virus (HBV), the <strong>first</strong> <strong>serologic marker</strong> to increase in level is <strong>HBsAg.&nbsp;</strong>It becomes detectable in the serum between <strong>1-12 weeks.&nbsp;</strong>It becomes undetectable 1&ndash;2 months after the onset of jaundice and rarely persists beyond 6 months. Once the HBsAg becomes undetectable,&nbsp;anti-HBs antibody starts rising in serum and remains detectable indefinitely thereafter. The gap between the disappearance of HBsAg and the appearance of anti-HBs antibodies is called the <strong>window period.</strong>&nbsp;</p>\n<p><strong>HBcAg</strong> is located <strong>inside the cells</strong> and is usually enclosed within an HBsAg coat when present in the serum. As a result, HBcAg is <strong>not commonly detectable</strong> in the serum of patients with HBV infection since naked core particles are not found in the bloodstream. Conversely, <strong>anti-HBc</strong> can be detected in the serum shortly after the emergence of HBsAg, usually within <strong>1-2 weeks. Anti-HBc</strong>&nbsp;may be the only <strong>serologic marker</strong>&nbsp;useful for the identification of HBV infection during the <strong>window period.&nbsp;</strong></p>\n<p class=\"p1\"><strong>HBeAg</strong> appears shortly after the appearance of HBsAg. Its appearance correlates with high levels of <strong>virus replication. Anti-HBe</strong> correlates with a period of <strong>lower infectivity.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59d66670c07a481abcc0e406a52edd56x1280x1156.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p> </p>\n<table>\n<tbody>\n<tr>\n<td> <strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/31aeec65e0c4450ebaab39c620fdc941.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5679",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old athlete injures his leg. He complains of pain in his knees. The following technique has been employed to alleviate his pain. Activation of which of the following types of nerve fibers near the site of injury is done by this method?",
      "choices": [
        {
          "id": 1,
          "text": "C & Aδ"
        },
        {
          "id": 2,
          "text": "Aα & Aδ"
        },
        {
          "id": 3,
          "text": "Aα & Aβ"
        },
        {
          "id": 4,
          "text": "Aβ & Aδ"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given image shows <strong>transcutaneous electrical nerve stimulation</strong> (TENS) used for pain relief. It is based on the&nbsp;<strong>gate control theory of pain</strong>.&nbsp;This method uses electrodes to activate <strong>A&alpha; and A&beta; fibers</strong> <strong>near the injury</strong> to relieve pain.</p>\n<p><strong>Gate control theory</strong> is based on the <strong>inhibition of the pain pathways in the spinal cord</strong>. Various sensory inputs from a particular dermatome reach the dorsal horn of the spinal cord. The pain is transmitted via A-delta and C fibers, whereas, A-beta fibers carry tactile sensations (touch, pressure) and A-alpha fibers carry proprioception.</p>\n<p>When these large-diameter A-beta/A-alpha fibers are stimulated, they inhibit the pain pathway in the spinal cord. This inhibition is thought to result from the <strong>local lateral inhibition of interneurons</strong> in the spinal cord.</p>\n<p>Gate control theory operates at the&nbsp;<strong>substantia gelatinosa</strong> of the&nbsp;<strong>dorsal horn of the spinal cord</strong>.</p>\n<p>The given image depicts the gate control theory of pain:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/282b5f42ca40421795588ad74e57cdffx1280x1037.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Types of mammalian nerve fibres (Erlanger and Gasser's classification)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Fiber type</strong></p>\n</td>\n<td>\n<p><strong>Function</strong></p>\n</td>\n<td>\n<p><strong>Fiber diameter(&mu;m)</strong></p>\n</td>\n<td>\n<p><strong>Conduction velocity(m/s)</strong></p>\n</td>\n<td>\n<p><strong>Spike duration(ms)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A&alpha;</p>\n</td>\n<td>\n<p>Proprioception, somatic motor</p>\n</td>\n<td>\n<p>12-20</p>\n</td>\n<td>\n<p>70-120</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>A&beta;</p>\n</td>\n<td>\n<p>Touch, pressure</p>\n</td>\n<td>\n<p>5-12</p>\n</td>\n<td>\n<p>30-70</p>\n</td>\n<td>\n<p>0.4-0.5</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A&gamma;</p>\n</td>\n<td>\n<p>Motor to muscle spindles</p>\n</td>\n<td>\n<p>3-6</p>\n</td>\n<td>\n<p>15-30</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>A&delta;</p>\n</td>\n<td>\n<p>Pain, temperature</p>\n</td>\n<td>\n<p>2-5</p>\n</td>\n<td>\n<p>12-30</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>Preganglionic autonomic</p>\n</td>\n<td>\n<p>&lt;3</p>\n</td>\n<td>\n<p>3-15</p>\n</td>\n<td>\n<p>1.2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C</p>\n<p>Dorsal root</p>\n</td>\n<td>\n<p>Pain, temperature</p>\n</td>\n<td>\n<p>0.4-1.2</p>\n</td>\n<td>\n<p>0.5-2</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C Sympathetic</p>\n</td>\n<td>\n<p>Post ganglionic sympathetic</p>\n</td>\n<td>\n<p>0.3-1.3</p>\n</td>\n<td>\n<p>0.7-2.3</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Numerical classification of sensory nerve fibers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Number </strong></p>\n</td>\n<td>\n<p><strong>Origin </strong></p>\n</td>\n<td>\n<p><strong>Fibre type</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ia</p>\n</td>\n<td>\n<p>Muscle Spindle, annulo-spiral ending</p>\n</td>\n<td>\n<p>A&alpha;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ib</p>\n</td>\n<td>\n<p>Golgi tendon organ</p>\n</td>\n<td>\n<p>A&alpha;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>II</p>\n</td>\n<td>\n<p>Muscle Spindle, flower spray ending; touch, pressure</p>\n</td>\n<td>\n<p>A&beta;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>III</p>\n</td>\n<td>\n<p>Pain and cold receptors; some touch receptors</p>\n</td>\n<td>\n<p>A&delta;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IV</p>\n</td>\n<td>\n<p>Pain, temperature, and other receptors</p>\n</td>\n<td>\n<p>C</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/1aa3c26771f74e3c9d498935d36c52b9.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5553",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following adverse effects is not encountered with the use of the agent that is considered the specific reversal agent for dabigatran?",
      "choices": [
        {
          "id": 1,
          "text": "Delirium"
        },
        {
          "id": 2,
          "text": "Constipation"
        },
        {
          "id": 3,
          "text": "Pyrexia"
        },
        {
          "id": 4,
          "text": "Hyperkalemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Idarucizumab</strong> is considered the <strong>specific reversal agent</strong> for dabigatran. It is associated with <strong>hypo</strong>kalemia, not hyperkalemia.</p>\n<p>Idarucizumab is a <strong>humanized monoclonal antibody fragment</strong> and is indicated in patients treated with <strong>dabigatran</strong> when <strong>reversal of anticoagulant</strong> <strong>effects</strong> is needed:</p>\n<ul>\n<li>For emergency surgery/urgent procedures</li>\n<li>In life-threatening or uncontrolled bleeding</li>\n</ul>\n<p>The most frequently reported adverse reactions are:</p>\n<ul>\n<li><strong>Hypokalemia</strong></li>\n<li><strong>Delirium</strong></li>\n<li><strong> Constipation</strong></li>\n<li><strong>Pyrexia</strong></li>\n<li><strong>Pneumonia</strong></li>\n</ul>\n<p><strong class=\"ng-binding\">Specific reversal agents for anticoagulants:</strong></p>\n<div class=\"panel-body ng-scope\">\n<ul>\n<li>Heparin: protamine sulfate</li>\n<li>Warfarin: vitamin K</li>\n<li>Rivaroxaban and other oral Xa inhibitors: andexanet alfa</li>\n<li>Dabigatran: idarucizumab</li>\n</ul>\n</div><hr><h3>Related Pearl: Classification of Anticoagulants</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b14dd7e06cd44c95a1d5289e3a32ad8ax1280x1944.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Classification of anticoagulants</strong></td>\n</tr>\n<tr>\n<td>1) Vitamin K antagonist</td>\n<td>Warfarin</td>\n</tr>\n<tr>\n<td>2) Direct thrombin inhibitors (DTI)&nbsp;&nbsp;&nbsp;</td>\n<td>\n<p><strong>Parenteral:&nbsp;Monovalent</strong> DTI-&nbsp;Argatroban</p>\n<p><strong>Bivalent</strong> DTI- Lepirudin, Desirudin, Bivalirudin</p>\n<p><strong>Oral</strong>:&nbsp;Dabigatran&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>3) Indirect thrombin inhibitors&nbsp;</td>\n<td>\n<p>Unfractionated heparin</p>\n<p>Low molecular weight heparins:&nbsp;Enoxaparin, Dalteparin, Tinzaparin, Nadroparin</p>\n</td>\n</tr>\n<tr>\n<td>4) Indirect factor Xa inhibitors</td>\n<td>Fondaparinux</td>\n</tr>\n<tr>\n<td>5) <strong>Oral</strong> Direct factor Xa inhibitors</td>\n<td>Rivaro<strong>xa</strong>ban,Api<strong>xa</strong>ban, Edo<strong>xa</strong>ban,Betri<strong>xa</strong>ban</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5586",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding auramine-rhodamine staining used for acid-fast bacillus?",
      "choices": [
        {
          "id": 1,
          "text": "After staining with auromine-rhodamine stain, bacilli resist decolorisation with sulphuric acid"
        },
        {
          "id": 2,
          "text": "Smears stained with auramine-rhodamine should not be exposed to ultraviolet illumination"
        },
        {
          "id": 3,
          "text": "Bacilli appear as bright rods against a dark background"
        },
        {
          "id": 4,
          "text": "Bacilli can be seen even under the high dry objective and hence this can be used for rapid smear screening"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Smears stained with auramine-rhodamine</strong> are <strong>visualized under ultraviolet light</strong> illumination to spot the <strong>fluorescent bacilli</strong>.</p>\n<p>After staining with auromine-rhodamine stain, acid-fast bacilli <strong>resist decolorization</strong> with sulphuric acid.&nbsp;Smears that are stained with auramine-rhodamine fluorescent dyes are examined under ultraviolet illumination or a LED light source. <strong>Bacilli</strong> appear as <strong>bright rods against a dark background</strong>.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9b5ed4ceed094489a9ced878f5a14dfex1280x844.PNG\" alt=\"Explanation Image\"><p>Due to the clear contrast, the bacilli can be <strong>seen even under the high-dry objective</strong>, which helps to screen large areas of the smear rapidly.&nbsp;When large numbers of smears is to be examined daily, it is more convenient to use fluorescent microscopy.</p><hr><h3>Related Pearl: Various stains and their applications in microbiology</h3><p><strong>A. Simple stains: </strong>Provides color contrast but gives same color to all bacteria and cells.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of stain</strong></td>\n<td><strong>Applications</strong></td>\n</tr>\n<tr>\n<td><strong>Acidic stains</strong></td>\n<td>\n<p>These include<strong> eosin, acid fuchsin, rose bengal, congo red</strong>, etc.</p>\n<p>Used to stain pathological specimens</p>\n</td>\n</tr>\n<tr>\n<td><strong>Basic stains</strong>.</td>\n<td>\n<p><strong>Loeffler&rsquo;s methylene blue</strong> stain is used in <strong>Quellung reaction</strong>.&nbsp;</p>\n<p><strong>Polychrome methylene blue</strong> is used in <strong>McFadyean&rsquo;s</strong> <strong>reaction.</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Neutral stains</strong></td>\n<td>\n<p><strong>Wright</strong> and <strong>Giemsa stains</strong> are <strong>Romanowsky stains</strong> used to stain peripheral blood and bone marrow smears. &nbsp;</p>\n<p><strong>Giemsa stain</strong> is used for histopathological diagnosis of malaria and other protozoan blood parasites.&nbsp;&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><p><strong>B. Differential stains: </strong>Imparts different colors to different bacteria. (These contain more than one stain).</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of stain</strong></td>\n<td><strong>Applications</strong></td>\n</tr>\n<tr>\n<td><strong>Gram stain:</strong></td>\n<td>To differentiate between <strong>gram</strong> <strong>positive</strong> (stain purple/violet) and <strong>gram</strong> <strong>negative</strong> bacteria (stain pink or red).</td>\n</tr>\n<tr>\n<td><strong>Acid-fast stain:&nbsp;</strong></td>\n<td>Used in <strong>Ziehl&ndash;Neelsen staining</strong> technique for identification of <strong>acid&ndash;fast microorganisms </strong>such as <em>M. tuberculosis</em>, <em>M. leprae</em>, and Nocardia.</td>\n</tr>\n<tr>\n<td><strong>Fluorochrome staining:</strong></td>\n<td><strong>Auramine-rhodamine</strong> is used in fluorochrome staining for screening for <strong>tuberculosis</strong>.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p><strong>C. Special stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of stain</strong></td>\n<td><strong>Applications</strong></td>\n</tr>\n<tr>\n<td><strong>Staining volutin-containing organisms</strong></td>\n<td><em><strong>Corynebacterium</strong> <strong>diphtheriae</strong> </em>stained by <strong>Albert&rsquo;s stain</strong>. Green colored bacilli showing \"<strong>chinese-letter\" </strong>pattern<strong>, </strong>containing bluish-black <strong>metachromatic</strong> granules of cells<strong>.</strong></td>\n</tr>\n<tr>\n<td><strong>Flagella stain</strong></td>\n<td><em><strong>Salmonella</strong> <strong>typhimurium</strong></em> stained by <strong>modified Ryu stain</strong> to show peritrichous flagella</td>\n</tr>\n<tr>\n<td><strong>Endospore stain</strong></td>\n<td>Used in <strong>Schaeffer and Fulton staining technique</strong> to stain the endospores, where the primary stain is <strong>malachite</strong> <strong>green</strong>, and the counterstain is safranin.</td>\n</tr>\n<tr>\n<td><strong>Capsule stain</strong></td>\n<td>Used in negative staining (<em><strong>Cryptococcus</strong> <strong>neoformans</strong></em>), McFadyean&rsquo;s reaction,&nbsp;Polychrome methylene blue (<strong>anthrax</strong> <strong>bacilli</strong>).</td>\n</tr>\n<tr>\n<td><strong>Silver impregnation</strong></td>\n<td><strong>Fontana&rsquo;s silver impregnation</strong> method used for staining <strong>treponeme</strong> and <strong>leptospire</strong>.</td>\n</tr>\n<tr>\n<td><strong>Silver staining</strong></td>\n<td>Used in <strong>Grocott&rsquo;s &ndash; Gomori&rsquo;s methenamine silver stain. </strong>GMS stain is used to identify <em><strong>Pneumocystis jirovecii</strong></em>, which classically appear as <strong>crushed ping-pong balls.</strong> <strong>&nbsp;</strong> Warthin&ndash;starry silver stain for spirochetes.</td>\n</tr>\n<tr>\n<td><strong>Calcofluor white staining</strong></td>\n<td>The cell walls of fungi will bind the stain <strong>calcofluor white.&nbsp;</strong>It is especially useful for the identification of<strong> mucor</strong> and the causative agents of <strong>zygomycosis</strong>.&nbsp; It is also used in staining <strong>acanthamoeba</strong></td>\n</tr>\n<tr>\n<td><strong>Chance's staining</strong></td>\n<td>For cell wall demonstration</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Acid fast Organisms</h3><table>\n<tbody>\n<tr>\n<td><strong>Acid-fast organisms</strong></td>\n<td><strong>Sulfuric acid (%) required for decolorization </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Mycobacterium tuberculosis </li>\n</ul>\n</td>\n<td>25%</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Mycobacterium leprae</li>\n</ul>\n</td>\n<td>5%</td>\n</tr>\n<tr>\n<td>\n<p> </p>\n<ul>\n<li>Eggs of Taenia saginata</li>\n<li>Eggs of Schistosoma mansoni</li>\n<li>Oocyst of Cryptosporidium</li>\n<li>Oocyst of Cyclospora</li>\n<li>Oocyst of Cystoisospora</li>\n</ul>\n</td>\n<td>1%</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Sperm head</li>\n<li>Legionella micdadei</li>\n<li>Nocardia</li>\n</ul>\n</td>\n<td>0.5-1%</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Bacterial spore</li>\n</ul>\n</td>\n<td>0.25-0.5%</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5617",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following media can be used for culturing the organism shown in the image below?",
      "choices": [
        {
          "id": 1,
          "text": "Wilson and Blair medium"
        },
        {
          "id": 2,
          "text": "BCYE agar"
        },
        {
          "id": 3,
          "text": "Macleod medium"
        },
        {
          "id": 4,
          "text": "Skirrow’s medium"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p1\">The given image shows <strong>gram-positive rods </strong>with club-shaped ends, a beaded appearance, and a<strong> chinese-letter pattern</strong> of arrangement indicative of <em><strong>Corynebacterium diphtheriae</strong></em>. They are cultured in <strong>MacLeod's medium.</strong></p>\n<p><strong>Macleod's medium</strong> is <strong>selective</strong> for <em><strong>C. diphtheriae</strong></em>. <strong>Potassium tellurite</strong> in McLeod's medium or potassium tellurite agar is reduced to metallic tellurium by <em>C. diphtheriae</em> to produce black colonies. Additionally, tellurite (0.04%) inhibits the growth of most other bacteria, acting as a selective agent.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Wilson and Blair's medium</strong> is <strong>selective</strong> for <strong>Salmonella</strong> species. It is a type of selective and indicator media. <strong><em>Salmonella typhi</em></strong> reduces sulphite to sulphide in the presence of glucose and produces <strong>jet-black colonies</strong> with a metallic sheen due to the production of <strong>H2S </strong>on Wilson and Blair bismuth sulphite medium. It is also a differential media. While <em>S. typhi </em>forms large black colonies, with a metallic sheen <strong><em>S. paratyphi. A</em></strong> produces <strong>green</strong> <strong>colonies </strong>due to the absence of H2S production. </p>\n<p>Option B: <strong>BCYE agar</strong> or buffered charcoal, yeast extract agar is selective for <strong><em>Legionella</em> species</strong>. Legionellae are nutritionally fastidious. Their growth is enhanced with <strong>iron salts</strong> and depends on the supplementation of media <strong>L-cysteine</strong>. </p>\n<p>Option D:<strong> Skirrow’s medium</strong> is selective for <strong><em>Campylobacter</em> species</strong>. It contains vancomycin, polymyxin B, and trimethoprim to inhibit the growth of other bacteria. Plates were incubated at 43°C with 5 % oxygen, 10% carbon dioxide, and 85% hydrogen. Colonies may be observed after overnight incubation.</p><hr><h3>Related Pearl: Organisms and selective Culture Media</h3><p>Appropriate culture media for various bacteria:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Organism</strong></td>\n<td><strong>Medium for culture</strong></td>\n</tr>\n<tr>\n<td>Staph aureus</td>\n<td>Mannitol salt agar<br />ludlam&rsquo;s medium<br />salt milk agar</td>\n</tr>\n<tr>\n<td>Strep. Pyogenes</td>\n<td>Crystal violet blood agar</td>\n</tr>\n<tr>\n<td>Neisseria meningitidis</td>\n<td>Thayer martin medium</td>\n</tr>\n<tr>\n<td>Corynebacterium</td>\n<td>Potassium tellurite agar<br />Tinsdale medium<br />Mcleod medium</td>\n</tr>\n<tr>\n<td>B.anthrax</td>\n<td>PLET medium</td>\n</tr>\n<tr>\n<td>B.cereus</td>\n<td>MYPA (Mannitol egg yolk phenol red polymyxin agar)<br />PEMBA(polymyxin in egg yolk mannitol bromothymol blue agar</td>\n</tr>\n<tr>\n<td>Clostridium&nbsp;</td>\n<td>CCFA ( cefoxitin cycloserine fructose agar)</td>\n</tr>\n<tr>\n<td>Shigella</td>\n<td>DCA, XLD, SSA</td>\n</tr>\n<tr>\n<td>Salmonella</td>\n<td>Wilson and Blair bismuth sulphite medium</td>\n</tr>\n<tr>\n<td>Vibrio</td>\n<td>TCBS<br />Monsur GTTA</td>\n</tr>\n<tr>\n<td>Pseudomonas</td>\n<td>Cetrimide agar</td>\n</tr>\n<tr>\n<td>B.pseudomallei</td>\n<td>Ashdown medium</td>\n</tr>\n<tr>\n<td>H. influenza</td>\n<td>Fildes agar <br />Levinthal medium</td>\n</tr>\n<tr>\n<td>Bordetella</td>\n<td>Bordet-Gengou glycerine potato blood agar</td>\n</tr>\n<tr>\n<td>Brucella</td>\n<td>Casteneda medium</td>\n</tr>\n<tr>\n<td>B.burgdorferi</td>\n<td>BSK medium</td>\n</tr>\n<tr>\n<td>Campylobacter</td>\n<td>\n<p>Skirrow's, Butzler's and Campy BAP media</p>\n</td>\n</tr>\n<tr>\n<td>Legionella pneumophilia</td>\n<td>\n<p>BCYE medium</p>\n</td>\n</tr>\n<tr>\n<td>Leptospira</td>\n<td>EMJH medium&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/93eeafa0806c409a955eeaaff9ae967e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5655",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following tests would be helpful in determining whether a particular stain is due to seminal fluid?<div class='question-desc-html'><ol>\n<li>Creatine phosphokinase test</li>\n<li>Kastle Meyer test</li>\n<li>Barberio test</li>\n<li>Acid phosphatase test</li>\n<li>Takayama test</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, & 4"
        },
        {
          "id": 2,
          "text": "1, 4, & 5"
        },
        {
          "id": 3,
          "text": "2, 3, & 5"
        },
        {
          "id": 4,
          "text": "1, 3, & 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>acid phosphatase test, Barberio test</strong>, and <strong>creatine phosphokinase test</strong> are used to detect seminal stains, hence <strong>option D</strong> is correct.&nbsp;</p>\n<p><strong>Kastle-Meyer test &amp;&nbsp;Takayama test</strong> are used to detect <strong>blood stains</strong> (not seminal stains).</p>\n<p><strong>Forensic tests for detection of seminal stains:</strong></p>\n<ul>\n<li><strong>Florence test</strong> detects <strong>choline</strong> (secreted by seminal vesicles). Florence solution consists of potassium iodide, iodine, and water. If semen is present, <strong>dark-brown crystals </strong>of <strong>choline</strong> iodide is seen</li>\n<li><strong>Barberio&rsquo;s test</strong> detects <strong>spermin (secreted by the prostate)</strong> and uses an&nbsp;<strong><strong>aqueous or alcoholic solution of picric acid. Y</strong></strong>ellow needle-shaped rhombic crystals of spermine picrate in the presence of seminal fluid.</li>\n<li>Acid phosphatase test is conclusive in case of absence of demonstrable sperms or Aspermia.</li>\n<li>The<strong> absolute proof </strong>of semen is finding at least<strong> one unbroken spermatozoon or electrophoretic LDH isoenzyme detection </strong>of sperms.</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Tests to detect seminal and blood stains</h3><p><strong>Tests for seminal stains</strong></p>\n<ul>\n<li>Barberio's test</li>\n<li>Florence test</li>\n<li>Acid phosphatase test</li>\n<li>Creatine phosphokinase test</li>\n<li>Immunological test to detect Prostate Specific Antigen</li>\n</ul>\n<p><strong>Tests for blood stains &nbsp;</strong></p>\n<ul>\n<li>Benzidine test</li>\n<li>Phenophthalein (Kastle Meyer) test</li>\n<li>Takayama hemochromogen crystal test</li>\n<li>Teichmann&rsquo;s hemin crystal test</li>\n<li>Spectroscopic test</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5525",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is incorrectly paired??",
      "choices": [
        {
          "id": 1,
          "text": "Epsilon chain - Black curve"
        },
        {
          "id": 2,
          "text": "Beta chain - Green curve"
        },
        {
          "id": 3,
          "text": "Delta chain - Blue curve"
        },
        {
          "id": 4,
          "text": "Alpha chain - Orange curve"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the given image, the <strong>orange curve&nbsp;</strong>represents the <strong>gamma-globin chain production</strong>. The gamma-globin chain is produced in the fetal period and drops to undetectable levels 6 months postpartum, which is the pattern represented by the orange curve. The <strong>alpha chain production</strong> is represented by the <strong>red curve</strong>.</p>\n<p>Hemoglobin in blood has different variants throughout life, in different proportions. The type of hemoglobin essentially depends on the combination of globin chains. Adult hemoglobin is made of 2 alpha and 2 beta chains, whereas fetal hemoglobin is made of 2 alpha and 2 gamma-globin chains. Other combinations of chains can be found in embryonic hemoglobin.</p>\n<p>Here,</p>\n<ul>\n<li>Gamma chain - Orange curve</li>\n<li>Alpha chain - Red curve</li>\n<li>Beta chain - Green curve</li>\n<li>Epsilon chain - Black curve</li>\n<li>Delta chain - Blue curve</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b4e52b4fdac84e8bbf455c2d6d133c7d.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5579",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following conditions show a secular trend?<div class='question-desc-html'><ol>\n<li>Coronary heart disease</li>\n<li>Polio</li>\n<li>Lung cancer</li>\n<li>Diabetes</li>\n<li>Influenza</li>\n<li>Measles</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 & 4 only"
        },
        {
          "id": 2,
          "text": "3, 4, 5"
        },
        {
          "id": 3,
          "text": "1, 2, 3"
        },
        {
          "id": 4,
          "text": "1, 2, 3, 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Coronary heart disease, Polio, Lung cancer &amp; Diabetes show a secular trend. <strong>Measles</strong> shows a <strong>seasonal</strong> trend and <strong>influenza</strong> shows a <strong>cyclic</strong> trend.</p>\n<p>Secular trend describes the occurrence of <strong>disease over a prolonged period</strong>, usually years. Even though it <strong>may have short-term fluctuations</strong>, there is a tendency for the disease occurrence to change consistently in a particular direction or a <strong>definite movement in one direction</strong>.</p>\n<p>Examples of the secular trend include <strong>coronary heart disease</strong>, <strong>lung cancer,</strong> and <strong>diabetes</strong>, which have shown a <strong>consistent upward</strong> trend in incidence as well as prevalence, in developed countries. Similarly, there has been a <strong>consistent decline in the diseases</strong> such as <strong>tuberculosis</strong>, <strong>typhoid fever</strong>, <strong>diphtheria</strong>, and <strong>polio</strong>.</p>\n<p><strong>Seasonal trends</strong> reflect seasonal changes in disease occurrence following changes in environmental conditions that enhance the ability of the agent to replicate or be transmitted. For example, <strong>measles</strong> (usually occurs in early spring), varicella, etc. Non-infectious conditions like hay fever and snake bites may also show seasonal variations.</p>\n<p><strong>Cyclic trend</strong> is shown by some diseases that occur in cycles spread over short periods of time which may be, days, weeks, months, or years.  Examples include the <strong>influenza pandemic</strong>, which is known to occur at intervals of<strong> every 7–10 years</strong> due to antigenic variations.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5506",
      "difficulty": "hard"
    },
    {
      "text": "A diabetic man takes his insulin bolus and then takes his meal. This would cause activation of all of the following enzymes, except _____.",
      "choices": [
        {
          "id": 1,
          "text": "Phosphofructokinase"
        },
        {
          "id": 2,
          "text": "Phosphoenolpyruvate carboxykinase"
        },
        {
          "id": 3,
          "text": "Glycogen synthase"
        },
        {
          "id": 4,
          "text": "Acetyl CoA carboxylase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Phosphoenolpyruvate&nbsp;carboxykinase </strong>is an enzyme that gets <strong>activated in low insulin</strong> situations, in a <strong>phosphorylated state</strong>,<strong>&nbsp;</strong>i.e., in a&nbsp;<strong>fasting</strong> state.</p>\n<p>It is active in the high glucagon:insulin ratio scenario, which is typically seen in the fasting state and participates in the process of <strong>gluconeogenesis</strong>.</p>\n<p>All other enzymes are active in the fed state when there are high insulin levels.</p><hr><h3>Related Pearl: Enzymes active in phosphorylated and dephosphorylated state</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phosphorylated state</strong></p>\n<p>(Low insulin)</p>\n</td>\n<td>\n<p><strong>Dephosphorylated state</strong></p>\n<p>(High insulin)</p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Fructose 2,6 bisphosphatase</li>\n<li>PEP carboxykinase</li>\n<li>Pyruvate carboxylase</li>\n<li>Glycogen phosphorylase</li>\n<li>Hormone-sensitive lipase</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Phosphofructokinase</li>\n<li>Pyruvate dehydrogenase</li>\n<li>Glycogen synthase</li>\n<li>Acetyl CoA carboxylase</li>\n<li>HMG CoA reductase</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Irreversible enzymes in gluconeogenesis pathway</h3><p>The&nbsp;enzymes can be remembered using the mnemonic <strong>P</strong>athway <strong>P</strong>roduces <strong>F</strong>resh <strong>G</strong>lucose.</p>\n<table>\n<tbody>\n<tr>\n<td>Enzymes</td>\n<td>Reaction and site</td>\n<td>Cofactors</td>\n</tr>\n<tr>\n<td><strong>P</strong>yruvate carboxylase</td>\n<td>\n<p>Pyruvate &rarr; Oxaloacetate</p>\n<p>mitochondria</p>\n</td>\n<td>\n<p>Biotin, ATP</p>\n<p>Activated by acetyl-CoA</p>\n</td>\n</tr>\n<tr>\n<td><strong>P</strong>hosphoenolpyruvate carboxykinase</td>\n<td>Oxaloacetate&nbsp;&rarr; PhosphoenolPyruvate (cytosol)</td>\n<td>GTP</td>\n</tr>\n<tr>\n<td><strong>F</strong>ructose-1,6-bisphosphatase</td>\n<td>Fructose-1,6-bisphosphate&nbsp;&rarr; fructose-6-phosphate (cytosol)</td>\n<td>\n<p>Citrate(+ve)</p>\n<p>Fructose 2,6 bisphosphate (-ve)</p>\n</td>\n</tr>\n<tr>\n<td><strong>G</strong>lucose-6-phosphatase</td>\n<td>Glucose-6-phosphate&nbsp;&rarr; glucose Endoplasmic reticulum</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5481",
      "difficulty": "medium"
    },
    {
      "text": "The oxygen flow rate of a non-rebreather mask is",
      "choices": [
        {
          "id": 1,
          "text": "3-5 L/min"
        },
        {
          "id": 2,
          "text": "5-6 L/min"
        },
        {
          "id": 3,
          "text": "7-15 L/min"
        },
        {
          "id": 4,
          "text": "3 L/min"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The oxygen flow rate of a <strong>non-rebreather mask</strong> is <strong>7-15 L/min</strong></p>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/131abf72758747c7b783aad16fe32b45x720x960.JPEG\" alt=\"Explanation Image\"><p><strong>Conventional oxygen therapy</strong> includes <strong>all the devices</strong> that are used in routine practices. It includes nasal prongs, low-flow nasal cannula, or masks. It is the main supportive treatment administered to patients after planned extubation. </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Oxygen delivery devices</strong></td>\n<td><strong>Flow rate (liter/min) </strong></td>\n<td><strong>Approximate FiO2</strong></td>\n</tr>\n<tr>\n<td>Nasal cannula </td>\n<td>1-6 </td>\n<td>0.24-0.44 </td>\n</tr>\n<tr>\n<td>Simple face mask </td>\n<td>6-10</td>\n<td>0.40-0.60</td>\n</tr>\n<tr>\n<td>Non-rebreathing mask</td>\n<td>10-15</td>\n<td>0.90-1.00 </td>\n</tr>\n<tr>\n<td>Venturi mask </td>\n<td>2-15 </td>\n<td>0.24-0.60</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Oxygen delivery devices can be broadly divided into low flow oxygen devices (eg: nasal cannula, simple face mask, non-rebreathing mask) and high flow oxygen devices (eg: venturi mask).</p>\n<p> </p>\n<p>The below image shows a <strong>nasal cannula</strong>, which delivers oxygen at <strong>1-6 L/min.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/75aa475d4a604f40a8ef8ebd50cd58aax1280x1280.PNG\" alt=\"Explanation Image\"><p>A <strong>conventional oxygen mask </strong>is a simple face mask that is used routinely in hospitals. It covers the nose and mouth of the patient. There are 2 exhalation ports through which the patient exhales carbon dioxide. This mask is held in place with elastic around the back of the head and a metal piece that fits over the nose. It provides <strong>40% to 60%</strong> of O<sub>2</sub> concentration and delivers O<sub>2</sub> at the rate of <strong>6 to 10 L/min.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0ca354697f3a4bf284bf265059e5bb1ax1280x1390.JPEG\" alt=\"Explanation Image\"><p>The below image shows a <strong>venturi mask</strong>, which delivers oxygen at <strong>2-15 L/min.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/64092b994c2348d38847b668aba7ad59x1280x1173.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5608",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs should never be prescribed to a pregnant woman with SLE?",
      "choices": [
        {
          "id": 1,
          "text": "Hydroxychloroquine"
        },
        {
          "id": 2,
          "text": "Azathioprine"
        },
        {
          "id": 3,
          "text": "Glucocorticoids"
        },
        {
          "id": 4,
          "text": "Mycophenolate mofetil"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Mycophenolate mofetil</strong> is <strong>teratogenic</strong> and hence is not safe during pregnancy. </p>\n<p><strong>Systemic lupus erythematosus</strong> (SLE) is a chronic autoimmune disorder involving the multisystem. It affects young women of <strong>childbearing age. </strong>The renal involvement of the disease can manifest in the form of<strong> active lupus nephritis </strong>or<strong> flare-ups </strong>during pregnancy.</p>\n<p>The <strong>features</strong> include fever, weight loss, migratory joint pain, and myalgias. It can lead to <strong>preterm births</strong>, <strong>preeclampsia</strong>, and <strong>pregnancy loss</strong> while the infant can suffer from <strong>neonatal lupus</strong> and heart block. </p>\n<p><strong>Antinuclear antibodies</strong> are useful to screen the disease. <strong>Double-stranded DNA</strong> (dsDNA) is highly specific in diagnosing SLE. Other antibodies such as lupus anticoagulant, antiphospholipid antibodies, anti-Ro, and anti-La antibodies are useful in diagnosis.</p>\n<p>Management is as follows:</p>\n<ul>\n<li><strong>Preconceptional planning</strong> plays an important role. Conception during a period of<strong> quiescence</strong> for at least <strong>6 months</strong> determines a successful outcome. Stable <strong>remission</strong> of <strong>renal disease</strong> for at least <strong>6 months</strong> before conception is recommended.</li>\n<li><strong>Corticosteroids</strong> are useful during episodes of lupus <strong>flare</strong> and can be used <strong>safely</strong> in pregnancy. For patients on chronic corticosteroid therapy, intravenous<strong> hydrocortisone 100 mg</strong>, three doses are given 8 hourly during labor or at the time of cesarean delivery.</li>\n<li><strong>Immunosuppressants</strong> such as <strong>azathioprine</strong> can be<strong> continued</strong> during pregnancy. It may be used in case of severe SLE</li>\n<li><strong>Hydroxychloroquine</strong> is found to be the <strong>best for maintenance and is safe in pregnancy.</strong> It can prevent the need for prolonged corticosteroid therapy.</li>\n</ul>\n<p> </p>\n<p>Drugs for treatment of pregnant women with SLE</p>\n<ul>\n<li>Recommended during pregnancy<br />\n<ul>\n<li>HCQ (Hydroxychloroquine)</li>\n<li>Low dose Aspirin</li>\n</ul>\n</li>\n<li>Selective use allowed during pregnancy\n<ul>\n<li>NSAIDs</li>\n<li>Glucocorticoids</li>\n<li>Azathioprine</li>\n<li>Cyclosporine</li>\n<li>Tacrolimus</li>\n</ul>\n</li>\n<li>Selective use with caution in pregnancy\n<ul>\n<li>Rituximab</li>\n<li>Belimumab</li>\n</ul>\n</li>\n<li>Contraindicated in pregnancy\n<ul>\n<li>Cyclophosphamide</li>\n<li>Mycophenolate mofetil</li>\n<li>Methotrexate</li>\n<li>Leflunomide</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Classification of Lupus Nephritis (International Society of Nephrology and Renal Pathology Society)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Class&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Findings</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal mesangial lupus nephritis (class I)</p>\n</td>\n<td>\n<p><strong>Immune complex deposition</strong> in&nbsp;the mesangium without structural changes by light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mesangial proliferative lupus nephritis (class II)</p>\n</td>\n<td>\n<p><strong>Mesangial cell proliferation</strong> with mesangial immune deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal lupus nephritis (class III)</p>\n</td>\n<td>\n<p>Focal, segmental <strong>glomerulonephritis</strong> involving <strong>less than 50%</strong> of all glomeruli.</p>\n<p>Focal subendothelial deposits with or without mesangial changes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse lupus nephritis (class IV)</p>\n</td>\n<td>\n<p>The most common and severe form of lupus nephritis</p>\n<p>Diffuse&nbsp;<strong>glomerulonephritis</strong> involving <strong>more than 50%</strong> of all glomeruli</p>\n<p>Diffuse subendothelial deposits with or without mesangial changes<strong>. &ldquo;Wire loop&rdquo;</strong> structures on light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous lupus nephritis (class V)</p>\n</td>\n<td>\n<p>Global or segmental&nbsp;<strong>subepithelial</strong> immune deposits with or without mesangial proliferation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Advanced sclerosing lupus nephritis (class VI)</p>\n</td>\n<td>\n<p><strong>Sclerosis</strong> of <strong>more than 90%</strong> of the glomeruli&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>Focal- Involves only a few glomeruli</li>\n<li>Diffuse- Involves almost all the glomeruli</li>\n<li>Segmental- Involves only a part of glomerulus</li>\n<li>Global- Involves entire glomerulus</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b83e16725c9e4acbae2e0ff8275ec1a5x1279x911.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Antibodies in Systemic lupus erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates  with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP <br />More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br />More common in blacks and whites </td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br />Primarily 60kDA and 52kDA</td>\n<td>Not Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased  risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br />(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp; β2 G1,<br />Sensitive prothrombin time (DRVVT)<br />Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane </td>\n<td> Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br />This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br />(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5628",
      "difficulty": "hard"
    },
    {
      "text": "For a given drug, animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies on humans. However, potential benefits may warrant the use of the drug in pregnant women despite potential risks. Such a drug would be classified as _____.",
      "choices": [
        {
          "id": 1,
          "text": "Category C"
        },
        {
          "id": 2,
          "text": "Category B"
        },
        {
          "id": 3,
          "text": "Category X"
        },
        {
          "id": 4,
          "text": "Category D"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>For a given drug, <strong>animal reproduction studies</strong> have <strong>shown an adverse effect</strong> on the fetus, but there are <strong>no adequate</strong> and well-controlled <strong>studies</strong> on <strong>humans</strong>. However, potential <strong>benefits may warrant</strong> <strong>the use</strong> of the drug in pregnant women despite potential risks. Such a drug would be classified as <strong>Category C.</strong></p>\n<p> </p>\n<p>The united states food and drug administration (FDA) system for teratogenic potential attempts to quantify teratogenic risk from category A (safe) to category X (definite human teratogenic risk).</p>\n<p><strong>Category A</strong>: The possibility of fetal <strong>harm</strong> <strong>is</strong> <strong>remote</strong> and studies on women have failed to demonstrate any evidence of risk to the fetus. Examples: doxylamine, folic acid, levothyroxine.</p>\n<p><strong>Category B</strong>: Either animal-reproduction studies have not demonstrated a fetal risk, but there are no controlled studies in pregnant women, or animal-reproduction studies have shown an adverse effect that was not confirmed in controlled studies in pregnant women. Example: Amoxicillin, loratadine, ondansetron.</p>\n<p><strong>Category C</strong>: Either studies in animals have revealed adverse effects on the fetus, that is, teratogenic or embryocidal, but there are no controlled studies in women, or studies in women and animals are not available. These drugs should be given only if the potential benefit justifies the potential risk to the fetus. Example: fluconazole, metoprolol, sertraline.</p>\n<p><strong>Category D</strong>: Though there is evidence of human fetal risk, the benefits from use in pregnant women may be acceptable despite the risk, for example, if the drug is needed in a life-threatening situation or for a disease for which safer drugs cannot be used or are ineffective. Example: lisinopril, lithium, phenytoin.</p>\n<p><strong>Category X</strong>: There is evidence of fetal risk based on human or animal experience and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The <strong>drug</strong> is <strong>contraindicated</strong> in women who are or may become pregnant. Example: methotrexate, simvastatin, warfarin.</p>\n<p> </p><hr><h3>Related Pearl: Drug regulatory schedules 1940: (2016 update)</h3><table>\n<tbody>\n<tr>\n<td><strong>Schedule</strong></td>\n<td><strong>Details</strong></td>\n</tr>\n<tr>\n<td>Schedule C</td>\n<td><strong>Biological</strong> and other special products e.g. <strong>Toxins, Insulin, Sera &amp; Antibiotics</strong>.</td>\n</tr>\n<tr>\n<td>Schedule D</td>\n<td>List of drugs <strong>exempted from the provision of import</strong> of drugs.</td>\n</tr>\n<tr>\n<td>Schedule F</td>\n<td>\n<p><strong>Blood</strong> and blood products</p>\n<p>F I - Production of Bacterial <strong>vaccines, Anti- Sera</strong></p>\n<p>F II - Specification of standards for <strong>Surgical dressing</strong></p>\n<p>FF- Specification of standard <strong>Ophthalmic</strong> preparation</p>\n</td>\n</tr>\n<tr>\n<td>Schedule G</td>\n<td>With a label of <strong>Caution, dangerous</strong> to use except under <strong>medical supervision</strong>.</td>\n</tr>\n<tr>\n<td>Schedule H</td>\n<td><strong>Prescription</strong> drugs.</td>\n</tr>\n<tr>\n<td>Schedule J</td>\n<td>List of diseases that a drug may not prevent or cure. Eg - <strong>HIV &amp; Atherosclerosis</strong></td>\n</tr>\n<tr>\n<td>Schedule M</td>\n<td>Regulations regarding good manufacturing practices</td>\n</tr>\n<tr>\n<td>Schedule P</td>\n<td>Regulations regarding&nbsp;the <strong>life period</strong> and storage of various drugs.</td>\n</tr>\n<tr>\n<td>Schedule W</td>\n<td>Drugs marketed under <strong>generic</strong> names.</td>\n</tr>\n<tr>\n<td>Schedule X</td>\n<td>Drugs having <strong>abuse</strong> and dependence liability.</td>\n</tr>\n<tr>\n<td>Schedule Y</td>\n<td>Requirement and guidelines for<strong> import/ manufacture or Clinical trials</strong> in India</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5584",
      "difficulty": "hard"
    },
    {
      "text": "Match the following with the best mode of management:<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>1. Osteosarcoma </td>\n<td>a. Wide excision</td>\n</tr>\n<tr>\n<td>2. Simple bone cyst </td>\n<td>b. Curettage </td>\n</tr>\n<tr>\n<td>3. Giant cell tumor</td>\n<td>c. Radiofrequency ablation </td>\n</tr>\n<tr>\n<td>4. Osteoid osteoma </td>\n<td>d. Intralesional steroid</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-d, 2-c, 3-b, 4-a"
        },
        {
          "id": 2,
          "text": "1-c, 2-a, 3-d, 4-b"
        },
        {
          "id": 3,
          "text": "1-a, 2-d, 3-b, 4-c"
        },
        {
          "id": 4,
          "text": "1-d, 2-a, 3-b, 4-c"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Option C is the correct answer. The given lesions and the correctly matched best modes of management are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Bone tumor</strong></td>\n<td><strong>Management</strong></td>\n</tr>\n<tr>\n<td>\n<p>1. Osteosarcoma</p>\n</td>\n<td>a. Wide excision</td>\n</tr>\n<tr>\n<td>2. Simple bone cyst</td>\n<td>d. Intralesional steroid </td>\n</tr>\n<tr>\n<td>3. Giant cell tumor</td>\n<td>b. Curettage</td>\n</tr>\n<tr>\n<td>4. Osteoid osteoma</td>\n<td>c. Radiofrequency ablation </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Osteosarcoma: </strong>It is a high-grade medullary osteoid-producing tumor. Osteosarcoma is the most common primary malignant tumor of the bone. The preferred method of treatment of osteosarcoma is <strong>wide resection</strong> and reconstruction. This is mainly owing to the possibility of <strong>limb salvage</strong>, and amputation is considered only when tumor-safe surgical margins are compromised.</p>\n<p>Multi-agent <strong>neoadjuvant chemotherapy</strong> with agents like doxorubicin, cisplatin, ifosfamide, and methotrexate is started immediately after diagnosis for 8-12 weeks. The tumor is then re-staged <strong>followed</strong> by <strong>wide resection</strong> and limb reconstruction. </p>\n<p>Radiographic findings: The periosteal reaction is the typical finding<strong> </strong>and it may take the form of a <strong>Codman's triangle</strong> or it may have a <strong>sunburst (sunray) appearance </strong>on X-ray. It is shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6bbcb6ac21d5419ca54da4e7f9d8a532x720x765.JPEG\" alt=\"Explanation Image\"><p><strong>Simple bone cyst: </strong>These are cystic bone cavities that are often solitary and unilocular filled with serous or serosanguinous material. The lesions usually regress with bone maturity. In cases where the <strong>lesions</strong> are <strong>active</strong>, <strong>injection of steroids</strong> is done. Only when there is a high risk of fracture, curettage, or fixation and stabilization may be required. </p>\n<p>It is seen as a well-outlined lytic centrally placed lesion with cortical thinning on X-ray. When there is a fracture, a small fragment may be visualized within the cavity, known as the <strong>fallen leaf sign</strong>. The image below shows a bone cyst in the humerus along with a pathological fracture and fallen leaf sign </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b19243db00df4a3c8cf9902578e1c93ax432x906.JPEG\" alt=\"Explanation Image\"><p><strong>Giant cell tumor:</strong> It is a benign, locally aggressive tumor of the bone due to the proliferation of mononuclear cells with scattered macrophages. They are noticed mostly when there is cortical erosion with or without soft tissue compromise (stages 2 or 3). </p>\n<p>In <strong>stages 1 and 2</strong>, <strong>intralesional curettage</strong> with debridement of the lesional wall is effective. <strong>Stage 3</strong> of the disease can be treated through <strong>curettage</strong> but some cases require <strong>en-bloc resection</strong>. Antibodies like denosumab (anti-RANKL) have been effective in controlling osteoclastic activity. </p>\n<p>Radiographic findings: </p>\n<ul>\n<li><strong>Eccentrically</strong> located <strong>solitary</strong> lytic lesion in the <strong>metaphyses</strong></li>\n<li><strong>Soap bubble appearance</strong></li>\n<li>Periosteal new bone formation is absent.</li>\n</ul>\n<p>Below image shows Soap bubble appearance seen in giant cell tumor.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b22b9260101a44219656ea2a6e877fc6x720x912.JPEG\" alt=\"Explanation Image\"><p><strong>Osteoid osteoma</strong>: It is a benign tumor formed of osteoid and woven bone surrounded by a halo of reactive bone. The preferred method of treatment in this condition is CT-guided <strong>radiofrequency ablation</strong> to eradicate the lesion and improve symptoms.</p>\n<p>Radiography shows a sclerotic peripheral rim with central radiolucent nidus.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6abc48aeccac45e4acc3c5cc78a73cf4x1280x1999.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Summary of Bone Tumors</h3><table>\n<tbody>\n<tr>\n<td><strong>Bone tumor</strong></td>\n<td><strong>Most common site</strong></td>\n<td><strong>Age</strong></td>\n</tr>\n<tr>\n<td>Simple bone cyst</td>\n<td>Proximal Humeral Metaphysis</td>\n<td>&lt;20years</td>\n</tr>\n<tr>\n<td>Enchondroma</td>\n<td>\n<p>Hand bones</p>\n<p>(Metaphysis of small bones of hand)</p>\n</td>\n<td>\n<p>4<sup>th</sup>&nbsp;&amp; 5<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteochondroma</p>\n<p>(Exostosis)</p>\n</td>\n<td>Distal Femoral Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteoid osteoma</td>\n<td>Diaphysis of Femur</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>Osteoblastoma</td>\n<td>Posterior column of vertebra</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteoclastoma (GCT)</p>\n</td>\n<td>Distal femoral epiphysis</td>\n<td>\n<p>2<sup>nd</sup> -4<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>Aneurysmal Bone Cyst</td>\n<td>Long bone Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteosarcoma</td>\n<td>Distal Femoral Metaphysis</td>\n<td>\n<p>BIMODAL</p>\n<p>Primary- 2<sup>nd</sup> Decade Secondary-6<sup>th</sup> and 7<sup>th</sup> Decade</p>\n</td>\n</tr>\n<tr>\n<td>Ewings sarcoma</td>\n<td>Diaphysis of Femur</td>\n<td>5-25 years</td>\n</tr>\n<tr>\n<td>Chondrosarcoma</td>\n<td>Any site in the bone - mc in proximal femur</td>\n<td>3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Clear cell chondrosarcoma</td>\n<td>Proximal femoral epiphysis</td>\n<td>&nbsp;3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Adamantinoma</td>\n<td>Diaphysis of Tibia</td>\n<td>&nbsp;20-40 years</td>\n</tr>\n<tr>\n<td>&nbsp;Fibrous dysplasia</td>\n<td>&nbsp;The upper end of femur &gt; tibia</td>\n<td>&nbsp;1st to 3rd decade</td>\n</tr>\n<tr>\n<td>&nbsp;Chordoma</td>\n<td>&nbsp;Sacrum</td>\n<td>&nbsp;5th to 7th decade</td>\n</tr>\n<tr>\n<td>Multiple myeloma</td>\n<td>Vertebrae</td>\n<td>5th to 7th decade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5654",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following post-mortem changes is a result of hydrolysis of lipids under warm and humid weather?",
      "choices": [
        {
          "id": 1,
          "text": "Image 1"
        },
        {
          "id": 2,
          "text": "Image 2"
        },
        {
          "id": 3,
          "text": "Image 3"
        },
        {
          "id": 4,
          "text": "Image 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Hydrolysis of lipids</strong> under warm and humid weather would result in <strong>adipocere formation</strong>, which is seen in <strong>image 4.&nbsp;</strong></p>\n<p>Postmortem changes are classified on the basis of time:</p>\n<ul>\n<li>Immediate signs of death (at the time of somatic or clinical death):\n<ol>\n<li>Insensibility and loss of voluntary power</li>\n<li>Cessation of respiration</li>\n<li>Cessation of circulation</li>\n</ol>\n</li>\n<li>Early signs of death. It is seen in cellular death:\n<ol>\n<li>Pallor and loss of elasticity of the skin</li>\n<li>Eye changes</li>\n<li>Primary flaccidity of muscles</li>\n<li><strong>Algor mortis</strong>/Postmortem cooling</li>\n<li>Postmortem lividity/<strong>Suggillation</strong></li>\n<li><strong>Rigor mortis</strong></li>\n</ol>\n</li>\n<li>Late signs of death:\n<ol>\n<li>Putrefaction</li>\n<li><strong>Adipocere</strong></li>\n<li>Mummification</li>\n</ol>\n</li>\n</ul>\n<p><strong>Adipocere&nbsp;formation </strong>(Image 4) is a&nbsp;<strong>late sign</strong>&nbsp;of death.&nbsp;The transformation is brought about by the <strong>gradual hydrolysis </strong>and <strong>hydrogenation</strong> of pre-existing fats, including olein, into higher fatty acids. These higher fatty acids then join with calcium and ammonium ions to produce insoluble soaps, which since they are acidic, prevent putrefactive bacteria. The usual time for adipocere formation is between 3 to 6 months. Still, in countries like India, it is accelerated by the&nbsp;<strong>warm and humid</strong>&nbsp;weather, resulting in the beginning of adipocere formation as early as <strong>4&nbsp;to 5 days</strong>&nbsp;after death.&nbsp;</p>\n<p>Image 1. <strong>Marbling</strong>:&nbsp;It is&nbsp;seen when blood in the vessels is&nbsp;<strong>hemolyzed to sulfate-hemoglobin</strong>, which&nbsp;<strong>stains the vessel walls</strong>&nbsp;and the adjacent tissues, giving rise to a&nbsp;<strong>marbled appearance</strong>. The marbling of the skin&nbsp;<strong>begins&nbsp;</strong>at&nbsp;about&nbsp;<strong>24 hours</strong>&nbsp;and becomes prominent&nbsp;&nbsp;<strong>36&ndash;48 hours</strong>&nbsp;after death.&nbsp;It is a visible postmortem change that is characterized by linear branching patterns on skin that correspond to the course of superficial veins&nbsp;of the abdomen, shoulders, chest, and inguinal region.</p>\n<p>Image 2. Cadaveric lividity:&nbsp;<strong>Postmortem hypostasis/Postmortem staining/Postmortem lividity/Livor mortis/Suggilation&nbsp;</strong>refers to bluish-purple or<strong>&nbsp;reddish-purple discoloration</strong>&nbsp;of the skin due to the collection of blood in most superficial layers of the dermis in the dependent parts&nbsp;of the body.&nbsp;Fixation of hypostasis&nbsp;occurs&nbsp;6 &ndash; 12 hours after death and persists until putrefaction sets in.</p>\n<p>Image 3.&nbsp;Mummification:&nbsp;It occurs in the absence of moisture in the air and continuous action of<strong> dry or warmed air.&nbsp;</strong>It is a process of&nbsp;<strong>dehydration</strong>&nbsp;or drying and&nbsp;<strong>shriveling</strong>&nbsp;of the&nbsp;<strong>cadaver</strong>&nbsp;that occurs from the&nbsp;<strong>evaporation</strong>&nbsp;of&nbsp;<strong>water.</strong>&nbsp;The natural appearances of the body and general facial features are preserved.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4a00578e22ba425c88b391ae61663711.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5528",
      "difficulty": "easy"
    },
    {
      "text": "Performing a myringoplasty would be contraindicated in all of the following, except:",
      "choices": [
        {
          "id": 1,
          "text": "Child of age 5 years"
        },
        {
          "id": 2,
          "text": "Presence of otitis externa"
        },
        {
          "id": 3,
          "text": "Presence of uncontrolled nasal allergy"
        },
        {
          "id": 4,
          "text": "Presence of active discharge from middle ear"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>&nbsp;Child of age &lt;3 years</strong> (not 5 years) is a <strong>contraindication</strong> for performing <strong>myringoplasty.</strong></p>\n<p><strong>Myringoplasty</strong> is the term given for the <strong>closure of perforation of pars tensa of tympanic membrane.&nbsp;</strong>It is done to check repeated infections from the external ear.</p>\n<p><strong>Contraindications for Myringoplasty:</strong></p>\n<ol>\n<li>Active discharge from the middle ear.</li>\n<li>Uncontrolled nasal allergy.</li>\n<li>Otitis externa.</li>\n<li>Ingrowth of squamous epithelium into the middle ear. In such cases, excision of squamous epithelium from the middle ear or a tympanomastoidectomy may be required.</li>\n<li>When the other ear is dead or not suitable for hearing aid rehabilitation.</li>\n<li>Children below 3 years.</li>\n</ol>\n<p>Myringoplasty techniques are based on the relation of the graft with lamina propria of tympanic membrane remnants and fibrous annulus.</p>\n<p>In&nbsp;the&nbsp;<strong>underlay</strong> technique,<strong>&nbsp;</strong>the <strong>graft</strong> is placed <strong>medial</strong> to the <strong>annulus.</strong> Whereas, in the <strong>overlay</strong> technique,&nbsp;the graft is placed<strong> lateral</strong> to the <strong>annulus. </strong>The graft<strong>&nbsp;</strong>is medial to malleus in both techniques.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/242ec9e7cd5a4bb19b4b0e295272ae77x1280x2558.194640338505.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5546",
      "difficulty": "medium"
    },
    {
      "text": "A worried mother brings her 18-month-old son to OPD with complaints of repeated urinary tract infections. During diagnostic work-up, pelvic USG shows the following finding. What is the definitive management for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Ureteric stenting"
        },
        {
          "id": 2,
          "text": "Transurethral ablation of leaflets"
        },
        {
          "id": 3,
          "text": "Urethral stenting"
        },
        {
          "id": 4,
          "text": "Percutaneous vesicostomy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario with the USG showing the <strong>key-hole sign</strong> suggests the presence of a <strong>posterior urethral valve (PUV)</strong>. It is seen due to dilatation of the bladder and the proximal urethra. <strong>Transurethral ablation of leaflets</strong> is the <strong>definitive management</strong> for this condition.</p>\n<p>The posterior urethral valves are <strong>membranes</strong> that have a small posterior slit, which lies just <strong>distal to the verumontanum. </strong>They function as flap valves and are <strong>obstructive to antegrade urinary flow</strong>.</p>\n<p>The PUV is the most common congenital cause of bladder outlet obstruction in males. PUV is classified into three types based on <strong>Young's classification.</strong></p>\n<div class=\"page\" title=\"Page 1498\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diagnosis is made <strong>antenatally</strong> with <strong>ultrasound</strong>, which demonstrates <strong>bilateral hydronephrosis above a distended bladder</strong>. If the diagnosis is not made antenatally, then neonates typically present with urinary infection or <strong>uremia</strong> and <strong>renal failure</strong>. </p>\n<div class=\"page\" title=\"Page 1498\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The investigation of choice for a posterior urethral valve is <strong>micturating cystourethrography (MCUG).</strong></p>\n<p>Initially, the obstruction is relieved by <strong>catheterization</strong> to preserve renal function. Definitive treatment is by <strong>urethroscopic destruction of the valves </strong>with lifelong supportive treatment. </p>\n<p>The following MCUG shows vesicoureteric reflux due to posterior urethral valves:</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/92222870b817434f822033561d0ba3e8x790x786.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/cf999e004cf44021b8fc5e1385294171.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5575",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following act via the Phospholipase C Second Messenger System?",
      "choices": [
        {
          "id": 1,
          "text": "Angiotensin II on vascular smooth muscle and Vasopressin via V1 receptor on vascular smooth muscle"
        },
        {
          "id": 2,
          "text": "Angiotensin II on vascular smooth muscle and Vasopressin via V2 receptor on epithelial cells"
        },
        {
          "id": 3,
          "text": "Angiotensin II on epithelial cells and Vasopressin via V1 receptor on vascular smooth muscle"
        },
        {
          "id": 4,
          "text": "Angiotensin II on epithelial cells and Vasopressin via V2 receptor on epithelial cells"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Angiotensin II on vascular smooth</strong> <strong>muscle</strong> and <strong>Vasopressin via V1</strong> receptor on <strong>vascular smooth muscle</strong> act via the&nbsp;<strong>Phospholipase C Second Messenger</strong> System.</p>\n<p>Angiotensin II on <strong>epithelial</strong> cells and Vasopressin via <strong>V2</strong> receptor on <strong>epithelial</strong> cells act via the&nbsp;<strong>Adenylyl Cyclase&ndash;cAMP Second Messenger System</strong></p><hr><h3>Related Pearl: Mechanisms of Action of Hormones</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Types of hormone receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to intracellular receptors</strong></td>\n</tr>\n<tr>\n<td rowspan=\"3\">Cytoplasmic receptors</td>\n<td>Glucocorticoids</td>\n</tr>\n<tr>\n<td>Mineralocorticoids</td>\n</tr>\n<tr>\n<td>Androgens</td>\n</tr>\n<tr>\n<td> </td>\n<td>Vitamin D</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Nuclear receptors</td>\n<td>Thyroid hormones</td>\n</tr>\n<tr>\n<td>Vitamins A</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to cell surface receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">1. <strong>G-protein coupled receptors</strong> (GPCR)</td>\n</tr>\n<tr>\n<td rowspan=\"9\"><strong>Gs</strong>: stimulation of second messenger cAMP</td>\n<td>ACTH, CRH</td>\n</tr>\n<tr>\n<td>TSH, GHRH</td>\n</tr>\n<tr>\n<td>FSH, LH, hCG</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Catecholamines (β receptors)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td>Glucagon</td>\n</tr>\n<tr>\n<td>Secretin</td>\n</tr>\n<tr>\n<td>Parathyroid hormone</td>\n</tr>\n<tr>\n<td rowspan=\"3\"><strong>Gi: </strong>inhibition of second messenger cAMP</td>\n<td>Catecholamines (ɑ<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Acetylcholine (M2, M4)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td rowspan=\"11\">\n<p><strong>Gq</strong>: second messenger is phospholipase C or cGMP</p>\n</td>\n<td><strong>Phospholipase C (IP3 DAG pathway):</strong></td>\n</tr>\n<tr>\n<td>GnRH, GHRH, TRH</td>\n</tr>\n<tr>\n<td>Catecholamines (ɑ<sub>1</sub> receptors)</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>1</sub> receptor)</td>\n</tr>\n<tr>\n<td>Gastrin</td>\n</tr>\n<tr>\n<td>Cholecystokinin</td>\n</tr>\n<tr>\n<td>Oxytocin</td>\n</tr>\n<tr>\n<td>Acetylcholine (M1, M3, M5)</td>\n</tr>\n<tr>\n<td><strong>cGMP:</strong></td>\n</tr>\n<tr>\n<td>Atrial natriuretic peptide</td>\n</tr>\n<tr>\n<td>Nitric oxide</td>\n</tr>\n<tr>\n<td colspan=\"2\">2. <strong>Tyrosine kinase</strong> receptors</td>\n</tr>\n<tr>\n<td rowspan=\"5\">Through the <strong>JAK-STAT</strong> (non-receptor tyrosine kinase) or <strong>MAP kinase</strong> (receptor tyrosine kinase) pathway </td>\n<td>Growth factors like IGF, VEGF, FGF, PDGF</td>\n</tr>\n<tr>\n<td>Growth hormone</td>\n</tr>\n<tr>\n<td>Erythropoietin</td>\n</tr>\n<tr>\n<td>Insulin</td>\n</tr>\n<tr>\n<td>Prolactin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br />Notes: <br />1. Even though the cytoplasmic receptors are present in the cytoplasm, once the <strong>hormone-receptor complex</strong> is formed it moves to the <strong>nucleus</strong> for its actions.</p>\n<p>2. <strong>Vitamin D</strong> is a <strong>cytoplasmic receptor.</strong> All intracellular receptors are inherently nuclear receptors as they bind and get activated at the nucleus as mentioned above but they have two sites of primary action- cytoplasm and nucleus. </p>\n<p>3. While receptor tyrosine kinases have intrinsic tyrosine kinase activity, non-receptor tyrosine kinases have an external tyrosine kinase component that interacts with the receptor as and when required. </p><hr><h3>Related Pearl: Membrane receptors and their mechanisms</h3><p><strong>1. G protein coupled receptor(GPCR)</strong></p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;<strong>Effect</strong></td>\n<td><strong>2nd messenger</strong></td>\n<td>&nbsp;<strong>Action</strong></td>\n</tr>\n<tr>\n<td>Gs</td>\n<td>Activates adenylate cyclase</td>\n<td>Stimulation of cAMP production</td>\n<td>Activates protein kinase A</td>\n</tr>\n<tr>\n<td>Gi</td>\n<td>Inhibits adenylate cyclase</td>\n<td>Inhibition of cAMP production</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Gq</td>\n<td>Activates phospholipase C</td>\n<td>Liberate DAG and IP3 which mobilize Ca2+ from endoplasmic reticulum</td>\n<td>Activates protein kinase C</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><strong>2. Guanylyl cyclase receptor</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Effector</strong></td>\n<td><strong>2nd messenger</strong></td>\n</tr>\n<tr>\n<td>Guanylyl cyclase</td>\n<td>Stimulation of cGMP production</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><strong>3. Receptor tyrosine kinase</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Effector</strong></td>\n<td><strong>2nd messenger</strong></td>\n</tr>\n<tr>\n<td>Tyrosine kinase</td>\n<td>MAP kinase</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><strong>4. Cytokine receptor tyrosine kinase</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Effector</strong></td>\n<td><strong>2nd messenger</strong></td>\n</tr>\n<tr>\n<td>JAK, tyrosine kinase</td>\n<td>STAT, MAP kinase</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><strong>5. Serine kinase</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Effector</strong></td>\n<td><strong>2nd messenger</strong></td>\n</tr>\n<tr>\n<td>Serine kinase</td>\n<td>Smads</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5557",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following processes occur within the mitochondria?<div class='question-desc-html'><ol>\n<li>Fatty acid oxidation (&beta;oxidation)</li>\n<li>Acetyl CoA production</li>\n<li>Glycolysis</li>\n<li>Ketogenesis</li>\n<li>HMP Shunt</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, 4"
        },
        {
          "id": 2,
          "text": "1, 2, 4"
        },
        {
          "id": 3,
          "text": "2, 3, 5"
        },
        {
          "id": 4,
          "text": "1, 2, 4, 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Glycolysis</strong> and <strong>HMP shunt</strong> occur in the <strong>cytoplasm</strong>, not within the mitochondria.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Sites of various pathways in cell</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Sites of metabolism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mitochondria</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fatty acid oxidation (&beta;oxidation)</p>\n<p>Acetyl CoA production</p>\n<p>TCA Cycle</p>\n<p>Oxidative phosphorylation</p>\n<p>Ketogenesis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cytoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glycolysis</p>\n<p>HMP Shunt</p>\n<p>Synthesis of steroids(SER)</p>\n<p>Proteins (RER and Ribosomes)</p>\n<p>Fatty acids</p>\n<p>Cholesterol</p>\n<p>Nucleotides</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Both</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heme synthesis</p>\n<p>Urea cycle</p>\n<p>Gluconeogenesis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Phases of HMP Shunt and the Enzymes Involved</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phases</strong></p>\n</td>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Irreversible oxidative phase</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Glucose-6-phosphate dehydrogenase</p>\n<p>6-Phosphogluconate dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reversible non-oxidative phase</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>3-Epimerase or Keto-isomerase</p>\n<p>Transketolase</p>\n<p>Transaldolase</p>\n<p>Phosphohexose isomerase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5482",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following methods uses specialized RT-PCR  to amplify the ends of mRNA transcripts?",
      "choices": [
        {
          "id": 1,
          "text": "RACE-PCR"
        },
        {
          "id": 2,
          "text": "Multiplex PCR"
        },
        {
          "id": 3,
          "text": "Nested PCR"
        },
        {
          "id": 4,
          "text": "Droplet digital PCR"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Rapid Amplification of cDNA Ends PCR</strong>, or <strong>RACE-PCR</strong>, is used to amplify the ends of messenger RNA (mRNA) transcripts using a specialized reverse transcription-polymerase chain reaction.</p>\n<p><strong>Polymerase chain reaction (PCR): </strong>PCR<strong> </strong>is a rapid automated method for the amplification of specific DNA sequences (or genes). </p>\n<p><strong>Reverse transcriptase PCR: </strong>The enzyme reverse transcriptase (RT) is used to synthesize a complimentary copy of DNA (cDNA) from RNA, and this cDNA is then used as a template for PCR.</p>\n<p>Using the known information from the center of the transcript, RACE-PCR allows the amplification of an unknown end portion of the transcript via a specialized reverse transcription-polymerase chain reaction (RT-PCR). RACE-PCR is also referred to as <strong>one-sided PCR</strong> or <strong>anchored PCR.</strong></p>\n<p><strong>Other special PCR types:</strong></p>\n<p><strong>Nested PCR:</strong> It involves the sequential use of <strong>two primer sets</strong>. The first primer set is used for amplification and the target sequence for the second primer is present only on the amplicon with the target sequence. Nested PCR is intended to reduce non-specific binding due to the amplification of unexpected primer binding sites.</p>\n<p> </p>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/24a6c67a71c147d48c2461e68e660e4ex1120x1354.PNG\" alt=\"Explanation Image\"><p><strong>Multiplex PCR:</strong> Multiple primers are used to amplify several DNA sequences simultaneously. As this process targets multiple genes at once, a single test run gives additional information that would otherwise require several times the reagents and technician time to perform. </p>\n<p><strong>Droplet digital PCR</strong> (ddPCR): ddPCR is an advanced and <strong>more precise</strong> type of <strong>quantitative PCR</strong>,<strong> </strong>which gives more consistent and reproducible results.<strong> </strong>It can <strong>accurately quantify</strong> the target nucleic acid sequence within a sample. It is useful for determining somatic mutation with low allele frequency. Mutant alleles of frequency as low as 0.25% can also be detected using this technique. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5479",
      "difficulty": "hard"
    },
    {
      "text": "Identify the instrument given below.",
      "choices": [
        {
          "id": 1,
          "text": "Proctoscope"
        },
        {
          "id": 2,
          "text": "Sims' speculum"
        },
        {
          "id": 3,
          "text": "Cusco’s speculum"
        },
        {
          "id": 4,
          "text": "Doyen's retractor"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The instrument shown in the image is<strong>&nbsp;a proctoscope.&nbsp;</strong></p>\n<p>A&nbsp;lubricated proctoscope to visualize lesions in the anus, anorectal junction, and lower rectum. Proctoscopy is done as an OPD procedure to detect hemorrhoids, polyps, or ulcers</p>\n<p><strong>Cusco&rsquo;s speculum</strong> is a self-retaining bivalve speculum used for <strong>visualisation of the cervix</strong>, <strong>vaginal fornices </strong>and for performing <strong>pap smear</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5d83f3c769c54152b53b9d75fc43e50cx360x270.JPEG\" alt=\"Explanation Image\"><p><strong>Sims' speculum</strong><strong>&nbsp;</strong>is used for the assessment of <strong>rectocele and cystocele</strong>. The speculum is applied against the vaginal wall and slowly retracted out until a bulge appears, indicating cystocele or rectocele.&nbsp; It can also be used for <strong>visualization of the vaginal walls</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/038269f5325540f2bc86d1514c63f589x360x270.JPEG\" alt=\"Explanation Image\"><p><strong>Doyen's retractor&nbsp;</strong>is used to retract the abdominal wall as well as the bladder to facilitate better exposure of the lower uterine segment during cesarian operation. It is also used to pull back the soft tissues to widen the surgical field during laparotomy.</p>\n<p>The image below shows Doyen's retractor.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/23156d3a9ed24d9ab277de68ad03bd7dx1279x1116.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Instruments in OBG</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59138be1e8d141fe9ebaef4f7e659432x1181x870.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/733db2f903e2492a86c5426c9474709bx1280x938.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1d44522851ed42ec8da170d61c415f12x1159x933.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8cbd2117a78e4c31a4487cddaa43a2c2x871x617.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d38c784ac734fa3ace7fd390520778ax880x699.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/47aee7f73b87421a9faa3402828666bfx953x721.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/072c8ca058fd4f4d92e6ae299cfdbd04x735x592.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/05dc8444e062403f8c826a7ad52c00d9x759x574.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f40b790592224b05ac1d680696b5c5bcx806x609.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2af70bdfbb4f4253992b9813d001f51dx800x600.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/42a06419caad4e8bb379998dfc73f30cx953x691.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1260a318cf0049718c5175a47f084400x855x654.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/46a8dbc68e894ba8b91d4c14d19b515ex771x677.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4b753a73ddde4ea2acc7c461fb7292a8x762x739.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/26a35cac6bd747bf957fed883a1fd850x922x638.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/91c0754e8b4846c0a6325cbf2e4f8721x1203x701.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/12052a1ae2a64be6937c40bbc4009652x750x705.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/935ba820c75f489ab3488c7270fc9c8b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5639",
      "difficulty": "easy"
    },
    {
      "text": "When should the screening for aggressive posterior retinopathy of prematurity be done for an infant born at 27 weeks of gestation?",
      "choices": [
        {
          "id": 1,
          "text": "4 weeks of postnatal age"
        },
        {
          "id": 2,
          "text": "6 weeks of postnatal age"
        },
        {
          "id": 3,
          "text": "3 weeks of postnatal age"
        },
        {
          "id": 4,
          "text": "2 weeks of postnatal age"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Screening for retinopathy of prematurity</strong> for an <strong>infant born at 27 weeks</strong> of gestation should be done at&nbsp;<strong>3 weeks of postnatal age.</strong></p>\n<p>Usually the <strong>first screening</strong> examination for <strong>ROP</strong> should be carried out at <strong>32 weeks Post Menstrual Age or 4 weeks Post Natal Age</strong>, whichever is later.</p>\n<p>But, for infants<strong> less than 28 weeks</strong>, screening is done at <strong>3 weeks PNA</strong> to detect APROP.&nbsp;<strong>Aggressive posterior (\"rush\" disease, AP-ROP)</strong> is uncommon, but if untreated, usually <strong>progresses</strong> to <strong>total retinal detachment (stage 5),</strong>&nbsp;sometimes within a few days. It is characterized by its <strong>posterior location, prominence</strong> of <strong>plus disease,</strong> and ill-defined nature of the retinopathy.</p>\n<p>The critical phase during screening is 34 to 38 weeks, when the infant is likely to reach the threshold stage of the disease and may require treatment for the prevention of blindness.</p><p>&nbsp;</p>\n<p>Retinopathy of prematurity occurs in&nbsp;<strong>premature infants</strong>&nbsp;with low birth weight, with a typical history of&nbsp;<strong>exposure to oxygen</strong>&nbsp;in&nbsp;<strong>high concentrations</strong>&nbsp;leading to bilateral proliferative retinopathy.&nbsp;</p>\n<p>Stages of Retinopathy of Prematurity:</p>\n<ul>\n<li>Stage 1- demarcation line formation at the edge of vessels, dividing the vascular from the avascular retina.</li>\n<li>Stage 2- intraretinal ridge formation</li>\n<li>Stage 3- ridge with extraretinal fibrovascular proliferation into the vitreous.</li>\n<li>Stage 4-&nbsp;subtotal retinal detachment</li>\n<li>Stage 5- total retinal detachment</li>\n<li><strong>'Plus' disease</strong>&nbsp;is characterized by&nbsp;<strong>dilatation</strong>&nbsp;and<strong>&nbsp;tortuosity of blood vessels</strong>&nbsp;in&nbsp;<strong>at least two quadrants</strong>&nbsp;of the&nbsp;<strong>posterior fundus</strong>. It signifies the progression of the disease.</li>\n</ul>\n<p>Location:</p>\n<p>Zone I: Circular area with a radius twice the distance from disc to the fovea, with the disc as the center. (as shown in the image)<br />Zone II: It covers the area beyond zone I circumferentially till nasal ora serrata.<br />Zone III: It consists of residual temporal crescent anterior to zone II.</p>\n<p><strong>Treatment</strong>&nbsp;is based on&nbsp;<strong>guidelines</strong>&nbsp;set by the early treatment of retinopathy of prematurity trial (<strong>ETROP</strong>).</p>\n<p><strong>Type 1</strong>: Treatment within 72 hours (<strong>High risk</strong>)</p>\n<ul>\n<li>Any ROP + plus disease</li>\n<li>Stage 3 ROP in zone I</li>\n<li>Stage 2/3 in zone II + plus disease.</li>\n</ul>\n<p><strong>Type 2</strong>: Observation (<strong>Low risk</strong>)</p>\n<ul>\n<li>Stage 1/2 in zone I only and no plus disease</li>\n<li>Stage 3 ROP within zone II and no plus disease.</li>\n</ul>\n<p>This can be summarized in the table below:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp; Stage 1</td>\n<td>&nbsp; Stage 2</td>\n<td>&nbsp; Stage 3</td>\n</tr>\n<tr>\n<td>Zone I</td>\n<td>Observation</td>\n<td>Observation</td>\n<td>Treatment</td>\n</tr>\n<tr>\n<td>Zone II - without plus disease</td>\n<td>&nbsp;</td>\n<td>Observation&nbsp;</td>\n<td>Observation</td>\n</tr>\n<tr>\n<td>Zone II- with plus disease</td>\n<td>&nbsp;</td>\n<td>Treatment</td>\n<td>Treatment</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>ROP of<strong>&nbsp;any stage</strong>&nbsp;in&nbsp;<strong>any zone,&nbsp;</strong>if associated<strong>&nbsp;with 'plus' disease,&nbsp;</strong>should<strong>&nbsp;</strong>receive&nbsp;<strong>treatment urgently.</strong></p>\n<p><strong>Treatment</strong>&nbsp;includes&nbsp;<strong>laser ablation</strong>&nbsp;of the avascular peripheral retina,&nbsp;<strong>anti-VEGF medication</strong>&nbsp;(bevacizumab), and pars plana&nbsp;<strong>vitrectomy</strong>&nbsp;for advanced disease. The high-risk patients requiring treatment should receive it within 72 hours.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f495b4239db446a4bc7a6e2add9dbe55x510x2089.GIF\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5542",
      "difficulty": "hard"
    },
    {
      "text": "As per the Drugs and Cosmetics Act, you would call a drug as misbranded in all of the following situations, except _____.",
      "choices": [
        {
          "id": 1,
          "text": "If it is made to appear of better or greater therapeutic value than it really is"
        },
        {
          "id": 2,
          "text": "If its label or container or anything accompanying the drug bears any false claim for the drug"
        },
        {
          "id": 3,
          "text": "If it is not labelled in the prescribed manner"
        },
        {
          "id": 4,
          "text": "If it is imported under a name that belongs to another drug"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>If a drug is <strong>imported</strong> <strong>under a name</strong> <strong>that belongs to another drug</strong>, it is considered a <strong>spurious drug</strong>.</p>\n<p><br />As per the Drugs and Cosmetics Act, a drug shall be deemed to be <strong>misbranded</strong> if</p>\n<ol>\n<li>It is made to appear of better or <strong>greater therapeutic value than it really is</strong></li>\n<li>It is <strong>not labeled</strong> in the <strong>prescribed manner</strong></li>\n<li>Its label or container or anything accompanying the drug bears <strong>any false claim</strong> for the drug</li>\n</ol>\n<p>&nbsp;</p>\n<p>As per the Drugs and Cosmetics Act, a drug shall be deemed to be <strong>spurious</strong> if</p>\n<ol>\n<li>It is imported under a <strong>name that belongs to another drug</strong></li>\n<li>It imitates/ resembles another drug in a manner likely to <strong>deceive</strong></li>\n<li>The <strong>manufacturer name is bogus</strong> (labeling a knock-off as a product of an established brand or manufacturing under a fake/non-existent identity)</li>\n<li>It has been <strong>substituted</strong>&nbsp; by another drug or substance&nbsp;<strong>wholly or in part</strong></li>\n</ol>\n<p><strong>Adulterated drugs</strong>&nbsp;include those drugs that contain&nbsp;<strong>filthy</strong>, or decomposed&nbsp;<strong>substances;</strong>&nbsp;substances that are&nbsp;<strong>injurious to health;</strong>&nbsp;or harmful substances that are added to&nbsp;<strong>reduce&nbsp;</strong>the<strong>&nbsp;quality&nbsp;</strong>or<strong>&nbsp;strength&nbsp;</strong>of the drug. It also includes drugs that were prepared in unsanitary conditions.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5488",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following statements is false regarding ligature strangulation?",
      "choices": [
        {
          "id": 1,
          "text": "Injury to muscles of the neck is commonly seen"
        },
        {
          "id": 2,
          "text": "Subcutaneous tissue underneath the ligature mark is usually hard, white, and glistening"
        },
        {
          "id": 3,
          "text": "Abrasions and  ecchymoses  are commonly present"
        },
        {
          "id": 4,
          "text": "Dribbling of saliva is very rarely seen in the victim"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Subcutaneous tissue</strong> underneath the ligature mark is usually <strong>hard, white, and glistening</strong> in cases of <strong>hanging</strong>, not ligature strangulation. In cases of <strong>ligature strangulation</strong>, the subcutaneous tissue appears <strong>ecchymosed</strong>.</p>\n<p><strong>Strangulation</strong> is a type of <strong>asphyxia</strong> where there is <strong>neck constriction without suspension</strong> of the body. The pressure on the neck is applied either by bare hands, a ligature or by any other instrument.</p>\n<div class=\"page\" title=\"Page 227\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>When strangulation is done by using a ligature, like a constricting band or rope, it is called ligature strangulation. The constricting band is tightened by a force other than the victim's body weight. It is characterized by the&nbsp;<strong>ligature mark</strong>&nbsp;which is <strong>transverse</strong> and completely encircling the neck below the thyroid cartilage. There is&nbsp;<strong>no dribbling</strong> of saliva. Bleeding may be present in the ears, nose, and mouth.</p>\n<p>Ligature and manual strangulations are mostly homicidal. Marks of violence are usually seen on other parts of the body.&nbsp;</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Difference between strangulation by Ligature and Hanging</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Trait</strong></p>\n</td>\n<td>\n<p><strong>Hanging</strong></p>\n</td>\n<td>\n<p><strong>Strangulation by ligature</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nature of death</p>\n</td>\n<td>\n<p>Mostly suicidal</p>\n</td>\n<td>\n<p>Mostly homicidal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Face</p>\n</td>\n<td>\n<p>Usually pale and petechiae are rare</p>\n</td>\n<td>\n<p>Congested, livid, and marked with petechiae</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tongue</p>\n</td>\n<td>\n<p>Swelling and protrusion is less marked</p>\n</td>\n<td>\n<p>Swelling and protrusion is more marked</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bleeding</p>\n</td>\n<td>\n<p>Bleeding from the nose, mouth, and ears is not common</p>\n</td>\n<td>\n<p>Bleeding from the nose, mouth, and ears may be found</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Saliva</p>\n</td>\n<td>\n<p>Often dribbles out of the mouth</p>\n</td>\n<td>\n<p>Dribbling of saliva is very rare</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ligature mark</p>\n</td>\n<td>\n<p>Oblique, non-continuous, placed high up in the neck between the chin and the larynx.&nbsp;</p>\n<p>The subcutaneous tissue underneath the mark is usually hard, white, and glistening</p>\n</td>\n<td>\n<p>Horizontal or transverse, continuous around the neck, low down in the neck below or across the thyroid.&nbsp; &nbsp;</p>\n<p>Subcutaneous tissue underneath may be ecchymosed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Abrasions and</p>\n<p>ecchymoses</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Injury to muscles of</p>\n<p>neck</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carotid arteries</p>\n</td>\n<td>\n<p>Internal coats are usually ruptured in violent cases of a long drop (Amussat's sign)</p>\n</td>\n<td>\n<p>Damage to the internal coat is rare</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyoid bone fracture</p>\n</td>\n<td>\n<p>Less common</p>\n</td>\n<td>\n<p>Less common (common in manual strangulation)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thyroid cartilage fracture</p>\n</td>\n<td>\n<p>Less common</p>\n</td>\n<td>\n<p>More common</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cervical vertebrae fracture or dislocation</p>\n</td>\n<td>\n<p>Common in judicial hanging</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5526",
      "difficulty": "medium"
    },
    {
      "text": "Fibers of the fornix terminate at which of the following structures?",
      "choices": [
        {
          "id": 1,
          "text": "Amygdala"
        },
        {
          "id": 2,
          "text": "Hippocampus"
        },
        {
          "id": 3,
          "text": "Caudate nucleus"
        },
        {
          "id": 4,
          "text": "Mammillary body"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Fibres of the <strong>fornix</strong> and its fibres terminate at the <strong>mamillary body</strong>. </p>\n<p>The fornix is a part of the connecting pathways of the<strong> limbic system</strong>. It <strong>arises</strong> from the hippocampus which wraps around the thalamus and ends in the <strong>mammillary body. </strong>It connects the hippocampus with distal brain sites. The fornix has two types of fibres:</p>\n<ul>\n<li>Association fibres: They connect the <strong>various cortical regions</strong> within the same hemisphere </li>\n<li>Commissural fibres: They connect the <strong>corresponding regions</strong> of <strong>two hemispheres. </strong>It is seen in the <strong>hippocampal commissure of the fornix.</strong> </li>\n</ul>\n<p>The blood supply of fornix is by the <strong>anterior communicating artery </strong>which arises from the <strong>anterior cerebral artery. </strong></p>\n<p>The <strong>limbic system</strong> is a group of structures seen between the cerebral cortex and the hypothalamus. It is involved in emotional and motivation activity, learning, and memory. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9f2ceeed90514047a17ebb16500dc301x850x592.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d90a6a294e7243c4945699fd1ac989b9x1279x890.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: <strong>Amygdala</strong> is a part of the limbic system that consists of lateral, central and basal nuclei. It can Influence the body's response to enviromnental changes. In a fearful situation it can change the heart rate, blood pressure, respiratory rate etc. </p>\n<p>Option C: <strong>Caudate nucleus </strong>is a C-shaped mass of grey matter. It is divided into a head, body, and tail. Degeneration of the caudate nucleus is seen in Huntington's disease. </p><hr><h3>Related Pearl: White matter tracts of the brain</h3><p><strong>Commissural fibers:</strong>&nbsp;connect corresponding regions of two hemispheres.</p>\n<p>They include</p>\n<ul>\n<li>Corpus callosum</li>\n<li>Anterior and posterior commissure</li>\n<li>Habenular commissure</li>\n<li>Hippocampal commissure of fornix</li>\n</ul><p><strong>Association fibers:</strong>&nbsp;connect various cortical regions within the same hemisphere.</p>\n<p>They are classified as&nbsp;</p>\n<ul>\n<li>Short association fibers: lie immediately under the cortex and connect adjacent gyri. Eg- arcuate fasciculus</li>\n<li>Long association fibers:\n<ul>\n<li>Uncinate fasciculus</li>\n<li>Cingulum</li>\n<li>Superior longitudinal fasciculus</li>\n<li>Inferior longitudinal fasciculus</li>\n<li>Fronto-occipital fasciculus</li>\n<li>Fornix (except hippocampal commissure of fornix)</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/34dcc45f34114e9e968caa2f3060181ex1280x1285.JPEG\" alt=\"Pearl Image\"><p><strong>Projection fibers:</strong>&nbsp;fibers passing to and from the brainstem to the cerebral cortex.&nbsp;</p>\n<ul>\n<li>Internal capsule</li>\n<li>Corona radiata</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/545b77e4b1dd4a6f803e840b3678549bx600x581.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5599",
      "difficulty": "medium"
    },
    {
      "text": "A man presents with severe vomiting. Homicidal poisoning is suspected as the vomitus appears luminous and emits a garlicky odor. Which of the following is most likely to be the poisoning agent?",
      "choices": [
        {
          "id": 1,
          "text": "White/yellow phosphorus"
        },
        {
          "id": 2,
          "text": "Arsenic"
        },
        {
          "id": 3,
          "text": "Red phosphorus"
        },
        {
          "id": 4,
          "text": "Thallium"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Luminous vomitus&nbsp;</strong>that gives off a<strong> garlicky odor&nbsp;</strong>is highly suggestive of <strong>white/yellow phosphorous</strong>&nbsp;poisoning.</p>\n<p><strong>White/yellow phosphorous</strong>&nbsp;is a waxy and translucent material that becomes <strong>luminous</strong>&nbsp;in the dark. It has a <strong>garlicky odor</strong> and taste. It gets oxidized on exposure to air, emits white fumes, and gets ignited at 34&deg;C.&nbsp;It is highly toxic.</p>\n<p>It is used in <strong>fertilizers</strong>, vermin-killers, <strong>rodenticides, fireworks</strong>, and gunpowder.</p>\n<p>Stages of acute poisoning:</p>\n<p><strong>First stage</strong>: Intake causes severe abdominal discomfort, throat and <strong>abdominal pain</strong>, extreme thirst, nausea, <strong>vomiting</strong>, and<strong> diarrhea</strong>. Excreta and breath have a <strong>garlic-like smell</strong>. <strong>Luminescent feces </strong>and<strong> vomit </strong>are characteristically seen. Skin contact results in second and third-degree burns that are deeply painful and take a long time to heal.</p>\n<p><strong>Second stage</strong>: This is a 2-3 days <strong>symptom-free</strong> period.</p>\n<p><strong>Third stage</strong>: There is <strong>hematemesis</strong>, enlargement of the liver, <strong>jaundice, pruritus</strong>, nausea, vomiting, diarrhea, and nausea. <strong>Shock</strong>, hepatic failure, injury to the central nervous system, hematemesis, and <strong>renal insufficiency</strong> are all potential causes of death.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd4a97939066491b880b7411a6d99c8ex206x311.JPEG\" alt=\"Explanation Image\"><p><strong>Red phosphorus</strong> is characteristically <strong>odorless</strong> and is <strong>non-luminous.</strong></p>\n<p>Arsenic and thallium may also be associated with a garlicky odor; they are not characteristically associated with&nbsp;luminous vomitus.</p><hr><h3>Related Pearl: Arsenic poisoning</h3><p>Summary of Arsenic poisoning</p>\n<p><strong>Source of exposure</strong>:&nbsp;Arsenic-containing pesticides, natural sources - drinking water and soil</p>\n<p><strong>Route of absorption</strong>:&nbsp;GI tract</p>\n<p><strong>Mechanism of action</strong>:&nbsp;binds to sulfhydryl groups and inhibits pyruvate dehydrogenase, gluconeogenesis, glutathione metabolism</p>\n<p>Characteristic clinical findings are as follows: Mnemonic-ARSENIC</p>\n<p><strong>A-&nbsp;</strong>Aldrich mees lines</p>\n<p><strong>R-&nbsp;</strong>raindrop pigmentation, rash,&nbsp;red velvety mucosa</p>\n<p><strong>S-&nbsp;</strong>subendocardial haemorrhage</p>\n<p><strong>E-&nbsp;</strong>Excessive pigmentation- Blackfoot&nbsp;disease</p>\n<p><strong>N-&nbsp;</strong>Neuritis</p>\n<p><strong>I-&nbsp;</strong>Iron oxide + BAL &ndash;treatment</p>\n<p><strong>C-&nbsp;</strong>Cholera like illness</p>\n<p><strong>Diagnosis</strong>:&nbsp;24-hour urine arsenic</p>\n<p><strong>Treatment</strong>:&nbsp;BAL; succimer(DMSA)</p>\n<p>Clinicopathological findings in acute and chronic arsenic poisoning:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>System</strong></p>\n</td>\n<td>\n<p><strong>Acute</strong></p>\n</td>\n<td>\n<p><strong>Chronic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Delayed hair loss (alopecia)</p>\n</td>\n<td>\n<p>Melanosis, Bowen&rsquo;s disease facial edema, hyperkeratosis, cutaneous cancer, hyperpigmentation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nails</p>\n</td>\n<td>\n<p>Mees&rsquo;s lines in 2-3 weeks post ingestion.</p>\n</td>\n<td>\n<p><strong>Mees' lines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurologic</p>\n</td>\n<td>\n<p>Hyperpyrexia, convulsions, tremors, coma</p>\n</td>\n<td>\n<p>Encephalopathy, polyneuropathy, tremors, axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI tract</p>\n</td>\n<td>\n<p>Abdominal pain, dysphagia, vomiting, bloody or rice water diarrhea, mucosal erosions.</p>\n</td>\n<td>\n<p>Nausea, vomiting, diarrhea, anorexia, weight loss</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver</p>\n</td>\n<td>\n<p>Fatty infiltration</p>\n</td>\n<td>\n<p>Hepatomegaly, jaundice, cirrhosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p>Tubular and glomerular changes &ndash; oliguria and uremia</p>\n</td>\n<td>\n<p>Nephritic finding</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemetologic</p>\n</td>\n<td>\n<p>thrombocytopenia, impaired folate metabolism</p>\n</td>\n<td>\n<p>Bone marrow hypoplasia, anemia, leukopenia, basophilic stippling, and karyorrhexis.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular</p>\n</td>\n<td>\n<ul>\n<li>S-T wave abnormalities,</li>\n<li>prolonged QT interval</li>\n<li>ventricular fibrillation</li>\n<li>atypical ventricular tachycardia&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>There is platelet activation and hypercoagulability of blood in peripheral arteries leading to blackfoot disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reproductive system</p>\n</td>\n<td>\n<p>Maternal ingestion of inorganic</p>\n<p>Arsenic crosses the placental barrier and infant death shortly after birth.</p>\n</td>\n<td>\n<p>-Nil-</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Characteristic Odor of Toxins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Odor</strong></span></p>\n</td>\n<td>\n<p><span><strong>Toxins</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Garlic odor</span></p>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span>Arsenic, phosphorous, malathion, thallium carbonate</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Odorless</span></p>\n</td>\n<td>\n<p><span>Thallium sulfate (most common),&nbsp;thallium oxide</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Garlic odor or rotten fish</span></p>\n</td>\n<td>\n<p><span>Zinc phosphide</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Odor of burnt rope</span></p>\n</td>\n<td>\n<p><span>Cannabis</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Phenolic odor</span></p>\n</td>\n<td>\n<p><span>Carbolic acid</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Smell of bitter almonds</span></td>\n<td><span>Cyanide</span></td>\n</tr>\n<tr>\n<td><span>Fruity odor</span></td>\n<td><span>Ethyl alcohol</span></td>\n</tr>\n<tr>\n<td><span>Rotten egg</span></td>\n<td><span>Hydrogen sulphide</span></td>\n</tr>\n<tr>\n<td><span>Smell of kerosene</span></td>\n<td><span>Organophosphorous</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Post-mortem Staining in Poisonings</h3><table>\n<tbody>\n<tr>\n<td><strong>Poisoning</strong></td>\n<td><strong>Color of lividity</strong></td>\n</tr>\n<tr>\n<td>Carbon monoxide</td>\n<td>Cherry red</td>\n</tr>\n<tr>\n<td>Cyanide</td>\n<td>Brick red or Dark pink</td>\n</tr>\n<tr>\n<td>Phosphorous, acute copper poisoning</td>\n<td>Dark brown</td>\n</tr>\n<tr>\n<td>Opium</td>\n<td>Black</td>\n</tr>\n<tr>\n<td>Hydrogen sulphide</td>\n<td>Blue-green</td>\n</tr>\n<tr>\n<td>Nitrate, nitrite, aniline, potassium chlorate</td>\n<td>Red-brown&nbsp;or chocolate brown</td>\n</tr>\n<tr>\n<td>Potassium cyanide</td>\n<td>Deep blue</td>\n</tr>\n<tr>\n<td>Clostridium perfringens infection</td>\n<td>Bronze</td>\n</tr>\n<tr>\n<td>Hypothermia</td>\n<td>Bright pink</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5523",
      "difficulty": "medium"
    },
    {
      "text": "As per the ANDI classification of benign breast disorders, all of the following would be considered under disorders of early reproductive years, except _____.",
      "choices": [
        {
          "id": 1,
          "text": "Adolescent hypertrophy"
        },
        {
          "id": 2,
          "text": "Nipple eversion"
        },
        {
          "id": 3,
          "text": "Fibroadenoma"
        },
        {
          "id": 4,
          "text": "Nipple inversion"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>As per the <strong>ANDI classification</strong> of benign breast disorders, <strong>nipple eversion</strong> is considered a <strong>normal</strong> feature of&nbsp;<strong>early reproductive years.&nbsp;</strong></p>\n<p>&nbsp;</p>\n<p><strong>ANDI</strong>&nbsp;<strong>Classification</strong>&nbsp;<strong>of Benign</strong>&nbsp;<strong>Breast Disorders:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Normal</strong></td>\n<td><strong>Disorders</strong></td>\n</tr>\n<tr>\n<td><strong>Early reproductive years (15&ndash;25 y)</strong></td>\n</tr>\n<tr>\n<td>Lobular development</td>\n<td>Fibroadenoma</td>\n</tr>\n<tr>\n<td>Stromal development</td>\n<td>Adolescent hypertrophy (Gggantomastia)</td>\n</tr>\n<tr>\n<td><strong>Nipple eversion</strong></td>\n<td>Nipple inversion (subareolar abscess, mammary duct fistula)</td>\n</tr>\n<tr>\n<td><strong>Later reproductive years (25&ndash;40 y)</strong></td>\n</tr>\n<tr>\n<td>Cyclical changes in menstruation</td>\n<td>Cyclical mastalgia</td>\n</tr>\n<tr>\n<td><strong>Involution (35&ndash;55 y)</strong></td>\n</tr>\n<tr>\n<td>Lobular involution</td>\n<td>Macrocysts, sclerosing lesions</td>\n</tr>\n<tr>\n<td>Duct involution</td>\n<td>Dilation (duct ectasia); sclerosis (nipple retraction)</td>\n</tr>\n<tr>\n<td>Epithelial turnover</td>\n<td>Epithelial hyperplasia (with atypia)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Anatomic Origins of Common Breast Lesions</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b52f182ae9ef4e41a63d4c52bf8469dbx1280x1413.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5569",
      "difficulty": "medium"
    },
    {
      "text": "All of the following structures form the floor of the 4th ventricle, except _____.",
      "choices": [
        {
          "id": 1,
          "text": "Area postrema"
        },
        {
          "id": 2,
          "text": "Superior and inferior medullary velum"
        },
        {
          "id": 3,
          "text": "Hypoglossal triangle"
        },
        {
          "id": 4,
          "text": "Facial colliculus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>All of the listed structures form the floor of the 4th ventricle, except <strong>superior and inferior medullary velum</strong>,<strong>&nbsp;</strong>which form the <strong>roof</strong> of the 4th ventricle.</p>\n<p><strong>Structures on the floor of the 4th ventricle (Rhomboid Fossa)</strong></p>\n<p>Ridges:</p>\n<ul>\n<li>Transverse fibers: <strong>Striae medullares</strong></li>\n<li>Striae medullares divides rhomboid fossa into 2 parts: <strong>Rostral pontine and Caudal medullary</strong>&nbsp;</li>\n</ul>\n<p>Medial to lateral in rostral pontine part:</p>\n<ul>\n<li>Midline longitudinal sulcus: <strong>Median sulcus </strong></li>\n<li>Bilateral eminences: <strong>Medial eminence</strong></li>\n<li>Bilateral longitudinal sulcus: <strong>Sulcus limitans</strong></li>\n<li>Bilateral areas: <strong>Vestibular area&nbsp;</strong>(deeper to it is the vestibular nucleus)</li>\n</ul>\n<p>Upper and lower ends of sulcus:</p>\n<ul>\n<li>Bluish-colored, uppermost area where sulcus limitans ends: <strong>Locus coeruleus</strong></li>\n<li>Depression, the upper area of sulcus limitans: <strong>Superior fovea</strong></li>\n<li>Depression, the lower area of sulcus limitans: <strong>Inferior fovea</strong></li>\n</ul>\n<p>Cranial nerve nucleus elevations:</p>\n<ul>\n<li>Elevation on the medial eminence: <strong>Facial colliculus</strong></li>\n<li>Elevations in the lowermost area in the shape of 2 triangles: <strong>Hypoglossal and vagal triangles</strong></li>\n</ul>\n<p>Circumventricular organ:</p>\n<ul>\n<li>Between the vagal triangle and gracile tubercle below: <strong>Area postrema</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/62fee830893345f79466731846426f51x1280x1938.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5600",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following drugs is an Anti-CTLA-4 antibody used in the treatment of advanced melanoma?",
      "choices": [
        {
          "id": 1,
          "text": "Pembrolizumab"
        },
        {
          "id": 2,
          "text": "Ipilimumab"
        },
        {
          "id": 3,
          "text": "Nivolumab "
        },
        {
          "id": 4,
          "text": "Trastuzumab "
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Anti-CTLA-4 antibody Ipilimumab</strong> was the <strong>first drug</strong> to significantly <strong>improve advanced-stage melanoma's</strong> survival. Cytotoxic T lymphocyte antigen 4 (CTLA-4) plays an important inhibitory role in the control of T-cell activation.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>Ipilimumab is a fully humanized <strong>IgG1 monoclonal antibody</strong> that inhibits cytotoxic T lymphocyte antigen-4 (CTLA-4).</p>\n<p>Other options:</p>\n</div>\n</div>\n<p>Option A -<strong> Pembrolizumab</strong> acts by inhibiting programmed death receptor - 1 (<strong>PD-1</strong>) and was used for the treatment of <strong>advanced melanoma</strong>. Now, the FDA has approved the use of pembrolizumab for any cancer with mismatch repair (<strong>MMR</strong>) deficiency or high microsatellite instability (<strong>MSI-H</strong>).</p>\n<p>Option C - <strong>Nivolumab</strong> is an immune checkpoint inhibitor that acts by inhibiting programmed death receptor - 1 (<strong>PD-1</strong>) and is used for the treatment of <strong>advanced melanoma </strong>and<strong> </strong>relapsed/refractory<strong> classical Hodgkin lymphoma.</strong></p>\n<p>Option D - <strong>Trastuzumab </strong>is a monoclonal antibody that inhibits the <strong>HER2 receptor</strong>. It is used in the treatment of <strong>HER2-positive breast cancer</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5591",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant lady at 20 weeks of gestation comes with acute-onset fever and pain in the right lumbar region. Chills, nausea, and vomiting are also present. Urinalysis reveals the presence of E. coli, and a diagnosis of acute pyelonephritis is made. You should titrate the volume resuscitation so as to target an urine output of _____________.",
      "choices": [
        {
          "id": 1,
          "text": "≥100 mL/hr"
        },
        {
          "id": 2,
          "text": "≥30 mL/hr"
        },
        {
          "id": 3,
          "text": "≥75 mL/hr"
        },
        {
          "id": 4,
          "text": "≥50 mL/hr"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Aggressive intravenous hydration</strong> to maintain adequate urine output is the <strong>mainstay</strong>&nbsp;in the&nbsp;<strong>treatment of pyelonephritis</strong>. A <strong>urinary output &ge;50 mL/h</strong>&nbsp;is maintained with<strong> intravenous crystalloids</strong>.</p>\n<p><strong>Acute pyelonephritis</strong> is one of the frequent and serious medical complications occurring in the second trimester of pregnancy. The most common causative organism is<em><strong> Eshcherichia coli</strong></em>. Clinical features include <strong>sudden-onset fever, chills,</strong> and <strong>aching pain</strong> in the lumbar region (usually unilateral). Nausea, vomiting, and anorexia are also present. <strong>Tenderness</strong> in the <strong>costovertebral angle</strong> can be elicited on examination.</p>\n<p>The diagnosis is confirmed by the collection of <strong>urine</strong> (preferably from catheterization) and analysis to look for <strong>leukocytes</strong> and bacteria.&nbsp;</p>\n<p><strong>Management</strong> protocol for pyelonephritis during pregnancy:&nbsp;</p>\n<ul>\n<li><strong>Hospitalization</strong> is recommended for all patients. Very rare cases of uncomplicated pyelonephritis can be managed on an outpatient basis.</li>\n<li><strong>Urine</strong> and <strong>blood</strong> (if the temperature is &gt;39&deg;C) samples are collected for <strong>culture.</strong></li>\n<li><strong>Aggressive intravenous hydration</strong> to maintain adequate urine output is the <strong>mainstay</strong>&nbsp;of treatment. A <strong>urinary output &ge;50 mL/h</strong>&nbsp;is maintained with<strong> intravenous crystalloids</strong>.</li>\n<li>Vital signs such as blood pressure, pulse, temperature, and oxygen saturation along with urine output should be <strong>monitored</strong> for signs of worsening <strong>sepsis</strong>.</li>\n<li>Empirical<strong> intravenous</strong>&nbsp;<strong>antibiotic therapy</strong> is started with ampicillin plus gentamicin, cefazolin, or ceftriaxone. It is <strong>switched</strong> to<strong> oral antibiotics</strong> once the patient is <strong>afebrile</strong>.</li>\n<li>In case of <strong>persistent</strong> infection or lack of clinical improvement by 48 to 72 hours, renal <strong>sonography</strong> is recommended to look for urinary tract abnormalities (like obstruction or calculi).</li>\n</ul><hr><h3>Related Pearl: Asymptomatic bacteriuria</h3><div class=\"topbullet\">&nbsp;</div>\n<div class=\"topbullet\"><strong>Asymptomatic bacteriuria: </strong>Urinary tract infection without any symptoms. Criteria for diagnosis are as follows:</div>\n<div class=\"topbullet\">&nbsp;</div>\n<table>\n<tbody>\n<tr>\n<td>Type of specimen</td>\n<td>Number of samples required&nbsp;</td>\n<td>Minimum colony-forming units (cfu)/mL required for diagnosis of UTI</td>\n</tr>\n<tr>\n<td>Midstream clean-catch urine specimen</td>\n<td>\n<p>For women: 2 consecutive samples</p>\n<p>For men: single sample</p>\n</td>\n<td><strong><strong>1,00,000&nbsp;</strong></strong>of the same bacterial species&nbsp;</td>\n</tr>\n<tr>\n<td>Catheterized urine specimen&nbsp;</td>\n<td>Single sample</td>\n<td>\n<p><strong><strong>100 </strong></strong>for&nbsp;asymptomatic bacteriuria (CA-ASB)</p>\n<p><strong>1000</strong> for catheter-associated urinary tract infection&nbsp;(CA-UTI)</p>\n</td>\n</tr>\n<tr>\n<td>Suprapubic aspirate</td>\n<td>Single sample</td>\n<td><strong>Any growth of microorganisms</strong> in the culture&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5625",
      "difficulty": "hard"
    },
    {
      "text": "Food poisoning due to which of the following organisms is typically associated with 8-16 hours of incubation period?<div class='question-desc-html'><ol>\n<li>Staphylococcus aureus</li>\n<li>Bacillus cereus - Emetic type</li>\n<li>Bacillus cereus - Diarrheal type</li>\n<li>Vibrio cholerae</li>\n<li>Clostridium perfringens</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2 & 5"
        },
        {
          "id": 2,
          "text": "3 & 5"
        },
        {
          "id": 3,
          "text": "1, 4, & 5"
        },
        {
          "id": 4,
          "text": "1, 2 & 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Food poisoning occurring due to <em><strong>Clostridium perfringens</strong></em> &amp; <strong><em>Bacillus cereus</em> - Diarrheal type</strong> are <strong>typically</strong> associated with<strong> 8-16 hours of incubation period.</strong></p>\n<p>Food poisoning caused by <em>B. cereus</em> is of <strong>two types</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td><em>Bacillus cereus</em></td>\n<td><strong>Diarrheal type</strong></td>\n<td>Emetic type</td>\n</tr>\n<tr>\n<td>Incubation period</td>\n<td><strong>8-16 hours</strong></td>\n<td>1-5 hours</td>\n</tr>\n<tr>\n<td>Toxin</td>\n<td>Secreted in intestine</td>\n<td>Preformed</td>\n</tr>\n<tr>\n<td>Heat</td>\n<td>Heat labile</td>\n<td>Heat stable</td>\n</tr>\n<tr>\n<td>Food items</td>\n<td>Meat</td>\n<td>Rice</td>\n</tr>\n<tr>\n<td>Clinical feature</td>\n<td>Diarrhea, abdominal cramps</td>\n<td>Vomiting, abdominal cramps</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p><em><strong>C. perfringens</strong></em> food poisoning usually occurs following the ingestion of <strong>contaminated meat</strong> dishes. The <strong>toxin is formed</strong> when the <strong>organisms sporulate in the gut.</strong> <strong>Diarrhea</strong> usually occurs <strong>without vomiting or fever</strong>. Usually, the illness lasts only 1–2 days.</p><hr><h3>Related Pearl: Food Poisoning</h3><table>\n<tbody>\n<tr>\n<td><strong>Organism</strong></td>\n<td><strong>Symptoms</strong></td>\n<td><strong>Common food source</strong></td>\n</tr>\n<tr>\n<td colspan=\"3\"><strong>1&ndash;6 hrs incubation&nbsp;period</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><em>Staphylococcus aureus</em></td>\n<td>Nausea, vomiting, diarrhea</td>\n<td>Ham, poultry, potato, cream pastries, mayonnaise</td>\n</tr>\n<tr>\n<td><em>Bacillus cereus</em></td>\n<td>Nausea, vomiting, diarrhea</td>\n<td>Fried rice</td>\n</tr>\n<tr>\n<td colspan=\"3\"><strong>8&ndash;16 hrs incubation&nbsp;period</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><em>Clostridium perfringes</em></td>\n<td>Abdominal cramps, diarrhea</td>\n<td>Beef, poultry, legume, gravies</td>\n</tr>\n<tr>\n<td><em>Bacillus cereus</em></td>\n<td>Abdominal cramps, diarrhea</td>\n<td>Meat, vegetables, dried beans, cereals</td>\n</tr>\n<tr>\n<td colspan=\"3\"><strong>&gt;16 hrs incubation period</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><em>Vibrio cholerae</em></td>\n<td>Watery diarrhea</td>\n<td>Shellfish, water</td>\n</tr>\n<tr>\n<td><em>Salmonella</em> species</td>\n<td>Inflammatory diarrhea</td>\n<td>Beef, poultry, eggs</td>\n</tr>\n<tr>\n<td>Enterotoxigenic <em>Escherichia coli</em></td>\n<td>Watery diarrhea</td>\n<td>Salads, cheese, meats</td>\n</tr>\n<tr>\n<td>Enterohemorrhagic <em>E. coli</em></td>\n<td>Bloody diarrhea</td>\n<td>Raw milk, raw vegetables, apple juice</td>\n</tr>\n<tr>\n<td><em>Campylobacter jejuni</em></td>\n<td>Inflammatory diarrhea</td>\n<td>Poultry, raw milk</td>\n</tr>\n<tr>\n<td><em>Shigella</em> species</td>\n<td>Dysentery</td>\n<td>Potato, egg salad, lettuce</td>\n</tr>\n<tr>\n<td><em>Vibrio parahaemolyticus</em></td>\n<td>Dysentery</td>\n<td>Molluscs, crustaceans</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5517",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is false about diabetic chieroarthropathy?",
      "choices": [
        {
          "id": 1,
          "text": "Limited joint mobility results due to periarticular fibrosing syndrome"
        },
        {
          "id": 2,
          "text": "Occurs due to enzymatic glycosylation of collagen"
        },
        {
          "id": 3,
          "text": "Seen in both type1 and type2 diabetes"
        },
        {
          "id": 4,
          "text": "Prevalence increases with age"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Diabetic cheiroarthropathy</strong>/diabetic stiff hand syndrome is due to the <strong>non</strong>-enzymatic glycosylation of collagen</p>\n<p><strong>Diabetic cheiroarthropathy</strong>/diabetic stiff hand syndrome is due to limited joint mobility as a result of the periarticular fibrosing syndrome. This is due to the non-enzymatic glycosylation of collagen. It is seen in<strong> both diabetes type1 and type2.</strong> Its prevalence <strong>increases with age</strong> and <strong>poor glycemic control</strong>.</p>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cd3201c140b04f8e848f89efb99b40dfx720x543.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5678",
      "difficulty": "hard"
    },
    {
      "text": "Match the following.<div class='question-desc-html'><ol>\n<li>Huntington&rsquo;s disease</li>\n<li>Hemochromatosis</li>\n<li>G-6-PD deficiency</li>\n<li>Rett syndrome</li>\n</ol>\n<ol>\n<li>X-linked dominant</li>\n<li>Autosomal dominant</li>\n<li>Autosomal recessive</li>\n<li>X-linked recessive</li>\n</ol>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-B, 2-C, 3-A, 4-D"
        },
        {
          "id": 2,
          "text": "1-C, 2-B, 3-D, 4-A"
        },
        {
          "id": 3,
          "text": "1-A, 2-C, 3-D, 4-B"
        },
        {
          "id": 4,
          "text": "1-B, 2-C, 3-D, 4-A"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The correctly matched pairs are as follows:&nbsp;</p>\n<ol>\n<li>Huntington disease -&nbsp;Autosomal dominant</li>\n<li>Hemochromatosis -&nbsp;Autosomal recessive</li>\n<li>G6PD deficiency -&nbsp;X-linked recessive</li>\n<li>Rett syndrome -&nbsp;X-linked dominant</li>\n</ol>\n<p>&nbsp;</p><hr><h3>Related Pearl: Inheritance pattern of important diseases</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington&rsquo;s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher&rsquo;s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don&rsquo;t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch&ndash;Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett&rsquo;s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot&ndash;Marie&ndash;Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on&rsquo;t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott&ndash;Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5646",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following bones is unlikely to be palpable along the floor of the anatomical snuff box?",
      "choices": [
        {
          "id": 1,
          "text": "Lunate"
        },
        {
          "id": 2,
          "text": "Scaphoid"
        },
        {
          "id": 3,
          "text": "Trapezium"
        },
        {
          "id": 4,
          "text": "First metacarpal"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Lunate</strong> is <strong>not palpable</strong> along the floor of the <strong>anatomical snuff box.&nbsp;</strong></p>\n<p>&nbsp;</p>\n<p><strong>Boundaries of the anatomical snuffbox:&nbsp;</strong></p>\n<ul>\n<li><strong>Lateral wall:</strong>\n<ul>\n<li>Abductor pollicis longus (APL)</li>\n<li>Extensor pollicis brevis (EPB)&nbsp;&nbsp;</li>\n</ul>\n</li>\n<li><strong>Medial wall:</strong>\n<ul>\n<li>Extensor pollicis longus&nbsp;(EPL)</li>\n</ul>\n</li>\n<li><strong>Roof:</strong>\n<ul>\n<li>Cephalic vein</li>\n<li>Superficial branch of the radial nerve</li>\n</ul>\n</li>\n<li><strong>Floor:</strong>\n<ul>\n<li>Radial styloid, <strong>scaphoid, trapezium, and 1st metacarpal</strong></li>\n</ul>\n</li>\n</ul>\n<p>Only content: Radial artery</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3f6a6c2e35bb4c2f985308fb2f5d1e06x833x1280.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5601",
      "difficulty": "medium"
    },
    {
      "text": "Injury to which of the following nerves would result in impaired sensation over the marked region?",
      "choices": [
        {
          "id": 1,
          "text": "Radial"
        },
        {
          "id": 2,
          "text": "Median"
        },
        {
          "id": 3,
          "text": "Ulnar"
        },
        {
          "id": 4,
          "text": "Axillary"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Regimental badge sign</strong> is seen in injury to <strong>axillary nerve.</strong></p>\n<p>An area of hypoaesthesia or anaesthesia is seen over the distal part of the deltoid muscle; this is referred to as the &lsquo;regimental badge patch&rsquo; of the skin or regimental badge sign. This&nbsp;<strong>reflects loss of function in the upper lateral cutaneous nerve of the arm,&nbsp;</strong>a branch of the axillary nerve.</p><hr><h3>Related Pearl: Fractures/dislocations and associated nerve injuries</h3><table>\n<tbody>\n<tr>\n<td><strong>Fracture/Dislocation</strong></td>\n<td><strong>Nerve injured</strong></td>\n</tr>\n<tr>\n<td>Fracture clavicle</td>\n<td>Brachial plexus</td>\n</tr>\n<tr>\n<td>Anterior or inferior shoulder dislocation</td>\n<td>Axillary (circumflex humeral) nerve</td>\n</tr>\n<tr>\n<td>Proximal humerus fracture</td>\n<td>Axillary nerve</td>\n</tr>\n<tr>\n<td>Shaft of humerus fracture</td>\n<td>Radial nerve</td>\n</tr>\n<tr>\n<td>Supracondylar fracture humerus&nbsp;</td>\n<td>Anterior interosseous nerve &gt; Median nerve &gt; Radial nerve</td>\n</tr>\n<tr>\n<td>Medial condyle of humerus&nbsp;</td>\n<td>Ulnar nerve</td>\n</tr>\n<tr>\n<td>Posterior dislocation elbow</td>\n<td>Ulnar nerve &gt;Median nerve</td>\n</tr>\n<tr>\n<td>Monteggia fracture</td>\n<td>Posterior interosseous nerve</td>\n</tr>\n<tr>\n<td>Volkman&rsquo;s ischemic contracture</td>\n<td>Anterior interosseous nerve</td>\n</tr>\n<tr>\n<td>Hook of hamate fracture</td>\n<td>Deep branch of the ulnar nerve</td>\n</tr>\n<tr>\n<td>Lunate dislocation<strong>&nbsp;</strong></td>\n<td>Median nerve</td>\n</tr>\n<tr>\n<td>Wrist injury</td>\n<td>Median nerve</td>\n</tr>\n<tr>\n<td>Posterior hip dislocation</td>\n<td>Sciatic nerve</td>\n</tr>\n<tr>\n<td>Anterior dislocation of hip and shaft femur fracture</td>\n<td>Femoral nerve</td>\n</tr>\n<tr>\n<td>Knee dislocation</td>\n<td>Common peroneal nerve</td>\n</tr>\n<tr>\n<td>Proximal tibial fractures and ankle injury</td>\n<td>Posterior tibial nerve</td>\n</tr>\n<tr>\n<td>Fracture neck of the fibula</td>\n<td>Lateral popliteal nerve (common peroneal nerve)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4c77ee13fe7341e1a9f3efb99b8e8414.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5605",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following features are typically associated with delirium?<div class='question-desc-html'><ol>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;- Impaired consciousness\\n- Sundowning\\n- Normal EEG\\n- Carphologia or floccillation \\n- Autonomic Dysfunction&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Impaired consciousness</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;- Impaired consciousness\\n- Sundowning\\n- Normal EEG\\n- Carphologia or floccillation \\n- Autonomic Dysfunction&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Sundowning<br /></span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;- Impaired consciousness\\n- Sundowning\\n- Normal EEG\\n- Carphologia or floccillation \\n- Autonomic Dysfunction&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Normal EEG<br /></span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;- Impaired consciousness\\n- Sundowning\\n- Normal EEG\\n- Carphologia or floccillation \\n- Autonomic Dysfunction&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Carphologia or floccillation <br /></span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;- Impaired consciousness\\n- Sundowning\\n- Normal EEG\\n- Carphologia or floccillation \\n- Autonomic Dysfunction&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Autonomic Dysfunction</span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3, & 4"
        },
        {
          "id": 2,
          "text": "2, 3, & 5"
        },
        {
          "id": 3,
          "text": "1, 3, & 5"
        },
        {
          "id": 4,
          "text": "1, 2, 4, & 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p1\"><strong>Delirium</strong> is associated with <strong>impaired consciousness</strong>, <strong>carphologia</strong> or floccillation, <strong>autonomic dysfunction,</strong> <strong>sundowning</strong>, and an <strong>abnormal EEG</strong>. </p>\n<p class=\"p1\">Delirium is characterized by</p>\n<ul>\n<li class=\"p1\">An acute decline in the level of awareness </li>\n<li class=\"p1\">Global impairment of cognitive functions (particularly attention)</li>\n</ul>\n<p>It also involves</p>\n<ul>\n<li class=\"p1\">Perceptual disturbances like illusions and hallucinations</li>\n<li class=\"p1\">Abnormal psychomotor activity</li>\n<li class=\"p1\">Sleep cycle impairment</li>\n</ul>\n<p><strong>Formication</strong> is a <strong>tactile</strong> (not visual) hallucination in which the patient experiences a feeling of insects crawling under the skin.</p><hr><h3>Related Pearl: Delirium vs Dementia</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><span><strong>Delirium</strong></span></p>\n</td>\n<td>\n<p><span><strong>Dementia</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Presentation</strong></td>\n<td>\n<p><span>Hallmark is impaired consciousness</span></p>\n</td>\n<td>\n<p><span>Loss of memory and intellectual abilities</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong><span>Commonly seen in&nbsp;</span></strong></p>\n</td>\n<td>\n<p><span>Children and elderly&nbsp;</span></p>\n</td>\n<td>\n<p><span>Elderly&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Associated physical findings</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>Acute medical illness&nbsp;</span></li>\n<li><span>Autonomic dysfunction</span></li>\n<li><span>Abnormal EEG&nbsp;</span></li>\n<li><span>Carphologia or&nbsp;floccillation&nbsp;(picking movements at cover-sheets and clothes)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>No medical illness</span></li>\n<li><span>Little autonomic dysfunction</span></li>\n<li><span>Normal EEG&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Psychological findings</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>Impaired consciousness</span></li>\n<li><span>Illusion, delusion&nbsp;</span></li>\n<li><span>Sundowning (symptoms much worse at night)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>Normal consciousness</span></li>\n<li><span>Depressed mood&nbsp;</span></li>\n<li><span>Personality changes in early stages in Pick&rsquo;s disease&nbsp;<br /></span></li>\n<li><span>Sundowning (symptoms much worse at night)&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Course</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>Develops quickly</span></li>\n<li><span>Fluctuating course with lucid intervals (waxing and waning)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>Insidious-onset</span></li>\n<li><span>Progressive downhill course</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><span><strong>Etiology</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>CNS disease (E.g: Huntington or Parkinson disease)</span></li>\n<li><span>CNS trauma</span></li>\n<li><span>CNS infection (E.g: Meningitis)</span></li>\n<li><span>Systemic disease (E.g., hepatic, cardiovascular)</span></li>\n<li><span>Substance abuse/withdrawal</span></li>\n<li><span>HIV infection</span></li>\n<li><span>Prescription drug overdose (E.g: atropine)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>Alzheimer's disease</span></li>\n<li><span>Vascular disease (15-30% of all dementias)</span></li>\n<li><span>CNS disease (E.g., Huntingtons or Parkinsons disease)</span></li>\n<li><span>CNS infection (HIV, Prion diseases)</span></li>\n<li><span>Lewy body dementia</span></li>\n<li><span>Pick's disease (Frontotemporal dementia)&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><span><strong>Treatment:</strong></span></p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><span>Treat the underlying medical cause</span></p>\n</td>\n<td>\n<p><span>Acetylcholinesterase inhibitors&nbsp;(donepezil, rivastigmine) and&nbsp;</span><span>NMDA antagonist (memantine)</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5621",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false about selective mutism due to childhood anxiety disorder?",
      "choices": [
        {
          "id": 1,
          "text": "The first-line treatment is using benzodiazepines"
        },
        {
          "id": 2,
          "text": "Children usually speak freely at home but exhibit symptoms when under social pressure"
        },
        {
          "id": 3,
          "text": "Develops in children 4 to 8 years of age"
        },
        {
          "id": 4,
          "text": "Maternal overprotection reinforces selective mutism behaviors."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>&nbsp;</p>\n<p><strong>Individual cognitive behavioral therapy</strong> is recommended as a <strong>first-line treatment&nbsp;</strong>for <strong>selective mutism.</strong></p>\n<p><strong>Selective mutism&nbsp;</strong>refers to the&nbsp;<strong>lack of speaking</strong>&nbsp;(being mute) in&nbsp;<strong>one or more specific social situations</strong>, commonly in school, but&nbsp;<strong>speaking well in other situations</strong>, commonly at home. The child may be either&nbsp;<strong>completely silent</strong>&nbsp;at school or maybe just&nbsp;<strong>whispering.&nbsp;</strong>Rarely, a child may be silent at home but communicating normally at school.</p>\n<p>The disorder may develop in children between&nbsp;<strong>4 to 8 years</strong>&nbsp;of age and is associated with a&nbsp;<strong>social anxiety disorder.</strong>&nbsp;They may have symptoms of separation anxi&shy;ety disorder, school refusal, and delayed language acquisition.&nbsp;Maternal overprotection and anxiety disorders in parents may reinforce selective mutism behaviors.</p>\n<p>The first-line treatment is individual&nbsp;<strong>cognitive behavioral therapy.</strong></p><hr><h3>Related Pearl: Autism Spectrum Disorder</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>&nbsp;</strong></span></td>\n<td><span><strong>Autism</strong></span></td>\n<td><span><strong>Rett syndrome</strong></span></td>\n<td><span><strong>Asperger syndrome</strong></span></td>\n<td><span><strong>Heller syndrome</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Onset</strong></span></td>\n<td><span>Before 3 years</span></td>\n<td><span>After 5 months</span></td>\n<td><span>After 3 years</span></td>\n<td><span>After 2 years</span></td>\n</tr>\n<tr>\n<td><span><strong>Gender predilection</strong></span></td>\n<td><span>Boys</span></td>\n<td><span>Girls</span></td>\n<td><span>Boys</span></td>\n<td><span>Boys</span></td>\n</tr>\n<tr>\n<td><span><strong>Intellectual disability</strong></span></td>\n<td><span>Present in 30% of the cases</span></td>\n<td><span>Present</span></td>\n<td><span>Absent</span></td>\n<td><span>Present</span></td>\n</tr>\n<tr>\n<td><span><strong>Language</strong></span></td>\n<td><span>Mostly poor</span></td>\n<td><span>Mostly poor</span></td>\n<td><span>Normal</span></td>\n<td><span>Mostly poor</span></td>\n</tr>\n<tr>\n<td><span><strong>Remarks</strong></span></td>\n<td><span>---</span></td>\n<td>\n<p><span>Normal head circumference at birth.</span></p>\n<p><span>Regression of milestones</span></p>\n</td>\n<td><span>---</span></td>\n<td>\n<p><span>Normal head circumference at birth.</span></p>\n<p><span>Regression of milestones</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fd179d1aaa7421ab241484cc63a4038x1279x1336.JPEG\" alt=\"Pearl Image\"><p><strong>NOTE</strong>: Rett's syndrome has been removed from DSM-5 because it was found to have a clear genetic basis.</p><table>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td>\n<div><span><strong>DSM - 4</strong></span></div>\n</td>\n<td>\n<div><span><strong>DSM - 5</strong></span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Change in Classification&nbsp;</strong></span></td>\n<td>\n<div><span>Pervasive Developmental disorders</span></div>\n</td>\n<td>\n<div><span>Autistic Spectrum Disorder</span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Number of Domains</strong>&nbsp;</span></td>\n<td>\n<div><span>3 domains</span></div>\n</td>\n<td>\n<div><span>2 domains</span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Impairment in social interaction and communication</strong>&nbsp;</span></td>\n<td>\n<div>\n<div><span>&nbsp;</span></div>\n<div>\n<ul>\n<li>\n<p><span>Delay or total lack of development of spoken language</span></p>\n</li>\n<li>\n<p><span>Stereotyped and repetitive use of language</span></p>\n</li>\n<li>\n<p><span>Impairment in the use of multiple nonverbal behaviors</span></p>\n</li>\n<li>\n<p><span>Failure to develop peer relationships</span></p>\n</li>\n<li><span>Lack of social or emotional reciprocity</span></li>\n</ul>\n</div>\n</div>\n<div><span>&nbsp;</span></div>\n</td>\n<td>\n<div><span>&nbsp;</span></div>\n<div>\n<ul>\n<li>\n<p><span>Deficits in nonverbal communicative behaviors</span></p>\n</li>\n<li>\n<p><span>Deficits in developing, maintaining, and understanding relationships</span></p>\n</li>\n<li><span>Deficits in social-emotional reciprocity&nbsp;</span></li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Repetitive and restricted</strong><br /><strong>interests/behaviors</strong>&nbsp;</span></td>\n<td>\n<div><span>&nbsp;</span></div>\n<div>\n<ul>\n<li><span>Stereotyped and repetitive motor mannerisms</span></li>\n<li>\n<p><span>Inflexible adherence to specific, nonfunctional routines</span></p>\n</li>\n<li>\n<p><span>Persistent preoccupation with parts of an object</span></p>\n</li>\n</ul>\n</div>\n</td>\n<td>\n<div>\n<div><span>&nbsp;</span></div>\n<div>\n<ul>\n<li>\n<p><span>Stereotyped or repetitive motor movements</span></p>\n</li>\n<li>\n<p><span>Insistence on sameness, inflexible adherence to routines</span></p>\n</li>\n<li>\n<p><span>Highly restricted, fixated interests.</span></p>\n</li>\n<li>\n<p><span>Hyper- or hyporeactivity to sensory input</span></p>\n</li>\n</ul>\n</div>\n<span>&nbsp;</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5623",
      "difficulty": "easy"
    },
    {
      "text": "A 20-year-old female patient with easy fatiguability and pallor presented to the OPD. An image of her hands is given below. Which of the following findings is least likely to be seen in her peripheral smear?",
      "choices": [
        {
          "id": 1,
          "text": "Hypersegmentation of Neutrophil nuclei"
        },
        {
          "id": 2,
          "text": "High reticulocyte count"
        },
        {
          "id": 3,
          "text": "Macro-ovalocytes"
        },
        {
          "id": 4,
          "text": "Nucleated red cell progenitors"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Skin hyperpigmentation</strong> especially on the dorsum of hands involving the knuckles is seen in cyanocobalamin or<strong>&nbsp;vitamin B12 deficiency </strong>which<strong>&nbsp;</strong>is a causative factor of&nbsp;<strong>megaloblastic anemia. </strong>The peripheral smear in this patient would show a reduction in reticulocyte count, not an increase.</p>\n<p>In megaloblastic anemia, there is an&nbsp;<strong>impairment</strong> of <strong>DNA synthesis</strong> that leads to <strong>ineffective hematopoiesis.</strong>&nbsp;It also causes distinctive morphologic changes, including abnormally large erythroid precursors and red cells.</p>\n<p><strong>Clinical features</strong> of megaloblastic anemia (cyanocobalamin and folate deficiency):</p>\n<table>\n<tbody>\n<tr>\n<td><strong>System</strong></td>\n<td><strong>Clinical features</strong></td>\n</tr>\n<tr>\n<td>Oral</td>\n<td>\n<p><strong>Glossitis</strong></p>\n<p>Angular cheilosis</p>\n</td>\n</tr>\n<tr>\n<td>Gastrointestinal</td>\n<td>\n<p>Anorexia</p>\n<p>Weight loss</p>\n<p>Diarrhea</p>\n<p>Constipation</p>\n</td>\n</tr>\n<tr>\n<td>Skin</td>\n<td><strong>Hyperpigmentation</strong> (reversible)</td>\n</tr>\n<tr>\n<td>Hematological</td>\n<td>\n<p>Thrombocytopenia</p>\n<p>Leucopenia</p>\n<p>Ineffective erythropoiesis and unconjugated<strong>&nbsp;</strong>jaundice</p>\n</td>\n</tr>\n<tr>\n<td>Cardiovascular</td>\n<td>\n<p>Atherosclerosis leading to PVD,&nbsp;CAD (due to elevated homocysteine)</p>\n</td>\n</tr>\n<tr>\n<td>Neurological (only B12)</td>\n<td>\n<p>Peripheral neuropathy</p>\n<p>Subacute combined degeneration (degeneration of the posterior and pyramidal tracts of the spinal cord)</p>\n</td>\n</tr>\n<tr>\n<td>Pregnancy (only folate)</td>\n<td>\n<p>Recurrent fetal loss</p>\n<p>Neural tube defects</p>\n</td>\n</tr>\n<tr>\n<td>Others</td>\n<td>\n<p><strong>Mild</strong> <strong>fever</strong> in severe cases</p>\n<p>Psychiatric disturbances</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Peripheral smear</strong> findings:</p>\n<ul>\n<li><strong>Macro-ovalocytes </strong>are seen.</li>\n<li>Most macrocytes lack the central pallor of normal red cells and even appear hyperchromic, but the MCHC is not elevated.</li>\n<li><strong>Reticulocyte </strong>count is <strong>low.</strong></li>\n<li>Nucleated red cell progenitors occasionally appear in the circulating blood when anemia is severe.</li>\n<li>Neutrophils are also larger than normal (macro polymorphonuclear) and show&nbsp;<strong>nuclear hypersegmentation</strong>, with five or more nuclear lobules.</li>\n</ul>\n<p>The image given below shows hypersegmented neutrophils seen in megaloblastic anemia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/52d81454a5e545f199775a54498ecf53x960x690.JPEG\" alt=\"Explanation Image\"><p><strong>Bone marrow</strong> findings:</p>\n<ul>\n<li>Markedly&nbsp;<strong>hypercellular</strong>&nbsp;as a result of increased hematopoietic precursors</li>\n<li><strong>Sieve-like </strong>pattern of<strong> chromatin</strong>&nbsp;of immature precursors (Megaloblasts)</li>\n<li>Granulocytic precursors display dysmaturation in the form of&nbsp;<strong>giant metamyelocytes </strong>and<strong> band forms</strong></li>\n<li>Megakaryocytes abnormally large and have bizarre, multilobate nuclei</li>\n<li>Derangement in DNA synthesis causes most precursors to undergo apoptosis in the marrow (<strong>ineffective hematopoiesis</strong>) and leads to<strong> pancytopenia</strong></li>\n</ul><hr><h3>Related Pearl: Causes of Megaloblastic Anemia</h3><p><strong>Vitamin B12 Deficiency causes:</strong></p>\n<ul>\n<li><strong>Decreased Intake</strong>\n<ul>\n<li>Inadequate diet</li>\n<li>Vegetarianism</li>\n</ul>\n</li>\n<li><strong>Impaired Absorption</strong>\n<ul>\n<li>Intrinsic factor deficiency</li>\n<li>Pernicious anemia</li>\n<li>Gastrectomy</li>\n<li>Malabsorption states</li>\n<li>Diffuse intestinal disease (e.g., lymphoma, systemic sclerosis)</li>\n<li>Ileal resection</li>\n<li>Ileitis</li>\n</ul>\n</li>\n<li><strong>Competitive parasitic uptake</strong>\n<ul>\n<li>Fish tapeworm infestation</li>\n<li>Bacterial overgrowth in blind loops and diverticula of bowel</li>\n</ul>\n</li>\n</ul>\n<p><strong>Folic Acid Deficiency causes:</strong></p>\n<ul>\n<li><strong>Decreased Intake</strong>\n<ul>\n<li>Inadequate diet</li>\n<li>Alcoholism</li>\n<li>Infancy</li>\n</ul>\n</li>\n<li><strong>Impaired Absorption</strong>\n<ul>\n<li>Malabsorption states</li>\n<li>Intrinsic intestinal disease</li>\n<li>Anticonvulsants</li>\n<li>Oral contraceptives</li>\n</ul>\n</li>\n<li><strong>Increased Loss</strong>\n<ul>\n<li>Hemodialysis</li>\n</ul>\n</li>\n<li><strong>Increased Requirement</strong>\n<ul>\n<li>Pregnancy, infancy</li>\n<li>Disseminated cancer</li>\n<li>Markedly increased hematopoiesis</li>\n</ul>\n</li>\n<li><strong>Impaired Utilization</strong>\n<ul>\n<li>Folic acid antagonists</li>\n<li>Unresponsive to vitamin B12 or folic acid therapy</li>\n<li>Metabolic inhibitors of DNA synthesis and/or folate metabolism</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Features of Peripheral Blood Smear in Different Anemias</h3><p><strong>Type of anemia </strong></p>\n<p><strong>Microcytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thalassemia trait</p>\n</td>\n<td>\n<p>Basophilic stippling, target cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron-deficiency</p>\n</td>\n<td>\n<p>Elliptocytes, target cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sideroblastic anemia</p>\n</td>\n<td>\n<p>Pappenheimer bodies, RBC dimorphism, ringed sideroblasts (Perl&rsquo;s stain)&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Macrocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myelodysplastic syndrome</p>\n</td>\n<td>\n<p>Hypogranular or hypolobulated neutrophils, blast cells, giant or hypogranular platelets, Pappenheimer bodies</p>\n<p>Minor population of hypochromic / microcytic cells (dimorphic), poikilocytosis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Megaloblastic anemia</p>\n</td>\n<td>\n<p>Hypersegmented neutrophils (&gt;5 lobes), ovalocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemolysis</p>\n</td>\n<td>\n<p>Polychromasia (purple reticulocyte) +/- spherocytes&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic liver disease</p>\n</td>\n<td>\n<p>Target cells&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Normocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemolytic anemia&nbsp;</p>\n</td>\n<td>\n<p>Anisocytosis, poikilocytosis, polychromasia, nucleated red cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hereditary spherocytosis</p>\n</td>\n<td>\n<p>RBC lack central zone of pallor, reticulocytosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency&nbsp;</p>\n</td>\n<td>\n<p>Heinz bodies (revealed by special staining),&lsquo;Bite&rsquo; cells</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/1790d7b0abad44b9a161e651b248d7b8.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5663",
      "difficulty": "medium"
    },
    {
      "text": "What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Rectal prolapse"
        },
        {
          "id": 2,
          "text": "Hemorrhoids"
        },
        {
          "id": 3,
          "text": "Uterocervical prolapse"
        },
        {
          "id": 4,
          "text": "Uterine inversion"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given image,<strong> concentric folds of the prolapsed rectum</strong>&nbsp;are seen, which implies that the most likely diagnosis is <strong>rectal prolapse.</strong></p>\n<p>Rectal prolapse occurs when a <strong>mucosal or full-thickness layer</strong> of rectal tissue protrudes through the anal orifice.&nbsp;Rectal prolapse is of <strong>two types</strong>:</p>\n<ul>\n<li><strong>Partial rectal prolapse:</strong>&nbsp;In this type, only the mucosal layer of the rectum is prolapsed. It is seen in children. The first episode is managed by digital repositioning. If there is a recurrence, then Theirsch's wiring or sclerotherapy is done.&nbsp;</li>\n<li><strong>Complete rectal prolapse:</strong>&nbsp;In this type, all the layers of the rectum are prolapsed. It is seen in adults due to the weakening of the pelvic floor. It is managed by using the following approaches:</li>\n</ul>\n<p><strong>The perineal approach</strong></p>\n<p>The <strong>perineal approach</strong>&nbsp;is often preferred in&nbsp;patients with<strong>&nbsp;high operative risk</strong>&nbsp;and limited life expectancy, i.e. in the&nbsp;<strong>elderly.</strong>&nbsp;It is&nbsp;associated with less morbidity but has a&nbsp;<strong>higher recurrence rate</strong>. Procedures based on this approach are as follows:</p>\n<ul>\n<li><strong>Thiersch's wiring</strong>: A steel wire/nylon tape is placed around the anal canal. This procedure is largely obsolete and rarely used now due to problems with chronic perineal sepsis, anal stenosis, and obstructed defecation.&nbsp;</li>\n<li><strong>Delorme's mucosectomy</strong>:<strong>&nbsp;</strong>In this procedure, the rectal mucosa is stripped circumferentially from the rectum over the length of the prolapse.&nbsp;The underlying muscle is plicated with a series of sutures. The excess rectal mucosa is excised and a mucosal anastomosis is performed.</li>\n<li><strong>Altemeier's rectosigmoidoscopy:</strong>&nbsp;In&nbsp;this procedure, the rectum is prolapsed through the anal canal and a full-thickness resection is performed, incorporating any associated colonic prolapse. Restoration of colorectal continuity can be performed by hand-sewn/stapled anastomosis. This is the procedure of choice in patients presenting with incarcerated and strangulated prolapse.</li>\n</ul>\n<p><strong>Abdominal approach</strong></p>\n<p>The <strong>abdominal approach</strong> is difficult, has more complications, but has a lower recurrence rate. Procedures based on this approach are as follows:&nbsp;</p>\n<ul>\n<li><strong>Ripstein's procedure:</strong>&nbsp;Involves the placement of a prosthetic mesh around the mobilized rectum, with the attachment of the mesh to the presacral fascia (anterior) below the sacral promontory</li>\n<li><strong>Well's procedure:</strong>&nbsp;Involves posterior rectopexy&nbsp;</li>\n<li>Suture rectopexy</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/33fcedc18db54525a43f30d7997bb5a2.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5567",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is unlikely to be seen as a side effect of lithium therapy?",
      "choices": [
        {
          "id": 1,
          "text": "Polyuria-polydipsia"
        },
        {
          "id": 2,
          "text": "Sialorrhea"
        },
        {
          "id": 3,
          "text": "Hand tremors"
        },
        {
          "id": 4,
          "text": "Hyperreflexia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Dry mouth </strong>and <strong>not</strong> sialorrhea, is a <strong>known side effect of lithium</strong> therapy.</p>\n<p>Known significant side effects of lithium therapy include</p>\n<ul>\n<li>Polyuria-polydipsia </li>\n<li>Dry mouth </li>\n<li>Leukocytosis </li>\n<li>Headache</li>\n<li>Hand tremors</li>\n<li>Confusion </li>\n<li>Decreased memory</li>\n<li>Muscle weakness</li>\n<li>Hyperreflexia </li>\n<li>Muscle twitch </li>\n<li>Vertigo </li>\n<li>ECG changes</li>\n<li>Nausea &amp; vomiting</li>\n<li>Diarrhea </li>\n</ul>\n<p> </p><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5592",
      "difficulty": "medium"
    },
    {
      "text": "For how long should you maintain records of medical termination of pregnancy?",
      "choices": [
        {
          "id": 1,
          "text": "For at least 7 years, from the end of the calendar year of MTP"
        },
        {
          "id": 2,
          "text": "For at least 10 years, from the beginning of the calendar year of MTP"
        },
        {
          "id": 3,
          "text": "For at least 3 years, from the beginning of the calendar year of MTP"
        },
        {
          "id": 4,
          "text": "For at least 5 years, from the end of the calendar year of MTP"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A <strong>register for recording the details</strong> <strong>of</strong> medical termination of pregnancy (<strong>MTP</strong>) must be kept <strong>for at least 5 years,</strong> from the end of the calendar year it relates to<strong>.</strong> The patient's name must not be entered;&nbsp;<strong>only the reference number</strong> is used.</p>\n<p>Unlawful disclosure of a patient's details is punishable with <strong>1-year imprisonment with or without fine.&nbsp;</strong><strong>Only</strong> the <strong>patient's consent</strong> is required for <strong>MTP</strong>;&nbsp;her male partner's consent is not required.&nbsp;Consent of <strong>parent/guardian</strong> is needed if the&nbsp;age of the&nbsp;<strong>patient</strong> is <strong>&lt;18&nbsp;yrs</strong>&nbsp;or if the patient is <strong>mentally ill</strong>.</p>\n<p>&nbsp;</p>\n<h1>&nbsp;</h1>\n<p>&nbsp;</p><hr><h3>Related Pearl: Medical Termination of Pregnancy Act - MTP Act 1971</h3><p><strong>MTP Act with 2021 amendments&nbsp;</strong></p>\n<p><strong>Indications:</strong></p>\n<ul>\n<li><strong>Therapeutic </strong>- to save the life of the mother</li>\n<li><strong>Eugenic </strong>- to prevent the&nbsp;risk of the child being born with serious mental or physical abnormality i.e. first-trimester viral infections, teratogenic drug intake, radiation exposure</li>\n<li><strong>Humanitarian </strong>-&nbsp;pregnancy resulted from rape or incest</li>\n<li><strong>Social </strong>-&nbsp;pregnancy resulted from failure of contraceptives&nbsp;</li>\n</ul>\n<p><strong>Rules:</strong></p>\n<ul>\n<li>Only a <strong>registered medical practitioner</strong> who is qualified (one who has assisted in the performance of 25 cases of MTP in a recognized hospital) can terminate a pregnancy.</li>\n<li>MTP should be carried out in a government or <strong>government-recognized hospital</strong>.&nbsp;Private hospitals may take up MTP if they obtain a license from the chief medical officer of the district.</li>\n<li>The termination of pregnancy by a person, who is not a registered medical practitioner (the person concerned), or in an unrecognised hospital (administrative head) shall be punished with rigorous imprisonment for a term not less than <strong>2 years</strong>, but which may extend to 7 years.&nbsp;</li>\n</ul>\n<p><strong>Consent</strong>:</p>\n<p>The consent of the woman is required for conducting an abortion. The written consent of the guardian is required if the woman is minor or mentally ill. Consent of the husband or partner is not necessary.&nbsp;</p>\n<p>If the woman is not willing, abortion cannot be performed at the request of the husband alone. The woman need not produce proof of her age.&nbsp;It is enough for the woman to say that she was raped, and it is not necessary that a complaint was lodged with the police.</p>\n<p><strong>Opinion of doctors:</strong></p>\n<ul>\n<li>Till 20 weeks - 1 doctor's opinion</li>\n<li>20 to 24 weeks - 2 doctors' opinion</li>\n<li>For substantial fetal anomalies - approval from the medical board consisting of obstetrician, paediatrician, radiologist and a person appointed by the state</li>\n</ul>\n<p><strong>Upper limit of MTP:</strong></p>\n<ul>\n<li>Up to <strong>24 weeks</strong> of gestation in victims of <strong>rape</strong> and incest, fetal anomalies, or congenital malformations</li>\n<li>Up to <strong>20 weeks</strong> in case of <strong>contraception failure</strong> (any female with her partner)</li>\n<li>At <strong>any gestational age</strong> for substantial <strong>fetal anomalies</strong> decided by the medical board</li>\n</ul>\n<p><strong>Confidentiality:</strong></p>\n<p>A <strong>register</strong> for recording the details of MTP must be kept for at least <strong>5 years</strong>. The patient's name must not be entered, only the reference number is used.&nbsp;Unlawful disclosure of patient's details is punishable with 1-year imprisonment&nbsp;&plusmn; fine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5629",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are true about macula densa except:",
      "choices": [
        {
          "id": 1,
          "text": "It causes afferent arteriolar constriction in response to increases Na+ concentration"
        },
        {
          "id": 2,
          "text": "It functions as a chemoreceptor for K+"
        },
        {
          "id": 3,
          "text": "It secretes PGE2"
        },
        {
          "id": 4,
          "text": "It is located at the end of the thick ascending limb of Henle and at the beginning of the distal tubule"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Macula densa </strong>serves as a <strong>chemoreceptor for Na+, not K+</strong></p>\n<p>At the end of the thick ascending limb of Henle, and at the beginning of the distal tubule, the tubular epithelial cells are specialized to form the macula densa.&nbsp;They detect the sodium concentration of the fluid in the tubule<strong> (chemoreceptor).&nbsp;</strong>Though changes in K+ also seems to have an effect on renin levels, even that seems to be mediated via Na+.&nbsp;&nbsp;</p>\n<p>In response to <strong>elevated sodium</strong>, the macula densa cells trigger<strong>&nbsp;</strong>the<strong> contraction of the afferent arteriole</strong>, <strong>reducing</strong>&nbsp;the flow of blood to the glomerulus and the <strong>glomerular filtration rate</strong>. This happens as follows: When there is increased sodium, there is increased <strong>sodium-potassium ATPase activity which</strong>&nbsp;leads to increased <strong>ATP hydrolysis</strong> causing more <strong>adenosine</strong> formation. The adenosine receptors on the macula densa cells stimulate it to release<strong> more calcium</strong>, so that there is vasoconstriction of the afferent arteriole, thereby decreasing the <strong>GFR.<br /></strong></p>\n<p>Macula densa secretes PGE2 along with&nbsp;RMICs(Renal Medullary Interstitial Cells) and cells in the collecting ducts.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5461ebba66b64151ba826ae7f04b9317x1280x1384.JPEG\" alt=\"Explanation Image\"><p>Apart from macula densa, the juxtaglomerular apparatus contains</p>\n<ul>\n<li>Lacis cells:<strong> Extraglomerular mesangial cells</strong> situated between afferent and efferent arteriole.</li>\n<li>Granular cells/JG cells:&nbsp;Modified <strong>smooth muscle cells of the afferent arteriole, </strong>they secrete renin.&nbsp;<strong>Fall in pressure</strong> in afferent arteriole stimulates renin release <strong>(mechanoreceptor)</strong>, which, in turn, <strong>increases blood pressure.</strong></li>\n</ul><hr><h3>Related Pearl: Factors that affect renin secretion</h3><p><strong>Stimulatory</strong></p>\n<ul>\n<li>Increased sympathetic activity via renal nerves</li>\n<li>Increased circulating catecholamines</li>\n<li>Prostaglandins</li>\n<li>Na<sup>+ </sup>depletion</li>\n<li>Diuretics</li>\n<li>Upright posture</li>\n<li>Hemorrhage</li>\n<li>Hypotension</li>\n<li>Dehydration</li>\n<li>Cardiac failure</li>\n<li>Cirrhosis</li>\n<li>Constriction of the renal artery or aorta</li>\n<li>Various psychological stimuli</li>\n</ul>\n<p><strong>Inhibitory</strong></p>\n<ul>\n<li>Increased Na<sup>+</sup> and Cl<sup>-</sup> reabsorption across macula densa</li>\n<li>Increased afferent arteriolar pressure</li>\n<li>Angiotensin II</li>\n<li>ADH (vasopressin)</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5560",
      "difficulty": "medium"
    },
    {
      "text": "At what age of gestation is an amniocentesis generally done?",
      "choices": [
        {
          "id": 1,
          "text": "Before 12 weeks of gestation"
        },
        {
          "id": 2,
          "text": "15-20 weeks of gestation"
        },
        {
          "id": 3,
          "text": "Before 16 weeks of gestation"
        },
        {
          "id": 4,
          "text": "20-24 weeks of gestation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>The best time</strong> for performing amniocentesis is <strong>15-20 weeks of gestation</strong></p>\n<p><strong>Amniocentesis </strong>is the <strong>most common</strong> prenatal diagnostic procedure. It is performed using an <strong>aseptic technique, </strong>under direct<strong> sonographic guidance</strong>, using a <strong>20–22 gauge spinal needle</strong>. The needle is directed perpendicularly into a clear pocket of amniotic fluid while avoiding the fetus and umbilical cord. Sonography is used to observe the uterine puncture site for bleeding and fetal cardiac motion is documented at the end of the procedure. Approximately <strong>20 to 30 mL</strong> <strong>of fluid</strong> is collected for <strong>fetal karyotyping</strong> or chromosomal microarray analysis. </p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>Study material</p>\n</td>\n<td>\n<p>Amniotic fluid with amniocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Time</p>\n</td>\n<td>\n<p><strong>15-20 weeks</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Early amniocentesis</p>\n</td>\n<td>\n<p>11-14 weeks (associated with increased fetal loss, foot deformities)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Indications</p>\n</td>\n<td>\n<ul>\n<li>Congenital infections</li>\n<li><strong>Fetal genetic disorders</strong></li>\n<li>Alloimmunization</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Complications</td>\n<td>\n<ul>\n<li>Fetal loss</li>\n<li>Amniotic fluid leakage</li>\n<li>Transvaginal spotting</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Below is an image showing the procedure of amniocentesis vs chorionic villus sampling.</p>\n<p>Note:</p>\n<p>Amniocentesis is generally done between 15-20 weeks but may be performed at any point later in gestation.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b254bbad07f04e35bfd9db5d9c9acdecx1280x3002.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Prenatal screening for Down’s syndrome</h3><ul>\n<li><strong>USG findings</strong>\n<ul>\n<li>Intrauterine growth retardation (so decreased blood flow)</li>\n<li>Choroid plexus cysts</li>\n<li>Increased <strong>nuchal translucency &gt;3 mm</strong></li>\n<li>Hypoplastic nasal bone</li>\n<li>Congenital heart defects</li>\n<li>Increased intestinal echogenicity</li>\n<li>Duodenal atresia</li>\n</ul>\n</li>\n<li><strong>Maternal serum markers</strong>\n<ul>\n<li>Decreased: Alpha-fetoprotein (AFP), unconjugated estriol, pregnancy-associated plasma protein-A (PAPP-A)</li>\n<li>Increased: Human chorionic gonadotrophin (HCG), inhibin, neutrophil alkaline phosphatase</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Amniocentesis</strong>: 14<sup>th</sup>-18<sup>th</sup> week of pregnancy</li>\n<li><strong>Chorionic villus sampling</strong>\n<ul>\n<li>10<sup>th</sup> to 12<sup>th</sup> week of pregnancy: Gives the&nbsp;diagnosis in the&nbsp;first trimester</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5640",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following tumor markers is least useful in assessing dysgerminoma?",
      "choices": [
        {
          "id": 1,
          "text": "Lactate dehydrogenase"
        },
        {
          "id": 2,
          "text": "Alpha-fetoprotein"
        },
        {
          "id": 3,
          "text": "Placental alkaline phosphatase"
        },
        {
          "id": 4,
          "text": "Beta-hCG"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Alpha-fetoprotein </strong>(AFP) is not a useful marker for dysgerminoma; it is a marker for <strong>endodermal sinus tumors</strong>. Dysgerminoma<strong> </strong>secretes placental alkaline phosphatase, lactate dehydrogenase (LDH), and β-hCG.</p>\n<p><strong>Dysgerminoma</strong> is a type of germ cell tumor corresponding to the testis's seminoma. It does not secrete either male or female sex hormones. It secretes <strong>placental</strong> <strong>alkaline phosphatase</strong> (ALP), <strong>lactate dehydrogenase</strong> (LDH), and <strong>β-hCG</strong>. Serum <strong>lactate dehydrogenase (LDH)</strong> is usually used to monitor these patients for disease recurrence.</p>\n<p><strong>Endodermal sinus tumor/ Yolk sac tumor </strong>is a type of ovarian germ cell tumor<strong> </strong>that is seen in premenarchal girls. <strong>Schiller-Duval bodies</strong> are pathognomonic in histopathology. <strong>Alpha-fetoprotein </strong>(AFP) is commonly produced by this tumor and is used as a tumor marker.</p><hr><h3>Related Pearl: Markers of Ovarian Neoplasm</h3><table>\n<tbody>\n<tr>\n<td><strong>Ovarian tumor</strong></td>\n<td><strong>Tumor marker</strong></td>\n<td><strong>Pathognomonic finding</strong></td>\n</tr>\n<tr>\n<td>\n<p>Epithelial ovarian tumors</p>\n</td>\n<td>CA-125,&nbsp; CA-19-9, CEA</td>\n<td>Psammoma bodies (Serous epithelial tumor)</td>\n</tr>\n<tr>\n<td>Endodermal sinus tumor</td>\n<td>AFP</td>\n<td>Schiller-Duval bodies</td>\n</tr>\n<tr>\n<td>Dysgerminoma</td>\n<td>LDH, PLAP</td>\n<td>Lymphocytic infiltration</td>\n</tr>\n<tr>\n<td>Embryonal carcinoma</td>\n<td>AFP, HCG</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Mature teratoma</td>\n<td>AFP</td>\n<td>Rokitansky protruberance</td>\n</tr>\n<tr>\n<td>Granulosa cell tumor</td>\n<td>Inhibin</td>\n<td>Call&ndash;Exner bodies</td>\n</tr>\n<tr>\n<td>Hilus cell tumor</td>\n<td>-</td>\n<td>Reinke's crystal</td>\n</tr>\n<tr>\n<td>Brenner tumor</td>\n<td>-</td>\n<td>Walthard cell nest</td>\n</tr>\n<tr>\n<td>Krukenberg tumor</td>\n<td>-</td>\n<td>Signet-ring cell</td>\n</tr>\n<tr>\n<td>Clear cell tumor</td>\n<td>-</td>\n<td>Hobnail cell</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Dysgerminoma&nbsp;(Mnemonic: DPL= Delhi Premier League)</p>\n<ul>\n<li>D: Dysgerminoma</li>\n<li>P: PLAP (placental alkaline phosphatase)</li>\n<li>L: LDH (lactate dehydrogenase)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5636",
      "difficulty": "medium"
    },
    {
      "text": "Workers of a chemical factory are suing the company, claiming compensation for unsafe working conditions that increase their risk of cancer. The cancer incidence data compared with the general population are provided below. What is the risk ratio?",
      "choices": [
        {
          "id": 1,
          "text": "5"
        },
        {
          "id": 2,
          "text": "50"
        },
        {
          "id": 3,
          "text": "0.5"
        },
        {
          "id": 4,
          "text": "1"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given scenario,&nbsp;<strong>risk ratio</strong> or <strong>relative risk</strong>&nbsp;(RR) is <strong>5</strong>.<br /><br />Relative Risk/ Risk Ratio&nbsp; (RR) = [ a/(a+b) ]/ [ c/(c+d) ] where,&nbsp;</p>\n<ul>\n<li>a - Number of people with cancer amongst the factory workers</li>\n<li>b - Number of people without cancer amongst the factory workers</li>\n<li>c - Number of people with cancer amongst the general population</li>\n<li>d - Number of people without cancer amongst the&nbsp;general population</li>\n</ul>\n<p>RR = [50/(50+950)]<strong> / </strong>[100/(100+9900)]</p>\n<p>=0.05/0.01</p>\n<p>=5</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Relative and Attributable Risk</h3><p>Relative Risk:</p>\n<ul>\n<li>Ratio of incidence of disease or death among exposed to that among the non-exposed is called <strong>relative risk (RR).</strong></li>\n<li>It is also called <strong>risk ratio</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f8f2d7bcf01a465699a42d1a750c87b8x1280x704.JPEG\" alt=\"Pearl Image\"><ul>\n<li>It is the direct measure of the <strong>strength of association</strong> between suspected cause and effect in <strong>cohort studies</strong>.</li>\n<li>RR &lt; 1 indicates inverse association(protective effect)</li>\n<li>RR = 1 indicates no association.</li>\n<li>RR &gt; 1 indicates positive association.</li>\n<li>RR of 2 indicates a 100% increase in risk.</li>\n<li>Relative risk calculation (RR) = [ a/(a+b) ]/ [ c/(c+d) ] where, </li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td colspan=\"3\">Cancer</td>\n</tr>\n<tr>\n<td rowspan=\"3\">Exposure</td>\n<td> </td>\n<td>yes</td>\n<td>no</td>\n</tr>\n<tr>\n<td>yes</td>\n<td>a</td>\n<td>b</td>\n</tr>\n<tr>\n<td>no</td>\n<td>c</td>\n<td>d</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Attributable Risk:</p>\n<ul>\n<li><strong>Attributable risk (AR)</strong> is the <strong>difference</strong> in incidence rates or proportions of disease or death between an exposed and non-exposed group.</li>\n<li>It is expressed in <strong>percentage</strong> and gives the extent to which the disease can be attributed to the exposure in a <strong>cohort study.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c96f4beb9eb942899198d757d3388918x1280x904.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9627e7337c334a34a6bb2791da8985e7.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5505",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is expressed on macrophages and monocytes?",
      "choices": [
        {
          "id": 1,
          "text": "CD 94"
        },
        {
          "id": 2,
          "text": "CD 3"
        },
        {
          "id": 3,
          "text": "CD 25"
        },
        {
          "id": 4,
          "text": "CD 68"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>CD68</strong>&nbsp;is expressed on <strong>macrophages</strong> and <strong>monocytes</strong>.</p>\n<p>The marker of the<strong> natural killer</strong> <strong>cells</strong> is <strong>CD94. </strong>It is expressed in natural killer cells and a small subset of T lymphocytes.&nbsp;</p>\n<p>&nbsp;</p><p><strong>CD 3</strong> is a <strong>T-cell receptor marker</strong>. It is involved in the transduction of signals to the T cells when an antigen binds to the T cell receptor.</p>\n<p><strong>CD 25</strong> is a component of the <strong>IL2 receptor</strong> and is important in T cell proliferation and activation.</p><hr><h3>Related Pearl: Immune Cell Antigens Detected by Monoclonal Antibodies</h3><table>\n<tbody>\n<tr>\n<td><strong><span class=\"TextRun SCXW86796565\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW86796565\">Antigen</span></span><span class=\"TextRun SCXW86796565\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW86796565\">&nbsp;</span></span><span class=\"TextRun SCXW86796565\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW86796565\">Designation</span></span><span class=\"TextRun SCXW86796565\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW86796565\">&nbsp;and their&nbsp;</span></span><span class=\"TextRun SCXW86796565\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW86796565\">Normal Cellular Distribution</span></span><span class=\"EOP SCXW86796565\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></strong></td>\n</tr>\n<tr>\n<td><strong><span class=\"TextRun SCXW130168874\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW130168874\">Primarily T-Cell Associated</span></span><span class=\"EOP SCXW130168874\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">CD1&nbsp;Thymocytes and Langerhans cells&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">CD3&nbsp;Thymocytes, mature T cells&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">CD4 Helper T cells, subset of thymocytes&nbsp;&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">CD5 T cells and a small subset of B cells&nbsp;&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">CD8 Cytotoxic T cells, subset of thymocytes, and some NK cells&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\"TextRun SCXW177769382\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW177769382\">Primarily B-Cell Associated</span></span></strong><span class=\"EOP SCXW177769382\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"4\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">CD10 Pre-B cells and germinal-center B cells&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"4\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">CD19 Pre-B cells and mature B cells, but not plasma cells&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"4\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">CD20 Pre-B cells after CD19 and mature B cells, but not plasma cells&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"4\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">CD21 EBV receptor; mature B cells and follicular dendritic cells</li>\n</ul>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"4\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">CD23 Activated mature B cells&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"4\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">CD79a Marrow pre-B cells and mature B cells&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\"TextRun SCXW5554072\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW5554072\">Primarily Monocyte or Macrophage Associated</span></span><span class=\"EOP SCXW5554072\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"6\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">CD11c Granulocytes, monocytes, and macrophages; also expressed&nbsp;by hairy cell leukemias&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"6\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">CD13 Immature and mature monocytes and granulocytes&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"6\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">CD14 Monocytes&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"6\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">CD15 Granulocytes; Reed-Sternberg cells and variants</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"6\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">CD33 Myeloid progenitors and monocytes&nbsp;&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"6\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">CD64 Mature myeloid cells&nbsp;&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\"TextRun SCXW245085851\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW245085851\">Primarily NK-CellAssociated</span></span><span class=\"EOP SCXW245085851\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"7\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">CD16 NK cells and granulocytes&nbsp;&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"7\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">CD56 NK cells and a subset of T cells&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\"TextRun SCXW128063462\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW128063462\">Primarily Stem Cell and Progenitor Cell Associated </span></span></strong><span class=\"EOP SCXW128063462\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><span class=\"TextRun SCXW128063462\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW128063462\"><span class=\"TextRun SCXW257355501\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW257355501\">CD34 Pluripotent hematopoietic stem cells and progenitor cells of many lineages</span></span><span class=\"EOP SCXW257355501\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></span></span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\"TextRun SCXW128063462\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW128063462\"><span class=\"TextRun SCXW237922357\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW237922357\">Activation Markers</span></span><span class=\"EOP SCXW237922357\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></span></span></strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><span class=\"TextRun SCXW128063462\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW128063462\"><span class=\"TextRun SCXW58944318\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW58944318\">CD30 Activated B cells, T cells, and monocytes; Reed-Sternberg cells and variants</span></span><span class=\"EOP SCXW58944318\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></span></span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span class=\"TextRun SCXW128063462\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW128063462\"><span class=\"TextRun SCXW58944318\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW58944318\"><strong><span class=\"TextRun SCXW110477194\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW110477194\">Present on All Leukocytes</span></span></strong><span class=\"EOP SCXW110477194\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></span></span></span></span></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><span class=\"TextRun SCXW128063462\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW128063462\"><span class=\"TextRun SCXW121164674\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW121164674\">CD45 All leukocytes; also known as leukocyte common antigen (LCA)</span></span><span class=\"EOP SCXW121164674\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></span></span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5642",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant woman at 10 weeks gestation, presents to the outpatient department with complaints of curdy white vaginal discharge, dysuria, and intense itching. Candidal vaginitis is suspected. As per the CDC, what will be the best management in this scenario?",
      "choices": [
        {
          "id": 1,
          "text": "Oral fluconazole 150 mg single dose"
        },
        {
          "id": 2,
          "text": "Oral fluconazole 150 mg two doses 1 week apart"
        },
        {
          "id": 3,
          "text": "Metronidazole 200 mg oral TDS for 7 days"
        },
        {
          "id": 4,
          "text": "Intravaginal topical azole  for 7 days"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient has <strong>candidal vaginitis. </strong>The best management in a pregnant woman is<strong> topical azoles </strong>like clotrimazole or miconazole, applied <strong>intravaginally</strong> for <strong>7 days</strong>.</p>\n<p>Although the treatment of vulvovaginal candidiasis involves <strong>oral fluconazole 150 mg single dose</strong> or topical azole therapy for 7 days in a <strong>non-pregnant woman</strong>, only <strong>topical azoles</strong> are recommended during<strong> pregnancy</strong>. Since the use of <strong>fluconazole</strong> has been associated with embryotoxicity and increased risk of cardiac malformations, it is recommended to be <strong>avoided</strong> during the first trimester.</p>\n<p>Risk Factors For candidal infection include</p>\n<ul>\n<li>Immunosuppression</li>\n<li>HIV</li>\n<li><strong>Pregnancy</strong></li>\n<li>Steroid therapy</li>\n<li>Following long-term broad-spectrum antibiotic therapy</li>\n<li>Oral contraceptive pills</li>\n<li>Diabe­tes mellitus</li>\n<li>Poor personal hygiene</li>\n<li>Obesity</li>\n</ul>\n<p>The clinical symptoms of vaginal candidiasis include <strong>curdy white vaginal discharge</strong>, dysuria, and intense itchin with <strong>vaginal pH &lt;4.5</strong>. The diagnosis can be confirmed by microscopic examination of smear of vaginal discharge with 10% KOH solution. The smear shows <strong>budding yeast cells and pseudohyphae</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7ea3350e69744fd794ad0c34f93164a1x1280x801.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Vaginal infections</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Bacterial vaginosis</strong></td>\n<td><strong>Trichomonas vaginitis</strong></td>\n<td>\n<p><strong>Candidal vaginitis</strong></p>\n</td>\n</tr>\n<tr>\n<td>Causative organism&nbsp;</td>\n<td>Altered vaginal flora- increased concentration of <strong><em>Gardnerella vaginalis</em></strong></td>\n<td><strong><em>Trichomonas vaginalis</em></strong></td>\n<td><strong><em>Candida albicans</em></strong></td>\n</tr>\n<tr>\n<td>Aetiology</td>\n<td>Increased vaginal pH</td>\n<td>Sexually transmitted</td>\n<td>Decreased immunity</td>\n</tr>\n<tr>\n<td>Sexual transmission</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Discharge</td>\n<td>Fishy, thin, yellow</td>\n<td>Frothy, green</td>\n<td>Curdy, white</td>\n</tr>\n<tr>\n<td>Symptoms</td>\n<td>Fishy odour, no itching</td>\n<td>Itching and burning</td>\n<td>Itching, burning</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>&gt;4.5</td>\n<td>&gt;4.5</td>\n<td>&lt;4.5</td>\n</tr>\n<tr>\n<td>Speculum</td>\n<td>No vaginal epithelium inflammation</td>\n<td>Strawberry cervix</td>\n<td>Inflamed-epithelium</td>\n</tr>\n<tr>\n<td>KOH</td>\n<td>Positive Whiff test</td>\n<td>The whiff test can be positive.</td>\n<td>Pseudohyphae seen.</td>\n</tr>\n<tr>\n<td>Wet mount</td>\n<td>Clue cells. No WBCs seen</td>\n<td>Motile trichomaonads, WBCs seen</td>\n<td>WBCs seen</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>Metronidazole or Clindamycin</td>\n<td>Metronidazole, treat&nbsp;partner also</td>\n<td>Oral or vaginal azole, no need to treat partner.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5633",
      "difficulty": "hard"
    },
    {
      "text": "A 43-year-old lady who had recently undergone a renal transplant comes with complaints of recurrent retrosternal chest pain and swallowing difficulty. As part of her workup, an upper GI endoscopy is done and it appears as below. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "CMV esophagitis"
        },
        {
          "id": 2,
          "text": "Candida esophagitis"
        },
        {
          "id": 3,
          "text": "Herpetic esophagitis"
        },
        {
          "id": 4,
          "text": "Eosinophilic esophagitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cytomegalovirus lesions</strong> appear as <strong>serpiginous ulcers</strong> in an otherwise normal mucosa, particularly in the <strong>distal esophagus</strong>.</p>\n<p>&nbsp;</p>\n<p>Transplant recipient patients are at higher risk of developing CMV infections. The typical presentation is with complaints that are associated with CMV infections of the other system as well.&nbsp;Complaints that are seen in patients with CMV esophagitis for include</p>\n<ul>\n<li>Dysphagia &amp; odynophagia</li>\n<li>Retrosternal pain/ Abdominal pain</li>\n<li>Nausea, vomiting, or diarrhea</li>\n<li>Fever</li>\n<li>Weight loss</li>\n<li>Hemoptysis</li>\n</ul><hr><h3>Related Pearl: Endoscopic Findings in Esophagitis</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Conditions</strong></td>\n<td><strong>Endoscopic findings</strong></td>\n</tr>\n<tr>\n<td>Infectious esophagitis</td>\n<td>Diffuse and involve the proximal esophagus &nbsp;</td>\n</tr>\n<tr>\n<td>HSV esophagitis</td>\n<td>Vesicles and small punched-out lesions (volcano ulcers)</td>\n</tr>\n<tr>\n<td>CMV&nbsp;esophagitis</td>\n<td>Serpiginous ulcers</td>\n</tr>\n<tr>\n<td>Peptic esophagitis</td>\n<td>Solitary and distal &nbsp;</td>\n</tr>\n<tr>\n<td>Eosinophilic esophagitis</td>\n<td>Multiple esophageal rings, linear furrows, or white punctate exudates (feline esophagus)</td>\n</tr>\n<tr>\n<td>Pill esophagitis</td>\n<td>Singular and deep at points of luminal narrowing with sparing of the distal esophagus</td>\n</tr>\n<tr>\n<td>Candida esophagitis</td>\n<td>White friable plaques, in advance form - adherent, grey-white pseudomembranes.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>The image below shows the lesions of CMV esophagitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4d3459a16bb04e7db0a37697b70d64f3x358x327.PNG\" alt=\"Pearl Image\"><p>The image below shows the lesions of candida esophagitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/27753ea663e94016878e0fdfbfe7ab80x526x488.PNG\" alt=\"Pearl Image\"><p>The image below shows feline esophagus in eosinophilic esophagitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd7fb7a1bf14483f9405672cd6b522dex592x472.JPEG\" alt=\"Pearl Image\"><p>The image below shows the erosive lesion of pill esophagitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b7d3184539ba462d8fa7bfd006f20927x512x399.PNG\" alt=\"Pearl Image\"><p>The image below shows the lesions of HSV esophagitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6b4e6f9f77b44981b91065e60457a1e6x388x439.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/687c97e967384fb883d81e0ac2bdf4a6.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5562",
      "difficulty": "easy"
    },
    {
      "text": "A 23-year-old man presents to your PHC with a Category III dog bite. But, Rabies Immunoglobulin (RIG) is not available at your center. How would you manage the patient?",
      "choices": [
        {
          "id": 1,
          "text": "Administer 1st dose of vaccine and refer to higher center for administration of RIG"
        },
        {
          "id": 2,
          "text": "Skip RIG as there is no use in administering it after the first dose of vaccine is administered"
        },
        {
          "id": 3,
          "text": "Withhold vaccine till RIG becomes available as RIG should be administered prior to first dose of vaccine"
        },
        {
          "id": 4,
          "text": "Withhold vaccine till RIG becomes available as they should be administered simultaneously"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Administer 1st dose of vaccine</strong> and <strong>refer</strong> to higher center <strong>for</strong> administration of <strong>Rabies Immunoglobulin.</strong></p>\n<p>Rabies immunoglobulin (RIG) is <strong>passive immunization</strong>.&nbsp;It is administered <strong>only once</strong>, preferably <strong>within 24 hours </strong>of the exposure, i.e., on day 0 of the anti-rabies vaccine (ARV). If RIG was not given with the ARV 1st dose, it can be <strong>given up to the 7th day</strong> after the first dose of ARV. It is not given after 7 days of receiving the 1st dose of ARV.</p>\n<p>The dose is <strong>20 IU/kg</strong> body weight for <strong>human rabies immunoglobulin&nbsp;</strong>(HRIG) and for <strong>equine rabies immunoglobulin </strong>(ERIG), the dose is<strong> 40 IU/kg</strong> body weight.&nbsp;When HRIG is not available, ERIG can be used. They are potent, safe, and less expensive.&nbsp;</p>\n<p>The entire RIG dose or as much as anatomically possible should be <strong>infiltrated into the wound</strong> <strong>or as close as possible</strong>. If it is likely that there are additional small wounds, the remaining RIG should be given IM as close as possible to the site of wound or exposure.</p>\n<p>All patients with&nbsp;<strong>category III</strong> exposures should be given RIG. This includes</p>\n<ul>\n<li>single/multiple transdermal bites/scratches,</li>\n<li>licks on broken skin,</li>\n<li>contamination of mucous membranes with saliva,</li>\n<li>contact with bats.</li>\n</ul>\n<p>In immunocompromised patients, RIG should be given to both category II and III exposures.</p><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5503",
      "difficulty": "easy"
    },
    {
      "text": "A woman comes to the OPD claiming that she was bitten by the insect shown in the image below, while out trekking. She may develop any of the following diseases due to this, except _____.",
      "choices": [
        {
          "id": 1,
          "text": "Relapsing fever"
        },
        {
          "id": 2,
          "text": "Rocky Mountain spotted fever"
        },
        {
          "id": 3,
          "text": "Q fever"
        },
        {
          "id": 4,
          "text": "Kyasanur Forest disease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">The given image is of a <strong>soft tick</strong>. The diseases transmitted by soft ticks are <strong>Q fever, </strong><strong>Relapsing fever &amp; </strong><strong>Kyasanur Forest disease</strong><strong>. Rocky Mountain spotted fever</strong> is transmitted by <strong>hard ticks</strong>, and hence is unlikely in this patient.</p>\n<p class=\"p1\"><strong>Hard ticks</strong> are covered by a chitinous shield on their dorsal surface, which is called the scutum. They have a head or capitulum present at the anterior end, which is visible from above. </p>\n<p class=\"p1\">Diseases transmitted by hard ticks:</p>\n<ul>\n<li class=\"p1\">Tick typhus (Rocky Mountain spotted fever)</li>\n<li class=\"p1\">Viral encephalitis (Russian spring-summer encephalitis)</li>\n<li class=\"p1\">Viral fevers (e.g., Colorado tick fever)</li>\n<li class=\"p1\">Viral hemorrhagic fevers (e.g. Kyasanur Forest disease in India)</li>\n<li class=\"p1\">Tularaemia</li>\n<li class=\"p1\">Tick paralysis</li>\n<li class=\"p1\">Human babesiosis.</li>\n</ul>\n<p><strong>Note: </strong>KFD in India can be transmitted with hard and soft ticks both.</p>\n<p>An image of a <strong>hard tick</strong> is shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bfae22b5830c4938ad11f48b14816b93x720x540.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Ticks</h3><ul>\n<li>The two types of ticks are <strong>hard ticks</strong> and <strong>soft ticks.</strong></li>\n<li>The general morphology of ticks includes an oval-shaped body, four pairs of legs, and no antennae.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Hard tick</strong></td>\n<td><strong>Soft tick</strong></td>\n</tr>\n<tr>\n<td>Scutum</td>\n<td>A chitinous shield that covers the entire back in males. Females have a small portion in the front.</td>\n<td>Absent.</td>\n</tr>\n<tr>\n<td>Head</td>\n<td>Situated at the anterior end.</td>\n<td>Lies on the underside of the body (ventrally). Not visible from above.</td>\n</tr>\n<tr>\n<td>Eggs</td>\n<td>Several hundreds or thousands laid at once</td>\n<td>Laid in batches of 20 &ndash; 100 over a long period</td>\n</tr>\n<tr>\n<td>Nymphal stages</td>\n<td>One</td>\n<td>Five</td>\n</tr>\n<tr>\n<td>Habits</td>\n<td>Cannot withstand starvation; feed night and day.</td>\n<td>Can withstand starvation for more than a year.</td>\n</tr>\n<tr>\n<td>Vectors for</td>\n<td>Tick typhus, viral encephalitis, viral fevers, tularemia, Kyasanur forest disease, babesiosis, tick paralysis. Ixodes type transmits Lyme disease.</td>\n<td>Soft tick is a reservoir for Q fever and a vector for relapsing fever.</td>\n</tr>\n<tr>\n<td>Life span</td>\n<td>Short</td>\n<td>Longer</td>\n</tr>\n<tr>\n<td>Habits</td>\n<td>Always found on their hosts.</td>\n<td>They hide in cracks and crevices during the day and come out to feed during the night.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Insecticidal control</strong> of ticks includes <strong>DDT, chlordane, dieldrin, lindane, malathion, and toxaphene.</strong> Environmental control and protection of workers must also be done to prevent disease transmission from ticks.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4d145a93c39f4987bdc6815eb5c9c257x1280x760.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Arthropod- borne diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>Arthropod</strong></td>\n<td><strong>Disease transmitted</strong></td>\n</tr>\n<tr>\n<td>Anopheles mosquito</td>\n<td>Malaria, Filariasis</td>\n</tr>\n<tr>\n<td>Culex mosquito</td>\n<td>Bancroftian filariasis, Japenese encephalitis, West nile fever, Viral arthritis</td>\n</tr>\n<tr>\n<td>Aedes mosquito</td>\n<td>Yellow fever, Dengue, Chikungunya, filariasis, zika</td>\n</tr>\n<tr>\n<td>Mansoni Mosquito</td>\n<td>Filariasis, Chikungunya</td>\n</tr>\n<tr>\n<td>Housefly</td>\n<td>Typhoid and paratyphoid fever, diarrhea, dysentery, cholera, gastroenteritis, amoebiasis, helminthic infestations, poliomyelitis, conjunctivitis, trachoma, anthrax, yaws, etc.</td>\n</tr>\n<tr>\n<td>Sandfly (Phlebotomus)</td>\n<td>Kala-azar(Visceral Leishmaniasis), oriental sore, Oroya fever, Sandfly fever</td>\n</tr>\n<tr>\n<td>Tsetse fly</td>\n<td>Sleeping sickness(African Trypanosomiasis)</td>\n</tr>\n<tr>\n<td>Louse</td>\n<td>Epidemic typhus, relapsing fever, trench fever, pediculosis</td>\n</tr>\n<tr>\n<td>Rat flea</td>\n<td>Bubonic plague, endemic typhus(Murine Typhus), hymenolepis diminuta</td>\n</tr>\n<tr>\n<td>Black fly(Simulium)</td>\n<td>Onchocerciasis</td>\n</tr>\n<tr>\n<td>Reduviid bug(Kissing bug/triatominae)</td>\n<td>Chagas disease(American Trypanosomiasis)</td>\n</tr>\n<tr>\n<td>Hard tick (Ixodes species)</td>\n<td>Tick typhus, viral encephalitis, viral fevers, viral hemorrhagic fever,(e.g. Kyasanur forest disease), tularemia, tick paralysis, human babesiosis, lyme disease</td>\n</tr>\n<tr>\n<td>Soft Tick (Argas species)</td>\n<td>Q fever, relapsing fever, Kyasanur forest disease (KFD) (can be casued by hard tick as well)</td>\n</tr>\n<tr>\n<td>Trombiculid mite</td>\n<td>Scrub typhus, Rickettsial pox</td>\n</tr>\n<tr>\n<td>Itch mites</td>\n<td>Scabies</td>\n</tr>\n<tr>\n<td>Cyclops</td>\n<td>Guinea-worm disease, fish tapeworm (D. latum)</td>\n</tr>\n<tr>\n<td>Cockroaches</td>\n<td>Enteric pathogens</td>\n</tr>\n<tr>\n<td>Sand flea (Tunga penetrance, Jiggar, Chigoe flea)</td>\n<td> Tungiasis, Ulcer in the feetnails</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/829dc7b3fadc496eb182cd8b47df27e9.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5519",
      "difficulty": "hard"
    },
    {
      "text": "Which among the following is wrong about DIC?",
      "choices": [
        {
          "id": 1,
          "text": "Prolonged activated partial thromboplastin time (aPTT)"
        },
        {
          "id": 2,
          "text": "Prolonged PT/TT"
        },
        {
          "id": 3,
          "text": "Increased platelet count"
        },
        {
          "id": 4,
          "text": "Decreased fibrinogen"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In disseminated intravascular coagulopathy (DIC), the <strong>platelet count</strong> is<strong> decreased.</strong></p>\n<p>The <strong>most common</strong> site of <strong>thrombi</strong> in DIC is the <strong>brain</strong>. The most common cause of DIC is Infections.</p>\n<p><strong>Laboratory investigations in DIC:</strong></p>\n<ul>\n<li>Decreased platelet count </li>\n<li>Prolonged PT/TT</li>\n<li>Prolonged activated partial thromboplastin time (aPTT)</li>\n<li>Decreased fibrinogen</li>\n<li>Elevated fibrin degradation products (D-dimers)</li>\n<li>Peripheral smear: microangiopathic hemolytic anemia in DIC with schistocytes (fragmented red blood cells) </li>\n</ul>\n<p>Cryoprecipitate can be used to rapidly raise the fibrinogen and factor VIII levels, particularly when bleeding is part of the DIC and the fibrinogen level is <strong>less than 1 g/L.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5683",
      "difficulty": "easy"
    },
    {
      "text": "A patient has normal fluency and repetition of speech but impaired naming and comprehension. He has _______.",
      "choices": [
        {
          "id": 1,
          "text": "Posterior transcortical aphasia"
        },
        {
          "id": 2,
          "text": "Anterior transcortical aphasia"
        },
        {
          "id": 3,
          "text": "Transcortical mixed aphasia"
        },
        {
          "id": 4,
          "text": "Anomic aphasia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The symptoms described in the question suggest that the patient has <strong>posterior transcortical aphasia, </strong>also called&nbsp;<strong>fluent transcortical aphasia.</strong></p>\n<p>In posterior transcortical aphasia, the clinical features are similar to that Wernicke's aphasia, but here the&nbsp;<strong>repetition is intact.</strong> The lesion site disconnects the intact core of the language network from other temporoparietal association areas. Hemianopia may be an associated finding in some cases.</p>\n<p>Common Causes:</p>\n<ul>\n<li>Cerebrovascular lesions including infarctions in the posterior watershed zone</li>\n<li>Neoplasms involving the temporoparietal cortex posterior to Wernicke&rsquo;s area</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9cdea7198ac445b7a892665843d61c51x1280x2558.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Aphasias and Related Conditions</h3><table><colgroup><col span=\"5\" /> </colgroup>\n<tbody>\n<tr>\n<td class=\"xl63\">&nbsp;</td>\n<td class=\"xl65\"><strong>Comprehension</strong></td>\n<td class=\"xl65\"><strong>Repetition of Spoken language</strong></td>\n<td class=\"xl65\"><strong>Naming</strong></td>\n<td class=\"xl65\"><strong>Fluency</strong></td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Wernicke's</strong></td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Broca's</strong></td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Decreased</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Global</strong></td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Decreased</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Conduction</strong></td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Anterior (nonfluent) transcortical</strong></td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Impaired</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Posterior (fluent) transcortical</strong></td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Isolation</strong></td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Echolalia</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">No purposeful speech</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Anomic</strong></td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved except for word finding pauses</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Pure Word Deafness</strong></td>\n<td class=\"xl64\">Impaired only for spoken language</td>\n<td class=\"xl64\">Impaired</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n<tr>\n<td class=\"xl65\"><strong>Pure Alexia</strong></td>\n<td class=\"xl64\">Impaired only for reading</td>\n<td class=\"xl64\">Preserved</td>\n<td class=\"xl64\">Preserved&nbsp;</td>\n<td class=\"xl64\">Preserved</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c1cb9177ba6f447ead67de336cd40692x1280x1590.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: CNS deficits and site of lesions</h3><table>\n<tbody>\n<tr>\n<td><strong>Term</strong></td>\n<td><strong>Defnition</strong></td>\n<td><strong>Site of lesion</strong></td>\n</tr>\n<tr>\n<td>Agnosia</td>\n<td>Inability to accurately perceive objects through normally functioning sensory mechanisms</td>\n<td>Posterior parietal cortex</td>\n</tr>\n<tr>\n<td>\n<p>Dyslexia</p>\n<p>(word blindness)</p>\n</td>\n<td>\n<p>Inability to interpret their meanings</p>\n<p>(the person may be able to see words and even know that they are words but not be able to interpret their meanings)</p>\n</td>\n<td>Angular gyrus</td>\n</tr>\n<tr>\n<td>Aphasia</td>\n<td>inability to produce and/or understand language</td>\n<td>\n<p class=\"p1\">All components of the language network are interconnected with each other and with</p>\n<p class=\"p1\">surrounding parts of the frontal, parietal, and temporal lobes. Damage</p>\n<p class=\"p1\">to this network gives rise to language impairments resulting in aphasia.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5555",
      "difficulty": "medium"
    },
    {
      "text": "Damage to the genitofemoral nerve during surgery would result in all of the following, except ______.",
      "choices": [
        {
          "id": 1,
          "text": "Loss of cremasteric reflex"
        },
        {
          "id": 2,
          "text": "Loss of sensation over the mons pubis and labium majus in females"
        },
        {
          "id": 3,
          "text": "Loss of sensation over the root of penis in males"
        },
        {
          "id": 4,
          "text": "Loss of sensation over the anteromedial skin of the thigh"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Injury to the<strong> femoral branch of the genitofemoral nerve</strong> causes <strong>hypoesthesia</strong> over the<strong> anterior thigh</strong> below the inguinal ligament.</p>\n<p>Injury to the <strong>genital branch</strong> of the genitofemoral nerve<strong> </strong>results in <strong>loss</strong> of <strong>sensation</strong> of the <strong>mons pubis</strong> and<strong> labia majora</strong> in <strong>females and loss of sensation in the skin of the scrotum of males.</strong> The genitofemoral nerve also innervates the cremaster muscle via the genital branch and is responsible for the<strong> cremasteric reflex.</strong></p>\n<p>Injury to the <strong>ilioinguinal nerve</strong> causes <strong>loss</strong> of<strong> sensation</strong> at the <strong>root</strong> of the<strong> penis </strong>and<strong> adjacent parts</strong> of the<strong> scrotum. </strong>It is<strong> most commonly</strong> injured within the inguinal canal in open hernia repair due to traction or thermal injury. </p>\n<div class=\"ng-scope\"> </div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a1ca800341d406bbeaf65fa173e26eax1279x1662.JPEG\" alt=\"Explanation Image\"><p>The <strong>iliohypogastric nerve</strong> carries the sensory supply from the <strong>suprapubic area.</strong> Injury to this nerve in the right iliac fossa rarely causes sensory disturbances, as the suprapubic area has a rich nerve supply from other sources too. If the <strong>nerve is severed</strong> above the <strong>anterior superior iliac spine,</strong> it can lead to the <strong>weakened posterior wall</strong> of the inguinal canal, resulting in a <strong>direct inguinal hernia</strong>. The iliohypogastric nerve can also get injured following <strong>appendicectomy</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5568",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is wrongly paired?",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia - \t t(8; 21)"
        },
        {
          "id": 2,
          "text": "Follicular lymphoma - t(14;19)"
        },
        {
          "id": 3,
          "text": "Chronic myelogenous leukemia - t(9;22)"
        },
        {
          "id": 4,
          "text": "Burkitt lymphoma - t(8; 14)"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>CLL</strong>/ Small lymphocytic lymphoma shows <strong>t(14;19)</strong>. <strong>Follicular</strong> lymphoma shows <strong>t(14;18). </strong></p>\n<p>Its hallmark is a translocation that juxtaposes the <strong>IgH</strong> locus on chromosome <strong>14</strong> and the <strong>BCL2</strong> locus on chromosome <strong>18</strong>. It is seen in up to 90% of follicular lymphomas and leads to<strong> overexpression</strong> of <strong>BCL2</strong>.</p>\n<p><strong>BCL2 inhibits apoptosis</strong> and promotes the survival of follicular lymphoma cells.</p><hr><h3>Related Pearl: Malignancies, Translocations and Affected Genes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Malignancy </strong></p>\n</td>\n<td>\n<p><strong>Translocation</strong></p>\n</td>\n<td>\n<p><strong>Affected Genes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CLL/ Small lymphocytic lymphoma</p>\n</td>\n<td>\n<p>t(14;19)</p>\n</td>\n<td>\n<p><em>-</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic myelogenous leukemia (CML)</p>\n</td>\n<td>\n<p>t(9;22)</p>\n</td>\n<td>\n<p><em>ABL </em>9q34</p>\n<p><em>BCR </em>22q11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute myeloid leukemia (AML)</p>\n</td>\n<td>\n<p>t(8; 21), t(15; 17)</p>\n</td>\n<td>\n<p><em>AML1 21</em>q22</p>\n<p><em>ETO 8</em>q22</p>\n<p><em>PML </em>15q22</p>\n<p><em>RARA </em>17q21</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Precursor B cell ALL</p>\n</td>\n<td>\n<p>t(9;22), t(4;11)</p>\n</td>\n<td>&nbsp;\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t(8; 14), t(2;8) t(8;22)</p>\n</td>\n<td>\n<p><em>c-myc&nbsp;</em>8q24</p>\n<p><em>IGH </em>14q32</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11; 14)</p>\n</td>\n<td>\n<p><em>CCND1 </em>11q13</p>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL1</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14; 18)</p>\n</td>\n<td>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL2 </em>18q21</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ewing sarcoma</p>\n</td>\n<td>\n<p>t(11; 22)</p>\n</td>\n<td>\n<p><em>FLI1 </em>11q24</p>\n<p><em>EWSR1 </em>22q12</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic adenocarcinoma</p>\n</td>\n<td>\n<p>t(7; 21), t(17; 21)</p>\n</td>\n<td>\n<p><em>TMPRSS2 </em>(21q22.3)</p>\n<p><em>ETV1</em> (7p21.2)</p>\n<p><em>ETV4 </em>(17q21)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma</p>\n</td>\n<td>&nbsp;t(14;18)</td>\n<td>&nbsp;\n<p><em>BCL-6</em>,&nbsp;p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>t(11;18)</td>\n<td><em>API2/MALT</em>, <em>BCL-10</em></td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>t(2;5)</td>\n<td><em>ALK</em></td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>t(9;14)</td>\n<td><em>PAX5, IGH</em></td>\n</tr>\n<tr>\n<td>\n<p>Synovial sarcoma</p>\n</td>\n<td>t(X;18)(p11;q11)&nbsp;</td>\n<td>&nbsp;\n<p><em>SS18-SSX2</em></p>\n<p><em>SS18-SSX4</em></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Alveolar soft-part sarcoma</td>\n<td>&nbsp;t(X;17)(p11.2;q25)</td>\n<td>&nbsp;<em>TFE3-ASPL</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5648",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a characteristic feature of hypomanic episodes in patients with bipolar disorder?",
      "choices": [
        {
          "id": 1,
          "text": "There is social and occupational impairment."
        },
        {
          "id": 2,
          "text": "The patient does not show psychotic symptoms."
        },
        {
          "id": 3,
          "text": "The episode lasts for at least 4 days."
        },
        {
          "id": 4,
          "text": "Patient has a elevated, expansive, or irritable mood."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A<strong> hypomanic episode does not cause</strong> social and occupational functioning <strong>impairment</strong>. <strong>Impairment</strong> is <strong>seen only in</strong> <strong>mania</strong>.</p>\n<p>A <strong>manic episode</strong> is defined as a persistent elevated, expansive, or irritable mood for at least 1 week which requires hospitalization. <strong>A hypomanic episode</strong> is also similar to a manic episode except it does not cause social and occupational functioning impairment. It lasts for at least 4 days, and the patient <strong>does not show psychotic symptoms</strong>. </p>\n<p>A person is said to be depressed if he has at least <strong>four</strong> of the following symptoms for at least <strong>2 weeks</strong>:</p>\n<ul>\n<li>Change in appetite and weight</li>\n<li>Change in sleep and activity</li>\n<li>Lack of energy</li>\n<li>Guilty feeling</li>\n<li>Recurring thoughts about death or suicide</li>\n</ul>\n<p><strong>Lithium</strong> is used for the pharmacological management of bipolar disorder.</p><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td><span><strong> Bipolar &amp; related disorders </strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Manic episode</strong></span></p>\n<ul>\n<li><span>Symptoms more <strong>severe</strong></span></li>\n<li><span><strong>1 week</strong> unless hospitalized</span></li>\n<li><span><strong>Marked impairment</strong> in social or occupational functioning or <strong>hospitalization</strong> necessary</span></li>\n<li><span>May have <strong>psychotic features</strong>; makes episode manic by definition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Hypomanic episode</strong> &nbsp;</span></p>\n<ul>\n<li><span>Symptoms <strong>less severe</strong></span></li>\n<li><span><strong>4 days&nbsp;</strong>to less than 7 days</span></li>\n<li><span>Unequivocal, observable change in functioning from patient's baseline</span></li>\n<li><span>Symptoms not severe enough to cause marked impairment or necessitate hospitalization</span></li>\n<li><span><strong>No psychotic features</strong></span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bipolar I</strong></span></p>\n<ul>\n<li><span><strong>Manic episode(s)</strong></span></li>\n<li><span>Depressive episodes common (but not required for diagnosis)</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bipolar II</strong></span></p>\n<ul>\n<li><span><strong>Hypomanic episode(s)</strong></span></li>\n<li><span>Major depressive episodes (required for diagnosis)</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Cyclothymic disorder</strong></span></p>\n<ul>\n<li><span>At least <strong>2 years</strong> of fluctuating, mild hypomanic &amp; depressive symptoms that </span><br /><span>do not meet criteria for hypomanic episodes or major depressive episodes</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5622",
      "difficulty": "hard"
    },
    {
      "text": "Sagar was being tried in court for the attempted murder of Mohan in the park. Shikhar appeared in court and said that he was told by Raju that Sagar tried to kill Mohan. What is this evidence known as?",
      "choices": [
        {
          "id": 1,
          "text": "Direct"
        },
        {
          "id": 2,
          "text": "Hearsay"
        },
        {
          "id": 3,
          "text": "Circumstantial"
        },
        {
          "id": 4,
          "text": "Indirect"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This evidence is known as <strong>hearsay</strong> <strong>evidence</strong>.&nbsp;</p>\n<p><strong>Hearsay</strong>&nbsp;evidence is given by someone&nbsp;about something that he/she&nbsp;<strong>did not personally witness</strong>. Sometimes, it might be <strong>obtained </strong>from a <strong>third party</strong>. It is presented in the court to claim&nbsp;that the facts contained in the statement are true, i.e. as a means of corroboration.&nbsp;</p>\n<p>Other types of <strong>oral evidence</strong><strong>:</strong></p>\n<p><strong>Direct</strong> evidence is the evidence of a fact that is actually in the issue. Examples: a witness saw A shooting B, <strong>prescription</strong>, consent form.</p>\n<p><strong>Indirect evidence</strong> is also known as <strong>circumstantial evidence</strong>.&nbsp;It is not the direct testimony of an eyewitness. It has an effect on other facts and subsidiary facts which are depended upon as consistent.&nbsp;</p>\n<div><strong>Documentary evidence&nbsp;</strong>is of three types:</div>\n<ul>\n<li>Medical certificates</li>\n<li>\n<div>Medicolegal reports</div>\n</li>\n<li>\n<div>Dying declaration</div>\n</li>\n</ul>\n<div><strong>&nbsp;</strong>A witness is a person who <strong>gives evidence</strong> regarding facts.&nbsp;There are 2 types of witnesses:</div>\n<ul>\n<li><strong>Common witness </strong>is&nbsp;a person who gives evidence about those facts that are <strong>observed </strong>or <strong>perceived </strong>by him/her.</li>\n<li><strong>Expert witness</strong>&nbsp;has the <strong>technical knowledge</strong> and is capable of drawing conclusions from facts presented&nbsp;(Section 45 of IEA).</li>\n</ul>\n<p>A witness can be considered a <strong>hostile witness</strong> when he/ she has a <strong>vested interest or motive</strong> for <strong>concealing</strong> part of the truth&nbsp;or for <strong>giving false evidence&nbsp;</strong>(Section 191 of IPC).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5524",
      "difficulty": "easy"
    },
    {
      "text": "Transport of iron from enterocytes into the blood is done by which of the following proteins:",
      "choices": [
        {
          "id": 1,
          "text": "Transferrin"
        },
        {
          "id": 2,
          "text": "Divalent metal transporter - 1"
        },
        {
          "id": 3,
          "text": "Hephaestin"
        },
        {
          "id": 4,
          "text": "Ferroportin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Transport of iron from enterocytes into the blood is done by <strong>ferroportin</strong>.</p>\n<p>Iron absorption occurs in the <strong>duodenum</strong>. Iron in our gut exists in 2 forms, they are <strong>non-heme</strong> and <strong>heme iron</strong>.&nbsp;Luminal non-heme iron is mostly in the <strong>Fe<sup>3+</sup></strong> (ferric) state and is reduced to <strong>Fe<sup>2+</sup></strong> (ferrous) iron by <strong>ferrireductases</strong>. Fe<sup>2+</sup> iron is then transported across the apical membrane by <strong>divalent metal transporter 1</strong> (DMT1).</p>\n<p>Given below is an image of iron absorption that shows divalent metal transporter-1 protein in intestinal mucosal cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b05574808efc4a0780f7afd696181bb0x1279x1210.JPEG\" alt=\"Explanation Image\"><p>Heme iron is moved across the apical membrane into the cytoplasm through <strong>heme transporters</strong>.</p>\n<p>In the duodenal cells, Fe<sup>2+</sup> iron can follow one of two pathways: transport to the blood or storage as mucosal iron. The nonstorage form of Fe<sup>2+</sup> iron is transported from the cytoplasm into circulation by the protein <strong>ferroportin</strong>.&nbsp;A protein called <strong>hephaestin</strong> (Hp) is associated with ferroportin 1. It is<strong> not a transporter itself</strong>, but it facilitates basolateral transport</p>\n<p>Once in circulation, Fe<sup>2+</sup> is again oxidized back to Fe<sup>3+</sup> iron by <strong>hephaestin</strong> and <strong>ceruloplasmin</strong>. The newly absorbed Fe<sup>3+</sup> iron binds rapidly to <strong>transferrin</strong>, which delivers iron to red cell progenitors in the marrow.</p>\n<p><strong>Hepcidin</strong>&nbsp;is a protein secreted from the liver that plays a major role in the regulation of iron absorption. When the body&rsquo;s iron stores are adequate, it downregulates the expression of ferroportin and thereby decreases iron absorption.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Factors affecting iron absorption</h3><p><strong>Enhancers:</strong></p>\n<ul>\n<li>Ascorbic acid</li>\n<li>Citric acid</li>\n<li>Amino acid</li>\n<li>Sugars in the diet</li>\n</ul>\n<p><strong>Inhibitors:</strong></p>\n<ul>\n<li>Tannins</li>\n<li>Carbonate</li>\n<li>Oxalate</li>\n<li>Phosphate</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5549",
      "difficulty": "medium"
    },
    {
      "text": "Licked candy stick appearance of the joints is seen in all of the following conditions, except ________.",
      "choices": [
        {
          "id": 1,
          "text": "Psoriatic arthropathy"
        },
        {
          "id": 2,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 3,
          "text": "Melorheostosis"
        },
        {
          "id": 4,
          "text": "Leprosy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Melorheostosis&nbsp;</strong>has a&nbsp;characteristic <strong>dripping wax appearance or flowing candle wax appearance.&nbsp;</strong></p>\n<p>The term <strong>licked candy stick appearance</strong> refers to the characteristic appearance of&nbsp;<strong>tapering of the tips of the metacarpal bones, metatarsal bones, phalanges, or clavicles.</strong>&nbsp;It is usually associated with the following conditions:</p>\n<ul>\n<li>Psoriatic arthropathy</li>\n<li>Rheumatoid arthritis</li>\n<li>Leprosy</li>\n<li>Neuropathic joint (including conditions like diabetic foot)</li>\n</ul>\n<p>&nbsp;</p>\n<p><strong>Melorheostosis</strong>&nbsp;is also known as Leri's disease. It&nbsp;is a rare mesenchymal dysplasia manifesting as regions of sclerosis of cortices with a characteristic&nbsp;<strong>dripping wax appearance or flowing candle wax appearance</strong>. The presentation is usually monostotic and unilateral. Symptoms include pain, deformity, skin and circulation problems, and contractures.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5595",
      "difficulty": "hard"
    },
    {
      "text": "Identify the fetal position.",
      "choices": [
        {
          "id": 1,
          "text": "Left mento-posterior"
        },
        {
          "id": 2,
          "text": "Right fronto-anterior"
        },
        {
          "id": 3,
          "text": "Right mento-anterior"
        },
        {
          "id": 4,
          "text": "Right fronto-posterior"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>&nbsp;The image shows a fetus in a <strong>longitudinal lie,</strong> with <strong>face presentation</strong>, in a<strong> right mento-anterior</strong> position.</p>\n<p>Definitions of various terminologies used for the fetus in utero:</p>\n<ul>\n<li><strong>Lie:</strong>&nbsp;Relationship of the <strong>long axis</strong> of the <strong>fetus</strong> to the long axis of the maternal <strong>spine</strong></li>\n<li><strong>Presentation</strong>:&nbsp;<strong>Part of the fetus</strong> occupying the <strong>lower pole</strong> of the pelvis</li>\n<li><strong>Presenting part:</strong>&nbsp;Part of the presentation that<strong> overlies the internal os</strong></li>\n<li><strong>Attitude</strong>:&nbsp;The <strong>relation</strong> <strong>of the different parts</strong> <strong>of</strong> the <strong>fetus</strong> to one another</li>\n<li><strong>Position</strong>:&nbsp;<strong>Relation of </strong>the<strong> denominator</strong> <strong>to </strong>the different quadrants of the <strong>pelvis</strong></li>\n</ul>\n<p><strong>Fetal denominator</strong>&nbsp;refers to the&nbsp;bony fixed point of reference on presenting part with respect to different quadrants of the pelvis. The denominators for various presentations are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Presentation</strong></td>\n<td><strong>Denominator</strong></td>\n</tr>\n<tr>\n<td>Breech</td>\n<td>Sacrum</td>\n</tr>\n<tr>\n<td>Vertex</td>\n<td>Occiput</td>\n</tr>\n<tr>\n<td>Face</td>\n<td>Mentum (chin)</td>\n</tr>\n<tr>\n<td>Brow</td>\n<td>Frontal eminence</td>\n</tr>\n<tr>\n<td>Shoulder</td>\n<td>Acromion</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>The image below shows various positions possible in a face presentation.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4f3118af560649e68205f8bd78a029b1x1280x1276.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f6bbff46ce2d4a63a2b86e05afaeb245.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5464",
      "difficulty": "easy"
    },
    {
      "text": "A worker found in a burning chemical factory is brought to the emergency in a state of hypotension and is suspected to have been exposed to hydrogen cyanide gas. Which of the following is best avoided during his management?",
      "choices": [
        {
          "id": 1,
          "text": "3% Sodium nitrite solution"
        },
        {
          "id": 2,
          "text": "25% solution Sodium thiosulfate"
        },
        {
          "id": 3,
          "text": "5 g Hydroxocobalamin"
        },
        {
          "id": 4,
          "text": "Sodium bicarbonate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Nitrites</strong> should be avoided in patients with <strong>cyanide toxicity</strong> presenting with <strong>hypotension, </strong>especially in the setting of concomitant carbon monoxide exposure.</p>\n<p>Burning buildings are a source of carbon monoxide exposure and can result in carboxyhaemoglobin. Nitrites are used in cyanide poisoning because of their ability to form methemoglobin, which binds cyanide more avidly than the ferric iron of cytochrome oxidase. <strong>Nitrite therapy</strong> should be <strong>avoided</strong> for those with <strong>both cyanide and CO poisoning</strong> because these compounds work by inducing methemoglobin formation, which further reduces the oxygen content of blood in patients with carboxyhemoglobin accumulation.</p>\n<p>Treatment of <strong>Cyanide Poisoning</strong> in <strong>Adults</strong></p>\n<ol>\n<li>100% oxygen</li>\n<li>IV crystalloids and vasopressors for hypotension</li>\n<li>Sodium bicarbonate for acidemia</li>\n<li class=\"p1\"><strong>Either</strong> Cyanide antidote kit\n<ul>\n<li>Amyl nitrite inhaler - crack vial and inhale over 30 s.</li>\n<li>3% solution Sodium nitrite  -300 mg IV given over no less than 5 min.</li>\n<li>25% solution Sodium thiosulfate: 12.5 g IV. </li>\n</ul>\n</li>\n<li><strong>Or</strong> Hydr<strong>oxo</strong>cobalamin - 5 g IV over 15 min, up to 10 g. </li>\n</ol>\n<p>Hydr<strong>oxo</strong>cobalamin(Vitamin B12a) is a <strong>metalloprotein</strong> with a cobalt center that <strong>binds cyanide</strong>, thereby removing it from cytochrome oxidase and <strong>forming cyanocobalamin</strong>. It is FDA-approved for the management of cyanide poisoning and is considered <strong>ideal in</strong> cases where the <strong>diagnosis</strong> of cyanide poisoning is <strong>uncertain</strong> <strong>or</strong> in cases where the <strong>methemoglobinemia induction would be detrimental, </strong>i.e., concomitant exposure to carbon monoxide as in building fires.</p>\n<p> </p><hr><h3>Related Pearl: Specific antidotes for poisoning</h3><table>\n<tbody>\n<tr>\n<td><strong>ANTIDOTE</strong></td>\n<td><strong>POISONING</strong></td>\n</tr>\n<tr>\n<td><strong>4-methyl pyrazole</strong></td>\n<td>Methanol and ethylene glycol</td>\n</tr>\n<tr>\n<td><strong>100% oxygen </strong></td>\n<td>Carbon monoxide, cyanide, methemoglobinemia</td>\n</tr>\n<tr>\n<td><strong>Ammonium chloride </strong></td>\n<td>Phencyclidine, amphetamine</td>\n</tr>\n<tr>\n<td><strong>Amyl nitrate </strong></td>\n<td>Cyanide, hydrogen sulphide</td>\n</tr>\n<tr>\n<td><strong>Atropine</strong></td>\n<td>Carbamate and organophosphorus poisoning</td>\n</tr>\n<tr>\n<td><strong>Bupropion</strong></td>\n<td>Nicotine</td>\n</tr>\n<tr>\n<td><strong>Calcium disodium edetate</strong></td>\n<td>Cadmium, chromium, cobalt, copper, lead, magnesium, nickel, uranium, zinc</td>\n</tr>\n<tr>\n<td><strong>Calcium gluconate </strong></td>\n<td>Precipitates fluorides, magnesium and oxalates</td>\n</tr>\n<tr>\n<td><strong>Chlorpromazine</strong></td>\n<td>Amphetamine</td>\n</tr>\n<tr>\n<td><strong>Deferoxamine</strong></td>\n<td>Iron, aluminium</td>\n</tr>\n<tr>\n<td><strong>Diazepam</strong></td>\n<td>Amphetamine, chloroquine, alcohol withdrawal</td>\n</tr>\n<tr>\n<td><strong>Dicobalt edetate</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Dimercaprol (BAL)</strong></td>\n<td>Antimony, arsenic, copper, lead, mercury, nickel and gold</td>\n</tr>\n<tr>\n<td><strong>Diphenhydramine</strong></td>\n<td>Phenothiazines and related drugs</td>\n</tr>\n<tr>\n<td><strong>Disodium calcium edetate</strong></td>\n<td><strong>&nbsp;</strong>Lead</td>\n</tr>\n<tr>\n<td><strong>DMPS *, (Unithiol)</strong></td>\n<td><strong>&nbsp;</strong>Mercury</td>\n</tr>\n<tr>\n<td><strong>DMSA ** </strong></td>\n<td><strong>&nbsp;</strong>Lead</td>\n</tr>\n<tr>\n<td><strong>D-Penicillamine (Cuprimine) </strong></td>\n<td>Copper, lead, mercury, chromate, nickel, zinc, arsenic</td>\n</tr>\n<tr>\n<td><strong>Ethanol</strong></td>\n<td>Methanol and ethylene glycol</td>\n</tr>\n<tr>\n<td><strong>Fab fragment</strong></td>\n<td>Digoxin, digitoxin, oleander tea</td>\n</tr>\n<tr>\n<td><strong>Flumazenil</strong></td>\n<td>Benzodiazepine</td>\n</tr>\n<tr>\n<td><strong>Glucagon</strong></td>\n<td>Propranolol and other beta-blockers toxicity</td>\n</tr>\n<tr>\n<td><strong>Hydroxocobalamin</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Labetalol hydrochloride</strong></td>\n<td>Hypertensive crisis due to cocaine</td>\n</tr>\n<tr>\n<td><strong>Methionine</strong></td>\n<td>Paracetamol</td>\n</tr>\n<tr>\n<td><strong>Methylene blue</strong></td>\n<td>Methemoglobinemia</td>\n</tr>\n<tr>\n<td><strong>N-acetylcysteine </strong></td>\n<td>Paracetamol, acetaminophen toxicity</td>\n</tr>\n<tr>\n<td><strong>Nalorphine</strong></td>\n<td>Morphine</td>\n</tr>\n<tr>\n<td><strong>Naloxone (Naltrexone)</strong></td>\n<td>Narcotic, opiates, CNS depressants</td>\n</tr>\n<tr>\n<td><strong>Nicotinamide</strong></td>\n<td>Vacor poisoning, phenylurea pesticide toxicity</td>\n</tr>\n<tr>\n<td><strong>Pancuronium bromide</strong></td>\n<td>Neuromuscular blocking agents</td>\n</tr>\n<tr>\n<td><strong>Penicillamine</strong></td>\n<td>Copper</td>\n</tr>\n<tr>\n<td><strong>Physostigmine salicylate </strong></td>\n<td>Coma, convulsions from anticholinergics</td>\n</tr>\n<tr>\n<td><strong>Pralidoxime (2-PAM) </strong></td>\n<td>Organophosphorus insecticides, nerve agents</td>\n</tr>\n<tr>\n<td><strong>Propranolol</strong></td>\n<td>Cocaine intoxication, beta adrenergics</td>\n</tr>\n<tr>\n<td><strong>Protamine sulphate </strong></td>\n<td>Heparin overdose</td>\n</tr>\n<tr>\n<td><strong>Prussian blue</strong></td>\n<td>Thallium</td>\n</tr>\n<tr>\n<td><strong>Pyridoxine (Vit. B6) </strong></td>\n<td>Isoniazid, hydrazine toxicity</td>\n</tr>\n<tr>\n<td><strong>Sodium bicarbonate </strong></td>\n<td>Urinary alkalinisation for salicylates, phenobarbital</td>\n</tr>\n<tr>\n<td><strong>Sodium nitrite</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Sodium thiosulphate</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Vitamin K</strong></td>\n<td>Warfarin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Certain specific clinical features diagnostic of poisons and poisoning</h3><table>\n<tbody>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td><strong>Possible causes</strong></td>\n</tr>\n<tr>\n<td>Pupillary constriction (Miosis)</td>\n<td>Barbiturates, caffeine, carbamates, carbolic acid (phenol), clonidine, methyl dopa, nicotine, opiates, organophosphates, parasympathomimetics.</td>\n</tr>\n<tr>\n<td>Pupillary dilatation (Mydriasis)</td>\n<td>Alcohol (constricted in coma), amphetamines, antihistamines, benzodiazepines, carbon monoxide, cocaine, cyanide, datura (atropine), ephedrine</td>\n</tr>\n<tr>\n<td><strong>Hippus (alternate constriction and dilatation of pupils)</strong></td>\n<td><strong>Aconite, alcohol, barbiturates.</strong></td>\n</tr>\n<tr>\n<td>Nystagmus</td>\n<td>Alcohol, barbiturates, carbamazepine, phencyclidine, phenytoin</td>\n</tr>\n<tr>\n<td>Pinpoint pupils, and reduced respiratory rate</td>\n<td>Opioids, cholinesterase inhibitors (organophosphorus or carbamate insecticides), clonidine, phenothiazines, Pontine hemorrhage</td>\n</tr>\n<tr>\n<td>Cyanosis</td>\n<td>Any CNS depressant or agent causing methemoglobinemia</td>\n</tr>\n<tr>\n<td>Needle tracks, pinpoint pupils, and reduced respiratory rate</td>\n<td>IV Opioids</td>\n</tr>\n<tr>\n<td>Dilated pupils or mid-point pupils, and reduced respiratory rate</td>\n<td>Benzodiazepines</td>\n</tr>\n<tr>\n<td>Dilated pupils, tachycardia</td>\n<td>\n<ul>\n<li>Tricyclic antidepressants &ndash; dry mouth, warm peripheries, may also be twitchy or have seizures</li>\n<li>Amphetamines, ecstasy, cocaine &ndash; may also be hallucinating or agitated</li>\n<li>Anticholinergic drugs such as benzhexol, benztropine &ndash; may also have hyperreflexia and myoclonus</li>\n<li>Antihistamines &ndash; may also be drowsy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Increased salivation</td>\n<td>Organophosphorus or carbamate insecticides</td>\n</tr>\n<tr>\n<td>\n<p>Hypothermia</p>\n<p>&nbsp;</p>\n</td>\n<td>Lithium, tricyclic antidepressants, anticholinergics, antihistamines</td>\n</tr>\n<tr>\n<td>\n<p>Hyperthermia</p>\n</td>\n<td>\n<ul>\n<li>Amphetamines, ecstasy, cocaine (also hypertension, tachycardia, agitation, rhabdomyolysis)</li>\n<li>Neuroleptic malignant syndrome (also confusion, fluctuating consciousness, rigidity, tremor, autonomic instability, sweating, rhabdomyolysis)</li>\n<li>Serotonin syndrome (also agitation, clonus, tremor, hyperreflexia, sweating, tachycardia)</li>\n<li>Salicylates including aspirin (also tachycardia, metabolic acidosis, restlessness, hyperventilation)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hypertension</td>\n<td>Amphetamine, ephedrine, cocaine, clonidine, MAO inhibitors, thyroid hormones</td>\n</tr>\n<tr>\n<td>Hypotension</td>\n<td>Cyanide, alcohol, digitalis, carbon monoxide, narcotics, barbiturates</td>\n</tr>\n<tr>\n<td>Abdominal cramps, diarrhea, tachycardia, restlessness, hallucinations</td>\n<td>Withdrawal from: Alcohol, benzodiazepines, opioids</td>\n</tr>\n<tr>\n<td>Bradycardia</td>\n<td>Beta-blockers, calcium antagonists (not dihydropyridines), digoxin, opioids, organophosphorus insecticides, centrally acting alpha agonists, e.g. clonidine</td>\n</tr>\n<tr>\n<td>Seizures</td>\n<td>Tricyclic antidepressants, theophylline, antihistamines, anticonvulsants, non-steroidal drugs, phenol, phenothiazines, isoniazid, cocaine, carbon monoxide, organophosphorus insecticides, strychnine</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Characteristic Odor of Toxins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Odor</strong></span></p>\n</td>\n<td>\n<p><span><strong>Toxins</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Garlic odor</span></p>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span>Arsenic, phosphorous, malathion, thallium carbonate</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Odorless</span></p>\n</td>\n<td>\n<p><span>Thallium sulfate (most common),&nbsp;thallium oxide</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Garlic odor or rotten fish</span></p>\n</td>\n<td>\n<p><span>Zinc phosphide</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Odor of burnt rope</span></p>\n</td>\n<td>\n<p><span>Cannabis</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Phenolic odor</span></p>\n</td>\n<td>\n<p><span>Carbolic acid</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Smell of bitter almonds</span></td>\n<td><span>Cyanide</span></td>\n</tr>\n<tr>\n<td><span>Fruity odor</span></td>\n<td><span>Ethyl alcohol</span></td>\n</tr>\n<tr>\n<td><span>Rotten egg</span></td>\n<td><span>Hydrogen sulphide</span></td>\n</tr>\n<tr>\n<td><span>Smell of kerosene</span></td>\n<td><span>Organophosphorous</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5493",
      "difficulty": "hard"
    },
    {
      "text": "Laboratory test results indicate normal levels of calcium, PTH, and phosphate, but raised alkaline phosphatase level. Which of the following conditions has such a biochemical profile?",
      "choices": [
        {
          "id": 1,
          "text": "Primary  hyperparathyroidism"
        },
        {
          "id": 2,
          "text": "Paget's disease"
        },
        {
          "id": 3,
          "text": "Secondary  hyperparathyroidism"
        },
        {
          "id": 4,
          "text": "Osteoporosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Patients with Paget's disease have normal levels of serum calcium, PTH, and phosphate, but <strong>raised serum ALP </strong>level. It is due to <strong>increased bone formation</strong>.</p>\n<p><strong>Hypocalcemia</strong> can be <strong>rarely seen</strong> in patients with Paget's disease. It is due to the active bone formation with <strong>insufficient calcium and vitamin D intake.</strong></p><hr><h3>Related Pearl: Biochemical parameters in metabolic bone diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Metabolic bone disease</strong></p>\n</td>\n<td><strong>Calcium</strong></td>\n<td><strong>PTH</strong></td>\n<td><strong>Phosphate</strong></td>\n<td><strong>ALP</strong></td>\n</tr>\n<tr>\n<td>\n<p>Rickets / Osteomalacia</p>\n</td>\n<td>&nbsp;&darr;/N</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&darr;</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Primary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp;&nbsp;&nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&darr;</td>\n<td>&nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Secondary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&darr;</td>\n<td>&nbsp;&nbsp; &uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Tertiary hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>Osteoporosis</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; N</td>\n</tr>\n<tr>\n<td>\n<p>Paget's&nbsp;disease</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; &uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Osteopetrosis</p>\n</td>\n<td>&nbsp; &darr;/N</td>\n<td>&uarr;/N</td>\n<td>&nbsp; &nbsp; &darr;/N</td>\n<td>&nbsp; N</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;&uarr;: Increased,&nbsp;&nbsp;&darr;: Decreased, N: Normal</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5650",
      "difficulty": "easy"
    },
    {
      "text": "A newborn with the given deformity is referred to you. Which of the following statements is false regarding this condition?",
      "choices": [
        {
          "id": 1,
          "text": "The infant must always be examined for associated disorders such as congenital hip dislocation and spina bifida."
        },
        {
          "id": 2,
          "text": "Relapse is uncommon in children managed with casts until the age of 1 year."
        },
        {
          "id": 3,
          "text": "The order of correction according to Ponseti method is cavus-adduction-varus-equinus."
        },
        {
          "id": 4,
          "text": "Foot abduction brace can be used to prevent relapse in these children."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows <strong>congenital talipes equinovarus</strong> (CTEV) or clubfoot and<strong> option B</strong> is the false statement.&nbsp;As <strong>relapse is common</strong>, continued bracing is required for the <strong>first 4 years</strong> of life <strong>to minimize</strong> this risk.</p>\n<p>CTEV is a <strong>congenital malformation</strong> of the <strong>foot</strong>. It is predominately seen in <strong>male children</strong>. The components of deformity are as follows:</p>\n<ul>\n<li><strong>Cavus:</strong>&nbsp;This deformity occurs due to exaggerated arching of the foot at the <strong>mid-tarsal joint.</strong></li>\n<li><strong>Adduction:</strong>&nbsp;This deformity occurs at the <strong>talonavicular joint.</strong></li>\n<li><strong>Inversion:</strong>&nbsp;This deformity occurs at the <strong>subtalar joint</strong>. The calcaneum is inverted and along with it, the whole foot is inverted. This leads to a medially facing sole.&nbsp;</li>\n<li><strong>Equinus:</strong>&nbsp;This deformity occurs at the <strong>ankle joint</strong> and <strong>tarsal joints.</strong></li>\n</ul>\n<p>Ponseti method is a successful method of manipulation in CTEV. It should begin as early as the <strong>first 2 weeks </strong>after <strong>birth</strong>. Weekly manipulation of the foot is done with the help of plaster casts.&nbsp;</p>\n<p>To begin with, the <strong>first metatarsal</strong> is <strong>elevated</strong> to correct the <strong>cavus</strong>. This creates a flat longitudinal medial border of the foot. Then, the<strong> forefoot</strong> is <strong>abducted</strong> in the plane of the <strong>metatarsals</strong>. This everts the hindfoot and corrects the forefoot out of supination. Finally, <strong>equinus</strong> is corrected by <strong>dorsiflexing</strong> the foot at the<strong> ankle joint</strong>. In most cases, a percutaneous Achilles tenotomy is required later for complete correction of the equinus.</p>\n<p>Following the complete correction of the club foot by serial casting, the deformity must be held using a <strong>foot abduction brace</strong> (FAB) <strong>to prevent relapse</strong>. For the&nbsp;<strong>first 3 months</strong>, it is used <strong>full-time (23 hours per day</strong>) and then <strong>at sleep time for 4 years.</strong></p>\n<p>The infant must always be examined for associated disorders such as <strong>congenital hip dislocation and spina bifida,</strong> as there is an association between these conditions.</p><hr><h3>Related Pearl: Age wise management of CTEV</h3><p>Initial treatment starts with Ponseti's POP cast as early as possible, but within 1 year of age.</p>\n<p>If deformity gets corrected:</p>\n<ul>\n<li>Dennis Brown splint is used till 1 year of age</li>\n<li>After 1 year upto 5 years CTEV shoes are used in day, and Dennis Brown splint is used at night</li>\n</ul>\n<p>If deformity is not corrected or untreated previously:</p>\n<ul>\n<li>1-3 years: Posteromedial soft tissue release (PMSTR)&nbsp;</li>\n<li>3-5 years: Dillwyn Evans procedure</li>\n<li>5-8 years: Dwyer osteotomy</li>\n<li>8-10 years: Wedge tarsectomy</li>\n<li>&gt;10 years: Triple arthrodesis, external fixators</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a1d7a0ec619d4540a6619b318298f007x440x1622.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ecee3cf00ebc4a66911fb7ed267a6e73.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5534",
      "difficulty": "medium"
    },
    {
      "text": "A 28-year-old lady seeks your advice regarding vaccination against warts. As per the WHO-SAGE guidelines, what should you advise her to take?",
      "choices": [
        {
          "id": 1,
          "text": "2 doses 6 months apart"
        },
        {
          "id": 2,
          "text": "2 doses 3 months apart"
        },
        {
          "id": 3,
          "text": "3 doses at 0, 1, and 6 months"
        },
        {
          "id": 4,
          "text": "3 doses at 0, 2, and 12 months"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Recommended <strong>HPV vaccination</strong> schedule for persons aged&nbsp;<strong>&gt;21 years,</strong>&nbsp;according to <strong>WHO SAGE guidelines,</strong> is&nbsp;<strong>2 doses 6 months apart.</strong></p>\n<p>The recommendations for different age groups are as follows:</p>\n<ul>\n<li><strong>1 or 2 doses</strong> schedule<strong>&nbsp;</strong>for the primary target of girls aged&nbsp;<strong>9&ndash;14 years</strong>.</li>\n<li><strong>1 or 2 doses</strong> schedule&nbsp;for young women aged&nbsp;<strong>15&ndash;20 years</strong>.</li>\n<li><strong>2</strong> doses with a <strong>6-month interval</strong> for women&nbsp;<strong>older than 21 years</strong>.</li>\n<li><strong>3</strong> doses (or atleast 2 doses) for <strong>immunocompromised</strong> individuals.</li>\n</ul>\n<p>Available vaccinations for HPV:&nbsp;</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li><strong>Gardasil 9</strong>&nbsp;(HPV9) is a nonavalent vaccine active against&nbsp;<strong>HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58</strong>.</li>\n<li><strong>Gardasil 4</strong> (HPV 4) is a quadrivalent vaccine against <strong>HPV types 6, 11, 16, and 18</strong>.&nbsp;This is now replaced by&nbsp;Gardasil 9 (HPV 9).</li>\n<li><strong>Cervarix</strong> (HPV 2) is a bivalent vaccine active against <strong>HPV types 16 and 18</strong>.</li>\n</ul>\n</div>\n</div>\n<div class=\"ng-scope\">&nbsp;</div><hr><h3>Related Pearl: Human Papilloma Virus (HPV) and Associated Lesions</h3><table>\n<tbody>\n<tr>\n<td><strong>HPV serotype</strong></td>\n<td><strong>Lesions</strong></td>\n</tr>\n<tr>\n<td>HPV 1,2,3,4</td>\n<td>\n<div class=\"page\" title=\"Page 566\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Common warts (verruca vulgaris, plantar wart)</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>HPV 6 and 11</td>\n<td>\n<ul>\n<li>Condyloma acuminatum (genital warts)</li>\n<li>Sinonasal papilloma</li>\n<li>Squamous papilloma of the larynx</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HPV 16</td>\n<td>\n<ul>\n<li>LSIL, HSIL, carcinoma cervix</li>\n<li>Vulval carcinoma</li>\n<li>Bowen disease (Carcinoma in situ of male external genitalia)</li>\n<li>Oropharyngeal squamous cell carcinoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HPV 18</td>\n<td>\n<ul>\n<li>LSIL, HSIL, Carcinoma of the cervix</li>\n<li>Carcinoma of the anogenital region</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HPV 5 and 8</td>\n<td>\n<ul>\n<li>Squamous cell carcinoma of the skin in epidermodysplasia verruciformis patients</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>LSIL: Low-grade squamous intraepithelial lesion</p>\n<p>HSIL: High-grade squamous intraepithelial lesion&nbsp;&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5630",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following parameters is abnormal in a patient with relative polycythemia?",
      "choices": [
        {
          "id": 1,
          "text": "EPO concentration"
        },
        {
          "id": 2,
          "text": "Red Cell Mass"
        },
        {
          "id": 3,
          "text": "Oxygen saturation"
        },
        {
          "id": 4,
          "text": "Plasma volume"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Relative polycythemia/ spurious polycythemia</strong> is an apparent <strong>increase in the hemoglobin level</strong> due to a <strong>decrease in plasma volume.</strong></p>\n<p><strong>Polycythemia</strong> denotes an abnormally high red cell count, usually with a corresponding increase in the hemoglobin level (&gt; 16 &plusmn;2 g/dL). It is <strong>2 types</strong>:</p>\n<ul>\n<li>Relative - hemoconcentration due to decreased plasma volume</li>\n<li>Absolute - increase in the total red cell mass</li>\n</ul>\n<p><strong>Causes</strong> of <strong>relative</strong> polycythemia include:</p>\n<ul>\n<li>Dehydration - deprivation of water, prolonged vomiting or diarrhea, excessive use of diuretics</li>\n<li>Gaisb&ouml;ck syndrome -&nbsp;stress polycythemia where affected individuals are usually hypertensive, obese, and anxious</li>\n</ul>\n<p><strong>Causes</strong> of <strong>absolute</strong> polycythemia include:</p>\n<ul>\n<li>Primary -&nbsp;intrinsic abnormality of hematopoietic precursors&nbsp;\n<ul>\n<li>Polycythemia vera</li>\n<li>Inherited erythropoietin receptor mutations</li>\n</ul>\n</li>\n<li>Secondary -&nbsp;red cell progenitors responding to increased levels of erythropoietin\n<ul>\n<li>Compensatory due to cyanotic heart and lung disease, high altitude</li>\n<li>Paraneoplastic erythropoietin secreting tumours</li>\n</ul>\n</li>\n</ul>\n<p>Note: In dengue hemorrhagic fever, increased vascular permeability causes plasma leakage and volume loss. Hence, relative polycythemia is seen.</p><hr><h3>Related Pearl: Comparison between Properties of Various Types of Polycythemia</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Plasma volume</td>\n<td>RBC Mass</td>\n<td>O<sub>2&nbsp;</sub>saturation</td>\n<td>EPO concentration</td>\n</tr>\n<tr>\n<td>\n<p>Relative</p>\n<p>polycythemia</p>\n</td>\n<td><strong>&nbsp; &nbsp; &darr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n<p>vera</p>\n</td>\n<td><strong>&nbsp; &nbsp; &uarr;</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>EPO- producing tumors</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>Hypoxia</p>\n<p>(High altitude)</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EPO: Erythropoietin</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5658",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following conditions of the oral cavity are considered premalignant?<div class='question-desc-html'><ol>\n<li>Granular Cell Myoblastoma</li>\n<li>Erythroplakia</li>\n<li>Pregnancy Granuloma</li>\n<li>Mucosal hyperpigmentation</li>\n<li>Pyogenic Granuloma</li>\n<li>Leukoplakia</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 4, 6"
        },
        {
          "id": 2,
          "text": "1, 2, 5"
        },
        {
          "id": 3,
          "text": "2, 3, 4"
        },
        {
          "id": 4,
          "text": "1, 2, 6"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Erythroplakia, Leukoplakia, </strong>and <strong>Mucosal hyperpigmentation</strong> are considered premalignant lesions.</p>\n<p><strong><span data-preserver-spaces=\"true\">Leukoplakia </span></strong>is<span data-preserver-spaces=\"true\"> defined as a <strong>clinical white patch</strong> that cannot be characterized clinically or pathologically as any other disease. </span><span data-preserver-spaces=\"true\">Oral hairy leukoplakia is caused by </span><strong><span data-preserver-spaces=\"true\">the Epstein–Barr virus</span></strong><span data-preserver-spaces=\"true\">. Smoking, tobacco chewing, and alcohol consumption are linked etiological factors. The most common sites involved are buccal mucosa and oral commissures. Males are affected two to three times more often.</span></p>\n<p><span data-preserver-spaces=\"true\"><strong>Erythroplakia</strong> is a <strong>red patch or plaque</strong> on the mucosal surface. The red color is due to <strong>decreased keratinization</strong> and as a result, the <strong>red vascular connective tissue of the submucosa shines through</strong>. The most common sites are lower alveolar mucosa, gingivobuccal sulcus, and the floor of the mouth.  There is no sex predilection. Malignant potential is 17 times higher than in leukoplakia.</span></p>\n<p><span data-preserver-spaces=\"true\"><strong>Melanosis and mucosal hyperpigmentation </strong>are benign pigmented lesions of the oral mucosa. They may transform into malignant melanomas. About one-fourth of mucosal melanomas may resemble benign lesions, and hence, biopsy may become mandatory.</span></p>\n<p>Benign lesions of the oral cavity include:</p>\n<ol>\n<li>Papilloma</li>\n<li>Fibroma (Fibroepithelial polyp)</li>\n<li>Hemangioma</li>\n<li>Lymphangioma</li>\n<li>Torus</li>\n<li>Pyogenic granuloma</li>\n<li>Pregnancy granuloma</li>\n<li>Granular cell myoblastoma or Granular cell tumor</li>\n<li>Minor salivary gland neoplasms</li>\n<li>Solitary fibrous tumor</li>\n<li>Mucocele</li>\n<li>Ranula</li>\n<li>Dermoid</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5548",
      "difficulty": "hard"
    },
    {
      "text": "The contrast-enhanced CT of a middle-aged woman shows a complicated renal cyst with thickened septae and solid non-enhancing nodules. You grade it as Bosniak III. What is the likelihood of malignancy?",
      "choices": [
        {
          "id": 1,
          "text": "~ 0%"
        },
        {
          "id": 2,
          "text": "<10%"
        },
        {
          "id": 3,
          "text": "50%"
        },
        {
          "id": 4,
          "text": ">90%"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>According to the Bosniak classification, renal cysts with <strong>thickened septae</strong> and <strong>solid non-enhancing</strong> nodules are classified as <strong>Bosniak III</strong>,<strong> </strong>and Bosniak III lesions have a ~50% likelihood of malignancy.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>Appearance</strong></td>\n<td><strong>Malignancy</strong></td>\n<td><strong>Management</strong></td>\n</tr>\n<tr>\n<td>Bosniak 1</td>\n<td><strong>Simple</strong> cyst: Rounded with imperceptible wall</td>\n<td>Not malignant</td>\n<td>No further workup required</td>\n</tr>\n<tr>\n<td>Bosniak 2</td>\n<td>\n<p><strong>Minimally complex</strong>: </p>\n<p>Size &lt;1 mm with septa and thin calcifications</p>\n<p> </p>\n</td>\n<td>Not malignant</td>\n<td>No further workup required</td>\n</tr>\n<tr>\n<td>Bosniak 2F</td>\n<td>\n<p><strong>Minimally complex</strong>:</p>\n<p>Size &gt;3 cm with increased number of septa</p>\n<p>Minimally thickened with nodular or thick calcifications</p>\n</td>\n<td>5% chance of malignancy</td>\n<td>Needs ultrasound/CT follow-up every 6 months</td>\n</tr>\n<tr>\n<td>Bosniak 3</td>\n<td>\n<p><strong>Complicated</strong> cysts:</p>\n<p>Thickened septa with nodular areas of calcification or solid non-enhancing areas</p>\n<p>Appears hyperdense on CT</p>\n</td>\n<td>55% chance of malignancy</td>\n<td>\n<p>Partial nephrectomy</p>\n<p>Radiofrequency ablation in elderly or poor surgical candidates</p>\n</td>\n</tr>\n<tr>\n<td>Bosniak 4</td>\n<td>Solid enhancing mass with a large cystic or <strong>necrotic</strong> component</td>\n<td>\n<p>Clearly malignant (100%)</p>\n</td>\n<td>Partial or total nephrectomy</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The following image shows a Bosniak 3 renal cyst:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0c2a93a464e14b328637a733b7d9a8e2x512x342.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5597",
      "difficulty": "medium"
    },
    {
      "text": "As per the Milan criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma, which of the following would disqualify a patient for liver transplantation?",
      "choices": [
        {
          "id": 1,
          "text": "Presence of a single tumor with diameter 4.2 cm"
        },
        {
          "id": 2,
          "text": "Presence of three tumors with diameters 2.5 cm, 2.2 cm, and 1.5 cm"
        },
        {
          "id": 3,
          "text": "Presence of macrovascular invasion"
        },
        {
          "id": 4,
          "text": "Presence of two tumors with diameter 2.2 cm and 1.5 cm"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The presence of <strong>major vessel involvement&nbsp;</strong>would <strong>disqualify a patient for liver transplantation</strong>, as per the <strong>Milan criteria.</strong></p>\n<p>The Milan criteria are used to assess the suitability of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. In order to be suitable for liver transplantation, the patient should have</p>\n<ul>\n<li>a single tumor with a diameter of &le;5 cm</li>\n<li>up to 3 tumors, each with a diameter &le;3 cm</li>\n<li>no extra-hepatic involvement</li>\n<li>no macrovascular invasion</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5574",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true regarding the WHO recommendation for antibiotic prophylaxis, in areas with ≥10% active trachoma prevalence in children of age 1-9 years?",
      "choices": [
        {
          "id": 1,
          "text": "Tetracycline eye ointment is recommended for those that have allergy to macrolides"
        },
        {
          "id": 2,
          "text": "Oral azithromycin must be administered to all children less than 9 years only"
        },
        {
          "id": 3,
          "text": "The mass antibiotic therapy should be given thrice a year for three years"
        },
        {
          "id": 4,
          "text": "The annual treatment should be continued till the TF prevalence in children of 1-9 years of that area becomes less than 2%."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Tetracycline eye ointment</strong> is recommended for those that have <strong>allergy to macrolides.</strong></p>\n<p>ln areas with ≥10% prevalence of active trachoma (TF in children 1-9 years), the WHO recommends the following measures: </p>\n<ul>\n<li>Antibiotic therapy\n<ul>\n<li>Oral azithromycin <strong>to all community members </strong>(not only children)</li>\n<li>Tetracycline eye ointment for all pregnant women, children&lt;6 months, and those allergic to macrolides.</li>\n</ul>\n</li>\n<li>Follow-up\n<ul>\n<li>The mass antibiotic therapy should be given <strong>once a year for three years continuously</strong>, after which reassessment of prevalence should be made.</li>\n<li>The annual treatment should be <strong>continued till the TF prevalence</strong> in 1-9 years children of that area becomes <strong>less than 5%.</strong>(not 2%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>Trachoma</strong> is a form of chronic infective conjunctivitis and is one of the<strong> leading causes</strong> of <strong>blindness</strong>. It has an ‘active’ inflammatory stage and a ‘cicatricial’ chronic stage.</p>\n<p>The<strong> active inflammatory stage</strong> is<strong> more prevalent</strong> in <strong>children</strong> and presents with nonspecific symptoms of ocular irritation, foreign body sensation, and discharge (often mild symptoms). Examination findings at this stage show: </p>\n<ul>\n<li><strong>Conjunctival follicles </strong>containing <strong>Leber cells </strong>(multinucleated lymphocytes)</li>\n<li>Corneal <strong>Herbert's follicles </strong>(similar to conjunctival follicles)</li>\n</ul>\n<p><strong>Cicatricial chronic stage</strong> is seen in <strong>middle age</strong>. And when the chronic infection with sequelae sets in, the patient complains of pain, lacrimation,<strong> photophobia</strong> and later blurring, and finally<strong> loss of vision</strong>. Conjunctiva shows <strong>c</strong><strong>oncretions</strong> (whitish deposits of inspissated mucus in depressions called glands of Henle). Corneal signs include: </p>\n<ul>\n<li><strong>Herbert pits</strong> (pitted scars in the limbal, which are remnants of healed Herbert follicles)</li>\n<li><strong>Corneal opacity </strong>is seen in later stages.</li>\n</ul>\n<p>There can be associated <strong>t</strong><strong>richiasis </strong>(when at least one eyelash rubs the eyeball) and entropion.</p>\n<p>At present <strong>WHO grading </strong>with <strong>`FISTO’</strong> is in use.</p>\n<p>Trachoma is treated according to the WHO classification using the <strong>SAFE</strong> <strong>strategy</strong> (<strong>S</strong>urgery, <strong>A</strong>ntibiotics,<strong> F</strong>acial hygiene, and <strong>E</strong>nvironmental improvement). <strong>Azithromycin</strong> is the <strong>antibiotic of choice</strong>, and surgery involves the correction of <strong>trichiasis and entropion</strong>. In case of significant corneal scarring, penetrating keratoplasty is done.</p><hr><h3>Related Pearl: WHO classification of trachoma (FISTO)</h3><p><strong>WHO grading of trachoma</strong></p>\n<ul>\n<li>TF = trachomatous inflammation (<strong>follicular</strong>): <strong>five or more follicles</strong> (&gt;0.5 mm) on the superior tarsal conjunctiva.</li>\n<li>TI = trachomatous inflammation (<strong>intense</strong>): <strong>diffuse involvement</strong> of the tarsal conjunctiva,<strong> obscuring 50% or more</strong> of the normal deep tarsal vessels; <strong>papillae</strong> are present</li>\n<li>TS = trachomatous conjunctival <strong>scarring</strong>: easily visible fibrous <strong>white tarsal bands</strong></li>\n<li>TT = trachomatous<strong> trichiasis</strong>: at least <strong>one lash</strong> touching the globe</li>\n<li>CO = <strong>corneal opacity</strong> sufficient to blur details of at least part of the pupillary margin</li>\n</ul><hr><h3>Related Pearl: WHO Programme to Control Trachoma: SAFE Strategy</h3><ul>\n<li><strong>S&mdash;</strong>Surgery: Trichiasis and entropion correction surgery&nbsp;&rarr; 3&deg;&nbsp;prevention.</li>\n<li><strong>A&mdash;</strong>Antibiotics: Oral azithromycin, topical <strong>1% tetracycline</strong>, topical 1% azithromycin&nbsp;&rarr; 2&deg; prevention</li>\n<li><strong>F&mdash;</strong>Facial hygiene&nbsp;&rarr; 1&deg; prevention.</li>\n<li><strong>E&mdash;</strong>Environmental cleanliness&nbsp;&rarr; primordial prevention</li>\n</ul>\n<p>The strategy depends on the prevalence of trachoma follicle in children (aged 1&ndash;9 yrs)</p>\n<ul>\n<li aria-level=\"1\">&gt;10% &rarr; Mass antibiotic treatment at the community level and FE measures</li>\n<li aria-level=\"1\">5 to 10% &rarr; Targeted antibiotic treatment (affected families) and FE measures</li>\n<li aria-level=\"1\">&lt; 5% &rarr; FE measures&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5541",
      "difficulty": "hard"
    },
    {
      "text": "All of the following measures are correct regarding the management of frostbite except:",
      "choices": [
        {
          "id": 1,
          "text": "Rewarming by asking the patient to exercise is not advised"
        },
        {
          "id": 2,
          "text": "Rapid rewarming can be accomplished by immersing the foot in a warm water bath"
        },
        {
          "id": 3,
          "text": "Rubbing/friction can be used to hasten up the process of rewarming"
        },
        {
          "id": 4,
          "text": "Tetanus prophylaxis must be given as there is increased risk of tetanus in frost bite"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Rewarming by<strong> exercise, rubbing, or friction</strong> is <strong>not advised. </strong></p>\n<p>In frostbite, tissue damage results from <strong>severe</strong> environmental <strong>cold exposure</strong> or from direct contact with a very cold object. Tissue injury results from both freezing and vascular stasis. It usually <strong>affects</strong> the distal aspects of the <strong>extremities</strong> or exposed parts of the face, such as the ears, nose, chin, and cheeks.</p>\n<p>Clinical features include <strong>decreased sensation </strong>(especially for pain, and temperature sensations) in the acral tips and extremities. Affected area appears waxy, mottled, or violaceous. Patients may have a wood-like sensation in the affected area.</p>\n<p>Treatment:</p>\n<ul>\n<li>Initial<strong> treatment</strong> is by rapid <strong>rewarming </strong>(or thawing), which is accomplished by immersion of the affected part in a water bath at temperatures of 37°–40°C (99°–104°F) for 30–60 min. Rewarming by exercise, rubbing, or friction is not advised. </li>\n<li><strong>Analgesics</strong> such as ibuprofen are often required during rewarming.</li>\n<li>Antithrombotics, <strong>thrombolytics</strong> and <strong>vasodilators</strong> such as prostacyclin can be given to improve circulation after rewarming.</li>\n<li>Frost bites are associated with an increased risk of <strong>infections</strong> and tetanus. Therefore, the injured area should be cleaned with soap or antiseptic, and sterile dressings should be applied. Tetanus prophylaxis must be given, but, empirical antibiotics are not recommended.</li>\n<li>The patient must be monitored for the development of compartment syndrome.</li>\n<li>Elective late <strong>amputation</strong> after imaging may be required in severe cases.</li>\n</ul>\n<p>Image showing frost bite of the toes</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e0a64eb40ba64ce5bb19166d95385f24x1280x956.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5672",
      "difficulty": "medium"
    },
    {
      "text": "Which of these first-line antitubercular drugs is proposed to be acting by collapsing the transmembrane proton motive force, thereby killing the bacteria?",
      "choices": [
        {
          "id": 1,
          "text": "Pyrazinamide"
        },
        {
          "id": 2,
          "text": "Rifampin"
        },
        {
          "id": 3,
          "text": "Isoniazid"
        },
        {
          "id": 4,
          "text": "Ethambutol"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pyrazinamide</strong> is the first-line antitubercular drug that is proposed to be <strong>acting by collapsing the transmembrane proton motive force,</strong> thereby killing the bacteria</p>\n<p><strong>Pyrazinamide</strong> is a prodrug that is activated by the enzyme pyrazinamidase(encoded by the <strong>pncA gene</strong>). It is converted into an active metabolite pyrazinoic acid. This metabolite makes the intracellular environment acidic which collapses the <strong>transmembrane proton motive force, </strong>thereby killing the bacteria. Hepatotoxicity and hyperuricemia are the common side effects.</p>\n<p><strong>Isoniazid</strong> is a first-line bactericidal drug that is used for the treatment of tuberculosis. This drug enters bacilli by <strong>passive diffusion</strong>. It then gets activated to its toxic form by the enzyme <strong>catalase-peroxidase</strong>(the enzyme encoded by the <strong>Kat gene</strong>). Normally, InhA and KasA are involved in the synthesis of mycolic acid. Upon activation, the reactive metabolite of isoniazid forms complexes with <strong>NAD</strong> that inhibit <strong>InhA</strong> and <strong>KasA</strong>. Hence, isoniazid inhibits the production of <strong>mycolic acid</strong>.</p>\n<p>The reactive isoniazid metabolite also forms complexes with <strong>NADP</strong>. This complex inhibits mycobacterial dihydrofolate reductase which results in the interruption of <strong>DNA synthesis</strong>.</p>\n<p>Side effects of isoniazid include <strong>peripheral neuritis.</strong>&nbsp;Therefore, <strong>pyridoxine 10mg/day (vitamin B6)</strong> is given prophylactically along with isoniazid to prevent neurotoxicity.&nbsp;<strong>Hepatitis,&nbsp;</strong>rashes, anemia, and arthralgia are also seen. Toxicity of isoniazid results in <strong>metabolic acidosis</strong> and <strong>seizures</strong>.&nbsp;</p>\n<p><strong>Rifampin</strong> is the first-line antitubercular drug. It binds to <strong>DNA-dependent RNA polymerase</strong> to form a stable drug-enzyme complex. This complex suppresses RNA synthesis. Side effects of rifampin are <strong>hepatitis</strong>, flu-like illness, and urine and secretions may become <strong>orange-red</strong> but this is harmless.</p>\n<p><strong>Ethambutol</strong> inhibits arabinose transferase III, thereby decreasing arabinogalactan biosynthesis. This results in, disruption in mycobacterial <strong>cell wall synthesis</strong>. The important side effect of ethambutol is <strong>optic neuritis</strong>, resulting in decreased visual acuity and <strong>loss of red-green discrimination.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5589",
      "difficulty": "medium"
    },
    {
      "text": "In which condition would a histopathological examination of the small intestine reveal infiltration of the lamina propria with macrophages containing PAS-positive inclusions?",
      "choices": [
        {
          "id": 1,
          "text": "Whipple's disease"
        },
        {
          "id": 2,
          "text": "Celiac disease"
        },
        {
          "id": 3,
          "text": "Tropical sprue"
        },
        {
          "id": 4,
          "text": "Bacterial overgrowth syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Histopathological examination of the small intestine showing infiltration of the lamina propria with <strong>macrophages</strong> containing <strong>PAS-positive</strong> inclusions is seen in <strong>Whipple's disease. </strong></p>\n<p>Exposure to the gram-positive <em><strong>Tropheryma whipplei</strong></em> can lead to an asymptomatic state; acute disease; or <strong>chronic</strong> infection, which is also known as <strong>Whipple's disease</strong>. It is characterized by a <strong>triad</strong> of <strong>diarrhea, weight loss,</strong> and <strong>arthralgia. </strong><strong>Malabsorptive diarrhea</strong> of Whipple's disease is due to bacteria-laden macrophages that accumulate within the small intestinal lamina propria and mesenteric lymph nodes causing <strong>lymphatic obstruction. Extraintestinal symptoms </strong>may precede malabsorption.</p>\n<p>Histopathological findings: </p>\n<ul>\n<li>A dense accumulation of distended, <strong>foamy macrophages</strong> is seen in the small intestinal<strong> lamina propria;</strong> these macrophages contain <strong>PAS-positive, diastase-resistant</strong> granules, which indicate <strong>partially digested bacteria</strong> with lysosomes—a <strong>hallmark</strong> of Whipple's disease.</li>\n<li>With disease progression, there is <strong>villous atrophy</strong>, <strong>crypt hyperplasia,</strong> and<strong> apoptosis of surface epithelial cells in the intestine,</strong> which can cause diarrhea due to decreased absorption and increased efflux of water and solutes. </li>\n<li><strong>Non-caseating granulomas</strong> may also be seen. </li>\n<li>Bacteria-laden macrophages can accumulate within mesenteric lymph nodes, synovial membranes, cardiac valves, brain, or other sites.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8c19474661754bbebcb0d28373fe4759x1280x1574.JPEG\" alt=\"Explanation Image\"><p><br />The treatment regimen for Whipple's disease includes <strong>ceftriaxone</strong> 1 g intravenously twice daily or <strong>meropenem</strong> 1 g intravenously three times daily<strong> for 2 weeks. </strong>It is followed by <strong>trimethoprim-sulfamethoxazole</strong> 160/800 mg twice daily <strong>for 12 months.</strong></p>\n<p>Other options:</p>\n<p>Option B: <strong>Celiac disease</strong> presents as a <strong>malabsorption</strong> syndrome secondary to the introduction of<strong> gluten in the diet.</strong></p>\n<p>It is characterized by the presence of <strong>IgA antigliadin</strong>, <strong>anti-endomysial</strong>, and <strong>anti-tissue transglutaminase</strong> antibodies. </p>\n<p>Histology shows a <strong>flat appearance</strong> of the intestine with <strong>crypt hyperplasia</strong>,<strong> villous atrophy,</strong> an increase in the number of intraepithelial lymphocytes, and increased numbers of lymphocytes and plasma cells in the lamina propria.</p>\n<p>The image below shows the intestinal biopsy of a patient with celiac disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/36002a4157b64614bab30ac9176882e9x1280x854.JPEG\" alt=\"Explanation Image\"><p><br />Option C: <strong>Tropical sprue</strong> is an acquired malabsorptive condition of probable <strong>infectious </strong>etiology. Histopathology shows <strong>partial villous atrophy </strong>with increased inflammatory cells in the lamina propria.</p>\n<p>The image below shows a duodenal biopsy of a patient with tropical sprue. Partial villous atrophy (arrow) and lymphoplasmacytic infiltration in the lamina propria (asterisk) are visible.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5ef7c8de9ed14bcf9d58c499df879426x512x327.PNG\" alt=\"Explanation Image\"><p><br />Option D: <strong>Bacterial overgrowth syndromes</strong> present as <strong>malabsorption</strong> syndrome with diarrhea, steatorrhea, and macrocytic anemia due to the proliferation of <strong>colonic-type bacteria</strong> within the small intestine.</p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5664",
      "difficulty": "easy"
    },
    {
      "text": "The brain of a 32-year-old HIV-positive man, who died following a CNS infection, is sent for examination. Histopathological section reveals a gelatinous mass growing in perivascular Virchow-Robin spaces within the gray matter, producing soap-bubble lesions. What is the likely causative organism?",
      "choices": [
        {
          "id": 1,
          "text": "Toxoplasma"
        },
        {
          "id": 2,
          "text": "Mucor"
        },
        {
          "id": 3,
          "text": "Cryptococcus"
        },
        {
          "id": 4,
          "text": "Pneumocystis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In immunosuppressed people, <em>Cryptococcus</em> infection evokes virtually no inflammatory reaction. As a result, <strong>gelatinous masses of fungi</strong> grow in the <strong>meninges</strong> or in the <strong>perivascular Virchow-Robin spaces</strong> <strong>within the gray matter</strong>, and expand it, producing the so-called <strong>soap-bubble lesions.&nbsp;</strong><em>Cryptococcus</em> mostly causes lesions in the CNS, involving the meninges, cortical gray matter, and basal nuclei.&nbsp;</p>\n<p><span data-preserver-spaces=\"true\"><em><strong>Cryptococcus</strong></em>&nbsp;is an&nbsp;</span><strong><span data-preserver-spaces=\"true\">opportunistic</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">fungus</span></strong><span data-preserver-spaces=\"true\">&nbsp;that is found worldwide as a saprophyte in&nbsp;</span><strong><span data-preserver-spaces=\"true\">soil enriched with pigeon droppings.</span></strong></p>\n<p><strong><span data-preserver-spaces=\"true\">Pathogenesis:</span></strong></p>\n<ul>\n<li>Infection is initiated by <strong>inhalation of the yeast cells.</strong></li>\n<li>The<strong> primary pulmonary infection</strong> may be asymptomatic&nbsp;or may mimic an influenza-like respiratory infection, often&nbsp;resolving spontaneously.</li>\n<li>In<strong> immunocompromised</strong>,&nbsp;the yeasts may multiply and <strong>disseminate</strong> to other parts of the&nbsp;body, but preferentially to the <strong>CNS</strong>, causing&nbsp;<strong>cryptococcal meningoencephalitis.</strong></li>\n<li>Other&nbsp;common sites of dissemination include the skin, adrenals,&nbsp;bone, eye, and prostate gland.</li>\n</ul>\n<p><strong>Clinical findings:</strong></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">Chronic meningitis (Headache, nuchal rigidity, disorientation)</span></li>\n<li><span data-preserver-spaces=\"true\">CSF pressure, protein concentration and cell count are elevated</span></li>\n<li><span data-preserver-spaces=\"true\">Cutaneous ulcers, granulomata</span></li>\n</ul>\n<p><strong>Diagnosis:</strong></p>\n<ol>\n<li>Specimens - CSF, tissue, exudates, sputum, blood, urine, skin scrapings</li>\n<li>Microscopy -&nbsp;\n<ul>\n<li>Gram staining shows <strong>gram-positive</strong> round budding yeast cells</li>\n<li><strong>India ink preparation</strong> reveals <strong>capsulated budding yeast cells</strong>; capsules are prominent in this staining.</li>\n</ul>\n</li>\n<li>Culture -&nbsp;\n<ul>\n<li>Colonies on SDA at 37&deg;C appears as <strong>smooth, mucoid and creamy white.</strong></li>\n</ul>\n</li>\n<li>Serology\n<ul>\n<li>Demonstration of <strong>cryptococcal antigen</strong> by latex agglutination test is a sensitive, specific and rapid method for identificcation of cryptococcal meningoencephalitis.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Treatment:</strong></p>\n<ol>\n<li>Cryptococcosis without CNS involvement: <strong>Fluconazole</strong> is the drug of choice</li>\n<li>HIV patient with CNS involvement:&nbsp;\n<ul>\n<li>Induction: Liposomal <strong>Amphotericin B with Flucytosine</strong>&nbsp;for at least 2 weeks&nbsp;</li>\n<li>Maintenance: <strong>Oral Fluconazole</strong>&nbsp;</li>\n</ul>\n</li>\n</ol>\n<p>The below image shows&nbsp;<em>Cryptococcus neoformans</em> stained with India ink. Note the prominent capsule.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/756a780eb53647dc82247fce9d0a9af8x1280x858.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0ccba7a295204e95ab2df8abadff6876x1280x2558.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: CNS infections and regions commonly affected</h3><table>\n<tbody>\n<tr>\n<td><strong>INFECTION</strong></td>\n<td><strong>REGION COMMONLY AFFECTED</strong></td>\n</tr>\n<tr>\n<td>Tubercular meningitis</td>\n<td>Basal part of the brain</td>\n</tr>\n<tr>\n<td>Tubercular encephalitis</td>\n<td>Intra parenchymal granulomas</td>\n</tr>\n<tr>\n<td>Meningovascular Neurosyphilis</td>\n<td>Base of the brain and meninges covering the cerebral convexities</td>\n</tr>\n<tr>\n<td>Paretic neurosyphilis</td>\n<td>Frontal lobe</td>\n</tr>\n<tr>\n<td>Tabes dorsalis(syphilis)</td>\n<td>Dorsal column of spinal cord</td>\n</tr>\n<tr>\n<td>HSV encephalitis</td>\n<td>Temporal and frontal lobes</td>\n</tr>\n<tr>\n<td>Varicella-zoster infection</td>\n<td>Dorsal root ganglia, Trigeminal ganglia</td>\n</tr>\n<tr>\n<td>Cytomegalovirus</td>\n<td>Choroid plexus and paraventricular subependymal regions</td>\n</tr>\n<tr>\n<td>Poliomyelitis</td>\n<td>Anterior horn cells of spinal cord</td>\n</tr>\n<tr>\n<td>JC virus</td>\n<td>Oligodendrocytes</td>\n</tr>\n<tr>\n<td>Rabies</td>\n<td>Hippocampus cerebellum</td>\n</tr>\n<tr>\n<td>HIV</td>\n<td>Subcortical regions</td>\n</tr>\n<tr>\n<td>Aspergillosis/ Mucormycosis</td>\n<td>Blood vessel walls, Intraparenchymal abscesses or granulomas</td>\n</tr>\n<tr>\n<td>Cryptococcosis</td>\n<td>Intra parenchymal abscesses or granulomas(soap bubble appearance)</td>\n</tr>\n<tr>\n<td>Toxoplasmosis</td>\n<td>Cerebral cortex(near grey matter-white matter junction)</td>\n</tr>\n<tr>\n<td>Cerebral malaria</td>\n<td>Blood vessels of brain</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5512",
      "difficulty": "medium"
    },
    {
      "text": "Match the following inclusion bodies with the respective disease conditions in which they may be seen.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>A. Torres bodies</td>\n<td>1. Granuloma inguinale</td>\n</tr>\n<tr>\n<td>B. Levinthal-Cole-Lillie bodies (LCL bodies)</td>\n<td>2. Trachoma</td>\n</tr>\n<tr>\n<td>C. Miyagawa’s granulocorpuscles</td>\n<td>3. Psittacosis</td>\n</tr>\n<tr>\n<td>D. Halberstaedter-Prowazek bodies</td>\n<td>4. Yellow fever</td>\n</tr>\n<tr>\n<td> </td>\n<td>5. Lymphogranuloma venereum</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p></div>",
      "choices": [
        {
          "id": 1,
          "text": "A-4, B-1, C-5, D-2"
        },
        {
          "id": 2,
          "text": "A-4, B-3, C-5, D-2"
        },
        {
          "id": 3,
          "text": "A-4, B-1, C-3, D-2"
        },
        {
          "id": 4,
          "text": "A-2, B-1, C-3, D-5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct pairs are as follows:</p>\n<ol>\n<li>Torres bodies - Yellow fever</li>\n<li>Levinthal-Cole-Lillie bodies (LCL bodies) - Psittacosis</li>\n<li>Miyagawa’s granulocorpuscles - Lymphogranuloma venereum</li>\n<li>Halberstaedter-Prowazek bodies - Trachoma</li>\n<li>Donovan bodies - Granuloma inguinale </li>\n</ol>\n<p><strong>Inclusion bodies</strong> are structures with distinct sizes and shapes that are seen in <strong>infected</strong> <strong>cells</strong> under light microscopy. </p>\n<p><strong>Torres bodies </strong>are amorphous <strong>eosinophilic</strong> <strong>nuclear</strong> <strong>inclusions</strong> associated with <strong>yellow</strong> <strong>fever</strong>, a disease caused by the <strong>Flavivirus</strong>.</p>\n<p>The <strong>Miyagawa</strong> <strong>corpuscles</strong> are inclusion bodies seen in <strong>lymphogranuloma</strong> <strong>venereum (LGV)</strong>. They are <strong>intracytoplasmic microcolonies</strong> of <em><strong>Chlamydia</strong> <strong>trachomatis</strong></em> seen on microscopy of the aspirated material from the buboes.</p>\n<p><strong>Levinthal-Cole-Lillie bodies</strong> are inclusion bodies of <em><strong>Chlamydia psittaci</strong></em> seen in infected cells including alveolar macrophages from patients suffering from psittacosis. They are present in cell cultures also. Distinguishing features from inclusion bodies of <em>C. trachomatis</em> are that they are more diffuse and irregular and are <strong>not stained by iodine.</strong></p>\n<p><strong>Halberstaedter-Prowazek (HP)</strong> <strong>bodies</strong> are demonstrated in <strong>conjunctival scrapings</strong> of patients with <strong>trachoma</strong>, after staining by Giemsa, Castaneda, or Macchiavello methods. They <strong>stain well with iodine</strong> as they contain <strong>glycogen</strong>. </p><hr><h3>Related Pearl: Inclusion bodies seen in various conditions/diseases</h3><p><strong>1. Bacterial Inclusion Bodies&nbsp;</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disease/Bacteria&nbsp;</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Granuloma inguinale,&nbsp;<em>Klebsiella granulomatis</em></td>\n<td>Donovan bodies</td>\n</tr>\n<tr>\n<td>Psittacosis, <em>Chlamydia psittacci&nbsp;</em></td>\n<td>Levinthal-Cole-Lille bodies (LCL bodies)</td>\n</tr>\n<tr>\n<td>Trachoma, <em>Chlamydia trachomatis</em></td>\n<td>Halberstaedter-Prowazek bodies</td>\n</tr>\n<tr>\n<td>Lymphogranuloma venereum,&nbsp;<em>Chlamydia trachomatis</em></td>\n<td>Miyagawa&rsquo;s granulocorpusles</td>\n</tr>\n<tr>\n<td>Diphtheria,&nbsp;<em>Corynebacterium diptheriae</em></td>\n<td>Babes-Ernst granules</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>2. Viral Inclusion Bodies</strong></p>\n<ul>\n<li><strong>Intra-cytoplasmic Inclusion Bodies</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Disease/Virus</strong></td>\n<td><strong>Inclusion bodies</strong></td>\n</tr>\n<tr>\n<td>Rabies</td>\n<td>Negri bodies</td>\n</tr>\n<tr>\n<td>Vaccinia, variola (smallpox)</td>\n<td>Guarnieri bodies</td>\n</tr>\n<tr>\n<td>Variola (smallpox)</td>\n<td>Paschen bodies</td>\n</tr>\n<tr>\n<td>Molluscum contagiosum</td>\n<td>Henderson-Patterson bodies</td>\n</tr>\n<tr>\n<td>Fowlpox</td>\n<td>Bollinger bodies</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Intra-nuclear Inclusion Bodies&nbsp;</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n<td><strong>Disease/Virus</strong></td>\n</tr>\n<tr>\n<td rowspan=\"2\">Cowdry type A</td>\n<td>Lipschutz inclusions</td>\n<td>Herpes Virus</td>\n</tr>\n<tr>\n<td>Torres bodies</td>\n<td>Yellow fever</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Cowdry type B</td>\n<td>Basophilic inclusions</td>\n<td>Adenovirus</td>\n</tr>\n<tr>\n<td>Acidophilic inclusions</td>\n<td>Poliovirus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Both Intra-nuclear and Intra-cytoplasmic Inclusion Bodies&nbsp;</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Disease/Virus&nbsp;</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Measles Virus</td>\n<td>Warthin-Finkedly giant cells</td>\n</tr>\n<tr>\n<td>Cytomegalovirus</td>\n<td>Owl-eye inclusions (basophilic,&nbsp;predominantly intra-nuclear, small granular intracytoplasmic inclusions are found)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>3. Inclusion Bodies in Parasitic Infections&nbsp;</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disease/Parasite</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Trypanosomiasis</td>\n<td>Morula cells with IgM Deposits</td>\n</tr>\n<tr>\n<td>Kala-azar</td>\n<td>Leishman-Donovan Bodies</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>4. Miscellaneous Inclusion Bodies&nbsp;</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disease/Location</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Ovarian cortex</td>\n<td>Walthard Inclusions</td>\n</tr>\n<tr>\n<td>Spherical globules surrounded by granulosa cells in the ovary</td>\n<td>Call-Exner bodies</td>\n</tr>\n<tr>\n<td>Parkinsonism, Lewy body dementia&nbsp;</td>\n<td>Lewy Bodies</td>\n</tr>\n<tr>\n<td>Amyotrophic Lateral Sclerosis&nbsp;</td>\n<td>Bunina bodies</td>\n</tr>\n<tr>\n<td>Multiple Myeloma</td>\n<td>Russell Bodies</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5520",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true?",
      "choices": [
        {
          "id": 1,
          "text": "Patients with severe anemia and even marked arterial desaturation may not display cyanosis as absolute quantity of reduced hemoglobin produces cyanosis"
        },
        {
          "id": 2,
          "text": "Patients with severe anemia and even mild arterial desaturation will display severe cyanosis as relative quantity of reduced hemoglobin produces cyanosis"
        },
        {
          "id": 3,
          "text": "Patients with severe anemia and even mild arterial desaturation will display severe cyanosis as absolute quantity of reduced hemoglobin produces cyanosis"
        },
        {
          "id": 4,
          "text": "Patients with severe anemia and even marked arterial desaturation may not display cyanosis as relative quantity of reduced hemoglobin produces cyanosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Patients with <strong>severe anemia</strong> and even <strong>marked arterial desaturation</strong> may <strong>not display cyanosis</strong> as <strong>absolute quantity of reduced hemoglobin</strong> <strong>produces</strong> <strong>cyanosis.</strong></p>\n<p>The <strong>absolute quantity of reduced hemoglobin</strong>&nbsp;is <strong>important in producing cyanosis.</strong> Thus, in a <strong>patient with severe anemia</strong>, the <strong>relative quantity</strong> of reduced hemoglobin in the venous blood may be <strong>very large</strong> when considered in relation to the total quantity of hemoglobin in the blood. However, since the<strong> concentration </strong>of hemoglobin is markedly<strong> reduced,</strong> the <strong>absolute quantity</strong> <strong>of reduced hemoglobin</strong> may <strong>still be low</strong>, and, therefore, <strong>patients with severe anemia</strong>&nbsp;<strong>may not display cyanosis&nbsp;</strong>even in situations with marked desaturation.</p>\n<p>The converse of this is that at <strong>higher total hemoglobin content</strong>, there is a <strong>greater tendency toward cyanosis</strong>. Thus, <strong>patients with marked polycythemia</strong> tend to be <strong>cyanotic at higher levels of SaO2</strong> <strong>than</strong> patients with <strong>normal</strong> hematocrit values.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5671",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following plots shows a Lineweaver-Burk plot corresponding to noncompetitive inhibition?",
      "choices": [
        {
          "id": 1,
          "text": "Image 3"
        },
        {
          "id": 2,
          "text": "Image 4"
        },
        {
          "id": 3,
          "text": "Image 2"
        },
        {
          "id": 4,
          "text": "Image 1"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Image 3 corresponds to a <strong>double reciprocal plot&nbsp;</strong>(<strong>Lineweaver-Burk plot</strong>) for <strong>non-competitive inhibition</strong>.</p>\n<p><span data-preserver-spaces=\"true\"><strong>Non-competitive inhibition</strong> occurs when the substrate and the inhibitor are chemically not similar and have different shapes. The inhibitor binds away from the active site, i.e., at the <strong>allosteric site</strong>. This type of inhibition is known as non-competitive inhibition.</span></p>\n<p><span data-preserver-spaces=\"true\">Ex: Pyruvate kinase reaction is inhibited by alanine.</span></p>\n<p><span data-preserver-spaces=\"true\">In non-competitive inhibition</span></p>\n<ul>\n<li><strong>V<sub>max</sub> decreases</strong></li>\n<li><strong>K<sub>m</sub> remains constant&nbsp;</strong></li>\n</ul>\n<p><span data-preserver-spaces=\"true\">In a Lineweaver-Burk plot, the addition of a non-competitive inhibitor causes plots with the <strong>same x-intercept</strong> (<strong>K<sub>m</sub> is unaffected</strong>) but <strong>different slopes and y-intercepts.</strong></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7810bbf695664063b9db9500778f3296x1280x2317.JPEG\" alt=\"Explanation Image\"><p>Although image 4 also corresponds to noncompetitive inhibition, the graph shows a plot of 1/V(Reaction Velocity) vs. concentration of inhibitor across various concentrations of substrate. Hence, it is a<strong> Dixon Plot</strong>.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d9ebc262fea340f981ce79bcc02154afx720x625.PNG\" alt=\"Explanation Image\"><ul>\n<li><strong>Km </strong>is the&nbsp;substrate concentration at which velocity is half of its maximum velocity.</li>\n<li><strong>Vmax</strong>&nbsp;is the maximum velocity of a reaction.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Inhibition</strong></td>\n<td><strong>K<sub>m</sub></strong></td>\n<td><strong>V<sub>max</sub></strong></td>\n</tr>\n<tr>\n<td>Competitive</td>\n<td>Increases</td>\n<td>Same</td>\n</tr>\n<tr>\n<td>Non Competitive</td>\n<td>Same</td>\n<td>Decreases</td>\n</tr>\n<tr>\n<td>Uncompetitive</td>\n<td>Decreases</td>\n<td>Decreases</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Competitive inhibition&nbsp;</strong>is when the inhibitor binds <strong>reversibly</strong> to the substrate-binding site and competes with the substrate for the active enzyme binding site. This effect of competitive inhibition can be overcome <strong>by increasing</strong> the <strong>substrate concentration</strong> by which maximum velocity can still be achieved. Therefore,&nbsp;<strong>V<sub>max</sub></strong>&nbsp;is&nbsp;<strong>unaltered</strong>&nbsp;in this type of inhibition. However, the concentration of the substrate required to achieve half of the maximum velocity is increased. Therefore,&nbsp;<strong>K<sub>m</sub></strong>&nbsp;is&nbsp;<strong>increased</strong>&nbsp;in this condition.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>The graph shows the changes in V<sub>max</sub>&nbsp;and K<sub>m</sub> in competitive inhibition.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8947681362f842c1ad6d953657f351a1x1280x2235.JPEG\" alt=\"Explanation Image\"><p>&nbsp;In<strong>&nbsp;uncompetitive inhibition,&nbsp;</strong>inhibitors bind with the enzyme-substrate&nbsp;<strong>intermediate complex</strong>, and inhibit it. This leads to decrease in both V<sub>max</sub> and K<sub>m</sub>. An example is the inhibition of&nbsp;<strong>placental</strong>&nbsp;alkaline phosphate (<strong>ALP</strong>) by&nbsp;<strong>phenylalanine</strong>.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd485ae9882e43d583801322edf0060bx720x530.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Difference between Competitive & Non-Competitive inhibitors</h3><p>Reversible inhibitors are of two types:</p>\n<ul>\n<li>Competitive inhibitors</li>\n<li>Non-Competitive inhibitors</li>\n</ul>\n<p>Difference between Competitive &amp; Non-Competitive inhibitors</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Competitive inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Non-Competitive inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Succinate dehydrogenase is inhibited by Malonate</p>\n</td>\n<td>\n<p>Pyruvate kinase is inhibited by alanine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Substrate &amp; inhibitor are chemically similar &amp; have same shape</p>\n</td>\n<td>\n<p>Substrate &amp; inhibitor are chemically not similar &amp; have different shape</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor binds to active site</p>\n</td>\n<td>\n<p>Inhibitor binds away from active site, i.e., at allosteric site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor does not change the shape of the active site</p>\n</td>\n<td>\n<p>Inhibitor changes the shape of the active site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Increase in substrate concentration reduces the inhibition</p>\n</td>\n<td>\n<p>Increase in substrate concentration does not affect the inhibition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vmax remains constant</p>\n</td>\n<td>\n<p>Vmax decreases</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Km Increases</p>\n</td>\n<td>\n<p>Km remains constant</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Some Examples of Suicidal Inhibitors</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Suicidal Inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Enzyme</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Allopurinol</p>\n</td>\n<td>\n<p>Xanthine oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Cyclooxygenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5-Flurouracil</p>\n</td>\n<td>\n<p>Thymidylate synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Penicillin</p>\n</td>\n<td>\n<p>Transpeptidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>DFMO</p>\n</td>\n<td>\n<p>Ornithine Decarboxylase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d730fbdc49504d4da31921ab4b25e72f.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5474",
      "difficulty": "medium"
    },
    {
      "text": "You notice an online campaign to help pay for nusinersen(Spinraza) for a patient with spinal muscular atrophy. All of the following are true about the drug except:",
      "choices": [
        {
          "id": 1,
          "text": "It is survival motor neuron - 2 (SMN2)-directed antisense oligonucleotide"
        },
        {
          "id": 2,
          "text": "Onasemnogene abeparvovec(Zolgensma) also shares the same mechanism"
        },
        {
          "id": 3,
          "text": "It can be used in both in pediatric and adult patients"
        },
        {
          "id": 4,
          "text": "After initial loading doses, it requires a maintenance dose once in four months"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Onasemnogene abeparvovec (Zolgensma) </strong>is an <strong>adeno-associated virus vector-based gene therapy, </strong>while<strong> nusinersan(Spinraza) is a survival motor neuron-2 (SMN2) directed antisense oligonucleotide.</strong></p>\n<p><strong>Onasemnogene abeparvovec</strong> is indicated for <strong>children&lt;2 years of age</strong> with spinal muscular atrophy due to bi-allelic mutations in the survival motor neuron 1 (<strong>SMN1</strong>) gene. It is administered as a <strong>single</strong> <strong>intravenous dose</strong>. </p>\n<p><strong>Nusinersen </strong>is indicated for the treatment of spinal muscular atrophy (SMA) in <strong>pediatric and adult patients</strong>. It is <strong>administered intrathecally. </strong>After initial loading doses, it requires a <strong>maintenance dose once in four months.</strong></p>\n<p>Spinal muscle atrophy is a <strong>lower motor neuron disease</strong> with early-onset and occurs as a result of the loss of a protein called survival motor neuron (SMN). Features of lower motor neuron disease include<strong> flaccid paralysis</strong>, <strong>muscle atrophy</strong>, <strong>fasciculations </strong>characterized by visible muscle twitches appearing as flickers under the skin, <strong>hypotonia</strong> (decreased muscle tone), <strong>hyporeflexia,</strong> or areflexia. </p>\n<p>Clinical forms of SMA are</p>\n<ul>\n<li>In<strong> infantile SMA,</strong> the onset is very early and rapid. It is characterized by decreased fetal movements in the third trimester. In infancy, features include weak and floppy infant (hypotonic) and they lack muscle stretch reflex. <strong>Tongue fasciculations</strong> are typically seen in a severe form of SMA known as <strong>Werdnig-Hoffman disease. </strong>It can affect infants between 0-6 months.</li>\n<li><strong>Chronic childhood SMA</strong> has a slow onset and a progressive course.</li>\n<li><strong>Juvenile SMA</strong> is seen in late childhood with a slow course.</li>\n</ul>\n<p> </p><hr><h3>Related Pearl: Features of Motor Neuron Lesions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Upper Motor Neuron Lesion</strong></p>\n</td>\n<td>\n<p><strong>Lower Motor Neuron Lesion</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Upper motor neuron typically refer to corticospinal tract neurons that innervate spinal motor neurons, but they can also include brainstem neurons that control spinal motor neurons</p>\n</td>\n<td>\n<p>Lower motor neurons are those whose axons terminate on skeletal muscles</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Little or no muscle wasting&nbsp;&rarr; weakness of relatively large group of muscles</p>\n</td>\n<td>\n<p>Muscle atrophy &rarr; muscle weakness of an individual and specific muscle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypertonia</p>\n</td>\n<td>\n<p>Hypotonia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Increased or exaggerated deep tendon reflexes (hyperreflexia)</p>\n</td>\n<td>\n<p>Hyporeflexia or areflexia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Spasticity</p>\n</td>\n<td>\n<p>Flaccidity</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Positive Babinski sign (abnormal plantar extensor reflex)</p>\n</td>\n<td>\n<p>Fasciculations</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5669",
      "difficulty": "hard"
    },
    {
      "text": "What is the qSOFA score in a patient whose examination findings are as shown below?<div class='question-desc-html'><ul>\n<li>GCS - 13/15</li>\n<li>RR - 26/min</li>\n<li>Pulse - 112/min</li>\n<li>BP - 96/62 mm Hg</li>\n<li>SpO2 - 89%</li>\n<li>Abdomen - soft, nontender</li>\n</ul></div>",
      "choices": [
        {
          "id": 1,
          "text": "4"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "1"
        },
        {
          "id": 4,
          "text": "3"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p2\"><span class=\"s3\">qSOFA score for this patient would be 3. </span><span class=\"s3\">Only 3 parameters are considered for its calculation, and the respective scores are as follows:</span></p>\n<ul>\n<li class=\"p2\"><span class=\"s3\">BP: 96/62 mmHg → Low blood pressure (SBP ≤100 mmHg) → Score 1</span></li>\n<li class=\"p2\"><span class=\"s3\">Respiratory rate: 26 breaths/min → High (≥22 breaths/min) → Score 1</span></li>\n<li class=\"p2\"><span class=\"s3\">Glasgow Coma Scale (GCS) score: 13/15 → Altered mentation (GCS score, &lt;15) → Score 1</span></li>\n</ul>\n<p class=\"p2\"><strong>qSOFA</strong> score (quickSOFA) is a bedside prompt that may identify patients with suspected infection who are at greater risk for a poor outcome outside the intensive care unit (ICU). It uses three criteria, assigning one point each for</p>\n<ul>\n<li>low blood pressure (SBP≤100 mmHg),</li>\n<li>high respiratory rate (≥22 breaths/min)</li>\n<li>altered mentation (Glasgow Coma Scale score, &lt;15).</li>\n</ul>\n<p>The score ranges from 0 to 3 points. The presence of 2 or more qSOFA points is a simple prompt to identify infected patients outside the ICU who are likely to develop sepsis. This is a simplified derivative of SOFA score. The primary method to evaluate the risk of organ dysfunction (sepsis) in patients with suspected infection is by determining the  <strong>Sequential</strong> (<strong>sepsis-related) organ failure assessment (SOFA) score</strong>; which includes assessment of:</p>\n<ul>\n<li>Circulation - Systolic BP &amp; need for vasopressors; platelet count</li>\n<li>Respiration - PaO<sub>2</sub>/FiO<sub>2</sub> &amp; need for mechanical ventilation</li>\n<li>Mentation - Glasgow Coma Scale score </li>\n<li>Hepatic function - Bilirubin level</li>\n<li>Renal function - Creatinine level</li>\n</ul>\n<p><strong>Organ dysfunction</strong> is defined by a <strong>SOFA score of ≥2</strong>.</p>\n<p>The SOFA score is limited by its requirement of multiple laboratory tests which makes it complex and time-consuming. In order to simplify the scoring process, the \"Sepsis - 3\" task force recommended the<strong> quick sepsis-related organ dysfunction assessment \"qSOFA\" score</strong>.</p>\n<p><strong>SOFA vs. qSOFA:</strong></p>\n<ul>\n<li><strong>SOFA</strong> is a more comprehensive and accurate scoring system, which is <strong>particulary superior to qSOFA in the ICU setting.</strong> </li>\n<li><strong>qSOFA</strong> is a simplified derivative of SOFA for bedside assessment of individuals at risk for sepsis <strong>particularly useful outside the ICU. setting </strong>(i.e. ward / emergency department). However, note that it was originally designed as predictive tool that calculates the risk of death from sepsis rather than a diagnostic tool.</li>\n</ul>\n<p>Thereby, the best description of sepsis based on \"Sepsis -3\" task force recommendations would be as follows:</p>\n<ul>\n<li>Suspected or documented infection with SOFA score of ≥2  <strong>Or</strong></li>\n<li>Suspected or documented infection with qSOFA score of ≥2</li>\n</ul>\n<p>Another score that has been used is the National Early Warning Score (NEWS). It ranges from 0 to 20 and is based on respiratory rate, oxygen saturation, use of supplemental O<sub>2</sub>, temperature, systolic blood pressure, pulse rate, and level of consciousness. ≥5 out of 20 is considered a positive score. </p>\n<p><span class=\"s3\">Other scoring systems for sepsis:</span></p>\n<p class=\"p2\"><span class=\"s3\">The </span><span class=\"s4\">Systemic Inflammatory Response Syndrome (<strong>SIRS</strong>)</span><span class=\"s3\"> score is no longer recommended as is it <strong>not specific to infection.</strong></span></p><hr><h3>Related Pearl: SOFA and qSOFA Scores</h3><p><strong>Sepsis</strong>&nbsp;is defined as a state of&nbsp;<strong>life-threatening organ dysfunction</strong>&nbsp;that occurs&nbsp;<strong>due to</strong>&nbsp;an unregulated host&nbsp;<strong>immune response to an infection</strong>. To objectively define the beginning of organ dysfunction, <strong>sequential organ failure assessment (SOFA) scoring</strong> is used. The variables in the SOFA score include:</p>\n<ul>\n<li class=\"p3\"><span class=\"s3\"><strong>Circulation</strong>&nbsp;- Systolic BP &amp; need for vasopressors and platelet count</span></li>\n<li class=\"p3\"><span class=\"s3\"><strong>Respiration</strong>&nbsp;- PaO2/FiO2 &amp; need for mechanical ventilation</span></li>\n<li class=\"p3\"><span class=\"s3\"><strong>Mentation</strong>&nbsp;-&nbsp;<strong>Glasgow coma score </strong>(GCS)</span></li>\n<li class=\"p3\"><span class=\"s3\"><strong>Hepatic function</strong>&nbsp;-<strong>&nbsp;Bilirubin</strong></span></li>\n<li class=\"p3\"><span class=\"s3\"><strong>Renal function</strong>&nbsp;-&nbsp;<strong>Creatinine</strong></span></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td colspan=\"6\">Sequential Organ Failure Assessment (SOFA) score</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cardiovascular</strong></p>\n<p>Hypotension</p>\n</td>\n<td>No hypotension</td>\n<td>\n<p>MAP &lt;70 mmHg</p>\n</td>\n<td>\n<p>Dopamine <span>&lt;</span>5 or <span>epi/norepi &le;0.1&curren;&nbsp;</span></p>\n</td>\n<td>Dopamine &gt;5 or epi/norepi &le;0.1&curren;</td>\n<td>Dopamine &gt;15 or epi/norepi &gt;0.1&curren;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Coagulation</strong></p>\n<p>Platelets (&times;10<sup>3</sup> per&nbsp;&mu;L)</p>\n</td>\n<td>&gt;150</td>\n<td>&le;150</td>\n<td>&le;100</td>\n<td>&le;50</td>\n<td>&nbsp;&le;20</td>\n</tr>\n<tr>\n<td>\n<p><strong>Respiration</strong></p>\n<p>(PaO<sub>2/</sub>FIO<sub>2</sub>) (mm Hg)</p>\n</td>\n<td>&gt;400</td>\n<td>&le;400</td>\n<td>&le;300</td>\n<td>&le;200 with respiratory support</td>\n<td>&le;100 with respiratory support</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mentation</strong></p>\n<p>GCS</p>\n</td>\n<td>15</td>\n<td>13&ndash;14</td>\n<td>10&ndash;12</td>\n<td>6&ndash;9</td>\n<td>&lt;6</td>\n</tr>\n<tr>\n<td>\n<p><strong>Liver</strong></p>\n<p>Bilirubin(&mu;mol/L)</p>\n</td>\n<td>&lt;20</td>\n<td>20&ndash;32</td>\n<td>33&ndash;101</td>\n<td>102&ndash;204</td>\n<td>&gt;204</td>\n</tr>\n<tr>\n<td>\n<p><strong>Kidney</strong></p>\n<p>Creatinine (&mu;mol/L) or urine output</p>\n</td>\n<td>&lt;110</td>\n<td>110&ndash;170</td>\n<td>171&ndash;299</td>\n<td>300&ndash;440 or &lt;500 mL/day</td>\n<td>&nbsp;&gt;440 or &lt;200 mL/day</td>\n</tr>\n<tr>\n<td colspan=\"6\">\n<p><strong>MAP =&nbsp;</strong>mean arterial pressure. <strong>Epi</strong> = epinephrine. <strong>Nonrepi</strong> = norepinephrine.&nbsp;<strong>&curren; = </strong>Adrenergic agents administered for at least 1 h (doses in&nbsp;&mu;g/kg per min).</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p1\">&nbsp;</p>\n<p class=\"p1\"><strong><span class=\"s1\">Organ dysfunction</span></strong><span class=\"s2\">&nbsp;is identified by a&nbsp;</span><strong><span class=\"s1\">SOFA score of&nbsp;&ge; 2</span></strong></p>\n<p class=\"p1\"><span class=\"s2\">A<strong>&nbsp;simplified</strong> version, recommended by the 'Sepsis 3' taskforce, is known as the </span><span class=\"s1\"><strong>quick sepsis-related organ dysfunction assessment \"qSOFA\" score</strong>.&nbsp;</span><span class=\"s2\">It includes:</span></p>\n<ul>\n<li class=\"p3\"><span class=\"s3\">Systolic BP &le;100 mmHg</span></li>\n<li class=\"p3\"><span class=\"s3\">Respiratory rate &ge; 22/min</span></li>\n<li class=\"p3\"><span class=\"s3\">Altered mentation/sensorium</span></li>\n</ul>\n<p class=\"p2\"><span class=\"s3\">Each criterion carries 1 point. A&nbsp;</span><strong><span class=\"s4\">qSOFA score of &ge; 2</span></strong><span class=\"s3\">&nbsp;is associated with&nbsp;</span><span class=\"s4\"><strong>increased mortality</strong>&nbsp;due to sepsis</span><span class=\"s3\">.</span></p>\n<p class=\"p1\"><strong><span class=\"s1\">SOFA vs qSOFA:</span></strong></p>\n<ul>\n<li class=\"p3\"><strong><span class=\"s4\">SOFA</span></strong><span class=\"s3\">&nbsp;is a more&nbsp;<strong>comprehensive</strong>&nbsp;and&nbsp;<strong>accurate</strong>&nbsp;scoring system that is&nbsp;</span><span class=\"s4\">particularly superior to&nbsp;qSOFA in the&nbsp;<strong>ICU setting.</strong></span></li>\n<li class=\"p3\"><strong><span class=\"s4\">qSOFA</span></strong><span class=\"s3\">&nbsp;is a&nbsp;<strong>simplified</strong>&nbsp;derivative of SOFA for&nbsp;<strong>bedside</strong>&nbsp;assessment that is&nbsp;</span><span class=\"s4\">particularly useful&nbsp;<strong>outside the ICU setting</strong></span><span class=\"s3\">&nbsp;(i.e. ward/emergency department).</span></li>\n</ul>\n<p class=\"p2\"><span class=\"s3\">Thereby, the best description of&nbsp;<strong>sepsis</strong>&nbsp;would be :</span></p>\n<ul>\n<li class=\"p3\"><span class=\"s3\">Suspected or documented infection with&nbsp;<strong>SOFA score &ge; 2</strong><br />OR</span></li>\n<li class=\"p3\"><span class=\"s3\">Suspected or documented infection with&nbsp;<strong>qSOFA score &ge; 2</strong></span></li>\n</ul>\n<p><span class=\"s3\">However, note that these scores were originally designed as a&nbsp;<strong>predictive tool</strong>&nbsp;that calculates the&nbsp;<strong>risk of death from sepsis</strong>&nbsp;rather than a diagnostic tool.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5563",
      "difficulty": "medium"
    },
    {
      "text": "An ophthalmological examination of a patient shows the following findings. This is likely to be the result of:",
      "choices": [
        {
          "id": 1,
          "text": "Blunt trauma to the eye causing pigment deposition"
        },
        {
          "id": 2,
          "text": "Corneal epithelial iron deposits"
        },
        {
          "id": 3,
          "text": "Intraocular deposition of copper"
        },
        {
          "id": 4,
          "text": "Age-related lipid degeneration of the cornea"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The finding given in the image is that of a <strong>Vossius ring</strong>.</p>\n<p>Vossius ring is a circular ring of faint or stippled opacity, seen on the<strong> anterior surface</strong> of the lens due to brown <strong>amorphous granules of pigment</strong> lying <strong>on the capsule of the lens</strong>. It is usually seen after <strong>blunt trauma</strong> to the eye and orbit.</p>\n<p>It usually has about the same diameter as the contracted pupil. The force of the blow drives the cornea and iris backward and thus producing an impression of the iris on the lens. The resorption of the pigment results in discrete subcapsular opacities.</p><p><strong>Corneal epithelial iron deposits</strong> are seen in <strong>keratoconus</strong> and are called <strong>Fleischer's ring</strong>. It is seen best with a cobalt blue filter. Slit-lamp examination reveals Fleischer's ring at the <strong>base of the cone</strong> formed.</p><p><strong>Intraocular deposition of copper</strong> is seen in <strong>Wilson's disease</strong> and would result in a KF ring/ <strong>Kayser-Fleischer</strong> ring on the <strong>cornea</strong>. A brownish-yellow zone is seen in the peripheral <strong>Descemet membrane</strong> of the cornea. Anterior capsular cataract, also knowns as a s<strong>unflower cataract</strong> may be seen in some patients.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/63233cf8d58149e4a2ee7c0c349043fex288x191.JPEG\" alt=\"Explanation Image\"><p>Age-related lipid degeneration of the cornea would result in <strong>Arcus lipoides/ Arcus senilis/ Gerontoxon. </strong>Arcus senilis (AS) is usually an <strong>age-related lipid degeneration</strong> of the peripheral cornea that forms a <strong>light grey or bluish ring</strong>. It is the <strong>most common peripheral corneal opacity</strong> and is usually <strong>found in the</strong> <strong>elderly</strong> where it is considered a benign condition.</p>\n<p>When AS is found in patients <strong>less than 40 years</strong> old it is termed <strong>arcus juvenilis.</strong> It represents an increased risk for cardiovascular disease and warrants screening for an underlying lipid disorder. AS is caused by leakage of lipoproteins (phospholipids and cholesterol) from limbal capillaries into the corneal stroma.</p>\n<ul>\n<li>Deposition begins at the superior and inferior aspects and progresses to encircle the entire peripheral cornea which is about 1 mm wide.</li>\n<li>The peripheral border of this ring opacity is sharp while the central border is diffuse.</li>\n<li>The exterior border of AS and the limbus is separated by a clear zone of the cornea called the <strong>interval of Vogt</strong>. (limbal sparing)</li>\n</ul><p>Noticing that the image shows the deposition within the area of the pupil, and hence indicated a likely deposition on the lens and not the cornea, would have helped rule out the other three options.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/84bdf943971a4d17a9c0bdebbec50fe4.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5540",
      "difficulty": "medium"
    },
    {
      "text": "Identify the pathology from the given flow-volume loop:",
      "choices": [
        {
          "id": 1,
          "text": "Fixed distal airway obstruction"
        },
        {
          "id": 2,
          "text": "Variable intrathoracic obstruction"
        },
        {
          "id": 3,
          "text": "Fixed central airway obstruction"
        },
        {
          "id": 4,
          "text": "Variable extrathoracic obstruction"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><span class=\"Apple-converted-space\">The graph shows airflow limitation and <strong>flattening in the expiratory limb</strong> of the loop seen in<strong> variable intrathoracic obstruction</strong>. </span></p>\n<p><span class=\"Apple-converted-space\"><strong>Variable</strong>&nbsp;(<strong>nonfixed) intrathoracic obstruction </strong>is seen in conditions like</span> bronchogenic cysts, tracheal lesions, etc.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d654d63968a24c23abee8962cbd54874x978x662.PNG\" alt=\"Explanation Image\"><p>The image below shows air flow limitation and <strong>flattening in the inspiratory limb</strong> of the loop.&nbsp;It is seen in nonfixed&nbsp;<strong>variable&nbsp;</strong><strong>extrathoracic obstruction</strong>. eg.&nbsp;vocal cord paralysis, extrathoracic tracheomalacia, polychondritis,<span class=\"Apple-converted-space\">&nbsp;etc.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9b7ff9aff2ef46e1b8363e4e90c5ac28x1279x967.JPEG\" alt=\"Explanation Image\"><p>The graph depicts&nbsp;air flow limited during <strong>both inspiration and expiration</strong> leading to flattening of both the inspiratory and expiratory limbs, which is seen in&nbsp;<strong>fixed obstruction</strong>&nbsp;of the <strong>central or upper airway</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/180c4882d8a0461fadae0c0a585288f7x600x523.JPEG\" alt=\"Explanation Image\"><p>The image given below shows a&nbsp;<strong>concave upward,</strong> pattern in the expiratory limb. This is also called the \"<strong>scooped-out\" or \"coved\"</strong> pattern. Eg.&nbsp;asthma, chronic obstructive pulmonary disease, bronchiectasis, and bronchiolitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0080bcd3ba994b41814ab15ba2ea1347x1279x967.JPEG\" alt=\"Explanation Image\"><p><strong>Saw tooth pattern</strong> of the loop&nbsp;consists of small, rapid oscillations in flow during both expiration and inspiration. It is seen in&nbsp;neuromuscular diseases, <strong>Parkinson disease</strong>, laryngeal dyskinesia, pedunculated tumors of the upper airway, tracheobronchomalacia, upper airway burns, and <strong>obstructive sleep apnea</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/09e908ecafc24f1d81969be31d69dc27x1280x1390.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Flow-volume graph/Loop</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0d448a20301a4373b39e03a726675434x1280x3207.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/eb44da00394d48c3a1d8deb4e6ddfe13.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5677",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is least likely to be seen in a patient with McArdle's disease?",
      "choices": [
        {
          "id": 1,
          "text": "Presentation in the first year of life"
        },
        {
          "id": 2,
          "text": "Exercise-induced muscle cramps"
        },
        {
          "id": 3,
          "text": "Second-Wind phenomenon"
        },
        {
          "id": 4,
          "text": "Myoglobinuria secondary to rhabdomyolysis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>McArdle disease, also known as <strong>type V</strong> glycogen storage disorder is an <strong>autosomal recessive</strong> condition. It typically presents during<strong> late childhood</strong> or in the <strong>second decade</strong> of life. The&nbsp;muscle glycogen phosphorylase enzyme deficiency interferes with ATP generation by glycogenolysis in the muscles. This causes muscle <strong>glycogen accumulation</strong>.</p>\n<p>Symptoms are <strong>exercise intolerance</strong> associated with <strong>muscle cramps</strong>. A <strong>second-wind phenomenon</strong> where the symptoms subside after a short period of rest can also be seen. <strong>Myoglobinuria</strong> secondary to<strong> rhabdomyolysis</strong> leads to the passage of <strong>burgundy-colored urine</strong> in some patients.&nbsp;</p>\n<p>Rarely, it can present during infancy as hypotonia, muscle weakness, and respiratory complications. It is generally fatal.&nbsp;<strong>Muscle biopsy</strong> to measure glycogen content is the standard diagnosis. Avoiding strenuous exercise prevents symptoms. Glucose administration before exercise can improve tolerance. <strong>Vitamin B6</strong> is also recommended.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Glycogen Storage Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p><strong>Von Gierke's disease</strong></p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierke's disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p><strong>Pompe's disease</strong></p>\n</td>\n<td>\n<p>Lysosomal &alpha;1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~ 2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p><strong>Cori's/Forbes disease</strong></p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched-chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n<p>Normal lactate and uric acid levels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p><strong>Andersen disease</strong></p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharides with few branch points</p>\n<p>Death at age ~ 5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p><strong>McArdle disease</strong></p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p><strong>Her's disease</strong></p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p><strong>Tarui's disease</strong></p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5483",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old man presents to the ENT OPD with complaints of recent onset right-sided hearing loss and tinnitus. On investigation, he was found to have a mass in his brain as shown below. Histological examination of the mass is likely to show all of the following features, except:",
      "choices": [
        {
          "id": 1,
          "text": "Bag of worms appearance"
        },
        {
          "id": 2,
          "text": "Antoni A regions"
        },
        {
          "id": 3,
          "text": "Antoni B areas"
        },
        {
          "id": 4,
          "text": "Verocay bodies"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The MRI scan image shows a tumor arising at the <strong>cerebellopontine angle</strong>. The most likely diagnosis based on the image and the clinical features of unilateral hearing loss and tinnitus would be <strong>vestibular schwannoma</strong>. A <strong>bag&nbsp;of worms appearance</strong> is seen in the case of <strong>plexiform neurofibroma </strong>and not vestibular schwannoma.&nbsp;They are a result of the expanded, ropy thickening of multiple nerve fascicles.</p>\n<p>Vestibular schwannomas are commonly known as&nbsp;<strong>acoustic neuromas.&nbsp;</strong>The term vestibular schwannoma is preferred as these tumors most frequently arise from the vestibular portion of the vestibulocochlear nerve and arise from Schwann cells.</p>\n<p>Vestibular schwannomas are the most common&nbsp;<strong>cerebellopontine angle tumors.</strong>&nbsp;Bilateral vestibular schwannomas are highly suggestive of neurofibromatosis type 2.</p>\n<p>Clinical features: Patients present with adult-onset sensorineural hearing loss, with non-pulsatile tinnitus. There is no relationship between the size of the tumor and the degree of hearing loss.&nbsp;</p>\n<p>Microscopically, they are compromised of dense and loose areas called &lsquo;<strong>Antoni A</strong>&rsquo; and &lsquo;<strong>Antoni B</strong>&rsquo; respectively.&nbsp;<strong>Antoni A</strong>&nbsp;is a&nbsp;<strong>dense</strong>&nbsp;eosinophilic area containing spindle cells with rod-shaped nuclei lying in the palisading pattern. The resulting structures with central &lsquo;nuclear-free zones&rsquo; ratified by the palisading of nuclei are termed &lsquo;<strong>verocay bodies</strong>&rsquo;.&nbsp; The&nbsp;<strong>loose</strong>&nbsp;hypocellular&nbsp;<strong>Antoni B&nbsp;</strong>area contains spindle cells spread apart by the myxoid extracellular matrix.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed53323cfa5a466f92f2f6f4d61ea8efx720x540.JPEG\" alt=\"Explanation Image\"><p>Diagnosis: MRI is the imaging technique of choice.&nbsp;High-resolution T2-weighted imaging is the most commonly used sequence.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/eab9b648cc154c4cbea9fbfef2845e64.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5545",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is a Y-shaped ligament that connects the calcaneum to the cuboid and navicular bone?",
      "choices": [
        {
          "id": 1,
          "text": "Lisfranc"
        },
        {
          "id": 2,
          "text": "Spring"
        },
        {
          "id": 3,
          "text": "Chopart"
        },
        {
          "id": 4,
          "text": "Deltoid"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Chopart's ligament</strong> is a Y-shaped ligament related to both <strong>calcaneocuboid </strong>and<strong> calcaneonavicular joints</strong>. It is a strong <strong>Y-shaped</strong> band, having a proximal stem and 2 distal limbs.</p>\n<ul>\n<li>The proximal limb is attached by a stem to the anterior part of the upper calcaneal surface.</li>\n<li>The distal limb divides into calcaneocuboid and calcaneonavicular parts.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/55e45b5aab1f4f3bbc769da6c8803aa2x1279x1358.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: The<strong> Lisfranc ligament</strong> connects the <strong>medial cuneiform</strong> to the <strong>base</strong> of the <strong>2nd metatarsal</strong>. It is a <strong>cuneometatarsal interosseous ligament. </strong>It is the <strong>strongest ligament</strong> <strong>among</strong> the <strong>three cuneometatarsal interosseous</strong> <strong>ligaments</strong>. It passes from the lateral surface of the medial cuneiform to the adjacent angle of the second metatarsal bone. </p>\n<p><strong>Deformity</strong> of this ligament can lead to instability and deformity of<strong> </strong>the<strong> tarsometatarsal</strong> joint.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1d8cd5b36a0f434599c4d9abc480060bx1280x1708.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>Option B: <strong>Spring ligament</strong>, also known as the <strong>plantar calcaneonavicular </strong>ligament, connects the <strong>sustentaculum tali</strong> to the <strong>navicular. </strong>It ties the calcaneus to the navicular and maintains the medial longitudinal arch of the foot. It is made up of the superomedial calcaneonavicular portion and the inferior calcaneonavicular portion.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/302ca308fbc141279e03136f31af2701x1280x1519.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>Option D: <strong>Deltoid ligament</strong> also called the <strong>medial collateral ligament </strong>is attached to the apex, anterior and posterior borders of the <strong>medial malleolus. </strong>It has 2 layers, superficial and deep:</p>\n<ul>\n<li>The<strong> superficial </strong>layer consists of tibionavicular fibers anteriorly, tibiocalcaneal fibers in the middle, and superficial posterior tibiotalar fibers posteriorly.</li>\n<li>The <strong>deep </strong>layer consists of anterior tibiotalar fibers, tibiocalcaneal in the middle, and deep posterior tibiotalar posteriorly.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a4440720c5b8443784ed3184692d18e9x1280x2558.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Named fractures of the lower limb</h3><table>\n<tbody>\n<tr>\n<td><strong>Fracture</strong></td>\n<td><strong>Location</strong></td>\n</tr>\n<tr>\n<td>Hoffa fracture</td>\n<td>Coronal fracture of femoral condyles</td>\n</tr>\n<tr>\n<td>Bumper fracture</td>\n<td>Comminuted fracture of lateral condyle of tibia&nbsp;</td>\n</tr>\n<tr>\n<td>Pilon fracture</td>\n<td>Comminuted intra-articular fracture of the distal end of the tibia&nbsp;</td>\n</tr>\n<tr>\n<td>Tillaux fracture</td>\n<td>Avulsion fracture of the tibia by the anterior tibiofibular ligament</td>\n</tr>\n<tr>\n<td>Runner's fracture</td>\n<td>Fracture of the distal shaft of fibula&nbsp;</td>\n</tr>\n<tr>\n<td>Pott&rsquo;s fracture</td>\n<td>Bimalleolar ankle fracture</td>\n</tr>\n<tr>\n<td>Cotton&rsquo;s fracture</td>\n<td>Trimalleolar ankle fracture</td>\n</tr>\n<tr>\n<td>Aviator's fracture</td>\n<td>Fracture of neck of talus</td>\n</tr>\n<tr>\n<td>Chopart&rsquo;s fracture</td>\n<td>Fracture between talonavicular and calcaneocuboid joints&nbsp;</td>\n</tr>\n<tr>\n<td>Lisfranc&rsquo;s fracture-dislocation</td>\n<td>Fracture of metatarsal bases with associated tarsometatarsal dislocation</td>\n</tr>\n<tr>\n<td>March fracture</td>\n<td>Fracture of the neck of 2<sup>nd</sup> or 3<sup>rd</sup> metatarsal</td>\n</tr>\n<tr>\n<td>Jone's fracture</td>\n<td>\n<p>Extra-articular fracture at the base of the 5th metatarsal</p>\n</td>\n</tr>\n<tr>\n<td>Dancer&rsquo;s fracture</td>\n<td>Fracture of distal shaft of the fifth metatarsal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: List of Names of Amputations and Their Levels</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>TYPE</strong><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>LEVEL OF AMPUTATION</strong><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lisfranc</p>\n</td>\n<td>\n<p>Tarsometatarsal joint<strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chopart&nbsp;</p>\n</td>\n<td>\n<p>Transverse tarsal joints&nbsp;(articulation of calcaneus with cuboid and talus with navicular)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pirogoff</p>\n</td>\n<td>\n<p>Calcaneum is rotated forward to be fused with tibia after vertical section through its middle&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syme&nbsp;</p>\n</td>\n<td>\n<p>Distal tibia &amp; fibula 0.6 cm proximal to the periphery of ankle joint passing through the dome of the ankle. Involves removal of both medial and lateral malleoli.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Boyd&nbsp;</p>\n</td>\n<td>\n<p>Talectomy, forward shift of the calcaneus and calcaneo-tibial arthrodesis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sarmiento&nbsp;</p>\n</td>\n<td>\n<p>Distal tibia and fibula: 1.3 cm proximal to the ankle joint and excision of medial and lateral malleoli&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/09ec2c4f725f4f2d8c8ee1d692677ae6x1280x1153.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5598",
      "difficulty": "hard"
    },
    {
      "text": "A 5-year-old child who has never received a vaccination for pertussis is brought by her parents. As per the IAP guidelines, what should you advise?",
      "choices": [
        {
          "id": 1,
          "text": "Tdap, Td, and Td at 0, 1, and 6 months"
        },
        {
          "id": 2,
          "text": "DTwP/DTaP at 0, and 6 months"
        },
        {
          "id": 3,
          "text": "DTwP/DTaP at 0, 1, and 6 months"
        },
        {
          "id": 4,
          "text": "Tdap, and Td at 0, and 6 months"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>DTwP/DTaP at 0, 1, and 6 months</strong> is advised for<strong> catch-up</strong> vaccination in children <strong>below 7 years</strong> of age. </p>\n<p><strong>DPT</strong> is a combined vaccine given for immunization against the three diseases: diphtheria, pertussis, and tetanus.</p>\n<p><strong>Routine</strong> vaccination:</p>\n<ul>\n<li><strong>Three primary doses at 6, 10, and 14 weeks</strong> and <strong>two boosters</strong> at 15–18 months and 4–5 years</li>\n<li>Minimum age: 6 weeks</li>\n<li>The first booster (4th dose) may be administered as early as age 12 months, provided at least 6 months have elapsed since the third dose</li>\n<li>DTaP or DTwP vaccine/combination may be used for the primary immunization series</li>\n</ul>\n<p> Catch-up vaccination:</p>\n<ul>\n<li>The second childhood booster is not required if the last dose has been given beyond the age of 4 years</li>\n<li><strong>Catch up below 7 years:</strong> DTwP/DTaP at 0, 1, and 6 months</li>\n<li>Catch up above 7 years: Tdap, Td, and Td at 0, 1, and 6 months</li>\n</ul>\n<p> </p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5501",
      "difficulty": "medium"
    },
    {
      "text": "Arrange the following insulin preparations in ascending order of their respective duration of action.<div class='question-desc-html'><ol>\n<li>Degludec</li>\n<li>Glargine</li>\n<li>Affrezza</li>\n<li>Aspart</li>\n<li>Regular</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3-5-4-1-2"
        },
        {
          "id": 2,
          "text": "4-2-5-3-1"
        },
        {
          "id": 3,
          "text": "3-4-5-2-1"
        },
        {
          "id": 4,
          "text": "4-5-2-3-1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The insulin preparations in <strong>ascending order</strong> of their respective <strong>duration of action</strong> are as follows:</p>\n<ol>\n<li>Afrezza</li>\n<li>Aspart</li>\n<li>Regular</li>\n<li>Glargine</li>\n<li>Degludec</li>\n</ol>\n<table>\n<tbody>\n<tr>\n<td>\n<p class=\"p1\">Preparation</p>\n</td>\n<td>\n<p class=\"p1\">Onset (h)</p>\n</td>\n<td>\n<p class=\"p1\">Peak (h)</p>\n</td>\n<td>\n<p class=\"p1\">Effective Duration (h)</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">Short-acting   </td>\n</tr>\n<tr>\n<td>\n<p> </p>\n<ul>\n<li><strong>Aspart</strong></li>\n<li>Glulisine</li>\n<li>Lispro</li>\n</ul>\n</td>\n<td>\n<p class=\"p1\">&lt;0.25</p>\n</td>\n<td>\n<p class=\"p1\">0.5–1.5</p>\n</td>\n<td>\n<p class=\"p1\"><strong>3–4</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Regular</strong></p>\n</td>\n<td>\n<p class=\"p1\">0.5–1.0</p>\n</td>\n<td>\n<p class=\"p1\">2–3</p>\n</td>\n<td>\n<p class=\"p1\"><strong>4–6</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">Long-acting</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Detemir</p>\n</td>\n<td rowspan=\"3\"> \n<p class=\"p1\">1–4</p>\n</td>\n<td rowspan=\"3\"> Minimal peak activity at steady state</td>\n<td>\n<p class=\"p1\">12–20</p>\n</td>\n</tr>\n<tr>\n<td><strong>Glargine</strong></td>\n<td><strong> 12–24</strong></td>\n</tr>\n<tr>\n<td><strong>Degludec</strong></td>\n<td><strong> 24–42</strong></td>\n</tr>\n<tr>\n<td>NPH</td>\n<td> 1–2</td>\n<td> 6–10</td>\n<td> 10–16</td>\n</tr>\n<tr>\n<td colspan=\"4\">Insulin combinations</td>\n</tr>\n<tr>\n<td> \n<p class=\"p1\">Mixture:</p>\n<p class=\"p1\">Short-acting (25%–50%) and Long acting (50%–76%)</p>\n</td>\n<td> &lt;0.25–1.0</td>\n<td> Depends on preparation</td>\n<td> Up to 10–16</td>\n</tr>\n<tr>\n<td colspan=\"4\">Inhaled insulin</td>\n</tr>\n<tr>\n<td><strong>Afrezza</strong></td>\n<td>&lt;0.25</td>\n<td>0.5–1.5</td>\n<td><strong>2–3</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>A graphical plot of various preparations of insulin vs time is as follows:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c5a000b0a75e4c4387bf23f0c11b5725x720x854.PNG\" alt=\"Explanation Image\"><table>\n<tbody>\n<tr>\n<td>Yellow curve</td>\n<td>NPH insulin</td>\n</tr>\n<tr>\n<td>Red curve</td>\n<td>Insulin Aspart  </td>\n</tr>\n<tr>\n<td>Green curve</td>\n<td>Insulin glargine  </td>\n</tr>\n<tr>\n<td>Dotted blue curve</td>\n<td>Regular insulin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p><strong>Panel A</strong> shows the administration of long-acting Insulin glargine (green curve) to provide basal insulin and a premeal short-acting insulin analog (red curve).</p>\n<p><strong>Panel B</strong> shows a twice-daily injection of NPH insulin providing basal insulin (yellow curve) and regular insulin (dotted curve) or insulin analog (red curve) providing mealtime insulin coverage. Note that only one type of short-acting insulin would be used.</p>\n<p>The insulin level attained following subcutaneous insulin (short-acting insulin analog) by an <strong>insulin pump</strong> programmed to deliver different basal rates would appear as below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3600afa8b9b5452e9ec20f692fbf0ed7x1279x884.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Insulin Classification According to Duration of Action</h3><p><strong>Inhaled insulin&nbsp;(2-3 hours)</strong></p>\n<ul>\n<li>Afrezza&nbsp;</li>\n</ul>\n<p><strong>Rapid acting (3-4 hours)</strong></p>\n<ul>\n<li>Aspart</li>\n<li>Glulisine</li>\n<li>Lispro</li>\n</ul>\n<p><strong>Short acting&nbsp;(6-8 hours)</strong></p>\n<ul>\n<li>Regular</li>\n</ul>\n<p><strong>Intermediate acting (10-16 hours)</strong></p>\n<ul>\n<li>NPH</li>\n<li>Lente</li>\n</ul>\n<p><strong>Long acting&nbsp;(12-24 hours)</strong></p>\n<ul>\n<li>Detemir</li>\n<li>Glargine</li>\n<li>Degludec <strong>(24-42 hours)</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5491",
      "difficulty": "medium"
    },
    {
      "text": "An association between ordinal position on one ranking and ordinal position on another ranking can be determined by which of the following techniques?",
      "choices": [
        {
          "id": 1,
          "text": "Chi-square test"
        },
        {
          "id": 2,
          "text": "Paired t-test"
        },
        {
          "id": 3,
          "text": "ANOVA"
        },
        {
          "id": 4,
          "text": "Spearman's rank-order correlation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p1\"><strong>Spearman's rank-order correlation </strong>is used to determine the <strong>association between</strong> <strong>ordinal</strong> <strong>position</strong> on one ranking and ordinal position on another ranking.</p>\n<p class=\"p1\">It is one of the two most commonly used correlation coefficients. It is used for <strong>ordinal scale data</strong>. The other one is <strong>Pearson product-moment correlation</strong>, which is used for <strong>interval or ratio scale data.</strong></p>\n<p>The <strong>Chi-Square test (χ<sup>2</sup>)</strong> is a non-parametric (non-numeric) test,<strong> </strong>and it is used to test hypotheses in relation to <strong>nominal scale data or categorical data.</strong></p>\n<ul>\n<li>It is a test of proportions and associations.</li>\n<li>A Chi-square distribution is usually<strong> positively skewed, </strong>but it approaches a normal distribution as its degrees of freedom increase.</li>\n<li>If the frequency of any of the cells of the categorical table is&lt;5, then <strong>Fisher’s exact test</strong> is used.</li>\n</ul>\n<p>A<strong> paired t-test</strong> compares paired data, or pre-intervention and post-intervention data, of the same group.</p>\n<p>The analysis of variance test (<strong>ANOVA)</strong> is used to test the difference between two or usually<strong> more than two groups (means), </strong>and here, the inferences are made by analyzing the variances.</p><hr><h3>Related Pearl: Scales of data measurement</h3><p>Data can be <strong>quantitative</strong> (numerical values) or <strong>qualitative</strong> (types, labels).</p>\n<p>Quantitative data can be <strong>discrete variables </strong>or<strong> continuous variables.</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p>Description</p>\n</td>\n<td>\n<p>Example</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Discrete data</strong></p>\n</td>\n<td>\n<p>Can take&nbsp;<strong>certain values and none in between</strong></p>\n</td>\n<td>\n<p>Number of cancer patients in a hospital.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Continuous data</strong></p>\n</td>\n<td>\n<p>Can <strong>take any value </strong>usually in between limits or a range.&nbsp;</p>\n</td>\n<td>\n<p>Most biomedical data is continuous.</p>\n<p>Height, weight, blood pressure, etc.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Data always forms one of four <strong>scales of measurement</strong> &ndash; <strong>nominal, ordinal, interval, or ratio</strong> scales (mnemonic: <strong>NOIR):</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Nominal Scale Data</strong></p>\n</td>\n<td>\n<p><strong>Ordinal Scale Data</strong></p>\n</td>\n<td>\n<p><strong>Interval Scale Data</strong></p>\n</td>\n<td>\n<p><strong>Ratio Scale Data</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Example</p>\n</td>\n<td>\n<p>Male/female; red/green; sub-urban/rural</p>\n</td>\n<td>\n<p>Students ranked 1st/2nd/3rd in their class.&nbsp;</p>\n<p>A customer feedback survey using terms like very good, good, poor and very poor or the <strong>Likert Scale.</strong></p>\n<p>Severity of a disease as mild, moderate, severe</p>\n<p>&nbsp;</p>\n</td>\n<td>Measurements on the celsius scale.</td>\n<td>Pulse rate;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Notes</p>\n</td>\n<td>\n<p>Have <strong>no quantitative value</strong>.</p>\n<p>They have no order or ratio.&nbsp;</p>\n</td>\n<td>\n<p>Arranged in a <strong>meaningful order.</strong></p>\n<p><strong>No size interval is defined</strong></p>\n</td>\n<td>\n<p>Arranged in a <strong>meaningful order </strong>with a<strong> well defined size interval</strong>.</p>\n<p>Example: Temperature in Celsius. If temperature in A is 40 deg Celsius and that in B is 20 deg Celsius, then A is 20 deg Celsius hotter than B (taking difference)</p>\n<p><strong>Does not have an absolute zero.</strong></p>\n<p>For example, Celsius scale has no such thing as &ldquo;no temperature&rdquo;. So the value cannot be zero.</p>\n</td>\n<td>\n<p>Arranged in a <strong>meaningful order </strong>with a<strong> well defined size interval</strong>.</p>\n<p>Eg: A pulse rate has well defined intervals and is meaningful in comparison. A 100/min pulse is exactly twice of 50 beats/min.</p>\n<p>&nbsp;</p>\n<p><strong>Has an absolute zero.</strong></p>\n<p>Eg: There can be a value of zero for pulse.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type</p>\n</td>\n<td>\n<p><strong>Qualitative</strong></p>\n</td>\n<td>\n<p><strong>Qualitative</strong></p>\n</td>\n<td>\n<p><strong>Quantitative</strong></p>\n</td>\n<td>\n<p><strong>Quantitative</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5504",
      "difficulty": "medium"
    },
    {
      "text": "A 59-year-old patient presents with right-sided nasal obstruction and occasional blood-stained nasal discharge. His CT and endoscopy findings are shown in the image below. What is the treatment of choice for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Medial maxillectomy"
        },
        {
          "id": 2,
          "text": "Endoscopic Polypectomy and FESS"
        },
        {
          "id": 3,
          "text": "Podophyllin application"
        },
        {
          "id": 4,
          "text": "Radiotherapy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>On the basis of the given images and the presenting history,<strong> inverted papilloma</strong> is the most likely diagnosis. The <strong>treatment of choice</strong> for inverted papilloma is <strong>medial maxillectomy.</strong></p>\n<p><span class=\"word\"><strong>Inverted papilloma</strong> (Ringertz tumor or transitional cell papilloma or&nbsp;Schneiderian papilloma) is</span> <span class=\"word\">a</span><strong>&nbsp;benign</strong> neoplasm&nbsp;<span class=\"word\">of</span> <span class=\"word\">the</span> <span class=\"word\">non-olfactory</span> <span class=\"word\">mucosa</span> <span class=\"word\">of the&nbsp;</span><span class=\"word\">nose</span> <span class=\"word\">(also called the <strong>Schneiderian</strong></span> <span class=\"word\"><strong>membrane</strong>)</span> <span class=\"word\">and</span> <span class=\"word\">paranasal</span> <span class=\"word\">sinuses.</span></p>\n<div class=\"parent-word\" data-transform-scale-x=\"1.1854041257827435\" data-canvas-width=\"332.0503333333334\"><span class=\"word\">The</span><strong><span class=\"word\"> lateral</span> <span class=\"word\">wall</span></strong> <span class=\"word\">of</span>&nbsp;the&nbsp;<span class=\"word\">nose</span> <span class=\"word\">in</span> <span class=\"word\">the&nbsp;</span><span class=\"word\">middle</span> <span class=\"word\">meatus is t</span>he most&nbsp;<span class=\"word\">common</span> <span class=\"word\">site</span> <span class=\"word\">of</span> <span class=\"word\">origin</span><span class=\"word\">. T</span><span class=\"word\">he</span> <span class=\"word\">hyperplastic</span> <span class=\"word\">papillomatous</span> <span class=\"word\">tissue&nbsp;</span><span class=\"word\">grows</span> <span class=\"word\">into</span> <span class=\"word\">the</span> <span class=\"word\">stroma</span><span class=\"word\">.</span></div>\n<div class=\"parent-word\" data-transform-scale-x=\"1.1854041257827435\" data-canvas-width=\"332.0503333333334\"><span class=\"word\">It is common in the 4<sup>th</sup> to 7<sup>th</sup> decades of life with a male preponderance. It</span> <span class=\"word\">is</span> <span class=\"word\">almost&nbsp;</span><span class=\"word\">always</span><strong> <span class=\"word\">unilateral</span></strong> <span class=\"word\">and</span> <span class=\"word\">presents</span> <span class=\"word\">with unilateral</span> <span class=\"word\">nasal</span> <span class=\"word\">obstruction,&nbsp;</span><span class=\"word\">nasal</span> <span class=\"word\">discharge,&nbsp;</span><span class=\"word\">and</span> <span class=\"word\">epistaxis.&nbsp;</span><span class=\"word\">It</span> <span class=\"word\">can</span> <span class=\"word\">invade</span> <span class=\"word\">sinuses</span> <span class=\"word\">or the orbit, the latter of which</span>&nbsp;<span class=\"word\">causes</span> <span class=\"word\">proptosis,</span> <span class=\"word\">diplopia,&nbsp;</span><span class=\"word\">and&nbsp;</span><span class=\"word\">lacrimation.</span></div>\n<div class=\"parent-word\" data-transform-scale-x=\"1.1854041257827435\" data-canvas-width=\"332.0503333333334\">&nbsp;</div>\n<div class=\"parent-word\" data-transform-scale-x=\"1.1854041257827435\" data-canvas-width=\"332.0503333333334\"><span class=\"word\">On</span> <span class=\"word\">examination</span> <span class=\"word\">of</span> <span class=\"word\">nose</span> <span class=\"word\">or</span> <span class=\"word\"><strong>endoscopy</strong>,</span> <span class=\"word\">it</span> <span class=\"word\">presents</span> <span class=\"word\">as</span> <span class=\"word\">a&nbsp;</span><strong><span class=\"word\">polypoidal</span> <span class=\"word\">mass</span></strong> <span class=\"word\">resembling</span> <span class=\"word\">simple</span> <span class=\"word\">nasal</span> <span class=\"word\">polyps</span><span class=\"word\">, as depicted by arrows in the endoscopic image above. A</span>&nbsp;<strong>computed tomography(CT)</strong><span class=\"word\">&nbsp;scan and/or</span>&nbsp;magnetic resonance imaging(MRI) show&nbsp;<span class=\"word\">the</span> <strong><span class=\"word\">location</span> <span class=\"word\">and</span> <span class=\"word\">extent</span></strong> <span class=\"word\">of</span> <span class=\"word\">the</span> <span class=\"word\">le</span><span class=\"word\">sion.</span> <span class=\"word\">MRI</span> <span class=\"word\">provides additional</span> <span class=\"word\">help&nbsp;</span><span class=\"word\">to</span> <span class=\"word\">differentiate</span> <span class=\"word\">associated</span> <span class=\"word\">secretions&nbsp;</span><span class=\"word\">in</span>&nbsp;the&nbsp;<span class=\"word\">sinus</span> <span class=\"word\">from</span> <span class=\"word\">the</span> <span class=\"word\">actual</span> <span class=\"word\">tumor</span> <span class=\"word\">mass.</span>&nbsp;A <strong>biopsy</strong>&nbsp;<span class=\"word\">is</span> <span class=\"word\">essential&nbsp;</span><span class=\"word\">for</span> <span class=\"word\">diagnosis.</span></div>\n<div class=\"parent-word\" data-transform-scale-x=\"1.1854041257827435\" data-canvas-width=\"332.0503333333334\">&nbsp;</div>\n<div class=\"parent-word\" data-transform-scale-x=\"1.1854041257827435\" data-canvas-width=\"332.0503333333334\"><strong><span class=\"word\">Medial</span> <span class=\"word\">maxillectomy</span></strong> <span class=\"word\">is</span> <span class=\"word\">the</span> <strong><span class=\"word\">treatment&nbsp;</span><span class=\"word\">of</span> </strong><span class=\"word\"><strong>choice</strong>, done preferably via endoscopy.<strong>&nbsp;</strong></span><span class=\"word\"><strong>Recurrence</strong> is common and malignancy has been observed in up to 15% of the cases. <strong>Radiotherapy</strong> may<strong> induce malignancy</strong> and hence is <strong>not advised.</strong></span></div>\n<div class=\"parent-word\" data-transform-scale-x=\"1.1854041257827435\" data-canvas-width=\"332.0503333333334\">&nbsp;</div>\n<div class=\"parent-word\" data-transform-scale-x=\"1.302474000495019\" data-canvas-width=\"322.31100000000015\">&nbsp;</div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e853ec0cc3d14e96b406551966d748a1.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5544",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following drugs is ineffective for the management of infection with Pseudomonas aeruginosa?",
      "choices": [
        {
          "id": 1,
          "text": "Ceftazidime"
        },
        {
          "id": 2,
          "text": "Cefixime"
        },
        {
          "id": 3,
          "text": "Ceftolozane"
        },
        {
          "id": 4,
          "text": "Cefepime"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Cefixime</strong> does <strong>not possess antipseudomonal activity</strong>. </p>\n<p><strong>Antipseudomonal cephalosporins</strong> include <strong>ceftazidime, ceftolozane, cefepime</strong>, and <strong>cefpirome</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td>Drug Class</td>\n<td>Antibacterial spectrum</td>\n</tr>\n<tr>\n<td>\n<p><strong>First generation</strong> :</p>\n<p>Cefazolin, cephalexin, cefadroxil, cephradine</p>\n</td>\n<td>Streptococci; <em>Staphylococcus aureus</em>, some <em>Proteus </em>spp., <em>E. coli</em>, <em>Klebsiella</em> </td>\n</tr>\n<tr>\n<td>\n<p><strong>Second generation</strong> :</p>\n<p>Cefuroxime</p>\n<p>Cefuroxime axetil</p>\n<p>Cefprozil</p>\n<p>Cefoxitin</p>\n<p>Cefotetan</p>\n<p>Cefmetazole </p>\n</td>\n<td><em>Escherichia coli, Klebsiella, Proteus, Haemophilus influenzae, Moraxella catarrhalis</em>. <strong>Not as active against</strong> <strong>gram-positive organisms </strong>as first-generation agents.   Inferior activity against <em>S. aureus</em> compared to cefuroxime but with <strong>added activity </strong>against <em>Bacteroides fragilis</em> and other <em>Bacteroides</em> spp. </td>\n</tr>\n<tr>\n<td>\n<p><strong>Third generation</strong></p>\n<p>Cefotaxime</p>\n<p>Ceftriaxone</p>\n<p>Cefdinir</p>\n<p>Cefditoren pivoxil</p>\n<p>Ceftibuten</p>\n<p>Cefpodoxime proxetil</p>\n<p>Ceftizoxime </p>\n</td>\n<td><em>Escherichia coli, Klebsiella, Proteus, Haemophilus influenzae, Moraxella catarrhalis, Citrobacter, Enterobacter; Serratia; Neisseria gonorrhoeae;</em>  Activity for <em>S. aureus, Streptococcus pneumoniae,</em> and <em>Streptococcus pyogenes</em> comparable to first-generation agents.  Activity against <em>Bacteroides</em> spp. inferior to that of cefoxitin and cefotetan. </td>\n</tr>\n<tr>\n<td>\n<p><strong>Antipseudomonal-</strong>Cephalosporins </p>\n<p>Ceftazidime  </p>\n<p>Ceftazidime/avibactam   </p>\n<p>Ceftolozane/tazobactam</p>\n<p>Cefepime </p>\n</td>\n<td>  Gram-negative activity similar to that of the third generation, with addition of activity against <em><strong>Pseudomonas</strong></em>; poor activity against gram-positive organisms.   Expands ceftazidime’s activity against <em>Pseudomonas</em> and multidrug-resistant Enterobacteriaceae, but not against gram-positives.   Similar to ceftazidime, with enhanced activity against <em>Pseudomonas</em> and extended-spectrum β-lactamase-producing <em>Enterobacteriaceae</em>.   Comparable to third generation but <strong>more resistant to some β-lactamases </strong>(especially those of <em>Pseudomonas</em> and <em>Enterobacter</em>); gram-positive activity similar to cefotaxime. </td>\n</tr>\n<tr>\n<td>\n<p><strong>Anti-MRSA-</strong>Cephalosporins </p>\n<p>Ceftaroline</p>\n<p>Ceftobiprole </p>\n</td>\n<td>   Similar activity to third generation but with activity against methicillin-resistant <em>Staphylococcus aureus</em> </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: The FDA has approved <strong>cefepime-enmetazobactam</strong>, a combination of a fourth-generation cephalosporin and beta-lactamase inhibitor for use in <strong>complicated UTI</strong>s (including pyelonephritis).</p><hr><h3>Related Pearl: Methicillin-Resistant Staphylococcus aureus (MRSA)</h3><p><strong>MRSA Definition</strong>: <strong>Methicillin</strong> MIC 8 &mu;g/ml or more, <strong>Oxacillin</strong> MIC 4 &mu;g/ml or more.</p>\n<p>Resistance in MRSA is mediated by <strong>mecA gene</strong> which is <strong>chromosomally coded</strong>. It alters <strong>PBP (penicillin-binding protein)</strong> present on S.aureus cell wall to <strong>PBP-2a</strong> which has less affinity for beta-lactam antibiotics.</p>\n<p>Penicillin Binding Protein:</p>\n<ul>\n<li>Normal protein present in all bacterial cell wall.</li>\n<li><strong>Transpeptidase</strong> in nature.</li>\n<li>Required for cross-linking of the peptidoglycan layer (essential for cell wall synthesis).</li>\n<li>It is also the site of attachment for- beta-lactam drugs to bind &amp; inhibit.</li>\n</ul>\n<p>Types of MRSA:</p>\n<ul>\n<li><strong>Community-acquired&nbsp;</strong>- mediated by <strong>mec A subtype IV</strong> and Possess <strong>PV Toxin(Panton-Valentine Toxin)</strong>, monodrug resistance,more virulent</li>\n<li><strong>Hospital-acquired</strong> - mediated by <strong>mec A subtype I, II, III</strong>, multidrug resistance,less virulent.</li>\n</ul>\n<p>Detection of MRSA:</p>\n<ul>\n<li>Antibiotic susceptibility test on <strong>Muller Hilton agar</strong> <strong>(Disk diffusion test)</strong> by using Methicillin or Oxacillin disc or cefoxitin disc.</li>\n<li><strong>PCR</strong> for detection of mecA gene.</li>\n</ul>\n<p>Treatment:</p>\n<ul>\n<li><strong>Vancomycin</strong> is Drug Of Choice (should be used only if other drugs are resistant ).</li>\n<li>Others- Teicoplanin, Linezolid, streptogramin, cipro/levofloxacin, cotrimoxazole, clindamycin, mupirocin, minocycline.</li>\n<li><strong>Newer Drugs</strong> &ndash; Daptomycin, <strong>ceftobiprole</strong>, tigecycline, oritavancin, dalbavancin, telavancin, delafloxacin.</li>\n<li><strong>Ceftobiprole </strong>and<strong> ceftaroline </strong>are 5th generation &beta; lactams effective against MRSA.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5582",
      "difficulty": "medium"
    },
    {
      "text": "What is the unit of study in a cohort study?",
      "choices": [
        {
          "id": 1,
          "text": "Individuals"
        },
        {
          "id": 2,
          "text": "Patients"
        },
        {
          "id": 3,
          "text": "Healthy people"
        },
        {
          "id": 4,
          "text": "Community"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cohort</strong> studies have <strong>individuals</strong> as the <strong>unit of study.</strong></p>\n<p>Types of epidemiological studies:</p>\n<ul>\n<li><strong>Observational studies -</strong>&nbsp;allow nature to take its own course, the investigator measures but does not intervene.\n<ol>\n<li><strong>Descriptive</strong> studies - limited to the description of the occurrence of a disease in a population.</li>\n<li><strong>Analytical</strong> studies - go further by analyzing the relationship between health status and other variables.\n<ul>\n<li>Ecological studies</li>\n<li>Cross-sectional studies</li>\n<li>Case-control studies</li>\n<li><strong>Cohort studies</strong></li>\n</ul>\n</li>\n</ol>\n</li>\n</ul>\n<p><strong>All analytical studies</strong> have <strong>individuals</strong> as the <strong>unit of study,&nbsp;</strong>except <strong>ecological study</strong> which has <strong>population</strong> as the unit of study.</p>\n<ul>\n<li><strong>Experimental studies</strong> or <strong>intervention</strong> studies involve an active attempt to change a disease determinant or the progress of a disease and are similar in design to experiments in other sciences.\n<ol>\n<li>Randomized controlled trials(<strong>RCT</strong>) - <strong>Patients</strong> are the unit of study</li>\n<li><strong>Field trials</strong> - <strong>healthy people</strong> are the unit of study</li>\n<li><strong>Community trials</strong>&nbsp;- <strong>Community</strong> is the unit of study &nbsp;</li>\n</ol>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5499",
      "difficulty": "medium"
    },
    {
      "text": "Arrange right lung hilar structures from superior to inferior.<div class='question-desc-html'><ol>\n<li>Superior lobar bronchus</li>\n<li>Pulmonary artery</li>\n<li>Principal bronchus</li>\n<li>Inferior pulmonary vein </li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3,4,1,2"
        },
        {
          "id": 2,
          "text": "2,3,4,1"
        },
        {
          "id": 3,
          "text": "1,2,3,4"
        },
        {
          "id": 4,
          "text": "4,3,2,1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>right lung hilar structures</strong> from superior to inferior<strong>:</strong></p>\n<ul>\n<li>Superior lobar bronchus</li>\n<li>Pulmonary artery</li>\n<li>Principal bronchus</li>\n<li>Inferior pulmonary vein</li>\n</ul>\n<p>The medial surface of the lung is connected to the heart and trachea by a group of structures that enter or leave the hilum. It is called the <strong>pulmonary root. </strong><span>It is anteriorly related to the phrenic nerve, pericardiacophrenic vessels, and anterior pulmonary plexus. The vagus nerve and posterior pulmonary plexus form the posterior relation and the pulmonary ligament the inferior relation. </span></p>\n<p>The <strong>superior vena cava</strong> and <strong>right atrium</strong> are seen in front of the<strong> </strong>right root and terminal part of the azygos vein superiorly.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1ae9ea328d594637a44d5b888a7bea14x1280x1175.JPEG\" alt=\"Explanation Image\"><p>The <strong>aortic arch</strong> is seen superiorly and <strong>descending thoracic aorta</strong> posteriorly of the <strong>left root</strong>. The left hilar structures are vertically arranged as:</p>\n<ul>\n<li>Pulmonary artery</li>\n<li>Principal bronchus</li>\n<li>Inferior pulmonary vein</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3e24c3fff25348ebaf63810389c5ed00x1200x1125.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Structures related to the mediastinal surface and hilum of the lungs</h3><p>Right lung:</p>\n<ul>\n<li>Anterior to the hilum -<strong>&nbsp;superior vena cava </strong>and <strong>right brachiocephalic vein. </strong></li>\n<li>Posterior to this groove-&nbsp;&nbsp;<strong>azygous vein. </strong></li>\n<li>Behind the hilum and pulmonary ligament- <strong>oesophagus</strong>.</li>\n<li>The <strong>cardiac impression</strong>&nbsp;-&nbsp;right auricle,&nbsp;right atrium and&nbsp;right ventricle</li>\n<li>Posteroinferiorly -<strong>&nbsp;inferior vena cava</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/31cd8fd201e643a389790a1188c717cfx600x690.JPEG\" alt=\"Pearl Image\"><p>Left lung:</p>\n<ul>\n<li>The <strong>cardiac impression -&nbsp;</strong>left ventricle and auricle and right ventricle</li>\n<li>Large groove that arches over the hilum and descends behind -&nbsp;&nbsp;<strong>Arch of aorta and descending aorta.</strong></li>\n<li>Arrow groove that ascends to the apex-&nbsp;<strong>left subclavian artery</strong></li>\n<li>Superior to the aortic groove-&nbsp;&nbsp;<strong>thoracic duct and esophagus</strong>.</li>\n<li>Anterior to subclavian groove -&nbsp;<strong>left brachiocephalic vein</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ce67d3683b64459a8f933032f965f622x600x722.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5602",
      "difficulty": "medium"
    },
    {
      "text": "A 20-year-old came to the emergency after a fall on an outstretched hand. He presents with the elbow in slight flexion and the forearm appears shortened. On examination, crepitus is absent and the three-point bony relation is disrupted. Which vessel is most likely to be damaged in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Radial artery"
        },
        {
          "id": 2,
          "text": "Brachial artery"
        },
        {
          "id": 3,
          "text": "Ulnar artery"
        },
        {
          "id": 4,
          "text": "Vascular damage is not seen as lack of crepitus indicates there is no fracture."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>elbow dislocation. </strong><strong>Brachial artery injury</strong> is likely to be associated with it.</p>\n<p><strong>Elbow dislocation</strong> commonly occurs after a fall on an outstretched hand. The elbow is held in <strong>slight flexion</strong>, and on examination, <strong>crepitus is absent</strong>. The <strong>three-point bony relations are disrupted</strong>. </p>\n<h1> </h1><hr><h3>Related Pearl: Three point bony relationship in elbow:</h3><p>The&nbsp;<strong>three bony points in the elbow</strong> are&nbsp;:</p>\n<ul>\n<li>Tip of the&nbsp;medial epicondyle</li>\n<li>Tip of the&nbsp;lateral epicondyle</li>\n<li>Olecranon</li>\n</ul>\n<p>When the <strong>elbow</strong> is in <strong>90 degrees of flexion</strong>, these points form an&nbsp;isosceles <strong>triangle</strong>. When the elbow is <strong>extended</strong>, they lie transversely in a<strong> straight line</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c00eaa4fd8a34f2bbe183c84122fea27x1280x1409.JPEG\" alt=\"Pearl Image\"><p>The three-point bony relationship is <strong>maintained</strong> in the case of <strong>supracondylar fracture of the humerus</strong> as the fracture occurs above the level of these bony landmarks.</p>\n<p>Conditions where it is <strong>distorted</strong>:</p>\n<ul>\n<li>Fracture medial condyle and epicondyle</li>\n<li>Fracture lateral condyle and epicondyle</li>\n<li>Intercondylar fracture of humerus</li>\n<li>Fracture olecranon</li>\n<li>Elbow dislocation</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5653",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions is incorrectly paired?",
      "choices": [
        {
          "id": 1,
          "text": "Fanconi's syndrome - Proximal tubule"
        },
        {
          "id": 2,
          "text": "Gitelman syndrome - Distal convoluted tubules"
        },
        {
          "id": 3,
          "text": "Bartter syndrome - Descending  loop of Henle"
        },
        {
          "id": 4,
          "text": "Liddle syndrome - Epithelial sodium channels"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Bartter syndrome</strong> occurs due to a defect in the <strong>Na<sup>+</sup>/K<sup>+</sup>/Cl<sup>-</sup> </strong>channel in the <strong>thick</strong> <strong>ascending loop of Henle.</strong></p>\n<p>A defect in the Na<sup>+</sup>/K<sup>+</sup>/Cl<sup>-</sup> channel impairs the transport functions of the thick ascending loop of Henle. It results in the following features:</p>\n<ul>\n<li>Polyuria and polydipsia</li>\n<li>Natriuresis with <strong>high</strong> <strong>aldosterone</strong> (due to RAAS activation)</li>\n<li><strong>Hypokalemia</strong></li>\n<li>Metabolic <strong>alkalosis</strong></li>\n<li>Hypomagnesemia </li>\n<li>Hypocalcemia and<strong> hypercalciuria</strong></li>\n</ul>\n<p class=\"p1\">The clinical features of this condition are <strong>similar</strong> <strong>to</strong> the effects of<strong> loop diuretics</strong>. These drugs also act on the Na<sup>+</sup>/K<sup>+</sup>/Cl<sup>-</sup> channel. Hence, response to loop diuretics may be blunted. Treatment is with potassium-sparing diuretics like spironolactone and amiloride.</p>\n<p class=\"p1\">Option A: Defect in the <strong>proximal tubule </strong>results in <strong>Fanconi's </strong>syndrome. These patients have <strong>acidosis</strong>, with glycosuria, generalized aminoaciduria, and phosphaturia.</p>\n<p class=\"p1\">Option B: Defect in the Na<sup>+</sup>/Cl<sup>-</sup> cotransporter in distal convoluted tubule (<strong>DCT</strong>) results in <strong>Gitelman </strong>syndrome. These patients also present with hypokalemic alkalosis and hypomagnesemia<strong>. </strong>However, they also develop, <strong>hypocalciuria</strong>, and chondrocalcinosis.</p>\n<p>Option D:<strong> </strong>Increased activation of the epithelial sodium channels (<strong>ENaC</strong>) channels results in <strong>Liddle</strong> syndrome.<strong> </strong>This causes increased reabsorption of Na<sup>+</sup> exchanged for K<sup>+ </sup>causing hypokalemia. Increased Na absorption leads to <strong>hypertension</strong>.</p><hr><h3>Related Pearl: Renal Tubular Syndromes</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7e5e18bdaa4a442981637c52affb466fx1280x3492.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5675",
      "difficulty": "easy"
    }
  ]
}